data_1qcv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qcv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.484 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -122.84 175.84 6.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.619 -0.676 . . . . 0.0 110.288 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.9 108.09 6.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.596 -0.69 . . . . 0.0 109.658 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -87.73 147.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.842 0.829 . . . . 0.0 111.209 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -102.59 101.21 11.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -47.5 -24.75 0.91 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.532 -0.73 . . . . 0.0 112.431 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.23 -49.85 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 0.0 110.566 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -127.6 -29.99 2.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.37 -0.831 . . . . 0.0 111.597 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.85 4.99 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -72.3 131.82 43.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.384 -1.068 . . . . 0.0 108.831 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.62 123.19 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.464 -0.772 . . . . 0.0 111.466 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 30.9 t80 -91.71 113.25 25.47 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.38 87.11 5.04 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.284 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 3.0 tt0 -53.86 -21.4 7.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.858 -0.526 . . . . 0.0 111.23 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.74 -31.49 72.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.354 -0.841 . . . . 0.0 109.026 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -35.07 5.83 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.294 0.569 . . . . 0.0 109.574 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 109.62 -107.06 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -176.28 90.54 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.431 -1.041 . . . . 0.0 109.949 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.09 -19.3 63.22 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.422 1.222 . . . . 0.0 110.533 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -30.32 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 109.307 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 6.3 48.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.69 . . . . 0.0 110.56 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.26 70.13 1.06 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -126.45 166.72 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.935 . . . . 0.0 111.2 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -65.42 148.08 98.25 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.012 -0.43 . . . . 0.0 110.409 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 119.07 5.91 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.488 1.257 . . . . 0.0 110.015 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.35 71.26 1.24 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -122.5 122.61 39.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.722 -0.869 . . . . 0.0 110.407 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.7 mttt -60.82 114.81 3.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.614 -0.679 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -51.13 -30.02 15.15 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.17 -0.956 . . . . 0.0 110.728 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -77.24 -2.85 36.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.684 -0.635 . . . . 0.0 110.824 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.29 -3.89 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 111.262 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.83 156.54 24.49 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.128 -0.982 . . . . 0.0 109.864 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.34 172.72 9.22 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.287 1.151 . . . . 0.0 110.404 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.88 -16.46 63.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.591 -0.693 . . . . 0.0 110.504 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -16.15 48.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 110.008 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -93.39 129.9 39.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.797 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 110.006 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.495 0.188 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 8.8 m-85 -109.78 -169.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.11 -0.994 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -160.07 121.34 3.12 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.482 -0.761 . . . . 0.0 109.534 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 18.4 mtpt -54.22 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.0 110.878 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.89 -12.5 23.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.697 -0.627 . . . . 0.0 111.188 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.083 -1.011 . . . . 0.0 110.943 -179.619 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.066 0.46 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.58 178.65 6.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.455 ' CZ2' ' CG ' ' A' ' 50' ' ' LYS . 17.1 m95 -140.39 143.86 35.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.92 137.53 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.752 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -92.76 95.7 9.71 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -51.11 -23.29 3.05 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.455 -0.778 . . . . 0.0 111.682 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.4 mt -81.37 -9.8 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.347 -0.845 . . . . 0.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -147.94 -41.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.976 -1.077 . . . . 0.0 111.507 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 -13.19 21.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.82 156.4 1.46 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.117 -1.225 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 43.6 mm -133.53 130.78 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 54.0 t80 -92.33 110.91 22.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.47 83.69 5.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 2.9 tt0 -51.02 -23.89 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.792 -0.568 . . . . 0.0 111.151 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.57 -30.09 71.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.411 -0.805 . . . . 0.0 108.935 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.39 -34.04 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.323 0.582 . . . . 0.0 109.62 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.62 -104.5 2.5 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -173.72 88.81 0.36 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.398 -1.06 . . . . 0.0 110.102 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 -21.1 62.04 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.427 1.225 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.46 -34.95 47.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.236 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -92.13 3.81 54.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.758 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.87 63.79 4.88 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -119.89 165.99 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.95 . . . . 0.0 110.728 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.13 143.31 88.69 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.442 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.85 115.93 4.49 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.333 1.175 . . . . 0.0 109.679 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.46 66.48 1.6 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -120.21 125.13 47.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.857 . . . . 0.0 110.146 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 30.6 mmtt -59.7 122.64 14.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.66 -0.65 . . . . 0.0 109.396 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 36.6 t80 -48.43 -33.15 8.78 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.21 -0.931 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.15 -22.92 62.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -82.44 -26.23 32.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.67 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' CG ' ' A' ' 36' ' ' TRP . 11.9 mt -57.64 141.17 79.74 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.251 -0.905 . . . . 0.0 109.806 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.11 175.59 6.44 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.151 1.079 . . . . 0.0 110.536 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.65 -18.14 58.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 110.405 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.81 -15.51 42.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.382 -0.824 . . . . 0.0 110.131 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CG ' HD12 ' A' ' 32' ' ' LEU . 78.2 t90 -86.23 136.14 33.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 0.0 109.805 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.581 -0.699 . . . . 0.0 109.776 -179.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.913 0.387 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 5.7 m-85 -105.33 -172.55 2.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.48 -0.762 . . . . 0.0 110.673 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.27 140.48 11.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CG ' ' CZ2' ' A' ' 3' ' ' TRP . 29.3 mtpt -57.99 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.194 -0.941 . . . . 0.0 110.452 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.2 tp -111.1 63.61 0.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.61 0.719 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.718 -0.614 . . . . 0.0 110.612 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.117 0.484 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -118.11 174.69 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -140.01 110.82 6.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.0 109.733 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p -81.93 150.68 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 111.112 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.473 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -111.33 118.18 35.15 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -55.46 -21.47 16.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.557 -0.714 . . . . 0.0 111.215 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -135.74 29.74 3.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 111.07 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.38 58.01 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.426 ' CD1' HD11 ' A' ' 5' ' ' LEU . 5.8 t80 -60.99 134.95 57.62 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.229 -1.159 . . . . 0.0 108.722 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.6 mm -117.14 118.48 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.557 -0.714 . . . . 0.0 111.205 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.438 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 27.4 t80 -85.41 112.55 20.96 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -79.56 82.34 5.7 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.086 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tm-20 -57.04 -19.5 19.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.686 -0.634 . . . . 0.0 110.776 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -62.28 -31.04 71.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.2 -0.937 . . . . 0.0 108.751 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.73 -44.07 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 127.65 -108.55 0.96 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.24 94.42 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.339 -1.094 . . . . 0.0 109.174 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -13.62 40.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.386 1.203 . . . . 0.0 110.971 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.95 -33.41 57.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.246 -0.908 . . . . 0.0 109.745 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -106.04 11.46 31.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.736 . . . . 0.0 110.852 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.95 66.99 2.44 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.431 HD11 ' CD1' ' A' ' 36' ' ' TRP . 46.7 mm -103.6 164.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.924 . . . . 0.0 110.686 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.05 172.83 8.85 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.931 -0.481 . . . . 0.0 110.051 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.85 107.11 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.335 1.176 . . . . 0.0 109.41 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.14 -95.71 1.67 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m 55.64 101.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.716 -0.873 . . . . 0.0 110.708 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -63.12 125.86 25.46 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.399 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.7 t80 -50.69 -25.93 4.87 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.49 -6.58 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.552 -0.718 . . . . 0.0 110.752 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.89 -16.52 14.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 ' CD1' ' A' ' 36' ' ' TRP . 11.5 mt -54.87 156.42 6.79 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.12 169.41 21.55 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.258 1.136 . . . . 0.0 110.985 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -71.74 -14.21 61.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.747 -0.596 . . . . 0.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -75.2 -3.12 31.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.411 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.431 ' CD1' HD11 ' A' ' 23' ' ' ILE . 74.8 t90 -80.32 120.78 24.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.141 -0.974 . . . . 0.0 110.024 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.738 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.648 0.261 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 13.7 m-85 -121.54 -172.45 2.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.865 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -160.2 122.75 3.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 2.8 mtpt -58.48 173.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.34 -28.31 21.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.673 -0.642 . . . . 0.0 110.268 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.58 -0.7 . . . . 0.0 110.565 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.87 -166.76 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 110.314 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.435 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 9.3 m95 -138.07 122.5 18.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 9.9 p -118.47 146.48 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.269 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 48' ' ' PHE . 1.5 tt -108.03 118.38 36.61 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.76 -39.81 68.71 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.326 -0.859 . . . . 0.0 111.414 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.56 -49.15 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.532 -0.73 . . . . 0.0 111.345 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.407 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 27.1 p -102.1 -57.77 2.0 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.13 -0.981 . . . . 0.0 110.79 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.5 23.64 4.02 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 29.3 m-85 -55.76 164.34 1.15 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.049 -1.265 . . . . 0.0 109.588 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.6 mm -146.5 83.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 63.8 t80 -79.8 109.94 14.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.984 -1.073 . . . . 0.0 108.659 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.45 85.81 5.2 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.1 tt0 -52.8 -22.6 5.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.778 -0.576 . . . . 0.0 111.089 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -29.39 70.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.376 -0.827 . . . . 0.0 109.086 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.69 -37.53 4.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.751 -0.593 . . . . 0.0 109.531 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 108.43 -105.26 2.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.59 90.13 0.22 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.377 -1.072 . . . . 0.0 109.795 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.6 -18.8 48.61 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.353 1.186 . . . . 0.0 110.638 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.14 -32.94 38.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.0 110.021 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -95.58 13.98 24.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.716 . . . . 0.0 110.735 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.5 66.37 2.89 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -122.51 166.89 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.692 -0.887 . . . . 0.0 111.157 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.06 148.97 89.44 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.826 -0.546 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 120.4 6.51 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.386 1.203 . . . . 0.0 109.985 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.82 70.12 1.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.0 m -124.25 121.35 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.713 -0.875 . . . . 0.0 110.247 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.68 120.22 7.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.804 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.419 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 33.5 t80 -48.7 -38.27 20.95 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.221 -0.924 . . . . 0.0 110.936 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.93 -20.06 63.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -91.01 -16.42 27.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 110.955 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.418 HD13 ' CG ' ' A' ' 36' ' ' TRP . 7.0 mt -56.03 159.34 5.83 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.073 -1.017 . . . . 0.0 110.144 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.91 -178.29 2.84 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.359 1.189 . . . . 0.0 110.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -67.55 -16.25 64.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.663 -0.648 . . . . 0.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.03 -16.72 46.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.824 . . . . 0.0 110.105 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.418 ' CG ' HD13 ' A' ' 32' ' ' LEU . 1.1 t90 -106.93 114.1 27.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.424 -0.798 . . . . 0.0 109.256 179.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 120.983 0.42 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.5 m-85 -79.81 -173.03 3.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 110.325 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -149.34 110.01 4.26 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.671 -0.643 . . . . 0.0 109.38 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -57.76 168.3 0.93 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.584 -0.697 . . . . 0.0 110.509 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.9 48.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.209 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.596 -0.69 . . . . 0.0 110.153 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.23 149.02 23.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 110.774 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.423 ' CZ2' ' HG2' ' A' ' 50' ' ' LYS . 19.9 m95 -114.84 173.04 6.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.557 -0.714 . . . . 0.0 110.061 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.35 142.05 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 110.29 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.461 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -109.89 117.56 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -52.66 -23.58 6.87 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.597 -0.689 . . . . 0.0 111.46 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.39 -57.39 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.377 -0.827 . . . . 0.0 110.586 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -146.81 36.59 0.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.225 -0.922 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.45 20.06 49.83 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 5' ' ' LEU . 3.2 t80 -58.41 164.88 2.31 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.138 -1.213 . . . . 0.0 108.643 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 12' ' ' TYR . 37.5 mt -141.52 165.79 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.282 1.039 . . . . 0.0 112.241 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.429 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 t80 -126.16 109.91 12.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -79.29 81.21 5.58 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.6 tt0 -48.94 -25.03 1.72 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.559 -0.713 . . . . 0.0 111.337 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.19 -30.02 71.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 0.0 108.905 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 -32.55 6.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.826 -0.546 . . . . 0.0 109.581 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.14 -103.26 2.7 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -174.48 88.7 0.33 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.41 -1.053 . . . . 0.0 110.059 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.64 -19.03 60.02 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.455 1.24 . . . . 0.0 110.533 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -34.7 39.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.77 11.2 23.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.677 -0.64 . . . . 0.0 110.765 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.02 55.5 27.77 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.35 165.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.751 -0.852 . . . . 0.0 111.246 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 t -65.1 143.05 98.78 Favored Pre-proline 0 N--CA 1.494 1.775 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.95 123.09 8.16 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.275 1.145 . . . . 0.0 110.007 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.24 67.65 1.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 m -122.76 123.76 41.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.789 -0.83 . . . . 0.0 110.315 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.82 120.65 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.662 -0.648 . . . . 0.0 109.387 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.429 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 69.6 t80 -46.66 -49.39 19.29 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.322 -0.862 . . . . 0.0 111.258 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -59.59 -20.06 53.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.0 110.492 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.27 -29.34 34.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.31 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 36' ' ' TRP . 11.5 mt -58.15 150.46 51.81 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.497 -0.752 . . . . 0.0 109.846 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.31 176.22 8.93 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.273 1.144 . . . . 0.0 110.724 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.11 -14.86 62.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.55 -0.719 . . . . 0.0 110.658 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.95 -9.13 50.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.476 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CD1' HD13 ' A' ' 32' ' ' LEU . 30.3 t90 -91.81 140.43 29.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 8.3 m-85 -84.41 178.74 7.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 110.877 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.25 147.82 16.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -72.25 157.19 38.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 35.35 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.585 -0.697 . . . . 0.0 109.921 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.228 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.191 0.519 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -121.94 175.2 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m95 -139.41 104.88 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.676 -0.64 . . . . 0.0 109.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.84 150.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.8 116.13 31.74 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -54.27 -21.03 8.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.521 -0.737 . . . . 0.0 111.373 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.9 mt -58.54 -68.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -123.29 -15.82 7.08 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.473 -0.767 . . . . 0.0 111.647 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 14.77 8.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.58 130.92 48.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.154 -1.204 . . . . 0.0 108.987 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm -111.34 114.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.706 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 23.1 t80 -82.58 113.34 20.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.41 87.44 5.05 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.813 0.816 . . . . 0.0 109.398 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -55.49 -21.21 15.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.632 -0.668 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.55 -32.12 73.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 108.694 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.91 -46.65 3.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 116.31 -106.47 1.51 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 176.17 94.14 0.1 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.391 -1.064 . . . . 0.0 109.282 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.57 -12.79 36.67 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.416 1.219 . . . . 0.0 111.085 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.7 -40.41 55.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.178 -0.951 . . . . 0.0 109.834 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.88 17.38 10.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.02 41.81 92.65 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.3 mm -84.83 165.59 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.787 -0.831 . . . . 0.0 110.848 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.3 154.22 74.38 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.84 107.35 2.19 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.307 1.161 . . . . 0.0 109.8 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.46 65.05 1.47 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -116.17 126.78 54.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.861 -0.787 . . . . 0.0 109.643 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 14.4 mtpt -63.56 118.44 8.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.731 -0.606 . . . . 0.0 110.048 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 30.4 t80 -51.34 -35.29 37.63 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.188 -0.945 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.06 -8.81 57.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.643 -0.661 . . . . 0.0 110.492 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -113.17 -4.42 13.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.201 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -52.99 171.4 0.23 Allowed Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 120.906 -1.121 . . . . 0.0 109.444 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -89.26 -175.04 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 122.967 0.983 . . . . 0.0 110.824 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.29 171.43 15.07 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.649 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.9 -0.12 2.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.591 -0.693 . . . . 0.0 112.113 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CD1' HD11 ' A' ' 23' ' ' ILE . 64.9 t90 -73.88 119.2 17.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.796 -1.19 . . . . 0.0 109.119 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 109.827 -179.743 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.5 m-85 -79.52 -172.49 3.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.541 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -160.23 125.59 3.97 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.753 -0.592 . . . . 0.0 109.651 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.418 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 21.2 mtmt -63.12 168.23 4.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.103 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.88 29.52 6.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 110.429 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.02 0.438 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.65 159.29 20.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.568 -0.707 . . . . 0.0 110.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.538 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.6 m95 -132.54 112.11 11.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.03 150.98 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.467 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.459 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -114.57 120.93 41.89 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -52.21 -22.14 4.06 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.483 -0.761 . . . . 0.0 111.715 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.15 -74.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -133.06 20.0 4.09 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.36 23.1 55.34 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.3 152.12 21.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.292 -1.122 . . . . 0.0 108.783 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.2 mm -135.4 137.9 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.326 -0.859 . . . . 0.0 111.654 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 49.8 t80 -105.11 112.71 25.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -79.26 81.96 5.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.341 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -50.19 -24.78 3.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.615 -0.678 . . . . 0.0 110.869 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.41 -31.92 73.21 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.2 -52.33 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.13 -107.42 1.04 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -175.61 88.72 0.29 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -14.39 44.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.475 1.25 . . . . 0.0 110.688 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.06 -37.15 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.309 -0.869 . . . . 0.0 109.793 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.33 12.98 27.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 110.701 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.68 66.6 2.7 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mm -119.39 166.06 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.964 . . . . 0.0 111.132 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.06 147.52 98.47 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.992 -0.442 . . . . 0.0 110.673 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.97 111.4 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.391 1.206 . . . . 0.0 109.834 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 66.31 1.47 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -117.81 127.85 54.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.826 -0.808 . . . . 0.0 110.006 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 18.8 mmtm -63.33 118.53 8.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.538 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 57.9 t80 -49.18 -34.85 15.46 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.287 -0.883 . . . . 0.0 111.092 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.79 -18.08 62.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -93.17 -17.76 23.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.161 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 36' ' ' TRP . 8.0 mt -58.64 155.53 29.08 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.15 -0.969 . . . . 0.0 110.137 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.06 165.31 26.27 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.31 1.163 . . . . 0.0 110.245 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.16 -12.35 60.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.682 . . . . 0.0 110.845 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.21 -1.88 28.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.748 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.413 ' CD1' HD13 ' A' ' 32' ' ' LEU . 62.8 t90 -86.12 127.4 34.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 0.0 109.883 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 0.0 109.724 179.774 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.641 0.257 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 14.2 m-85 -125.11 -173.93 2.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.307 -0.871 . . . . 0.0 110.994 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -160.41 131.4 5.62 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 23.5 mtmt -76.11 151.92 36.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 47.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.631 -0.668 . . . . 0.0 110.157 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.743 . . . . 0.0 110.709 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -111.21 173.7 6.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 0.0 110.063 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -139.72 111.34 7.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.494 -0.754 . . . . 0.0 109.623 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.61 145.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.873 0.844 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -96.42 98.98 10.68 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -52.27 -24.33 7.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.384 -0.823 . . . . 0.0 111.153 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 7' ' ' ILE . 50.4 mm -75.93 -13.87 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.7 p -149.72 -54.14 0.16 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.094 -1.004 . . . . 0.0 111.061 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 132.59 -9.18 5.27 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -50.62 150.57 2.7 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.267 . . . . 0.0 110.075 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.1 mm -130.08 123.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.502 -0.749 . . . . 0.0 110.939 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 32.2 t80 -88.81 111.54 22.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -79.81 84.99 5.52 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.292 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -55.25 -20.18 10.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.582 -0.699 . . . . 0.0 110.839 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -61.78 -30.41 70.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.146 -0.971 . . . . 0.0 108.819 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.36 -41.78 3.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.0 109.067 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.17 -108.05 1.17 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.25 95.12 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.325 -1.103 . . . . 0.0 109.045 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.46 -12.57 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.301 1.158 . . . . 0.0 111.247 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.94 -33.82 72.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.221 -0.924 . . . . 0.0 109.899 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.53 16.09 20.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.56 -0.713 . . . . 0.0 110.802 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.29 62.97 5.75 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 36' ' ' TRP . 42.4 mm -94.13 163.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.968 . . . . 0.0 110.598 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.01 172.9 8.66 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.863 -0.523 . . . . 0.0 110.007 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.84 108.42 2.28 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.272 1.143 . . . . 0.0 109.457 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.89 -94.87 1.74 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.9 m 55.11 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.947 . . . . 0.0 110.636 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 16.1 mttm -60.05 123.8 18.25 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.101 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -49.75 -26.29 3.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.152 -0.967 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 -12.67 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.622 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -101.88 -16.86 16.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 111.038 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.86 151.96 11.0 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.108 -0.995 . . . . 0.0 109.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.21 156.06 42.04 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.237 1.125 . . . . 0.0 110.858 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.25 -18.14 56.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.622 -0.673 . . . . 0.0 110.589 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.25 1.02 22.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.433 ' CD1' HD13 ' A' ' 23' ' ' ILE . 68.6 t90 -61.79 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.087 -1.008 . . . . 0.0 109.72 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.539 -0.725 . . . . 0.0 110.912 179.624 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.518 0.199 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.465 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 11.3 m-85 -116.66 -170.29 1.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.0 110.456 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -160.12 123.53 3.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 109.447 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mtmt -58.42 167.19 1.47 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.277 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -81.15 -27.53 35.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.357 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.49 -0.756 . . . . 0.0 110.756 -179.75 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.18 0.514 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -82.33 156.33 24.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.456 ' CZ2' ' CD ' ' A' ' 50' ' ' LYS . 28.5 m95 -130.41 167.93 17.79 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.7 139.71 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.82 -1.175 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -102.04 121.0 41.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -56.11 -20.37 17.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.458 -0.776 . . . . 0.0 111.11 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.22 -63.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.86 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -144.88 44.24 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.212 -0.93 . . . . 0.0 111.976 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.39 20.25 43.91 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.947 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD2' ' CZ ' ' A' ' 48' ' ' PHE . 31.6 t80 -64.16 132.21 49.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -1.137 . . . . 0.0 108.195 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 12' ' ' TYR . 37.2 mt -119.52 166.66 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.355 1.074 . . . . 0.0 112.233 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 16.2 t80 -127.19 109.2 11.59 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -78.86 73.94 5.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 12' ' ' TYR . 1.2 tt0 -50.4 -25.73 4.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.741 -0.6 . . . . 0.0 110.812 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.24 -25.37 64.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.7 -54.31 2.5 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 110.247 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.6 68.12 0.54 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t0 21.61 82.09 0.13 Allowed Pre-proline 0 N--CA 1.51 2.53 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.43 -21.32 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.664 1.35 . . . . 0.0 109.955 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -80.29 -45.16 18.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.447 -0.783 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.91 -35.14 17.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.47 -0.769 . . . . 0.0 110.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.06 52.04 0.85 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 36' ' ' TRP . 18.8 mm -89.68 155.69 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.491 -1.005 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -47.62 145.36 4.34 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.602 . . . . 0.0 111.444 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.17 105.46 1.2 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.5 1.263 . . . . 0.0 110.329 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.52 83.59 0.31 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -140.09 117.14 11.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.677 -0.896 . . . . 0.0 110.024 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -51.76 126.68 18.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 110.098 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -42.26 -29.27 0.24 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.449 -0.782 . . . . 0.0 112.165 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.304 -0.873 . . . . 0.0 110.93 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -87.0 -31.69 20.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.683 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.424 HD22 ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -47.2 149.78 1.67 Allowed Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.464 -0.772 . . . . 0.0 111.702 -179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -85.28 -178.29 3.04 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.57 1.3 . . . . 0.0 110.482 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.42 -14.67 59.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.637 -0.664 . . . . 0.0 110.7 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.63 -12.73 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.256 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CG ' HD22 ' A' ' 32' ' ' LEU . 55.8 t90 -96.25 95.79 8.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.09 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 109.905 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -79.39 -179.49 6.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.858 0.837 . . . . 0.0 111.326 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.11 144.72 14.68 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CD ' ' CZ2' ' A' ' 3' ' ' TRP . 1.1 mtmt -61.89 170.66 1.98 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 tp -106.5 61.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.692 0.758 . . . . 0.0 109.728 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.849 -0.532 . . . . 0.0 110.716 -179.552 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.005 0.431 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -118.97 166.7 12.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.715 . . . . 0.0 110.37 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.501 ' CZ3' ' CD1' ' A' ' 29' ' ' PHE . 12.8 m95 -130.0 106.44 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.737 -0.602 . . . . 0.0 109.4 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.7 147.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.649 0.738 . . . . 0.0 111.146 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -100.89 101.17 11.93 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -54.73 -21.57 11.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 111.455 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.46 -9.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.339 -0.851 . . . . 0.0 111.232 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.1 p -148.2 -47.23 0.16 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.955 -1.09 . . . . 0.0 111.225 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.27 -13.89 9.5 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -52.5 140.56 22.34 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.17 -1.194 . . . . 0.0 109.655 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.08 121.4 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.48 -0.763 . . . . 0.0 111.343 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 38.3 t80 -85.92 111.23 20.04 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -79.51 81.63 5.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.71 0.767 . . . . 0.0 109.427 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -54.08 -21.32 8.2 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.755 -0.591 . . . . 0.0 110.933 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -29.14 70.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.933 . . . . 0.0 108.754 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.34 -43.5 2.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.97 -108.21 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.44 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.33 -14.35 42.5 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.353 1.186 . . . . 0.0 110.694 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.91 -39.11 31.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -92.24 17.76 9.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.563 -0.711 . . . . 0.0 110.448 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.08 65.07 3.81 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.5 mm -114.27 165.4 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.733 -0.863 . . . . 0.0 111.958 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 148.93 72.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.675 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 105.25 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.237 1.125 . . . . 0.0 110.709 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.67 61.73 1.35 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 m -115.99 134.05 55.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.934 -0.745 . . . . 0.0 109.833 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -76.87 124.84 28.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.661 -0.65 . . . . 0.0 110.307 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CD1' ' CZ3' ' A' ' 3' ' ' TRP . 6.3 t80 -45.55 -43.61 12.1 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.166 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.42 -25.49 10.1 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -103.56 -87.42 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 36' ' ' TRP . 6.7 mt 52.15 179.52 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.295 0 O-C-N 120.99 -1.069 . . . . 0.0 110.042 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -83.63 -164.05 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 109.804 -0.883 . . . . 0.0 109.804 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -93.44 160.41 14.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 110.475 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 58.33 17.24 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.486 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 76.4 t90 -65.21 112.9 3.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.181 -0.949 . . . . 0.0 109.35 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.499 1.979 0 O-C-N 121.399 -0.813 . . . . 0.0 110.062 -179.427 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.235 0.54 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 6.2 m-85 -120.28 -167.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.729 -0.607 . . . . 0.0 110.567 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -160.13 112.26 2.02 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.675 -0.641 . . . . 0.0 109.758 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 12.2 mtpt -55.88 177.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.442 -0.787 . . . . 0.0 110.67 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.65 18.1 5.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.584 -0.698 . . . . 0.0 111.181 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.175 -0.953 . . . . 0.0 110.768 -179.678 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.064 0.459 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -114.98 179.12 4.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 110.158 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.54 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -139.87 104.23 4.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 109.749 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.65 158.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.96 0.886 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.462 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -119.44 113.48 20.84 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.501 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -53.26 -22.62 7.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.432 -0.793 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.81 -52.7 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.674 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -149.47 33.42 0.71 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.251 -0.905 . . . . 0.0 111.403 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 15.94 58.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.421 ' CD1' HD11 ' A' ' 5' ' ' LEU . 4.2 t80 -60.54 146.18 45.95 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.079 -1.248 . . . . 0.0 108.875 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 11' ' ' ILE . 42.7 mt -131.3 166.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 122.221 1.01 . . . . 0.0 111.624 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t80 -134.17 110.71 9.75 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.18 87.19 4.92 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.95 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.2 tt0 -53.55 -21.4 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.857 -0.527 . . . . 0.0 111.104 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.09 -31.18 71.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.229 -0.919 . . . . 0.0 108.844 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.26 -49.61 3.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.285 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.21 -107.84 1.08 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 95.35 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.497 -1.002 . . . . 0.0 109.076 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.19 -11.66 32.2 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.376 1.198 . . . . 0.0 111.416 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.79 -39.2 70.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.76 23.62 9.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 110.264 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.69 48.24 66.95 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 36' ' ' TRP . 47.0 mm -87.83 160.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.86 -0.788 . . . . 0.0 111.337 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 154.9 74.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.965 -0.459 . . . . 0.0 109.906 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.51 106.44 1.95 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.359 1.189 . . . . 0.0 110.0 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 69.33 1.38 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -119.17 124.61 47.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.7 -0.883 . . . . 0.0 110.289 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.3 mptt -62.14 113.52 2.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.818 -0.551 . . . . 0.0 109.856 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 26.2 t80 -49.22 -32.75 11.1 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.379 -0.826 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.18 -21.24 46.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.376 -0.827 . . . . 0.0 109.62 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -109.55 -81.82 0.57 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.412 ' CD2' ' HD3' ' A' ' 33' ' ' PRO . 6.1 mt 52.47 -179.63 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.085 -1.01 . . . . 0.0 109.605 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 49.3 Cg_endo -82.47 157.2 16.68 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.92 158.71 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.327 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t0 59.02 15.99 4.38 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.586 -0.696 . . . . 0.0 111.707 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.47 ' CD1' HD12 ' A' ' 23' ' ' ILE . 61.4 t90 -60.58 126.08 26.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.972 -1.08 . . . . 0.0 109.421 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.766 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.739 0.304 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.497 ' CD2' ' CZ ' ' A' ' 29' ' ' PHE . 10.1 m-85 -116.85 164.78 14.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.122 -0.986 . . . . 0.0 110.532 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -128.12 117.93 22.49 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 33.1 mtpt -57.07 -173.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.548 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 32.74 5.84 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.425 0.631 . . . . 0.0 109.748 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.748 -0.595 . . . . 0.0 110.637 -179.747 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.188 0.518 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 158.48 21.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.72 . . . . 0.0 110.687 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 17.1 m95 -131.83 112.84 12.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.62 158.65 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.467 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -116.8 101.11 8.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -24.87 2.02 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.409 -0.807 . . . . 0.0 111.809 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.45 -23.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.488 -0.758 . . . . 0.0 110.851 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.3 p -150.71 -41.84 0.12 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.136 -0.977 . . . . 0.0 111.702 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.67 -0.93 11.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.02 160.52 0.47 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.049 -1.265 . . . . 0.0 109.913 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.5 mm -134.88 125.65 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.386 -0.821 . . . . 0.0 111.248 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 48.0 t80 -93.85 111.22 22.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.37 87.1 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -52.55 -22.63 5.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.819 -0.55 . . . . 0.0 111.197 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.07 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.416 -0.803 . . . . 0.0 108.966 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.65 -30.45 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.68 -0.638 . . . . 0.0 109.857 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.56 -104.74 2.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.67 89.31 0.29 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.429 -1.042 . . . . 0.0 109.843 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.27 -22.84 52.74 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.41 1.216 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.28 -30.55 60.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.563 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.07 8.8 43.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.695 . . . . 0.0 110.625 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.19 63.84 4.95 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.06 166.71 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 110.91 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.68 145.71 98.62 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.814 -0.554 . . . . 0.0 110.333 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.53 119.55 5.8 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.351 1.185 . . . . 0.0 109.804 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.72 64.99 1.82 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -118.39 126.04 51.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.696 -0.885 . . . . 0.0 109.939 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -61.17 122.24 14.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.626 -0.671 . . . . 0.0 109.761 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 69.3 t80 -49.25 -26.95 3.31 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.265 -0.897 . . . . 0.0 110.993 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -19.67 53.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.44 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -87.77 -24.24 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 mt -56.79 142.76 71.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.254 -0.904 . . . . 0.0 109.798 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.67 -175.68 2.57 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.308 1.162 . . . . 0.0 110.992 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.37 -18.9 62.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.71 -0.619 . . . . 0.0 110.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.02 -14.28 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.453 -0.779 . . . . 0.0 110.07 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -89.74 127.52 35.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 109.315 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.956 0.408 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 9.9 m-85 -119.03 171.32 8.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 110.014 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 92.92 2.99 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.579 -0.701 . . . . 0.0 109.676 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -60.62 164.59 4.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.59 -0.694 . . . . 0.0 110.28 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.16 59.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.692 -0.63 . . . . 0.0 110.34 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 N--CA 1.501 2.089 0 O-C-N 121.697 -0.627 . . . . 0.0 111.323 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -100.58 -170.28 1.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.689 . . . . 0.0 110.112 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 8.0 m95 -140.27 119.36 12.76 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 14.0 p -117.95 146.28 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.33 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 tt -107.56 115.86 30.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.013 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -53.11 -40.3 64.06 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.241 -0.912 . . . . 0.0 111.397 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.61 -58.7 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -0.75 . . . . 0.0 110.598 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.409 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 33.1 p -93.18 -59.44 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.33 -0.856 . . . . 0.0 110.828 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.01 23.07 3.37 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 28.2 m-85 -54.91 165.91 0.58 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.989 -1.3 . . . . 0.0 109.692 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 36.3 mm -148.89 82.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.548 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 66.4 t80 -79.81 108.33 13.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -79.39 84.84 5.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 4.3 tt0 -49.0 -24.79 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.578 -0.701 . . . . 0.0 111.337 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -64.55 -29.9 70.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.411 -0.806 . . . . 0.0 109.036 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.58 -32.43 6.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.812 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.23 -104.46 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -175.45 88.77 0.3 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.396 -1.061 . . . . 0.0 110.088 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.85 -19.8 46.3 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.356 1.187 . . . . 0.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.15 -31.02 38.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.1 13.4 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.532 -0.73 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.25 67.08 2.39 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.4 167.36 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.693 -0.886 . . . . 0.0 111.113 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.36 145.51 95.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.913 -0.492 . . . . 0.0 110.309 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.24 120.21 6.17 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.324 1.171 . . . . 0.0 110.184 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 67.3 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 m -122.89 126.33 47.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.68 -0.894 . . . . 0.0 110.088 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.4 mttt -59.08 120.89 9.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.404 -0.81 . . . . 0.0 109.852 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 53.6 t80 -49.05 -44.01 41.28 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.328 -0.858 . . . . 0.0 110.799 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.9 -18.07 64.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.601 -0.687 . . . . 0.0 110.421 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.53 -8.29 29.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.391 -0.818 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.416 HD12 ' CE1' ' A' ' 12' ' ' TYR . 5.8 mt -57.47 155.54 19.36 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.052 -1.03 . . . . 0.0 109.89 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.54 -174.41 1.79 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 O-C-N 123.275 1.145 . . . . 0.0 110.852 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.11 -17.25 63.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.677 -0.64 . . . . 0.0 110.449 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.63 -16.06 45.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 109.999 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.405 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -109.16 117.46 34.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 109.862 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 109.028 179.766 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.037 0.446 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 3.1 m-85 -79.82 -170.29 2.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -160.19 124.34 3.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 22.1 mtpt -52.28 177.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.281 -0.887 . . . . 0.0 111.294 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.46 -25.84 20.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 110.508 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.304 -0.873 . . . . 0.0 110.902 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.11 0.481 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -116.0 176.99 4.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.341 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 15.5 m95 -135.66 105.36 6.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . 7.9 p -87.16 147.27 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.758 0.789 . . . . 0.0 110.942 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -105.32 116.27 31.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -54.61 -21.06 9.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.502 -0.749 . . . . 0.0 111.502 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.84 -61.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.324 -0.86 . . . . 0.0 110.571 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -131.07 0.23 4.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 111.753 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.94 35.61 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -63.17 129.1 38.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.311 -1.111 . . . . 0.0 108.895 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 35.8 mm -113.68 142.84 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.489 -0.757 . . . . 0.0 111.263 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.4 t80 -116.08 112.99 22.55 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -79.59 83.97 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.413 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.79 -17.39 22.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.662 -0.649 . . . . 0.0 110.698 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -63.01 -30.36 71.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.088 -1.007 . . . . 0.0 108.7 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -46.68 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.26 -107.03 0.82 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.28 94.5 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.374 -1.074 . . . . 0.0 109.115 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.6 -12.44 35.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.408 1.215 . . . . 0.0 111.292 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.07 -42.34 57.01 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -96.51 14.18 25.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 110.682 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.04 67.63 2.11 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.438 HD12 ' CD1' ' A' ' 36' ' ' TRP . 43.7 mm -103.98 166.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.908 . . . . 0.0 111.354 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.05 167.66 33.9 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 122.001 -0.437 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.94 110.51 2.61 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.391 1.206 . . . . 0.0 109.364 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.07 -91.07 1.18 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m 54.75 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.918 . . . . 0.0 110.618 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 125.95 25.63 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.115 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 25.6 t80 -50.57 -28.28 8.35 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -79.57 -0.91 35.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.625 -0.672 . . . . 0.0 110.64 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -122.59 -6.08 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 111.211 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.427 HD11 ' CD2' ' A' ' 36' ' ' TRP . 6.4 mt -52.45 162.87 0.83 Allowed Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 120.979 -1.076 . . . . 0.0 109.412 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -93.7 -165.54 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 120.874 1.05 . . . . 0.0 110.986 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.75 176.47 6.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.694 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t70 68.33 2.41 3.28 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.44 -0.788 . . . . 0.0 111.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' HD12 ' A' ' 23' ' ' ILE . 6.6 t90 -106.23 119.63 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.818 -1.176 . . . . 0.0 109.764 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 0.0 110.218 179.621 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -97.44 -170.82 2.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.981 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -160.21 118.08 2.59 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.769 -0.582 . . . . 0.0 109.733 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.464 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 28.2 mtmt -62.97 166.32 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 110.428 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.65 48.66 1.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.11 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 110.698 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.088 0.471 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -96.74 169.15 10.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.213 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.1 m95 -133.09 110.41 10.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.55 -0.719 . . . . 0.0 109.516 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . 8.5 p -89.03 147.59 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.045 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.32 97.73 7.76 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -50.84 -24.28 3.41 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.44 -0.788 . . . . 0.0 111.66 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.0 mt -75.8 -13.08 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.409 -0.807 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 76.1 p -148.97 -47.72 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.172 -0.955 . . . . 0.0 111.265 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.92 -10.37 7.91 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -50.58 146.65 5.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.118 -1.224 . . . . 0.0 110.114 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 36.2 mm -128.99 111.65 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.549 -0.719 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 51.8 t80 -79.96 110.46 15.36 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.56 87.39 5.14 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.8 tt0 -53.72 -21.32 6.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.798 -0.563 . . . . 0.0 111.174 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -29.75 70.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.255 -0.903 . . . . 0.0 108.898 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.92 -41.71 3.32 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 119.28 -106.39 1.25 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.6 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.43 -1.041 . . . . 0.0 109.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.15 -13.65 40.91 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.349 1.184 . . . . 0.0 110.979 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.28 -33.3 59.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 109.809 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.99 18.59 21.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.514 -0.741 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 55.9 27.38 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 36' ' ' TRP . 46.0 mm -98.62 163.92 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.612 -0.934 . . . . 0.0 110.846 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.09 156.5 74.31 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 122.011 -0.431 . . . . 0.0 109.971 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.88 99.46 0.87 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.302 1.159 . . . . 0.0 110.145 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 69.95 1.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 m -120.24 125.99 49.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.751 -0.852 . . . . 0.0 109.954 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mptt -61.23 119.46 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.591 -0.693 . . . . 0.0 109.883 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.516 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 44.5 t80 -50.96 -39.71 55.77 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.38 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.64 -13.41 62.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.661 -0.65 . . . . 0.0 110.31 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -112.56 2.78 16.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 111.252 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' CD2' ' HD3' ' A' ' 33' ' ' PRO . 7.0 mt -54.26 173.96 0.2 Allowed Pre-proline 0 N--CA 1.506 2.334 0 O-C-N 120.888 -1.133 . . . . 0.0 109.351 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 50.0 Cg_endo -88.46 -174.57 1.11 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 122.944 0.97 . . . . 0.0 110.899 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.33 170.18 16.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 109.853 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 69.0 0.94 2.97 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.541 -0.725 . . . . 0.0 112.146 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CD1' HD13 ' A' ' 23' ' ' ILE . 55.1 t90 -71.41 129.54 39.07 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.791 -1.193 . . . . 0.0 109.453 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 109.557 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.901 0.381 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.8 m-85 -119.69 -170.74 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.392 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -160.27 118.91 2.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.671 -0.643 . . . . 0.0 109.878 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 17.5 mtmm -62.18 163.45 8.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 0.0 109.926 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.98 -30.9 39.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.583 -0.698 . . . . 0.0 110.106 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.845 -179.788 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.09 0.471 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -114.99 175.34 5.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.3 m95 -136.58 106.66 6.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.504 -0.748 . . . . 0.0 109.207 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -86.23 151.07 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.683 0.754 . . . . 0.0 111.431 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.445 ' HG ' ' CE1' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -110.8 117.96 34.85 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -54.18 -21.62 9.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.364 -0.835 . . . . 0.0 111.475 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.21 -59.39 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.851 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -137.62 34.22 2.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.195 -0.94 . . . . 0.0 111.51 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.67 20.57 39.78 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.418 ' CD2' HD13 ' A' ' 5' ' ' LEU . 26.9 t80 -60.95 129.25 40.47 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.107 . . . . 0.0 109.035 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.76 164.51 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.838 0.828 . . . . 0.0 111.33 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.417 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 33.3 t80 -135.7 112.52 10.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.5 79.2 5.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.893 0.854 . . . . 0.0 109.166 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.28 -21.45 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.708 -0.62 . . . . 0.0 111.005 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.58 -30.69 71.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.323 -0.86 . . . . 0.0 108.87 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.87 -45.66 3.18 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.83 -107.79 1.04 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.25 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.422 -1.046 . . . . 0.0 109.456 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.383 1.202 . . . . 0.0 111.106 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -75.06 -45.7 39.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.936 . . . . 0.0 110.054 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.35 17.48 9.77 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.688 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.1 60.18 9.37 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.4 mm -101.44 166.57 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.771 -0.841 . . . . 0.0 111.098 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.91 153.35 75.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.878 -0.514 . . . . 0.0 109.777 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.46 112.5 3.36 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.251 1.132 . . . . 0.0 110.236 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.52 66.24 1.81 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.8 m -114.44 118.36 33.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.777 -0.837 . . . . 0.0 110.042 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -59.22 123.68 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -48.2 -28.62 3.1 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.301 -0.874 . . . . 0.0 111.142 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.19 -20.11 52.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.547 -0.721 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.51 -15.18 27.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.355 -0.841 . . . . 0.0 111.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -53.72 162.48 1.33 Allowed Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.031 -1.043 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -93.69 -165.72 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 120.91 1.073 . . . . 0.0 110.932 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -80.11 176.39 9.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.354 0.597 . . . . 0.0 109.981 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 67.78 3.36 3.44 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.898 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CD1' HD11 ' A' ' 23' ' ' ILE . 23.2 t90 -96.92 125.62 41.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.84 -1.162 . . . . 0.0 109.384 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.119 0.485 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 7.6 m-85 -117.92 -169.03 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.563 -0.711 . . . . 0.0 110.515 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -159.33 123.11 3.79 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.706 -0.621 . . . . 0.0 109.427 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 20.9 mtpt -57.69 178.11 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.469 -0.769 . . . . 0.0 110.552 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -95.28 -26.06 16.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.697 -0.627 . . . . 0.0 110.321 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.467 -0.77 . . . . 0.0 111.033 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -120.54 176.23 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.372 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.518 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.3 m95 -141.4 110.0 6.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.698 . . . . 0.0 109.435 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.3 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.844 0.831 . . . . 0.0 111.511 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -111.42 117.41 33.0 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -58.04 -19.84 34.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.542 -0.724 . . . . 0.0 111.155 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.41 -48.71 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.854 . . . . 0.0 110.754 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -150.61 30.63 0.66 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.27 -0.893 . . . . 0.0 111.468 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.34 15.15 60.8 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.677 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.87 138.48 57.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.088 -1.242 . . . . 0.0 108.824 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.4 mm -121.41 114.18 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 42.8 t80 -81.09 111.37 17.48 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -79.43 85.83 5.19 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.155 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 5.9 tt0 -51.43 -23.36 3.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.786 -0.571 . . . . 0.0 111.283 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.37 -29.95 71.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.317 -0.864 . . . . 0.0 108.947 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -28.62 7.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.709 -0.619 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.06 -102.52 2.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -173.92 88.32 0.36 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.448 -1.031 . . . . 0.0 109.974 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.86 -19.01 58.79 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.421 1.222 . . . . 0.0 110.444 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -76.75 -29.96 56.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.782 . . . . 0.0 109.579 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.55 12.19 37.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.62 -0.675 . . . . 0.0 110.603 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.28 68.29 1.74 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.31 167.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.89 . . . . 0.0 111.138 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 143.08 92.39 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.925 -0.484 . . . . 0.0 110.504 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 114.53 3.97 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.263 1.138 . . . . 0.0 109.938 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.01 66.55 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.2 m -119.09 125.41 49.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.825 -0.809 . . . . 0.0 110.002 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -60.8 119.21 7.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.605 -0.684 . . . . 0.0 109.746 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.518 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.8 t80 -51.11 -28.12 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.244 -0.91 . . . . 0.0 110.577 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.72 -2.98 41.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.653 -0.654 . . . . 0.0 110.895 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -112.93 -15.87 12.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.889 . . . . 0.0 111.053 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD11 ' CG ' ' A' ' 36' ' ' TRP . 5.6 mt -54.54 150.64 16.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.09 -1.006 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.4 -175.75 2.48 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.285 1.15 . . . . 0.0 110.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.4 -16.51 61.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.722 -0.611 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.26 -13.39 49.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CG ' HD11 ' A' ' 32' ' ' LEU . 24.6 t90 -101.9 121.86 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.465 -0.772 . . . . 0.0 110.455 179.906 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 120.941 0.4 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -87.8 -170.32 2.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 0.0 110.425 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -160.3 121.9 3.14 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.686 -0.634 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 34.0 mtmt -59.9 165.63 3.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.99 51.3 1.23 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.658 -0.651 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 110.705 -179.849 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.051 0.453 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 -164.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.625 -0.672 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 8.0 m95 -138.53 117.1 12.12 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -121.78 152.29 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.015 -1.074 . . . . 0.0 113.281 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.01 117.96 35.39 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.18 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -54.48 -21.4 9.85 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.566 -0.709 . . . . 0.0 111.812 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.0 -61.09 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.247 -0.908 . . . . 0.0 110.984 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.4 p -80.18 -58.72 3.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.28 -0.887 . . . . 0.0 110.415 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.03 21.43 3.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 28.0 m-85 -55.98 164.18 1.28 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.991 -1.299 . . . . 0.0 109.515 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 35.3 mm -150.47 79.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.803 -0.561 . . . . 0.0 109.618 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 57.0 t80 -79.9 107.89 13.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.821 -1.175 . . . . 0.0 108.914 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -79.61 90.09 5.14 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 3.4 tt0 -52.75 -23.23 6.36 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.98 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.99 -29.04 70.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.431 -0.793 . . . . 0.0 108.942 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.32 -43.8 3.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.687 -0.633 . . . . 0.0 109.417 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 113.37 -105.81 1.7 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -179.84 90.42 0.2 Allowed Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.405 -1.056 . . . . 0.0 109.706 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.89 -20.67 45.03 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.319 1.168 . . . . 0.0 110.67 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -80.05 -33.77 38.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.392 -0.817 . . . . 0.0 110.276 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.06 17.3 11.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.15 65.13 3.68 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.01 167.38 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.646 -0.914 . . . . 0.0 110.83 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -78.25 151.3 78.16 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.77 -0.581 . . . . 0.0 110.219 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 119.3 6.01 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.399 1.21 . . . . 0.0 110.133 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.77 71.46 1.16 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 m -125.0 122.12 36.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.706 -0.879 . . . . 0.0 110.274 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.19 113.92 2.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.151 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 64.4 t80 -49.42 -31.72 10.28 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.37 -0.831 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.45 -12.18 60.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.548 -0.72 . . . . 0.0 110.611 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -127.85 19.41 6.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 12' ' ' TYR . 7.4 mt -62.65 171.03 1.97 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.324 -0.86 . . . . 0.0 109.39 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 -174.89 2.44 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.216 1.114 . . . . 0.0 110.47 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.81 -15.54 56.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.565 -0.709 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -67.42 -11.28 57.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CZ3' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -103.99 96.48 6.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.045 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.429 -0.794 . . . . 0.0 109.593 179.28 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 120.661 0.267 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.7 m-85 -83.97 -170.74 3.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.261 -0.899 . . . . 0.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.12 119.42 2.79 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.485 -0.76 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 11.4 mtmt -55.29 165.63 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.86 -23.41 31.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.692 -0.63 . . . . 0.0 110.565 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.332 -0.855 . . . . 0.0 111.22 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.06 159.63 23.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 110.7 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.4 m95 -130.78 110.09 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.746 -0.596 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.58 142.33 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 110.98 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -97.81 103.27 15.2 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.522 -0.736 . . . . 0.0 111.26 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.1 mt -71.77 -20.45 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.83 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.1 p -148.56 -48.46 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.146 -0.972 . . . . 0.0 111.136 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.76 -3.95 7.0 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -51.75 155.29 1.73 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.324 . . . . 0.0 109.753 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -132.83 124.18 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.77 . . . . 0.0 111.233 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.432 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 35.5 t80 -93.45 111.34 22.98 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.4 87.59 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.055 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 2.7 tt0 -52.82 -22.35 5.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.782 -0.574 . . . . 0.0 111.156 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -31.65 72.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.313 -0.867 . . . . 0.0 108.883 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.71 -29.82 7.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.74 -0.6 . . . . 0.0 109.754 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 98.47 -104.62 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.65 88.99 0.32 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.429 -1.042 . . . . 0.0 109.947 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 -19.15 59.47 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.433 1.228 . . . . 0.0 110.382 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -80.04 -31.99 39.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.644 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -93.79 8.73 39.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.64 -0.662 . . . . 0.0 110.743 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.8 62.65 6.07 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -121.41 166.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.936 . . . . 0.0 110.729 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -67.7 146.31 98.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.827 -0.546 . . . . 0.0 110.302 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.19 122.44 8.03 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.351 1.185 . . . . 0.0 110.091 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.58 67.04 1.74 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -122.09 126.99 49.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.772 -0.84 . . . . 0.0 109.949 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 6.9 mptt -61.08 119.64 8.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -49.69 -39.58 37.18 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.183 -0.948 . . . . 0.0 110.784 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.07 -17.37 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.587 -0.695 . . . . 0.0 110.291 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -91.16 -21.92 20.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.876 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mt -54.94 151.43 16.01 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.21 -0.931 . . . . 0.0 109.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.71 178.88 6.14 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.272 1.143 . . . . 0.0 110.735 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.74 -18.02 63.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.659 -0.651 . . . . 0.0 110.528 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.7 -15.22 51.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.367 -0.833 . . . . 0.0 109.969 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.89 139.05 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 110.092 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.3 m-85 -86.57 -169.83 2.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 110.854 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.04 119.0 6.21 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 7.7 mtmm -54.29 171.47 0.11 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 110.541 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.78 -22.84 42.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.66 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 N--CA 1.498 1.925 0 O-C-N 121.439 -0.788 . . . . 0.0 110.953 -179.758 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.029 0.442 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -128.45 177.03 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 110.27 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 11.1 m95 -141.26 108.18 5.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.579 -0.701 . . . . 0.0 109.452 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.17 148.31 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.741 0.781 . . . . 0.0 111.22 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -106.33 116.41 31.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -55.43 -21.12 14.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.506 -0.746 . . . . 0.0 111.347 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 7' ' ' ILE . 92.8 mt -65.72 -56.34 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 110.732 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 t -136.19 27.76 3.16 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.343 -0.848 . . . . 0.0 111.219 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.35 50.54 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -62.18 131.49 49.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.2 mm -112.81 118.19 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 111.446 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 31.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -79.31 83.09 5.38 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.766 0.793 . . . . 0.0 109.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tt0 -53.36 -22.7 7.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.737 -0.602 . . . . 0.0 110.968 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 0.0 109.044 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.04 -37.07 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.489 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 111.41 -105.94 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.94 90.19 0.28 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.403 -1.057 . . . . 0.0 109.82 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.14 -16.08 53.33 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.403 1.212 . . . . 0.0 110.531 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -101.65 10.7 39.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.59 -0.694 . . . . 0.0 110.704 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.56 1.2 Allowed Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.67 163.38 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.939 . . . . 0.0 111.454 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.41 145.61 81.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.86 118.29 5.23 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.367 1.193 . . . . 0.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.65 64.97 1.97 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -117.07 126.85 53.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.842 -0.799 . . . . 0.0 109.673 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 11.7 mptt -61.28 123.73 18.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.551 -0.718 . . . . 0.0 109.624 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.5 t80 -48.99 -43.85 40.61 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.242 -0.912 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.8 -20.21 65.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.589 -0.694 . . . . 0.0 110.117 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -90.71 -15.54 30.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.438 -0.789 . . . . 0.0 111.333 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD12 ' CD2' ' A' ' 36' ' ' TRP . 5.6 mt -52.69 156.44 3.23 Favored Pre-proline 0 N--CA 1.506 2.341 0 O-C-N 121.028 -1.045 . . . . 0.0 109.686 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.62 -165.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.154 1.236 . . . . 0.0 110.937 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.98 -179.2 2.64 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.17 1.85 2.99 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.379 -0.825 . . . . 0.0 111.916 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CD2' HD12 ' A' ' 32' ' ' LEU . 52.0 t90 -101.35 103.14 14.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.849 -1.157 . . . . 0.0 108.644 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.475 -0.766 . . . . 0.0 110.352 -179.357 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.816 0.341 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 8.4 m-85 -95.05 -168.58 1.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.775 . . . . 0.0 110.673 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.84 123.23 4.04 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.733 -0.604 . . . . 0.0 109.371 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.432 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -56.3 165.58 1.03 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.577 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -82.84 -27.76 30.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 110.182 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.518 -0.739 . . . . 0.0 110.895 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.021 0.438 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.98 175.43 10.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 110.48 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.0 m95 -141.14 124.68 16.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -119.8 147.29 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.075 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 48' ' ' PHE . 1.3 tt -103.5 119.72 39.45 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.107 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -57.26 -38.89 74.56 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.369 -0.832 . . . . 0.0 111.119 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.57 -50.26 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.549 -0.719 . . . . 0.0 111.15 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 22.0 p -101.51 -57.25 2.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.219 -0.925 . . . . 0.0 110.606 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.94 25.78 3.5 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 24.0 m-85 -60.31 170.2 1.4 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.13 -1.217 . . . . 0.0 109.586 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 26.9 mm -147.74 89.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 55.0 t80 -79.76 111.71 16.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.877 -1.139 . . . . 0.0 108.8 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -79.47 85.07 5.28 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.686 0.755 . . . . 0.0 109.287 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.49 -22.32 7.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.66 -31.7 72.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 108.898 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.07 -53.74 2.61 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.445 0.64 . . . . 0.0 109.311 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 130.05 -108.54 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.33 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.411 -1.052 . . . . 0.0 109.283 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.6 -12.7 36.28 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.414 1.218 . . . . 0.0 111.135 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -77.63 -44.78 27.08 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.19 16.04 10.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.436 -0.79 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.74 40.16 88.35 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.429 HD11 ' CD1' ' A' ' 36' ' ' TRP . 38.3 mm -81.75 161.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.663 -0.904 . . . . 0.0 110.365 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 156.78 79.41 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.757 -0.589 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 112.32 3.28 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.272 1.143 . . . . 0.0 110.026 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.93 67.77 1.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -120.32 121.13 37.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.733 -0.863 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.2 119.36 6.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.744 . . . . 0.0 109.815 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 34.9 t80 -49.64 -29.16 6.8 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.224 -0.923 . . . . 0.0 110.961 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.87 -18.03 59.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.527 -0.733 . . . . 0.0 110.508 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -92.66 -19.69 21.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 111.001 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.32 166.79 0.82 Allowed Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.192 -0.942 . . . . 0.0 110.12 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.72 154.63 26.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -65.04 -16.65 63.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.637 -0.665 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.06 -7.68 48.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 110.235 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.429 ' CD1' HD11 ' A' ' 23' ' ' ILE . 40.6 t90 -71.06 132.55 45.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.463 -0.773 . . . . 0.0 108.928 -179.92 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.844 0.354 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 2.7 m-85 -79.44 -174.24 4.12 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.566 -0.709 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.11 114.81 2.28 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.638 -0.664 . . . . 0.0 109.651 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -58.37 163.6 2.97 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.534 -0.729 . . . . 0.0 110.19 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -29.9 22.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.643 -0.661 . . . . 0.0 110.208 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 0.0 111.413 179.266 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -104.8 -166.87 1.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 11.6 m95 -141.47 121.03 13.3 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 10.3 p -120.88 152.42 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.058 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.3 118.32 36.01 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.324 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -53.43 -39.6 64.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.428 -0.795 . . . . 0.0 111.43 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.53 -59.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.782 . . . . 0.0 110.908 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.409 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 23.5 p -89.51 -58.2 2.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.322 -0.861 . . . . 0.0 110.678 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' A' ' 8' ' ' THR . . . 116.01 25.05 3.7 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 28.7 m-85 -56.97 168.76 0.6 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.133 -1.216 . . . . 0.0 109.44 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 33.7 mm -149.34 79.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 70.6 t80 -79.89 108.29 13.35 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.771 -1.205 . . . . 0.0 108.716 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.45 84.64 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.5 tt0 -49.92 -24.67 2.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.26 -30.0 71.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.803 . . . . 0.0 109.028 178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.54 -29.4 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 97.62 -102.94 2.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.99 89.25 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.429 -1.042 . . . . 0.0 109.761 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.14 -23.14 46.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.34 1.179 . . . . 0.0 110.488 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.95 -31.11 39.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.798 . . . . 0.0 110.0 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.11 16.82 15.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.485 -0.76 . . . . 0.0 110.523 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.59 63.2 5.43 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 ' CG2' HD21 ' A' ' 32' ' ' LEU . 47.0 mm -121.53 167.07 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.69 -0.888 . . . . 0.0 111.183 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.68 148.61 87.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.964 -0.46 . . . . 0.0 110.512 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 110.98 3.21 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.475 1.25 . . . . 0.0 109.997 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.71 1.37 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.9 m -121.39 126.06 48.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.787 -0.831 . . . . 0.0 110.084 -179.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 5.3 mptt -60.77 121.09 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 58.7 t80 -47.39 -50.43 22.5 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.349 -0.844 . . . . 0.0 111.016 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.85 -17.29 55.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.632 -0.668 . . . . 0.0 110.55 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.66 -12.55 23.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.24 -0.912 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 23' ' ' ILE . 6.4 mt -55.43 160.39 3.74 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.056 -1.028 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.32 -176.52 3.0 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.213 1.112 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.43 -16.24 62.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 0.0 110.582 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.73 -14.52 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.109 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.24 116.81 32.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 109.817 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.882 179.845 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.099 0.476 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.4 m-85 -79.86 -168.73 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.691 . . . . 0.0 110.537 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.31 115.93 2.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.639 -0.663 . . . . 0.0 109.402 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -62.06 163.67 7.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.431 -0.793 . . . . 0.0 110.07 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -45.28 19.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 110.04 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.516 2.831 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.491 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -89.54 155.05 19.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.535 -0.728 . . . . 0.0 110.787 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CE2' ' CG ' ' A' ' 50' ' ' LYS . 31.4 m95 -129.6 158.6 38.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.32 144.52 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.209 -0.932 . . . . 0.0 111.473 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -104.49 120.77 42.01 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -56.28 -20.43 18.65 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.429 -0.795 . . . . 0.0 110.969 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.3 mm -55.09 -66.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.309 -0.87 . . . . 0.0 110.965 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -143.33 31.91 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.192 -0.943 . . . . 0.0 111.754 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.34 17.19 79.68 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.84 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.412 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 32.6 t80 -61.58 129.57 41.72 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.079 -1.248 . . . . 0.0 108.5 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.58 147.42 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.13 -0.981 . . . . 0.0 112.511 -177.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.419 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 33.6 t80 -108.93 107.94 18.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -79.61 83.26 5.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.9 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.1 -17.65 19.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.883 -0.51 . . . . 0.0 110.871 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.17 -30.37 71.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.097 -1.002 . . . . 0.0 108.616 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.87 -41.52 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 125.82 -106.46 0.87 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.31 93.61 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.322 -1.105 . . . . 0.0 109.167 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.4 -14.79 46.79 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.387 1.204 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.0 -33.28 39.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.28 -0.888 . . . . 0.0 109.677 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -101.96 13.8 33.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.59 -0.694 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.71 71.9 0.67 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 36' ' ' TRP . 43.1 mm -116.52 162.33 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.545 -0.974 . . . . 0.0 110.855 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.06 170.67 14.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.873 -0.517 . . . . 0.0 110.034 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.03 112.3 3.09 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.34 1.179 . . . . 0.0 109.195 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.16 -98.1 2.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 -178.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.2 m 55.52 101.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.695 -0.885 . . . . 0.0 110.674 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 19.2 mttt -63.18 130.85 46.36 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.202 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -48.41 -30.4 5.0 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.139 -0.976 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.57 -18.6 59.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.475 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.43 -16.47 22.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 111.127 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.431 HD12 ' CD1' ' A' ' 36' ' ' TRP . 12.7 mt -54.36 165.22 0.89 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.042 -1.037 . . . . 0.0 110.061 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.42 175.77 9.29 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.238 1.125 . . . . 0.0 110.885 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.86 -4.15 53.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.649 -0.657 . . . . 0.0 110.865 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.36 21.28 6.23 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.431 ' CD1' HD12 ' A' ' 32' ' ' LEU . 71.3 t90 -92.25 117.43 29.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.863 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.597 -0.689 . . . . 0.0 110.017 -179.772 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.718 0.294 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -78.84 165.11 23.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.253 -0.905 . . . . 0.0 111.401 -179.096 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -160.13 126.53 4.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.86 148.72 2.09 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.3 -0.875 . . . . 0.0 111.213 -179.152 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.5 tt -79.91 -10.33 59.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.683 -0.636 . . . . 0.0 111.129 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.995 0 O-C-N 121.113 -0.992 . . . . 0.0 111.013 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.143 0.496 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -129.57 -178.87 4.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.699 . . . . 0.0 110.283 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.513 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -137.58 108.13 6.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.755 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -86.04 148.35 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.758 0.789 . . . . 0.0 111.311 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.431 ' HG ' ' CE1' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -107.49 119.06 38.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -53.24 -21.95 6.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 111.312 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.25 -68.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -130.94 37.41 3.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.283 -0.885 . . . . 0.0 111.72 -178.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.79 36.56 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.411 ' OH ' ' CH2' ' A' ' 36' ' ' TRP . 40.7 t80 -61.24 130.39 45.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.331 -1.1 . . . . 0.0 108.962 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.4 164.69 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.003 0.906 . . . . 0.0 111.728 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.7 t80 -133.26 113.08 12.23 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -79.32 77.05 5.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.843 0.83 . . . . 0.0 108.981 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.22 -22.67 4.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.855 -0.528 . . . . 0.0 111.198 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.72 -31.05 72.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.898 . . . . 0.0 108.975 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.63 -30.81 6.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 0.0 109.784 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 106.49 -106.5 2.55 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.98 88.18 0.35 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.484 -1.009 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.07 -24.08 52.69 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.412 1.217 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -31.9 57.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.757 . . . . 0.0 109.327 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -95.62 5.81 50.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.665 -0.647 . . . . 0.0 110.57 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.98 3.18 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.04 166.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.683 -0.892 . . . . 0.0 111.438 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -60.86 143.12 91.81 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 122.014 -0.429 . . . . 0.0 110.145 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 122.24 7.44 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.321 1.169 . . . . 0.0 110.147 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.89 67.04 1.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.2 m -118.73 119.99 36.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.77 -0.841 . . . . 0.0 110.309 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.4 125.76 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 179.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.513 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.1 t80 -46.84 -29.31 1.91 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.357 -0.839 . . . . 0.0 111.452 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -20.31 58.99 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.501 -0.749 . . . . 0.0 110.552 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.41 -24.63 25.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.79 138.5 70.74 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.335 -0.853 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.67 -179.27 5.03 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.148 1.078 . . . . 0.0 110.796 -179.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -16.2 59.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 110.65 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.69 -9.19 48.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.241 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.411 ' CH2' ' OH ' ' A' ' 10' ' ' TYR . 14.5 t90 -113.01 120.75 42.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t . . . . . 0 N--CA 1.496 1.85 0 O-C-N 121.474 -0.766 . . . . 0.0 109.667 179.46 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.241 0.543 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.431 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 6.2 m-85 -96.67 -169.29 1.86 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 110.652 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -155.97 122.44 5.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -57.5 174.91 0.19 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.399 -0.813 . . . . 0.0 110.408 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tp -79.99 -32.35 39.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.632 . . . . 0.0 109.936 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.466 -0.771 . . . . 0.0 111.174 179.46 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.111 0.481 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.76 179.8 4.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.522 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 14.9 m95 -139.08 107.67 5.88 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.632 -0.668 . . . . 0.0 109.378 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.67 143.72 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.956 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -95.55 112.75 24.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -54.66 -21.45 10.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.414 -0.804 . . . . 0.0 111.384 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.02 -63.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.324 -0.86 . . . . 0.0 110.413 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -122.02 -22.4 5.69 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.374 -0.829 . . . . 0.0 111.549 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.85 18.02 7.61 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.96 140.44 58.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.33 -1.1 . . . . 0.0 108.703 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.53 149.06 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.444 -178.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.3 t80 -119.18 112.7 19.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.5 82.84 5.57 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.692 0.758 . . . . 0.0 109.311 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.02 -18.48 24.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.66 -0.65 . . . . 0.0 110.795 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.13 -31.33 72.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 0.0 108.698 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.19 -46.23 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.81 -108.0 0.87 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.42 94.3 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.377 -1.072 . . . . 0.0 109.297 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.07 -11.93 33.24 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.457 1.241 . . . . 0.0 111.217 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.82 -36.76 62.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.171 -0.956 . . . . 0.0 110.123 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -105.13 16.96 24.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.8 68.11 1.86 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -106.29 165.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.662 -0.905 . . . . 0.0 110.938 -178.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.92 165.93 44.02 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.913 -0.492 . . . . 0.0 110.222 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.8 111.29 2.57 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.332 1.175 . . . . 0.0 109.233 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.71 -96.94 1.88 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 -178.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.9 m 55.08 102.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.741 -0.858 . . . . 0.0 110.688 178.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.9 mttt -63.0 131.86 50.05 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.104 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.6 t80 -48.75 -42.11 34.34 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.001 -1.062 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 17.0 mt-10 -72.13 -8.59 55.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.508 -0.745 . . . . 0.0 110.625 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -105.14 -12.73 15.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 36' ' ' TRP . 6.6 mt -52.27 168.91 0.28 Allowed Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.037 -1.04 . . . . 0.0 109.316 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -89.37 -167.29 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 122.953 0.975 . . . . 0.0 110.756 -178.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.54 169.66 13.36 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.321 0.581 . . . . 0.0 110.002 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t0 65.2 8.28 4.74 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.514 -0.741 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CD2' HD13 ' A' ' 32' ' ' LEU . 91.6 t90 -71.92 -75.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 109.175 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.952 -0.467 . . . . 0.0 111.457 179.573 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.139 0.495 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.442 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.4 m-85 -114.75 -168.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.832 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -160.0 123.76 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.747 -0.596 . . . . 0.0 109.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.5 mtmt -60.22 166.13 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 0.0 110.256 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -82.4 -25.9 33.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.704 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.385 -0.822 . . . . 0.0 110.836 -179.66 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.29 173.91 6.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.552 -0.717 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.508 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 10.9 m95 -139.04 107.05 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.026 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -98.43 106.29 18.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.14 -19.34 19.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.762 . . . . 0.0 111.472 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.15 -9.59 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 111.653 -178.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -149.33 -47.84 0.14 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.989 -1.069 . . . . 0.0 111.625 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.54 -15.1 9.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -51.71 117.75 2.91 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.117 -1.226 . . . . 0.0 109.584 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.76 140.2 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.527 -0.733 . . . . 0.0 111.332 -178.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 36.4 t80 -104.91 110.95 23.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.21 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.4 78.73 5.9 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.74 0.781 . . . . 0.0 109.26 -179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -51.52 -22.67 3.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.782 -0.574 . . . . 0.0 111.255 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.71 -29.65 70.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.234 -0.916 . . . . 0.0 108.997 178.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.66 -41.66 3.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.74 -0.6 . . . . 0.0 109.516 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 131.69 -109.17 0.85 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.37 91.45 0.18 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.411 -1.052 . . . . 0.0 109.806 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.41 -13.88 41.77 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.337 1.178 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -80.19 -41.03 26.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -95.57 12.2 30.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.519 -0.738 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.55 73.23 0.43 Allowed Glycine 0 N--CA 1.502 3.085 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.52 166.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.697 -0.884 . . . . 0.0 111.49 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.97 141.3 98.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.46 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.48 107.78 2.37 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.154 1.081 . . . . 0.0 110.671 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.1 63.99 1.3 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -123.34 134.85 53.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.759 -0.848 . . . . 0.0 110.122 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -70.88 132.27 45.0 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 13.3 t80 -47.97 -38.52 17.01 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.184 -0.947 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -67.92 -22.43 65.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.545 -0.722 . . . . 0.0 110.136 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.66 -19.96 30.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.535 -0.728 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD11 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -52.53 158.1 2.22 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.085 -1.009 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -93.59 -170.73 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.098 1.052 . . . . 0.0 110.436 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -76.76 174.87 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.651 -0.655 . . . . 0.0 109.902 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 66.34 7.07 4.66 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.399 -0.813 . . . . 0.0 111.801 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 91.0 t90 -86.54 4.21 40.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.931 -1.106 . . . . 0.0 110.392 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.06 -1.025 . . . . 0.0 109.787 -179.82 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.064 0.459 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.0 m-85 -83.53 -169.18 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.595 -0.691 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.03 118.41 2.69 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 15.4 mtmt -55.06 171.12 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.391 -0.818 . . . . 0.0 110.71 -179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tt -80.04 -26.97 39.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.703 -0.623 . . . . 0.0 110.341 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.465 -0.772 . . . . 0.0 110.997 -179.83 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.023 0.439 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.8 175.39 7.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.506 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 11.1 m95 -141.63 98.79 3.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.545 -0.722 . . . . 0.0 109.633 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -89.32 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.656 0.741 . . . . 0.0 111.224 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -99.65 101.98 13.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.391 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -57.79 -19.65 29.86 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.502 -0.749 . . . . 0.0 110.95 -179.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.403 HG23 HD12 ' A' ' 7' ' ' ILE . 83.1 mt -71.22 -19.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.303 -0.873 . . . . 0.0 111.059 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -154.14 -34.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.141 -0.974 . . . . 0.0 112.394 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.55 -17.09 6.54 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.442 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -51.05 150.01 3.34 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.096 -1.237 . . . . 0.0 109.871 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.491 HG21 HD12 ' A' ' 11' ' ' ILE . 45.0 mt -136.01 167.14 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.042 0.925 . . . . 0.0 111.789 -179.218 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.438 ' HB2' ' CH2' ' A' ' 36' ' ' TRP . 46.0 t80 -135.82 106.81 6.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -79.24 86.89 4.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 3.3 tt0 -47.55 -25.88 1.26 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 0.0 111.697 -178.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.0 -29.72 70.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.394 -0.816 . . . . 0.0 109.179 178.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.23 -25.28 9.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.663 -0.648 . . . . 0.0 110.241 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 101.83 -105.61 2.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.62 87.07 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.46 -1.023 . . . . 0.0 109.912 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.11 -28.73 40.73 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.428 1.225 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.1 -32.15 72.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.605 -0.684 . . . . 0.0 109.191 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.91 6.39 36.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.699 -0.626 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.0 66.73 2.51 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.451 HG13 ' CD1' ' A' ' 36' ' ' TRP . 44.6 mm -118.99 167.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.175 0.988 . . . . 0.0 112.683 -176.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 t -48.04 121.01 8.5 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.699 179.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 131.13 18.17 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.179 1.094 . . . . 0.0 111.217 -179.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.78 59.7 8.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 32' ' ' LEU . 1.8 m -123.42 132.74 54.04 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.827 -0.808 . . . . 0.0 110.289 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -62.16 126.99 29.27 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.836 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 7.8 t80 -48.89 -27.01 2.77 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.43 -0.794 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -91.34 7.9 38.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -0.752 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -142.62 17.95 2.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 111.4 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.472 ' CD1' ' CG ' ' A' ' 36' ' ' TRP . 1.1 pt? -80.57 -163.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.093 -1.004 . . . . 0.0 108.866 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 32' ' ' LEU . 41.6 Cg_endo -89.66 143.02 4.27 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 122.457 0.714 . . . . 0.0 110.539 -177.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -52.93 171.69 0.06 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.691 -0.631 . . . . 0.0 110.432 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t70 72.88 -6.43 1.68 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.811 -0.556 . . . . 0.0 112.257 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.472 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 86.4 t90 -77.09 114.55 16.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.626 -1.296 . . . . 0.0 109.621 179.153 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.499 2.016 0 O-C-N 121.682 -0.636 . . . . 0.0 109.585 179.434 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 120.961 0.41 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 7.2 m-85 -79.91 -167.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.4 -0.813 . . . . 0.0 110.263 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.22 123.24 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.715 -0.616 . . . . 0.0 109.526 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.0 mtmt -55.35 167.5 0.47 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.586 -0.696 . . . . 0.0 110.898 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tt -83.22 -25.49 31.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.659 . . . . 0.0 110.576 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.46 -0.775 . . . . 0.0 110.832 -179.769 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.154 0.502 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -123.13 172.47 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 110.256 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.502 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.05 109.81 7.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 109.417 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.47 150.23 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.896 0.855 . . . . 0.0 111.384 -179.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.445 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -110.02 118.0 35.26 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.749 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -19.96 22.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.414 -0.804 . . . . 0.0 111.126 -179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 7' ' ' ILE . 47.4 mm -64.47 -58.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.835 . . . . 0.0 110.653 -179.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 t -137.85 26.98 2.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.299 -0.876 . . . . 0.0 111.373 -179.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.17 65.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 5' ' ' LEU . 7.9 t80 -61.0 136.27 58.04 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -1.202 . . . . 0.0 108.791 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.4 mm -119.84 127.41 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.409 -0.807 . . . . 0.0 111.551 -178.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 29.0 t80 -94.55 113.57 25.42 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.5 82.44 5.63 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.388 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.61 -21.13 9.56 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.874 -0.516 . . . . 0.0 111.06 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.37 -32.97 74.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.305 -0.872 . . . . 0.0 108.975 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.67 -43.3 4.08 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 179.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.69 -108.27 1.16 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.99 94.38 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.359 -1.083 . . . . 0.0 109.243 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.93 -13.06 38.09 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.438 1.231 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -77.52 -40.02 44.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.204 -0.935 . . . . 0.0 109.949 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -97.94 16.57 20.53 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.596 -0.69 . . . . 0.0 110.674 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 58.0 16.7 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 36' ' ' TRP . 44.8 mm -100.43 157.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.97 . . . . 0.0 110.63 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -74.2 158.22 85.77 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.873 -0.517 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.57 109.52 2.65 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.299 1.157 . . . . 0.0 110.31 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.34 79.89 0.74 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -132.49 119.49 20.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.749 -0.854 . . . . 0.0 110.116 -179.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.2 mttt -55.38 121.57 9.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.477 -0.764 . . . . 0.0 110.04 179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.0 t80 -46.79 -46.36 20.57 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.396 -0.815 . . . . 0.0 111.269 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mt-10 -63.72 -18.83 64.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.475 -0.766 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -87.79 -21.13 25.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.35 163.7 2.34 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.114 -0.991 . . . . 0.0 109.829 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.43 163.12 38.52 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.148 1.078 . . . . 0.0 110.977 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.49 -18.62 61.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.632 -0.667 . . . . 0.0 110.622 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -75.68 -2.02 27.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 110.336 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.433 ' CD1' HD13 ' A' ' 23' ' ' ILE . 37.4 t90 -75.6 134.5 40.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.099 -1.001 . . . . 0.0 109.814 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.489 -0.757 . . . . 0.0 109.693 179.972 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 120.929 0.395 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 10.2 m-85 -119.76 -168.11 1.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.406 -0.809 . . . . 0.0 110.45 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -160.07 121.57 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.681 -0.637 . . . . 0.0 109.362 179.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -54.98 173.11 0.1 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.375 -0.828 . . . . 0.0 110.841 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tp -86.74 -32.17 20.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.031 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.618 -0.676 . . . . 0.0 111.145 -179.831 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.4199999999999999 110.261 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -114.92 173.39 6.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 2.6899999999999999 110.098 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.936 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 15.2 m95 -130.83 120.09 23.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.51000000000000001 109.736 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.965 ' HA ' HD11 ' A' ' 11' ' ' ILE . 13.3 p -100.21 139.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 1.3999999999999999 110.717 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.782 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -100.26 100.26 11.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 1.4299999999999999 109.991 179.726 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -44.39 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.351 -0.843 . . . . 2.46 110.943 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' LEU . 4.7 mt -66.96 -40.76 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 2.6099999999999999 110.474 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 8' ' ' THR . 0.5 OUTLIER -149.23 15.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 2.4199999999999999 110.52 -179.867 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 11' ' ' ILE . . . 77.65 -3.41 60.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.694 -1.362 . . . . 0.90000000000000002 109.694 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.909 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 39.9 t80 -39.89 125.39 1.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -1.225 . . . . 2.8900000000000001 109.615 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.965 HD11 ' HA ' ' A' ' 4' ' ' VAL . 27.9 mm -114.93 145.29 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 1.4299999999999999 111.204 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.9 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 27.6 t80 -116.04 109.55 17.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.769 -0.826 . . . . 2.0800000000000001 108.769 178.42 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 1.065 ' OD2' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -79.65 82.01 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 2.2200000000000002 110.35 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.574 ' CD ' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -51.81 -18.62 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 1.1399999999999999 110.049 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -18.59 65.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.74 109.621 179.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 1.065 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . . . -127.88 -23.85 3.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.768 . . . . 1.05 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.756 ' O ' ' HB2' ' A' ' 18' ' ' ASP . . . 101.87 -98.24 1.72 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.46999999999999997 109.677 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.756 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 164.74 97.82 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.244 -1.15 . . . . 1.3500000000000001 110.072 -179.886 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.82 -14.93 36.57 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.129 1.594 . . . . 0.90000000000000002 110.372 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -35.09 37.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 1.6000000000000001 109.901 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -102.38 24.81 9.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.51 110.081 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.11 58.53 4.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.502 -1.439 . . . . 0.66000000000000003 109.502 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.782 HD11 HD23 ' A' ' 32' ' ' LEU . 51.6 mm -104.92 166.71 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 1.3899999999999999 110.286 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.68 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -76.36 157.71 82.41 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 1.23 110.147 179.993 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.05 110.81 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.65000000000000002 110.317 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 14' ' ' GLU . . . 78.09 67.39 1.63 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.418 -1.473 . . . . 1.1100000000000001 109.418 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.747 HG23 ' HG ' ' A' ' 32' ' ' LEU . 1.1 m -118.23 114.16 22.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -1.124 . . . . 1.03 110.458 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HA ' ' CD ' ' A' ' 14' ' ' GLU . 6.4 mptt -47.98 117.48 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.268 -0.895 . . . . 2.1600000000000001 110.303 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.75 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 36.4 t80 -46.14 -41.17 12.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.895 . . . . 2.1600000000000001 110.116 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -68.44 -13.11 62.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 2.1400000000000001 110.371 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' LEU . 21.8 tt0 -99.52 -26.05 14.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 1.9199999999999999 110.547 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 1.08 HD22 ' HD2' ' A' ' 33' ' ' PRO . 6.4 mt -40.82 160.92 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.95 . . . . 1.1299999999999999 110.087 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 1.08 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.4 Cg_endo -78.62 -179.14 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.979 1.515 . . . . 1.1799999999999999 110.18 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -80.26 -31.97 38.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 2.7799999999999998 109.942 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -7.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 2.7599999999999998 109.706 179.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.696 ' HH2' ' HE2' ' A' ' 10' ' ' TYR . 23.7 t90 -90.72 135.25 33.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 1.03 110.191 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 1.037 HG11 ' O ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.034 . . . . 2.29 110.488 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' O ' HD22 ' A' ' 5' ' ' LEU . 9.7 tp10 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.224 0.535 . . . . 2.04 110.188 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.909 ' CE2' ' CD2' ' A' ' 10' ' ' TYR . 7.1 m-85 -103.89 -171.89 2.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 1.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 1.082 ' O ' ' O ' ' A' ' 50' ' ' LYS . 16.0 tt0 -160.18 100.95 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.39 -0.819 . . . . 2.2400000000000002 109.758 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 1.082 ' O ' ' O ' ' A' ' 49' ' ' GLU . 13.3 mtpt -29.17 -172.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.853 . . . . 2.2400000000000002 110.366 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.665 ' O ' ' O ' ' A' ' 52' ' ' GLU . 6.1 tt -111.09 -14.35 13.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.6099999999999999 109.821 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.665 ' O ' ' O ' ' A' ' 51' ' ' LEU . 6.2 pt-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.427 -0.796 . . . . 2.3799999999999999 110.531 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.484 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -122.84 175.84 6.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.619 -0.676 . . . . 0.0 110.288 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.9 108.09 6.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.596 -0.69 . . . . 0.0 109.658 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -87.73 147.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.842 0.829 . . . . 0.0 111.209 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -102.59 101.21 11.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -47.5 -24.75 0.91 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.532 -0.73 . . . . 0.0 112.431 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.23 -49.85 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 0.0 110.566 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -127.6 -29.99 2.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.37 -0.831 . . . . 0.0 111.597 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.85 4.99 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -72.3 131.82 43.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.384 -1.068 . . . . 0.0 108.831 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.62 123.19 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.464 -0.772 . . . . 0.0 111.466 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 30.9 t80 -91.71 113.25 25.47 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.38 87.11 5.04 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.284 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 3.0 tt0 -53.86 -21.4 7.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.858 -0.526 . . . . 0.0 111.23 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.74 -31.49 72.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.354 -0.841 . . . . 0.0 109.026 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -35.07 5.83 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.294 0.569 . . . . 0.0 109.574 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 109.62 -107.06 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -176.28 90.54 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.431 -1.041 . . . . 0.0 109.949 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.09 -19.3 63.22 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.422 1.222 . . . . 0.0 110.533 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -30.32 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 109.307 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 6.3 48.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.69 . . . . 0.0 110.56 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.26 70.13 1.06 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -126.45 166.72 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.935 . . . . 0.0 111.2 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -65.42 148.08 98.25 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.012 -0.43 . . . . 0.0 110.409 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 119.07 5.91 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.488 1.257 . . . . 0.0 110.015 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.35 71.26 1.24 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -122.5 122.61 39.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.722 -0.869 . . . . 0.0 110.407 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.7 mttt -60.82 114.81 3.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.614 -0.679 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -51.13 -30.02 15.15 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.17 -0.956 . . . . 0.0 110.728 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -77.24 -2.85 36.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.684 -0.635 . . . . 0.0 110.824 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.29 -3.89 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 111.262 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.83 156.54 24.49 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.128 -0.982 . . . . 0.0 109.864 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.34 172.72 9.22 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.287 1.151 . . . . 0.0 110.404 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.88 -16.46 63.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.591 -0.693 . . . . 0.0 110.504 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -16.15 48.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 110.008 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -93.39 129.9 39.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.797 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.421 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 10.0 p -167.43 117.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 110.006 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.71 177.17 0.24 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.656 -0.653 . . . . 0.0 110.459 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.3 -160.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.353 1.186 . . . . 0.0 110.328 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 tp -48.94 -36.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.208 -0.932 . . . . 0.0 111.349 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -77.59 87.48 3.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -0.788 . . . . 0.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.4 164.67 38.11 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . . . -169.17 -62.65 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.429 -1.042 . . . . 0.0 110.982 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 43' ' ' ALA . 43.4 Cg_endo -70.33 -170.76 0.45 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 O-C-N 122.944 0.971 . . . . 0.0 110.827 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 74.1 mmtt -89.27 -45.67 9.35 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.651 0.739 . . . . 0.0 110.343 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.0 m -54.82 -21.62 11.82 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.84 -0.537 . . . . 0.0 111.238 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.62 7.15 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.351 -0.843 . . . . 0.0 111.427 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 8.8 m-85 -109.78 -169.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.11 -0.994 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -160.07 121.34 3.12 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.482 -0.761 . . . . 0.0 109.534 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 18.4 mtpt -54.22 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.0 110.878 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.89 -12.5 23.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.697 -0.627 . . . . 0.0 111.188 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -52.36 148.73 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.083 -1.011 . . . . 0.0 110.943 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.451 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.066 0.46 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.58 178.65 6.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.455 ' CZ2' ' CG ' ' A' ' 50' ' ' LYS . 17.1 m95 -140.39 143.86 35.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.92 137.53 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.752 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -92.76 95.7 9.71 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -51.11 -23.29 3.05 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.455 -0.778 . . . . 0.0 111.682 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.4 mt -81.37 -9.8 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.347 -0.845 . . . . 0.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -147.94 -41.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.976 -1.077 . . . . 0.0 111.507 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 -13.19 21.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.82 156.4 1.46 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.117 -1.225 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 43.6 mm -133.53 130.78 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 54.0 t80 -92.33 110.91 22.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.47 83.69 5.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 2.9 tt0 -51.02 -23.89 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.792 -0.568 . . . . 0.0 111.151 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.57 -30.09 71.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.411 -0.805 . . . . 0.0 108.935 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.39 -34.04 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.323 0.582 . . . . 0.0 109.62 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.62 -104.5 2.5 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -173.72 88.81 0.36 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.398 -1.06 . . . . 0.0 110.102 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 -21.1 62.04 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.427 1.225 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.46 -34.95 47.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.236 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -92.13 3.81 54.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.758 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.87 63.79 4.88 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -119.89 165.99 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.95 . . . . 0.0 110.728 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.13 143.31 88.69 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.442 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.85 115.93 4.49 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.333 1.175 . . . . 0.0 109.679 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.46 66.48 1.6 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -120.21 125.13 47.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.857 . . . . 0.0 110.146 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 30.6 mmtt -59.7 122.64 14.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.66 -0.65 . . . . 0.0 109.396 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 36.6 t80 -48.43 -33.15 8.78 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.21 -0.931 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.15 -22.92 62.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -82.44 -26.23 32.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.67 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' CG ' ' A' ' 36' ' ' TRP . 11.9 mt -57.64 141.17 79.74 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.251 -0.905 . . . . 0.0 109.806 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.11 175.59 6.44 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.151 1.079 . . . . 0.0 110.536 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.65 -18.14 58.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 110.405 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.81 -15.51 42.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.382 -0.824 . . . . 0.0 110.131 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CG ' HD12 ' A' ' 32' ' ' LEU . 78.2 t90 -86.23 136.14 33.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 0.0 109.805 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -168.17 126.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.581 -0.699 . . . . 0.0 109.776 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.76 141.5 87.39 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.582 -0.698 . . . . 0.0 110.253 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.11 -8.65 22.44 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.358 1.189 . . . . 0.0 111.301 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 40' ' ' ILE . 47.7 mm -62.53 94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 m 53.04 29.6 8.25 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.556 -0.715 . . . . 0.0 110.796 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 117.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.67 112.2 3.17 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.949 . . . . 0.0 110.137 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.08 -175.08 1.11 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.143 1.075 . . . . 0.0 110.174 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.65 -24.84 19.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -73.17 -12.2 60.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.399 -0.813 . . . . 0.0 110.845 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -95.67 21.8 7.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 5.7 m-85 -105.33 -172.55 2.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.48 -0.762 . . . . 0.0 110.673 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.27 140.48 11.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CG ' ' CZ2' ' A' ' 3' ' ' TRP . 29.3 mtpt -57.99 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.194 -0.941 . . . . 0.0 110.452 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.2 tp -111.1 63.61 0.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.61 0.719 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -55.9 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.718 -0.614 . . . . 0.0 110.612 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 N--CA 1.5 2.05 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.821 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.117 0.484 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -118.11 174.69 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -140.01 110.82 6.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.0 109.733 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p -81.93 150.68 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 111.112 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.473 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -111.33 118.18 35.15 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -55.46 -21.47 16.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.557 -0.714 . . . . 0.0 111.215 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -135.74 29.74 3.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 111.07 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.38 58.01 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.426 ' CD1' HD11 ' A' ' 5' ' ' LEU . 5.8 t80 -60.99 134.95 57.62 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.229 -1.159 . . . . 0.0 108.722 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.6 mm -117.14 118.48 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.557 -0.714 . . . . 0.0 111.205 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.438 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 27.4 t80 -85.41 112.55 20.96 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -79.56 82.34 5.7 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.086 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tm-20 -57.04 -19.5 19.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.686 -0.634 . . . . 0.0 110.776 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -62.28 -31.04 71.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.2 -0.937 . . . . 0.0 108.751 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.73 -44.07 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 127.65 -108.55 0.96 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.24 94.42 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.339 -1.094 . . . . 0.0 109.174 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -13.62 40.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.386 1.203 . . . . 0.0 110.971 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.95 -33.41 57.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.246 -0.908 . . . . 0.0 109.745 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -106.04 11.46 31.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.736 . . . . 0.0 110.852 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.95 66.99 2.44 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.431 HD11 ' CD1' ' A' ' 36' ' ' TRP . 46.7 mm -103.6 164.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.924 . . . . 0.0 110.686 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.05 172.83 8.85 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.931 -0.481 . . . . 0.0 110.051 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.85 107.11 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.335 1.176 . . . . 0.0 109.41 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.14 -95.71 1.67 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m 55.64 101.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.716 -0.873 . . . . 0.0 110.708 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -63.12 125.86 25.46 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.399 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.7 t80 -50.69 -25.93 4.87 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.49 -6.58 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.552 -0.718 . . . . 0.0 110.752 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.89 -16.52 14.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 ' CD1' ' A' ' 36' ' ' TRP . 11.5 mt -54.87 156.42 6.79 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.12 169.41 21.55 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.258 1.136 . . . . 0.0 110.985 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -71.74 -14.21 61.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.747 -0.596 . . . . 0.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -75.2 -3.12 31.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.411 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.431 ' CD1' HD11 ' A' ' 23' ' ' ILE . 74.8 t90 -80.32 120.78 24.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.141 -0.974 . . . . 0.0 110.024 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -154.13 118.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . . . -88.3 -62.35 0.22 Allowed Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 111.228 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -71.88 -162.46 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.909 0.952 . . . . 0.0 110.061 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 tt -50.45 167.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.406 -0.809 . . . . 0.0 110.711 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 p -53.48 98.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.406 -0.809 . . . . 0.0 110.985 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.45 61.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -138.83 51.06 3.18 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.496 -1.002 . . . . 0.0 110.802 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 43.2 Cg_endo -69.61 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.263 1.138 . . . . 0.0 110.381 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 67.7 mmtt -83.86 -20.1 33.72 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 0.0 110.947 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.0 p -78.13 0.58 24.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 111.553 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -114.3 20.25 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.042 -1.036 . . . . 0.0 111.001 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 13.7 m-85 -121.54 -172.45 2.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.865 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -160.2 122.75 3.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 2.8 mtpt -58.48 173.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.34 -28.31 21.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.673 -0.642 . . . . 0.0 110.268 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -56.69 141.35 44.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.58 -0.7 . . . . 0.0 110.565 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.7 -179.814 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.87 -166.76 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 110.314 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.435 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 9.3 m95 -138.07 122.5 18.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 9.9 p -118.47 146.48 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.269 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 48' ' ' PHE . 1.5 tt -108.03 118.38 36.61 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.76 -39.81 68.71 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.326 -0.859 . . . . 0.0 111.414 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.56 -49.15 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.532 -0.73 . . . . 0.0 111.345 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.407 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 27.1 p -102.1 -57.77 2.0 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.13 -0.981 . . . . 0.0 110.79 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.5 23.64 4.02 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 29.3 m-85 -55.76 164.34 1.15 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.049 -1.265 . . . . 0.0 109.588 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.6 mm -146.5 83.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 63.8 t80 -79.8 109.94 14.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.984 -1.073 . . . . 0.0 108.659 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.45 85.81 5.2 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.1 tt0 -52.8 -22.6 5.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.778 -0.576 . . . . 0.0 111.089 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -29.39 70.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.376 -0.827 . . . . 0.0 109.086 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.69 -37.53 4.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.751 -0.593 . . . . 0.0 109.531 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 108.43 -105.26 2.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.59 90.13 0.22 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.377 -1.072 . . . . 0.0 109.795 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.6 -18.8 48.61 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.353 1.186 . . . . 0.0 110.638 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.14 -32.94 38.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.0 110.021 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -95.58 13.98 24.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.716 . . . . 0.0 110.735 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.5 66.37 2.89 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -122.51 166.89 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.692 -0.887 . . . . 0.0 111.157 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.06 148.97 89.44 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.826 -0.546 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 120.4 6.51 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.386 1.203 . . . . 0.0 109.985 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.82 70.12 1.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.0 m -124.25 121.35 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.713 -0.875 . . . . 0.0 110.247 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.68 120.22 7.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.804 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.419 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 33.5 t80 -48.7 -38.27 20.95 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.221 -0.924 . . . . 0.0 110.936 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.93 -20.06 63.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -91.01 -16.42 27.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 110.955 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.418 HD13 ' CG ' ' A' ' 36' ' ' TRP . 7.0 mt -56.03 159.34 5.83 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.073 -1.017 . . . . 0.0 110.144 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.91 -178.29 2.84 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.359 1.189 . . . . 0.0 110.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -67.55 -16.25 64.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.663 -0.648 . . . . 0.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.03 -16.72 46.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.824 . . . . 0.0 110.105 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.418 ' CG ' HD13 ' A' ' 32' ' ' LEU . 1.1 t90 -106.93 114.1 27.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -174.08 150.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.424 -0.798 . . . . 0.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.98 109.28 31.7 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.591 -0.693 . . . . 0.0 110.562 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -22.2 15.68 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.255 1.134 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.76 -40.25 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 109.982 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -154.36 46.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.183 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.7 -169.45 28.31 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . . . -177.0 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.995 . . . . 0.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 51.8 Cg_endo -93.6 174.82 1.56 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.086 1.045 . . . . 0.0 110.274 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -70.44 -40.97 73.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.535 -0.728 . . . . 0.0 110.327 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -70.14 63.29 0.23 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.761 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -33.1 1.3 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.745 . . . . 0.0 110.501 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.5 m-85 -79.81 -173.03 3.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 110.325 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -149.34 110.01 4.26 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.671 -0.643 . . . . 0.0 109.38 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -57.76 168.3 0.93 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.584 -0.697 . . . . 0.0 110.509 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.9 48.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.209 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.23 168.58 3.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.596 -0.69 . . . . 0.0 110.153 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.172 179.804 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.23 149.02 23.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 110.774 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.423 ' CZ2' ' HG2' ' A' ' 50' ' ' LYS . 19.9 m95 -114.84 173.04 6.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.557 -0.714 . . . . 0.0 110.061 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.35 142.05 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 110.29 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.461 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -109.89 117.56 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -52.66 -23.58 6.87 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.597 -0.689 . . . . 0.0 111.46 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.39 -57.39 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.377 -0.827 . . . . 0.0 110.586 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -146.81 36.59 0.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.225 -0.922 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.45 20.06 49.83 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 5' ' ' LEU . 3.2 t80 -58.41 164.88 2.31 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.138 -1.213 . . . . 0.0 108.643 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 12' ' ' TYR . 37.5 mt -141.52 165.79 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.282 1.039 . . . . 0.0 112.241 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.429 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 t80 -126.16 109.91 12.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -79.29 81.21 5.58 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.6 tt0 -48.94 -25.03 1.72 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.559 -0.713 . . . . 0.0 111.337 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.19 -30.02 71.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 0.0 108.905 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 -32.55 6.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.826 -0.546 . . . . 0.0 109.581 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.14 -103.26 2.7 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -174.48 88.7 0.33 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.41 -1.053 . . . . 0.0 110.059 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.64 -19.03 60.02 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.455 1.24 . . . . 0.0 110.533 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -34.7 39.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.77 11.2 23.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.677 -0.64 . . . . 0.0 110.765 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.02 55.5 27.77 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.35 165.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.751 -0.852 . . . . 0.0 111.246 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 t -65.1 143.05 98.78 Favored Pre-proline 0 N--CA 1.494 1.775 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.95 123.09 8.16 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.275 1.145 . . . . 0.0 110.007 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.24 67.65 1.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 m -122.76 123.76 41.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.789 -0.83 . . . . 0.0 110.315 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.82 120.65 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.662 -0.648 . . . . 0.0 109.387 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 69.6 t80 -46.66 -49.39 19.29 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.322 -0.862 . . . . 0.0 111.258 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -59.59 -20.06 53.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.0 110.492 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.27 -29.34 34.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.31 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 36' ' ' TRP . 11.5 mt -58.15 150.46 51.81 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.497 -0.752 . . . . 0.0 109.846 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.31 176.22 8.93 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.273 1.144 . . . . 0.0 110.724 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.11 -14.86 62.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.55 -0.719 . . . . 0.0 110.658 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.95 -9.13 50.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.476 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CD1' HD13 ' A' ' 32' ' ' LEU . 30.3 t90 -91.81 140.43 29.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -154.86 -160.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.74 155.34 63.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.615 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.88 83.88 1.1 Allowed 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.471 1.248 . . . . 0.0 110.844 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 tt -169.19 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.938 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.5 m -161.73 -44.04 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.659 -0.651 . . . . 0.0 110.015 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.47 78.51 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.46 116.01 62.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.436 -1.038 . . . . 0.0 110.691 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.34 -163.48 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.22 1.116 . . . . 0.0 110.292 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 29' ' ' PHE . 72.8 mmtt -76.6 -36.39 57.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -0.781 . . . . 0.0 110.187 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -19.63 40.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.884 -0.51 . . . . 0.0 111.03 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -91.92 -21.94 20.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 111.032 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 8.3 m-85 -84.41 178.74 7.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 110.877 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.25 147.82 16.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -72.25 157.19 38.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 35.35 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.585 -0.697 . . . . 0.0 109.921 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.04 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.228 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 N--CA 1.502 2.162 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.622 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.191 0.519 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -121.94 175.2 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m95 -139.41 104.88 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.676 -0.64 . . . . 0.0 109.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.84 150.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.718 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.8 116.13 31.74 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -54.27 -21.03 8.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.521 -0.737 . . . . 0.0 111.373 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.9 mt -58.54 -68.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -123.29 -15.82 7.08 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.473 -0.767 . . . . 0.0 111.647 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 14.77 8.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.58 130.92 48.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.154 -1.204 . . . . 0.0 108.987 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.4 mm -111.34 114.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.706 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 23.1 t80 -82.58 113.34 20.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.41 87.44 5.05 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.813 0.816 . . . . 0.0 109.398 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -55.49 -21.21 15.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.632 -0.668 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.55 -32.12 73.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 108.694 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.91 -46.65 3.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 116.31 -106.47 1.51 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 176.17 94.14 0.1 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.391 -1.064 . . . . 0.0 109.282 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.57 -12.79 36.67 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.416 1.219 . . . . 0.0 111.085 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.7 -40.41 55.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.178 -0.951 . . . . 0.0 109.834 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.88 17.38 10.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.02 41.81 92.65 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.3 mm -84.83 165.59 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.787 -0.831 . . . . 0.0 110.848 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.3 154.22 74.38 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.84 107.35 2.19 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.307 1.161 . . . . 0.0 109.8 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.46 65.05 1.47 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -116.17 126.78 54.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.861 -0.787 . . . . 0.0 109.643 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 14.4 mtpt -63.56 118.44 8.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.731 -0.606 . . . . 0.0 110.048 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 30.4 t80 -51.34 -35.29 37.63 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.188 -0.945 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.06 -8.81 57.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.643 -0.661 . . . . 0.0 110.492 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -113.17 -4.42 13.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.201 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -52.99 171.4 0.23 Allowed Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 120.906 -1.121 . . . . 0.0 109.444 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -89.26 -175.04 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 122.967 0.983 . . . . 0.0 110.824 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.29 171.43 15.07 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.649 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.9 -0.12 2.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.591 -0.693 . . . . 0.0 112.113 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CD1' HD11 ' A' ' 23' ' ' ILE . 64.9 t90 -73.88 119.2 17.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.796 -1.19 . . . . 0.0 109.119 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -150.17 106.62 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 109.827 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.47 154.76 52.85 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.532 -0.73 . . . . 0.0 109.968 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.52 61.37 6.05 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.384 1.202 . . . . 0.0 110.75 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -140.98 71.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.505 -0.747 . . . . 0.0 109.934 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.5 p 44.28 70.31 0.34 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.825 -0.547 . . . . 0.0 111.734 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.23 141.01 0.24 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.25 57.14 0.62 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.934 . . . . 0.0 110.134 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.18 -164.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.41 1.216 . . . . 0.0 110.39 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mmtm -78.43 -57.87 3.55 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.338 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.34 68.17 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.389 0.614 . . . . 0.0 109.807 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -160.17 -33.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.701 -0.624 . . . . 0.0 111.073 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.5 m-85 -79.52 -172.49 3.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.541 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -160.23 125.59 3.97 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.753 -0.592 . . . . 0.0 109.651 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 21.2 mtmt -63.12 168.23 4.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.103 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.88 29.52 6.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -60.26 157.08 14.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 110.429 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.502 2.135 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.886 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.02 0.438 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.65 159.29 20.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.568 -0.707 . . . . 0.0 110.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.538 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.6 m95 -132.54 112.11 11.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.03 150.98 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.467 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.459 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -114.57 120.93 41.89 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -52.21 -22.14 4.06 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.483 -0.761 . . . . 0.0 111.715 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.15 -74.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.725 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -133.06 20.0 4.09 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.36 23.1 55.34 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.3 152.12 21.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.292 -1.122 . . . . 0.0 108.783 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.2 mm -135.4 137.9 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.326 -0.859 . . . . 0.0 111.654 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 49.8 t80 -105.11 112.71 25.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -79.26 81.96 5.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.341 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -50.19 -24.78 3.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.615 -0.678 . . . . 0.0 110.869 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.41 -31.92 73.21 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.2 -52.33 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.13 -107.42 1.04 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -175.61 88.72 0.29 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -14.39 44.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.475 1.25 . . . . 0.0 110.688 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.06 -37.15 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.309 -0.869 . . . . 0.0 109.793 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.33 12.98 27.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 110.701 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.68 66.6 2.7 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mm -119.39 166.06 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.964 . . . . 0.0 111.132 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.06 147.52 98.47 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.992 -0.442 . . . . 0.0 110.673 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.97 111.4 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.391 1.206 . . . . 0.0 109.834 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 66.31 1.47 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -117.81 127.85 54.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.826 -0.808 . . . . 0.0 110.006 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 18.8 mmtm -63.33 118.53 8.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.538 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 57.9 t80 -49.18 -34.85 15.46 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.287 -0.883 . . . . 0.0 111.092 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.79 -18.08 62.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -93.17 -17.76 23.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.161 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 36' ' ' TRP . 8.0 mt -58.64 155.53 29.08 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.15 -0.969 . . . . 0.0 110.137 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.06 165.31 26.27 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.31 1.163 . . . . 0.0 110.245 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.16 -12.35 60.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.682 . . . . 0.0 110.845 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.21 -1.88 28.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.748 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.413 ' CD1' HD13 ' A' ' 32' ' ' LEU . 62.8 t90 -86.12 127.4 34.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 0.0 109.883 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -154.41 117.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 0.0 109.724 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . . . -77.02 -58.65 1.0 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.446 -0.784 . . . . 0.0 110.613 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 38' ' ' ALA . 45.2 Cg_endo -71.81 -163.03 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.075 1.039 . . . . 0.0 110.057 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 tt -51.86 168.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.8 p -50.97 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.353 -0.842 . . . . 0.0 110.973 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.12 73.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.62 56.6 1.99 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.969 . . . . 0.0 110.29 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.21 -164.82 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.441 1.232 . . . . 0.0 110.466 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.14 -20.18 30.66 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.464 -0.772 . . . . 0.0 110.842 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.6 m -79.98 5.2 14.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.495 -0.753 . . . . 0.0 111.82 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -118.84 22.09 12.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.002 -1.061 . . . . 0.0 110.917 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 14.2 m-85 -125.11 -173.93 2.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.307 -0.871 . . . . 0.0 110.994 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -160.41 131.4 5.62 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 23.5 mtmt -76.11 151.92 36.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 47.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.631 -0.668 . . . . 0.0 110.157 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.67 143.72 29.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.743 . . . . 0.0 110.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.212 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -111.21 173.7 6.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 0.0 110.063 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -139.72 111.34 7.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.494 -0.754 . . . . 0.0 109.623 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.61 145.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.873 0.844 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -96.42 98.98 10.68 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -52.27 -24.33 7.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.384 -0.823 . . . . 0.0 111.153 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 7' ' ' ILE . 50.4 mm -75.93 -13.87 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.7 p -149.72 -54.14 0.16 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.094 -1.004 . . . . 0.0 111.061 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 132.59 -9.18 5.27 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -50.62 150.57 2.7 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.267 . . . . 0.0 110.075 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.1 mm -130.08 123.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.502 -0.749 . . . . 0.0 110.939 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 32.2 t80 -88.81 111.54 22.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -79.81 84.99 5.52 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.292 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -55.25 -20.18 10.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.582 -0.699 . . . . 0.0 110.839 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -61.78 -30.41 70.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.146 -0.971 . . . . 0.0 108.819 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.36 -41.78 3.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.0 109.067 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.17 -108.05 1.17 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.25 95.12 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.325 -1.103 . . . . 0.0 109.045 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.46 -12.57 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.301 1.158 . . . . 0.0 111.247 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.94 -33.82 72.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.221 -0.924 . . . . 0.0 109.899 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.53 16.09 20.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.56 -0.713 . . . . 0.0 110.802 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.29 62.97 5.75 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 36' ' ' TRP . 42.4 mm -94.13 163.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.968 . . . . 0.0 110.598 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.01 172.9 8.66 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.863 -0.523 . . . . 0.0 110.007 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.84 108.42 2.28 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.272 1.143 . . . . 0.0 109.457 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.89 -94.87 1.74 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.9 m 55.11 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.947 . . . . 0.0 110.636 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 16.1 mttm -60.05 123.8 18.25 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.101 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -49.75 -26.29 3.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.152 -0.967 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 -12.67 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.622 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -101.88 -16.86 16.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 111.038 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.86 151.96 11.0 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.108 -0.995 . . . . 0.0 109.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.21 156.06 42.04 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.237 1.125 . . . . 0.0 110.858 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.25 -18.14 56.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.622 -0.673 . . . . 0.0 110.589 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.25 1.02 22.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.433 ' CD1' HD13 ' A' ' 23' ' ' ILE . 68.6 t90 -61.79 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.087 -1.008 . . . . 0.0 109.72 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t 52.84 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.539 -0.725 . . . . 0.0 110.912 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.09 172.73 0.2 Allowed Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.507 -0.746 . . . . 0.0 110.91 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -76.71 -57.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.408 1.215 . . . . 0.0 111.177 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.8 mm -75.65 98.29 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -0.769 . . . . 0.0 110.192 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m 51.96 45.04 28.95 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.507 -0.746 . . . . 0.0 110.664 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.53 169.65 10.84 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -168.29 174.9 2.03 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.967 . . . . 0.0 110.289 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.05 -164.78 0.12 Allowed 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.465 1.245 . . . . 0.0 110.66 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 39.8 mmtm -81.68 -21.55 38.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 p -75.72 -1.3 24.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 111.558 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -114.29 11.29 17.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.01 -1.056 . . . . 0.0 111.343 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.465 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 11.3 m-85 -116.66 -170.29 1.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.0 110.456 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -160.12 123.53 3.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 109.447 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mtmt -58.42 167.19 1.47 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.277 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -81.15 -27.53 35.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.357 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.92 158.08 4.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.49 -0.756 . . . . 0.0 110.756 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.695 -179.819 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.18 0.514 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -82.33 156.33 24.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.456 ' CZ2' ' CD ' ' A' ' 50' ' ' LYS . 28.5 m95 -130.41 167.93 17.79 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.7 139.71 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.82 -1.175 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -102.04 121.0 41.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -56.11 -20.37 17.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.458 -0.776 . . . . 0.0 111.11 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.22 -63.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.86 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -144.88 44.24 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.212 -0.93 . . . . 0.0 111.976 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.39 20.25 43.91 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.947 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD2' ' CZ ' ' A' ' 48' ' ' PHE . 31.6 t80 -64.16 132.21 49.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -1.137 . . . . 0.0 108.195 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 12' ' ' TYR . 37.2 mt -119.52 166.66 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.355 1.074 . . . . 0.0 112.233 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 16.2 t80 -127.19 109.2 11.59 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -78.86 73.94 5.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 12' ' ' TYR . 1.2 tt0 -50.4 -25.73 4.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.741 -0.6 . . . . 0.0 110.812 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.24 -25.37 64.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.7 -54.31 2.5 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 110.247 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.6 68.12 0.54 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t0 21.61 82.09 0.13 Allowed Pre-proline 0 N--CA 1.51 2.53 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.43 -21.32 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.664 1.35 . . . . 0.0 109.955 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -80.29 -45.16 18.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.447 -0.783 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.91 -35.14 17.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.47 -0.769 . . . . 0.0 110.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.06 52.04 0.85 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 36' ' ' TRP . 18.8 mm -89.68 155.69 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.491 -1.005 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -47.62 145.36 4.34 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.602 . . . . 0.0 111.444 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.17 105.46 1.2 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.5 1.263 . . . . 0.0 110.329 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.52 83.59 0.31 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -140.09 117.14 11.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.677 -0.896 . . . . 0.0 110.024 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -51.76 126.68 18.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 110.098 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -42.26 -29.27 0.24 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.449 -0.782 . . . . 0.0 112.165 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.304 -0.873 . . . . 0.0 110.93 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -87.0 -31.69 20.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.683 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.424 HD22 ' CG ' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -47.2 149.78 1.67 Allowed Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.464 -0.772 . . . . 0.0 111.702 -179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -85.28 -178.29 3.04 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.57 1.3 . . . . 0.0 110.482 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.42 -14.67 59.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.637 -0.664 . . . . 0.0 110.7 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.63 -12.73 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.256 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CG ' HD22 ' A' ' 32' ' ' LEU . 55.8 t90 -96.25 95.79 8.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.09 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.73 -166.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 109.905 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.3 146.54 62.01 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.714 -0.617 . . . . 0.0 110.005 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.21 -171.19 0.75 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.316 1.166 . . . . 0.0 110.783 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.4 mt 54.56 23.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 110.553 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -160.77 -43.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.16 -140.06 11.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -155.34 61.56 2.98 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.55 -0.971 . . . . 0.0 110.921 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 51.4 Cg_endo -93.07 125.74 0.62 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.068 1.036 . . . . 0.0 109.93 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -58.11 -39.49 78.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.277 -0.889 . . . . 0.0 110.034 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -80.11 57.15 2.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 110.208 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -114.5 -42.71 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.258 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -79.39 -179.49 6.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.858 0.837 . . . . 0.0 111.326 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.11 144.72 14.68 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CD ' ' CZ2' ' A' ' 3' ' ' TRP . 1.1 mtmt -61.89 170.66 1.98 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 tp -106.5 61.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.692 0.758 . . . . 0.0 109.728 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -57.06 -50.61 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.849 -0.532 . . . . 0.0 110.716 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.779 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.005 0.431 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -118.97 166.7 12.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.715 . . . . 0.0 110.37 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.501 ' CZ3' ' CD1' ' A' ' 29' ' ' PHE . 12.8 m95 -130.0 106.44 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.737 -0.602 . . . . 0.0 109.4 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.7 147.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.649 0.738 . . . . 0.0 111.146 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -100.89 101.17 11.93 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -54.73 -21.57 11.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 111.455 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.2 mp -82.46 -9.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.339 -0.851 . . . . 0.0 111.232 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.1 p -148.2 -47.23 0.16 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.955 -1.09 . . . . 0.0 111.225 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.27 -13.89 9.5 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -52.5 140.56 22.34 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.17 -1.194 . . . . 0.0 109.655 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.08 121.4 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.48 -0.763 . . . . 0.0 111.343 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 38.3 t80 -85.92 111.23 20.04 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -79.51 81.63 5.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.71 0.767 . . . . 0.0 109.427 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -54.08 -21.32 8.2 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.755 -0.591 . . . . 0.0 110.933 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -29.14 70.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.933 . . . . 0.0 108.754 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.34 -43.5 2.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.97 -108.21 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.44 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.33 -14.35 42.5 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.353 1.186 . . . . 0.0 110.694 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.91 -39.11 31.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -92.24 17.76 9.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.563 -0.711 . . . . 0.0 110.448 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.08 65.07 3.81 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.5 mm -114.27 165.4 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.733 -0.863 . . . . 0.0 111.958 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 148.93 72.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.675 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 105.25 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.237 1.125 . . . . 0.0 110.709 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.67 61.73 1.35 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 m -115.99 134.05 55.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.934 -0.745 . . . . 0.0 109.833 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -76.87 124.84 28.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.661 -0.65 . . . . 0.0 110.307 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CD1' ' CZ3' ' A' ' 3' ' ' TRP . 6.3 t80 -45.55 -43.61 12.1 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.166 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.42 -25.49 10.1 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -103.56 -87.42 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 36' ' ' TRP . 6.7 mt 52.15 179.52 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.295 0 O-C-N 120.99 -1.069 . . . . 0.0 110.042 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -83.63 -164.05 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 109.804 -0.883 . . . . 0.0 109.804 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -93.44 160.41 14.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 110.475 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 58.33 17.24 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.486 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 76.4 t90 -65.21 112.9 3.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.181 -0.949 . . . . 0.0 109.35 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m -146.54 -149.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.399 -0.813 . . . . 0.0 110.062 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . . . -169.27 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.985 . . . . 0.0 110.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 38' ' ' ALA . 45.9 Cg_endo -70.74 -164.23 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 122.98 0.989 . . . . 0.0 110.486 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.6 tt -113.0 -26.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.726 . . . . 0.0 110.505 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 p -60.17 93.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 0.0 109.967 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.18 -177.53 6.89 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -147.5 61.83 6.58 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.47 -1.018 . . . . 0.0 111.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 50.5 Cg_endo -96.11 119.67 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.25 -1.096 . . . . 0.0 109.25 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.41 65.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.148 -0.97 . . . . 0.0 109.818 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 p -80.71 54.11 2.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.01 31.1 4.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 109.695 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 6.2 m-85 -120.28 -167.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.729 -0.607 . . . . 0.0 110.567 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -160.13 112.26 2.02 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.675 -0.641 . . . . 0.0 109.758 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 12.2 mtpt -55.88 177.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.442 -0.787 . . . . 0.0 110.67 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.65 18.1 5.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.584 -0.698 . . . . 0.0 111.181 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.19 170.08 0.22 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.175 -0.953 . . . . 0.0 110.768 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.72 -179.798 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.064 0.459 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -114.98 179.12 4.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 110.158 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.54 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -139.87 104.23 4.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 109.749 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.65 158.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.96 0.886 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.462 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -119.44 113.48 20.84 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.501 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -53.26 -22.62 7.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.432 -0.793 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.5 mt -58.81 -52.7 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.674 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -149.47 33.42 0.71 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.251 -0.905 . . . . 0.0 111.403 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 15.94 58.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.421 ' CD1' HD11 ' A' ' 5' ' ' LEU . 4.2 t80 -60.54 146.18 45.95 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.079 -1.248 . . . . 0.0 108.875 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 11' ' ' ILE . 42.7 mt -131.3 166.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 122.221 1.01 . . . . 0.0 111.624 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t80 -134.17 110.71 9.75 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.18 87.19 4.92 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.95 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.2 tt0 -53.55 -21.4 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.857 -0.527 . . . . 0.0 111.104 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.09 -31.18 71.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.229 -0.919 . . . . 0.0 108.844 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.26 -49.61 3.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.285 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.21 -107.84 1.08 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 95.35 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.497 -1.002 . . . . 0.0 109.076 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.19 -11.66 32.2 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.376 1.198 . . . . 0.0 111.416 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.79 -39.2 70.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.76 23.62 9.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 110.264 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.69 48.24 66.95 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 36' ' ' TRP . 47.0 mm -87.83 160.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.86 -0.788 . . . . 0.0 111.337 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 154.9 74.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.965 -0.459 . . . . 0.0 109.906 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.51 106.44 1.95 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.359 1.189 . . . . 0.0 110.0 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 69.33 1.38 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -119.17 124.61 47.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.7 -0.883 . . . . 0.0 110.289 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.3 mptt -62.14 113.52 2.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.818 -0.551 . . . . 0.0 109.856 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 26.2 t80 -49.22 -32.75 11.1 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.379 -0.826 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.18 -21.24 46.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.376 -0.827 . . . . 0.0 109.62 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -109.55 -81.82 0.57 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.412 ' CD2' ' HD3' ' A' ' 33' ' ' PRO . 6.1 mt 52.47 -179.63 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.085 -1.01 . . . . 0.0 109.605 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 49.3 Cg_endo -82.47 157.2 16.68 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.92 158.71 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.327 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t0 59.02 15.99 4.38 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.586 -0.696 . . . . 0.0 111.707 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.47 ' CD1' HD12 ' A' ' 23' ' ' ILE . 61.4 t90 -60.58 126.08 26.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.972 -1.08 . . . . 0.0 109.421 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -155.73 112.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . . . -55.58 -56.89 24.6 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.587 -0.696 . . . . 0.0 110.794 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 38' ' ' ALA . 48.0 Cg_endo -73.62 -165.09 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.162 1.085 . . . . 0.0 110.188 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.9 mt -67.6 -40.56 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.562 -0.711 . . . . 0.0 109.793 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -170.28 131.1 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 110.277 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.97 44.35 0.41 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.433 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -142.5 51.3 1.86 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.527 -0.984 . . . . 0.0 110.716 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 43.0 Cg_endo -68.66 -164.05 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.182 1.096 . . . . 0.0 110.48 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -93.54 -24.92 17.79 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.497 -0.752 . . . . 0.0 110.586 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -80.19 4.71 16.63 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.541 -0.724 . . . . 0.0 111.734 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -117.77 18.51 14.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.057 -1.027 . . . . 0.0 111.09 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.497 ' CD2' ' CZ ' ' A' ' 29' ' ' PHE . 10.1 m-85 -116.85 164.78 14.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.122 -0.986 . . . . 0.0 110.532 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -128.12 117.93 22.49 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 33.1 mtpt -57.07 -173.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.548 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 32.74 5.84 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.425 0.631 . . . . 0.0 109.748 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.08 -175.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.748 -0.595 . . . . 0.0 110.637 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.797 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.188 0.518 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 158.48 21.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.72 . . . . 0.0 110.687 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 17.1 m95 -131.83 112.84 12.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.62 158.65 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.467 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -116.8 101.11 8.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -24.87 2.02 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.409 -0.807 . . . . 0.0 111.809 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.45 -23.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.488 -0.758 . . . . 0.0 110.851 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.3 p -150.71 -41.84 0.12 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.136 -0.977 . . . . 0.0 111.702 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.67 -0.93 11.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.02 160.52 0.47 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.049 -1.265 . . . . 0.0 109.913 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.5 mm -134.88 125.65 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.386 -0.821 . . . . 0.0 111.248 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 48.0 t80 -93.85 111.22 22.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.37 87.1 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -52.55 -22.63 5.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.819 -0.55 . . . . 0.0 111.197 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.07 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.416 -0.803 . . . . 0.0 108.966 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.65 -30.45 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.68 -0.638 . . . . 0.0 109.857 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.56 -104.74 2.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.67 89.31 0.29 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.429 -1.042 . . . . 0.0 109.843 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.27 -22.84 52.74 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.41 1.216 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.28 -30.55 60.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.563 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.07 8.8 43.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.695 . . . . 0.0 110.625 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.19 63.84 4.95 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.06 166.71 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 110.91 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.68 145.71 98.62 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.814 -0.554 . . . . 0.0 110.333 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.53 119.55 5.8 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.351 1.185 . . . . 0.0 109.804 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.72 64.99 1.82 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -118.39 126.04 51.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.696 -0.885 . . . . 0.0 109.939 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -61.17 122.24 14.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.626 -0.671 . . . . 0.0 109.761 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 69.3 t80 -49.25 -26.95 3.31 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.265 -0.897 . . . . 0.0 110.993 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -19.67 53.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.44 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -87.77 -24.24 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 mt -56.79 142.76 71.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.254 -0.904 . . . . 0.0 109.798 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.67 -175.68 2.57 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.308 1.162 . . . . 0.0 110.992 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.37 -18.9 62.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.71 -0.619 . . . . 0.0 110.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.02 -14.28 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.453 -0.779 . . . . 0.0 110.07 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -89.74 127.52 35.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p -174.29 122.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 109.315 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.46 141.43 78.39 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 0.0 110.53 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.31 -21.74 17.22 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.23 1.121 . . . . 0.0 111.3 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.9 tt -54.52 -40.39 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.251 -0.906 . . . . 0.0 110.686 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.0 m -160.82 169.4 22.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.578 -0.701 . . . . 0.0 109.856 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.55 90.22 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.97 76.47 0.45 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.693 -0.886 . . . . 0.0 110.503 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 -164.14 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.387 1.203 . . . . 0.0 109.979 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -83.05 -56.41 3.81 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.473 -0.767 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.6 m -73.5 59.12 0.6 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.54 -0.725 . . . . 0.0 110.829 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -160.14 25.7 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.163 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 9.9 m-85 -119.03 171.32 8.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 110.014 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 92.92 2.99 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.579 -0.701 . . . . 0.0 109.676 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -60.62 164.59 4.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.59 -0.694 . . . . 0.0 110.28 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.16 59.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.692 -0.63 . . . . 0.0 110.34 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -47.56 -67.38 0.28 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.697 -0.627 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.097 179.621 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -100.58 -170.28 1.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.689 . . . . 0.0 110.112 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 8.0 m95 -140.27 119.36 12.76 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 14.0 p -117.95 146.28 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.33 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 tt -107.56 115.86 30.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.013 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -53.11 -40.3 64.06 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.241 -0.912 . . . . 0.0 111.397 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.61 -58.7 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -0.75 . . . . 0.0 110.598 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.409 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 33.1 p -93.18 -59.44 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.33 -0.856 . . . . 0.0 110.828 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.01 23.07 3.37 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 28.2 m-85 -54.91 165.91 0.58 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.989 -1.3 . . . . 0.0 109.692 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 36.3 mm -148.89 82.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.548 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 66.4 t80 -79.81 108.33 13.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -79.39 84.84 5.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 4.3 tt0 -49.0 -24.79 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.578 -0.701 . . . . 0.0 111.337 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -64.55 -29.9 70.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.411 -0.806 . . . . 0.0 109.036 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.58 -32.43 6.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.812 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.23 -104.46 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -175.45 88.77 0.3 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.396 -1.061 . . . . 0.0 110.088 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.85 -19.8 46.3 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.356 1.187 . . . . 0.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.15 -31.02 38.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.1 13.4 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.532 -0.73 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.25 67.08 2.39 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.4 167.36 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.693 -0.886 . . . . 0.0 111.113 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.36 145.51 95.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.913 -0.492 . . . . 0.0 110.309 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.24 120.21 6.17 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.324 1.171 . . . . 0.0 110.184 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 67.3 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 m -122.89 126.33 47.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.68 -0.894 . . . . 0.0 110.088 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.4 mttt -59.08 120.89 9.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.404 -0.81 . . . . 0.0 109.852 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 53.6 t80 -49.05 -44.01 41.28 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.328 -0.858 . . . . 0.0 110.799 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.9 -18.07 64.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.601 -0.687 . . . . 0.0 110.421 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.53 -8.29 29.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.391 -0.818 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.416 HD12 ' CE1' ' A' ' 12' ' ' TYR . 5.8 mt -57.47 155.54 19.36 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.052 -1.03 . . . . 0.0 109.89 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.54 -174.41 1.79 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 O-C-N 123.275 1.145 . . . . 0.0 110.852 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.11 -17.25 63.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.677 -0.64 . . . . 0.0 110.449 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.63 -16.06 45.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 109.999 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.405 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -109.16 117.46 34.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 109.862 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.6 p -174.84 123.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 109.028 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . . . -52.4 150.53 8.68 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.504 -0.747 . . . . 0.0 110.798 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.78 -14.6 32.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.408 1.215 . . . . 0.0 111.575 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.6 tp -54.27 159.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.131 -0.981 . . . . 0.0 110.395 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -53.88 100.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.417 -0.802 . . . . 0.0 110.727 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.5 97.7 0.03 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -130.19 52.56 9.63 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.586 -0.949 . . . . 0.0 110.405 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 46.3 Cg_endo -71.0 -164.11 0.14 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.333 1.175 . . . . 0.0 110.559 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.15 -26.37 65.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 0.0 110.515 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -80.03 2.7 22.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.764 -0.585 . . . . 0.0 111.516 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.82 -31.72 12.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.06 -1.025 . . . . 0.0 110.447 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 3.1 m-85 -79.82 -170.29 2.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -160.19 124.34 3.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 22.1 mtpt -52.28 177.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.281 -0.887 . . . . 0.0 111.294 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.46 -25.84 20.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 110.508 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.7 -29.88 19.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.304 -0.873 . . . . 0.0 110.902 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 t0 . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.705 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.11 0.481 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -116.0 176.99 4.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.341 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 15.5 m95 -135.66 105.36 6.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . 7.9 p -87.16 147.27 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.758 0.789 . . . . 0.0 110.942 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -105.32 116.27 31.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -54.61 -21.06 9.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.502 -0.749 . . . . 0.0 111.502 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.84 -61.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.324 -0.86 . . . . 0.0 110.571 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -131.07 0.23 4.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 111.753 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.94 35.61 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -63.17 129.1 38.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.311 -1.111 . . . . 0.0 108.895 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 35.8 mm -113.68 142.84 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.489 -0.757 . . . . 0.0 111.263 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.4 t80 -116.08 112.99 22.55 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -79.59 83.97 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.413 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.79 -17.39 22.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.662 -0.649 . . . . 0.0 110.698 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -63.01 -30.36 71.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.088 -1.007 . . . . 0.0 108.7 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -46.68 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.26 -107.03 0.82 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.28 94.5 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.374 -1.074 . . . . 0.0 109.115 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.6 -12.44 35.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.408 1.215 . . . . 0.0 111.292 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.07 -42.34 57.01 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -96.51 14.18 25.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 110.682 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.04 67.63 2.11 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.438 HD12 ' CD1' ' A' ' 36' ' ' TRP . 43.7 mm -103.98 166.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.908 . . . . 0.0 111.354 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.05 167.66 33.9 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 122.001 -0.437 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.94 110.51 2.61 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.391 1.206 . . . . 0.0 109.364 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.07 -91.07 1.18 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m 54.75 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.918 . . . . 0.0 110.618 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 125.95 25.63 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.115 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 25.6 t80 -50.57 -28.28 8.35 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -79.57 -0.91 35.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.625 -0.672 . . . . 0.0 110.64 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -122.59 -6.08 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 111.211 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.427 HD11 ' CD2' ' A' ' 36' ' ' TRP . 6.4 mt -52.45 162.87 0.83 Allowed Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 120.979 -1.076 . . . . 0.0 109.412 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -93.7 -165.54 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 120.874 1.05 . . . . 0.0 110.986 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.75 176.47 6.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.694 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t70 68.33 2.41 3.28 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.44 -0.788 . . . . 0.0 111.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' HD12 ' A' ' 23' ' ' ILE . 6.6 t90 -106.23 119.63 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.818 -1.176 . . . . 0.0 109.764 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.8 t -144.13 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 0.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.92 161.49 3.72 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.32 10.85 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.284 1.15 . . . . 0.0 110.269 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.2 mt 60.08 148.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 121.46 0.648 . . . . 0.0 110.745 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.2 p 44.57 -166.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.706 -0.621 . . . . 0.0 111.78 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.53 170.21 1.1 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . . . -171.28 -51.33 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.616 -0.932 . . . . 0.0 110.86 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 45.5 Cg_endo -94.03 118.18 0.29 Allowed 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 122.885 0.939 . . . . 0.0 109.95 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 -19.32 40.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 110.707 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 t -76.37 0.68 18.66 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.338 -0.851 . . . . 0.0 111.348 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -95.66 24.5 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.15 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -97.44 -170.82 2.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.981 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -160.21 118.08 2.59 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.769 -0.582 . . . . 0.0 109.733 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 28.2 mtmt -62.97 166.32 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 110.428 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.65 48.66 1.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.11 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.29 131.2 44.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.817 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.088 0.471 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -96.74 169.15 10.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.213 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.1 m95 -133.09 110.41 10.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.55 -0.719 . . . . 0.0 109.516 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . 8.5 p -89.03 147.59 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.045 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.32 97.73 7.76 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -50.84 -24.28 3.41 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.44 -0.788 . . . . 0.0 111.66 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.0 mt -75.8 -13.08 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.409 -0.807 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 76.1 p -148.97 -47.72 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.172 -0.955 . . . . 0.0 111.265 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.92 -10.37 7.91 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -50.58 146.65 5.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.118 -1.224 . . . . 0.0 110.114 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 36.2 mm -128.99 111.65 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.549 -0.719 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 51.8 t80 -79.96 110.46 15.36 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.56 87.39 5.14 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.8 tt0 -53.72 -21.32 6.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.798 -0.563 . . . . 0.0 111.174 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -29.75 70.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.255 -0.903 . . . . 0.0 108.898 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.92 -41.71 3.32 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 119.28 -106.39 1.25 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.6 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.43 -1.041 . . . . 0.0 109.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.15 -13.65 40.91 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.349 1.184 . . . . 0.0 110.979 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.28 -33.3 59.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 109.809 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.99 18.59 21.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.514 -0.741 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 55.9 27.38 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 36' ' ' TRP . 46.0 mm -98.62 163.92 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.612 -0.934 . . . . 0.0 110.846 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.09 156.5 74.31 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 122.011 -0.431 . . . . 0.0 109.971 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.88 99.46 0.87 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.302 1.159 . . . . 0.0 110.145 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 69.95 1.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 m -120.24 125.99 49.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.751 -0.852 . . . . 0.0 109.954 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mptt -61.23 119.46 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.591 -0.693 . . . . 0.0 109.883 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.516 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 44.5 t80 -50.96 -39.71 55.77 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.38 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.64 -13.41 62.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.661 -0.65 . . . . 0.0 110.31 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -112.56 2.78 16.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 111.252 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' CD2' ' HD3' ' A' ' 33' ' ' PRO . 7.0 mt -54.26 173.96 0.2 Allowed Pre-proline 0 N--CA 1.506 2.334 0 O-C-N 120.888 -1.133 . . . . 0.0 109.351 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 50.0 Cg_endo -88.46 -174.57 1.11 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 122.944 0.97 . . . . 0.0 110.899 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.33 170.18 16.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 109.853 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 69.0 0.94 2.97 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.541 -0.725 . . . . 0.0 112.146 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CD1' HD13 ' A' ' 23' ' ' ILE . 55.1 t90 -71.41 129.54 39.07 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.791 -1.193 . . . . 0.0 109.453 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.5 p -173.69 121.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.85 176.36 0.25 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.526 -0.733 . . . . 0.0 110.565 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.8 -12.66 26.55 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 O-C-N 123.503 1.265 . . . . 0.0 111.565 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.03 -169.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.196 -0.94 . . . . 0.0 110.287 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.5 m -104.9 93.75 4.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.557 -0.714 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.38 84.3 1.76 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -135.67 52.33 6.68 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.952 . . . . 0.0 110.527 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 44.5 Cg_endo -71.74 -168.73 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.246 1.129 . . . . 0.0 110.454 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -58.79 3.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.608 -0.683 . . . . 0.0 110.756 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 p -72.42 59.83 0.44 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.478 -0.764 . . . . 0.0 111.155 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.14 23.99 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 0.0 110.479 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.8 m-85 -119.69 -170.74 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.392 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -160.27 118.91 2.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.671 -0.643 . . . . 0.0 109.878 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 17.5 mtmm -62.18 163.45 8.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 0.0 109.926 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.98 -30.9 39.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.583 -0.698 . . . . 0.0 110.106 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.45 116.95 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.845 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.61 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.09 0.471 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -114.99 175.34 5.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.3 m95 -136.58 106.66 6.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.504 -0.748 . . . . 0.0 109.207 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -86.23 151.07 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.683 0.754 . . . . 0.0 111.431 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.445 ' HG ' ' CE1' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -110.8 117.96 34.85 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -54.18 -21.62 9.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.364 -0.835 . . . . 0.0 111.475 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.21 -59.39 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.851 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -137.62 34.22 2.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.195 -0.94 . . . . 0.0 111.51 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.67 20.57 39.78 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.418 ' CD2' HD13 ' A' ' 5' ' ' LEU . 26.9 t80 -60.95 129.25 40.47 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.107 . . . . 0.0 109.035 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.76 164.51 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.838 0.828 . . . . 0.0 111.33 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.417 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 33.3 t80 -135.7 112.52 10.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.5 79.2 5.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.893 0.854 . . . . 0.0 109.166 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.28 -21.45 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.708 -0.62 . . . . 0.0 111.005 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.58 -30.69 71.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.323 -0.86 . . . . 0.0 108.87 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.87 -45.66 3.18 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.83 -107.79 1.04 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.25 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.422 -1.046 . . . . 0.0 109.456 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.383 1.202 . . . . 0.0 111.106 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -75.06 -45.7 39.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.936 . . . . 0.0 110.054 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.35 17.48 9.77 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.688 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.1 60.18 9.37 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.4 mm -101.44 166.57 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.771 -0.841 . . . . 0.0 111.098 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.91 153.35 75.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.878 -0.514 . . . . 0.0 109.777 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.46 112.5 3.36 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.251 1.132 . . . . 0.0 110.236 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.52 66.24 1.81 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.8 m -114.44 118.36 33.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.777 -0.837 . . . . 0.0 110.042 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -59.22 123.68 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -48.2 -28.62 3.1 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.301 -0.874 . . . . 0.0 111.142 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.19 -20.11 52.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.547 -0.721 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.51 -15.18 27.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.355 -0.841 . . . . 0.0 111.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -53.72 162.48 1.33 Allowed Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.031 -1.043 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -93.69 -165.72 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 120.91 1.073 . . . . 0.0 110.932 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -80.11 176.39 9.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.354 0.597 . . . . 0.0 109.981 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 67.78 3.36 3.44 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.898 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CD1' HD11 ' A' ' 23' ' ' ILE . 23.2 t90 -96.92 125.62 41.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.84 -1.162 . . . . 0.0 109.384 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.24 -80.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -169.72 178.94 0.84 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.42 -22.49 21.48 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.309 1.163 . . . . 0.0 110.822 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.7 tp -159.4 -40.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.84 . . . . 0.0 110.683 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 p -78.18 146.55 34.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.329 -0.857 . . . . 0.0 110.421 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.94 172.92 30.89 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . . . -171.68 -52.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.996 . . . . 0.0 110.944 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -89.95 138.9 3.03 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 O-C-N 122.866 0.93 . . . . 0.0 110.291 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -58.88 -44.5 91.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.411 -0.806 . . . . 0.0 110.083 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 m -72.39 64.24 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.606 -0.684 . . . . 0.0 109.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -157.14 28.11 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 7.6 m-85 -117.92 -169.03 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.563 -0.711 . . . . 0.0 110.515 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -159.33 123.11 3.79 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.706 -0.621 . . . . 0.0 109.427 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 20.9 mtpt -57.69 178.11 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.469 -0.769 . . . . 0.0 110.552 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -95.28 -26.06 16.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.697 -0.627 . . . . 0.0 110.321 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.49 178.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.467 -0.77 . . . . 0.0 111.033 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.095 179.864 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -120.54 176.23 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.372 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.518 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.3 m95 -141.4 110.0 6.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.698 . . . . 0.0 109.435 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.3 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.844 0.831 . . . . 0.0 111.511 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -111.42 117.41 33.0 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -58.04 -19.84 34.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.542 -0.724 . . . . 0.0 111.155 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.41 -48.71 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.854 . . . . 0.0 110.754 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -150.61 30.63 0.66 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.27 -0.893 . . . . 0.0 111.468 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.34 15.15 60.8 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.677 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.87 138.48 57.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.088 -1.242 . . . . 0.0 108.824 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.4 mm -121.41 114.18 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 42.8 t80 -81.09 111.37 17.48 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -79.43 85.83 5.19 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.155 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 5.9 tt0 -51.43 -23.36 3.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.786 -0.571 . . . . 0.0 111.283 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.37 -29.95 71.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.317 -0.864 . . . . 0.0 108.947 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -28.62 7.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.709 -0.619 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.06 -102.52 2.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -173.92 88.32 0.36 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.448 -1.031 . . . . 0.0 109.974 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.86 -19.01 58.79 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.421 1.222 . . . . 0.0 110.444 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -76.75 -29.96 56.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.782 . . . . 0.0 109.579 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.55 12.19 37.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.62 -0.675 . . . . 0.0 110.603 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.28 68.29 1.74 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.31 167.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.89 . . . . 0.0 111.138 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 143.08 92.39 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.925 -0.484 . . . . 0.0 110.504 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 114.53 3.97 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.263 1.138 . . . . 0.0 109.938 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.01 66.55 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.2 m -119.09 125.41 49.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.825 -0.809 . . . . 0.0 110.002 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -60.8 119.21 7.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.605 -0.684 . . . . 0.0 109.746 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.518 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.8 t80 -51.11 -28.12 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.244 -0.91 . . . . 0.0 110.577 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.72 -2.98 41.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.653 -0.654 . . . . 0.0 110.895 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -112.93 -15.87 12.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.889 . . . . 0.0 111.053 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD11 ' CG ' ' A' ' 36' ' ' TRP . 5.6 mt -54.54 150.64 16.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.09 -1.006 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.4 -175.75 2.48 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.285 1.15 . . . . 0.0 110.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.4 -16.51 61.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.722 -0.611 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.26 -13.39 49.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CG ' HD11 ' A' ' 32' ' ' LEU . 24.6 t90 -101.9 121.86 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -162.39 121.64 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.465 -0.772 . . . . 0.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . . . -74.81 -56.24 2.23 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.614 -0.679 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 38' ' ' ALA . 46.4 Cg_endo -73.47 -164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.315 1.166 . . . . 0.0 110.422 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.4 pt -59.29 -165.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -56.78 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.482 -0.761 . . . . 0.0 110.786 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 -65.83 0.88 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . 51.54 62.95 10.22 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.494 -1.004 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 42.6 Cg_endo -92.22 121.01 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.171 1.09 . . . . 0.0 110.072 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -61.03 -19.07 60.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.551 -0.718 . . . . 0.0 110.774 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -78.76 0.24 27.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.491 -0.756 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -87.4 -24.84 24.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -87.8 -170.32 2.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 0.0 110.425 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -160.3 121.9 3.14 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.686 -0.634 . . . . 0.0 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 34.0 mtmt -59.9 165.63 3.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.99 51.3 1.23 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.658 -0.651 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -55.16 132.4 47.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 110.705 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 t0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.159 179.833 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.051 0.453 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 -164.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.625 -0.672 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 8.0 m95 -138.53 117.1 12.12 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -121.78 152.29 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.015 -1.074 . . . . 0.0 113.281 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.01 117.96 35.39 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.18 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -54.48 -21.4 9.85 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.566 -0.709 . . . . 0.0 111.812 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.0 -61.09 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.247 -0.908 . . . . 0.0 110.984 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.4 p -80.18 -58.72 3.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.28 -0.887 . . . . 0.0 110.415 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.03 21.43 3.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 28.0 m-85 -55.98 164.18 1.28 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.991 -1.299 . . . . 0.0 109.515 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 35.3 mm -150.47 79.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.803 -0.561 . . . . 0.0 109.618 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 57.0 t80 -79.9 107.89 13.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.821 -1.175 . . . . 0.0 108.914 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -79.61 90.09 5.14 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 3.4 tt0 -52.75 -23.23 6.36 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.98 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.99 -29.04 70.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.431 -0.793 . . . . 0.0 108.942 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.32 -43.8 3.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.687 -0.633 . . . . 0.0 109.417 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 113.37 -105.81 1.7 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -179.84 90.42 0.2 Allowed Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.405 -1.056 . . . . 0.0 109.706 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.89 -20.67 45.03 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.319 1.168 . . . . 0.0 110.67 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -80.05 -33.77 38.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.392 -0.817 . . . . 0.0 110.276 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.06 17.3 11.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.15 65.13 3.68 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.01 167.38 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.646 -0.914 . . . . 0.0 110.83 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -78.25 151.3 78.16 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.77 -0.581 . . . . 0.0 110.219 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 119.3 6.01 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.399 1.21 . . . . 0.0 110.133 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.77 71.46 1.16 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.6 m -125.0 122.12 36.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.706 -0.879 . . . . 0.0 110.274 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.19 113.92 2.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.151 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 64.4 t80 -49.42 -31.72 10.28 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.37 -0.831 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.45 -12.18 60.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.548 -0.72 . . . . 0.0 110.611 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -127.85 19.41 6.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 12' ' ' TYR . 7.4 mt -62.65 171.03 1.97 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.324 -0.86 . . . . 0.0 109.39 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 -174.89 2.44 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.216 1.114 . . . . 0.0 110.47 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.81 -15.54 56.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.565 -0.709 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -67.42 -11.28 57.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CZ3' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -103.99 96.48 6.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.045 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -150.27 111.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.429 -0.794 . . . . 0.0 109.593 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.08 113.13 6.16 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.147 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 -14.2 38.11 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.148 1.078 . . . . 0.0 111.251 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.76 151.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 96.1 m 56.22 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.712 -0.618 . . . . 0.0 111.226 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.78 -141.22 11.09 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.403 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . . . -178.24 -57.86 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.528 -0.983 . . . . 0.0 111.271 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 43' ' ' ALA . 42.6 Cg_endo -69.42 -158.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 O-C-N 122.949 0.973 . . . . 0.0 111.071 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -89.58 -24.23 21.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.165 -0.96 . . . . 0.0 110.465 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -6.68 43.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.583 -0.698 . . . . 0.0 111.8 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.0 -21.73 23.36 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.049 -1.032 . . . . 0.0 110.915 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.7 m-85 -83.97 -170.74 3.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.261 -0.899 . . . . 0.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.12 119.42 2.79 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.485 -0.76 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 11.4 mtmt -55.29 165.63 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.86 -23.41 31.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.692 -0.63 . . . . 0.0 110.565 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -22.79 7.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.332 -0.855 . . . . 0.0 111.22 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.06 159.63 23.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 110.7 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.4 m95 -130.78 110.09 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.746 -0.596 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.58 142.33 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 110.98 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -97.81 103.27 15.2 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.522 -0.736 . . . . 0.0 111.26 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.1 mt -71.77 -20.45 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.83 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.1 p -148.56 -48.46 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.146 -0.972 . . . . 0.0 111.136 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.76 -3.95 7.0 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -51.75 155.29 1.73 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.324 . . . . 0.0 109.753 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -132.83 124.18 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.77 . . . . 0.0 111.233 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.432 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 35.5 t80 -93.45 111.34 22.98 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.4 87.59 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.055 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 2.7 tt0 -52.82 -22.35 5.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.782 -0.574 . . . . 0.0 111.156 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -31.65 72.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.313 -0.867 . . . . 0.0 108.883 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.71 -29.82 7.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.74 -0.6 . . . . 0.0 109.754 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 98.47 -104.62 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.65 88.99 0.32 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.429 -1.042 . . . . 0.0 109.947 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 -19.15 59.47 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.433 1.228 . . . . 0.0 110.382 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -80.04 -31.99 39.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.644 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -93.79 8.73 39.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.64 -0.662 . . . . 0.0 110.743 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.8 62.65 6.07 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -121.41 166.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.936 . . . . 0.0 110.729 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 t -67.7 146.31 98.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.827 -0.546 . . . . 0.0 110.302 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.19 122.44 8.03 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.351 1.185 . . . . 0.0 110.091 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.58 67.04 1.74 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -122.09 126.99 49.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.772 -0.84 . . . . 0.0 109.949 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 6.9 mptt -61.08 119.64 8.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -49.69 -39.58 37.18 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.183 -0.948 . . . . 0.0 110.784 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.07 -17.37 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.587 -0.695 . . . . 0.0 110.291 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -91.16 -21.92 20.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.876 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mt -54.94 151.43 16.01 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.21 -0.931 . . . . 0.0 109.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.71 178.88 6.14 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.272 1.143 . . . . 0.0 110.735 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.74 -18.02 63.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.659 -0.651 . . . . 0.0 110.528 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.7 -15.22 51.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.367 -0.833 . . . . 0.0 109.969 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.89 139.05 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -168.34 166.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 110.092 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.67 178.21 1.05 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.17 81.8 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.253 1.133 . . . . 0.0 110.591 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 40' ' ' ILE . 82.6 mt -135.47 169.04 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.646 -0.659 . . . . 0.0 109.577 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.6 p -54.95 -77.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.0 -143.56 0.42 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -161.65 57.93 0.85 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.458 -1.025 . . . . 0.0 111.396 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 43.4 Cg_endo -97.34 102.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 N-CA-C 109.328 -1.066 . . . . 0.0 109.328 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -22.91 12.47 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.259 -0.901 . . . . 0.0 110.7 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.3 t -80.07 6.16 12.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.475 -0.765 . . . . 0.0 111.392 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -80.9 4.85 17.96 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.018 -1.051 . . . . 0.0 111.268 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.3 m-85 -86.57 -169.83 2.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 110.854 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.04 119.0 6.21 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 7.7 mtmm -54.29 171.47 0.11 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 110.541 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.78 -22.84 42.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.66 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -53.76 135.85 40.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.439 -0.788 . . . . 0.0 110.953 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.74 -179.73 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.029 0.442 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -128.45 177.03 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 110.27 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 11.1 m95 -141.26 108.18 5.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.579 -0.701 . . . . 0.0 109.452 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.17 148.31 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.741 0.781 . . . . 0.0 111.22 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -106.33 116.41 31.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -55.43 -21.12 14.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.506 -0.746 . . . . 0.0 111.347 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 7' ' ' ILE . 92.8 mt -65.72 -56.34 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 110.732 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 t -136.19 27.76 3.16 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.343 -0.848 . . . . 0.0 111.219 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.35 50.54 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -62.18 131.49 49.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.2 mm -112.81 118.19 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 111.446 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 31.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -79.31 83.09 5.38 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.766 0.793 . . . . 0.0 109.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tt0 -53.36 -22.7 7.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.737 -0.602 . . . . 0.0 110.968 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 0.0 109.044 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.04 -37.07 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.489 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 111.41 -105.94 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.94 90.19 0.28 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.403 -1.057 . . . . 0.0 109.82 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.14 -16.08 53.33 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.403 1.212 . . . . 0.0 110.531 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -101.65 10.7 39.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.59 -0.694 . . . . 0.0 110.704 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.56 1.2 Allowed Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.67 163.38 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.939 . . . . 0.0 111.454 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.41 145.61 81.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.86 118.29 5.23 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.367 1.193 . . . . 0.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.65 64.97 1.97 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -117.07 126.85 53.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.842 -0.799 . . . . 0.0 109.673 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 11.7 mptt -61.28 123.73 18.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.551 -0.718 . . . . 0.0 109.624 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.5 t80 -48.99 -43.85 40.61 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.242 -0.912 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.8 -20.21 65.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.589 -0.694 . . . . 0.0 110.117 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -90.71 -15.54 30.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.438 -0.789 . . . . 0.0 111.333 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD12 ' CD2' ' A' ' 36' ' ' TRP . 5.6 mt -52.69 156.44 3.23 Favored Pre-proline 0 N--CA 1.506 2.341 0 O-C-N 121.028 -1.045 . . . . 0.0 109.686 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.62 -165.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.154 1.236 . . . . 0.0 110.937 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.98 -179.2 2.64 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.17 1.85 2.99 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.379 -0.825 . . . . 0.0 111.916 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CD2' HD12 ' A' ' 32' ' ' LEU . 52.0 t90 -101.35 103.14 14.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.849 -1.157 . . . . 0.0 108.644 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.9 t -142.73 116.35 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.475 -0.766 . . . . 0.0 110.352 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' N ' ' CD ' ' A' ' 39' ' ' PRO . . . -85.08 -50.14 0.56 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.152 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 38' ' ' ALA . 51.0 Cg_endo -82.63 -163.67 0.23 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 O-C-N 123.239 1.126 . . . . 0.0 109.993 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 tt -114.06 67.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 t -161.25 58.85 0.29 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.48 -155.8 36.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.37 71.4 82.29 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.452 -1.028 . . . . 0.0 110.236 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -93.58 114.62 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.154 1.081 . . . . 0.0 110.222 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -59.48 -24.85 63.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.565 -0.709 . . . . 0.0 110.355 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -8.52 54.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.743 -0.598 . . . . 0.0 110.781 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.91 -20.86 44.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 8.4 m-85 -95.05 -168.58 1.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.775 . . . . 0.0 110.673 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -158.84 123.23 4.04 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.733 -0.604 . . . . 0.0 109.371 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -56.3 165.58 1.03 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.577 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -82.84 -27.76 30.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 110.182 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -26.29 36.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.518 -0.739 . . . . 0.0 110.895 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.851 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.021 0.438 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.98 175.43 10.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 110.48 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.0 m95 -141.14 124.68 16.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -119.8 147.29 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.075 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 48' ' ' PHE . 1.3 tt -103.5 119.72 39.45 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.107 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -57.26 -38.89 74.56 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.369 -0.832 . . . . 0.0 111.119 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.57 -50.26 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.549 -0.719 . . . . 0.0 111.15 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 22.0 p -101.51 -57.25 2.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.219 -0.925 . . . . 0.0 110.606 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.94 25.78 3.5 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 24.0 m-85 -60.31 170.2 1.4 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.13 -1.217 . . . . 0.0 109.586 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 26.9 mm -147.74 89.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 55.0 t80 -79.76 111.71 16.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.877 -1.139 . . . . 0.0 108.8 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -79.47 85.07 5.28 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.686 0.755 . . . . 0.0 109.287 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.49 -22.32 7.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.66 -31.7 72.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 108.898 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.07 -53.74 2.61 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.445 0.64 . . . . 0.0 109.311 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 130.05 -108.54 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.33 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.411 -1.052 . . . . 0.0 109.283 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.6 -12.7 36.28 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.414 1.218 . . . . 0.0 111.135 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -77.63 -44.78 27.08 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.19 16.04 10.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.436 -0.79 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.74 40.16 88.35 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.429 HD11 ' CD1' ' A' ' 36' ' ' TRP . 38.3 mm -81.75 161.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.663 -0.904 . . . . 0.0 110.365 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 156.78 79.41 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.757 -0.589 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 112.32 3.28 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.272 1.143 . . . . 0.0 110.026 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.93 67.77 1.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -120.32 121.13 37.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.733 -0.863 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.2 119.36 6.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.744 . . . . 0.0 109.815 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 34.9 t80 -49.64 -29.16 6.8 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.224 -0.923 . . . . 0.0 110.961 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.87 -18.03 59.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.527 -0.733 . . . . 0.0 110.508 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -92.66 -19.69 21.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 111.001 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.32 166.79 0.82 Allowed Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.192 -0.942 . . . . 0.0 110.12 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.72 154.63 26.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -65.04 -16.65 63.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.637 -0.665 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.06 -7.68 48.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 110.235 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.429 ' CD1' HD11 ' A' ' 23' ' ' ILE . 40.6 t90 -71.06 132.55 45.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t -149.98 137.19 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.463 -0.773 . . . . 0.0 108.928 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HB1' ' CZ ' ' A' ' 10' ' ' TYR . . . -84.6 -48.49 0.65 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.675 -0.641 . . . . 0.0 111.939 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -74.66 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.055 1.029 . . . . 0.0 110.871 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -136.9 -67.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.049 -1.032 . . . . 0.0 110.075 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -151.24 36.27 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.34 57.95 0.47 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -160.85 55.4 0.65 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.638 -0.919 . . . . 0.0 110.221 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -163.05 0.1 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.381 1.2 . . . . 0.0 110.263 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -56.85 -36.51 70.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.393 -0.817 . . . . 0.0 110.276 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.85 60.35 3.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 0.0 109.758 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -159.34 -41.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 110.422 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 2.7 m-85 -79.44 -174.24 4.12 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.566 -0.709 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.11 114.81 2.28 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.638 -0.664 . . . . 0.0 109.651 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -58.37 163.6 2.97 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.534 -0.729 . . . . 0.0 110.19 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -29.9 22.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.643 -0.661 . . . . 0.0 110.208 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 48.41 -169.53 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 0.0 111.413 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.674 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -104.8 -166.87 1.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 11.6 m95 -141.47 121.03 13.3 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 10.3 p -120.88 152.42 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.058 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.3 118.32 36.01 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.324 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -53.43 -39.6 64.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.428 -0.795 . . . . 0.0 111.43 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.53 -59.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.782 . . . . 0.0 110.908 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.409 ' OG1' ' CE2' ' A' ' 10' ' ' TYR . 23.5 p -89.51 -58.2 2.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.322 -0.861 . . . . 0.0 110.678 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' A' ' 8' ' ' THR . . . 116.01 25.05 3.7 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 28.7 m-85 -56.97 168.76 0.6 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.133 -1.216 . . . . 0.0 109.44 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 33.7 mm -149.34 79.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 70.6 t80 -79.89 108.29 13.35 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.771 -1.205 . . . . 0.0 108.716 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.45 84.64 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.5 tt0 -49.92 -24.67 2.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.26 -30.0 71.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.803 . . . . 0.0 109.028 178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.54 -29.4 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 97.62 -102.94 2.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.99 89.25 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.429 -1.042 . . . . 0.0 109.761 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.14 -23.14 46.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.34 1.179 . . . . 0.0 110.488 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.95 -31.11 39.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.798 . . . . 0.0 110.0 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.11 16.82 15.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.485 -0.76 . . . . 0.0 110.523 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.59 63.2 5.43 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 ' CG2' HD21 ' A' ' 32' ' ' LEU . 47.0 mm -121.53 167.07 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.69 -0.888 . . . . 0.0 111.183 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.68 148.61 87.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.964 -0.46 . . . . 0.0 110.512 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 110.98 3.21 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.475 1.25 . . . . 0.0 109.997 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.71 1.37 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.9 m -121.39 126.06 48.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.787 -0.831 . . . . 0.0 110.084 -179.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 5.3 mptt -60.77 121.09 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 58.7 t80 -47.39 -50.43 22.5 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.349 -0.844 . . . . 0.0 111.016 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.85 -17.29 55.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.632 -0.668 . . . . 0.0 110.55 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.66 -12.55 23.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.24 -0.912 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 23' ' ' ILE . 6.4 mt -55.43 160.39 3.74 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.056 -1.028 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.32 -176.52 3.0 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.213 1.112 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.43 -16.24 62.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 0.0 110.582 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.73 -14.52 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.109 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -107.24 116.81 32.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 109.817 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 p -169.44 167.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.882 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.34 137.76 22.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 110.338 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.79 93.87 1.0 Allowed 'Trans proline' 0 N--CA 1.485 1.01 0 O-C-N 123.25 1.131 . . . . 0.0 110.519 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.4 mt -126.3 -65.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -150.36 36.34 0.66 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.67 . . . . 0.0 109.805 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.33 -120.45 2.09 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -170.91 64.23 0.42 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.964 . . . . 0.0 110.38 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -93.07 123.08 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.128 1.068 . . . . 0.0 109.855 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -33.15 69.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.346 -0.846 . . . . 0.0 110.03 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 p -80.34 50.19 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.759 -0.588 . . . . 0.0 110.738 179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.54 -27.77 7.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.4 m-85 -79.86 -168.73 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.691 . . . . 0.0 110.537 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.31 115.93 2.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.639 -0.663 . . . . 0.0 109.402 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -62.06 163.67 7.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.431 -0.793 . . . . 0.0 110.07 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -45.28 19.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 110.04 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 32.67 56.91 0.42 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.77 -179.808 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -89.54 155.05 19.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.535 -0.728 . . . . 0.0 110.787 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CE2' ' CG ' ' A' ' 50' ' ' LYS . 31.4 m95 -129.6 158.6 38.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.32 144.52 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.209 -0.932 . . . . 0.0 111.473 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -104.49 120.77 42.01 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -56.28 -20.43 18.65 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.429 -0.795 . . . . 0.0 110.969 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.3 mm -55.09 -66.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.309 -0.87 . . . . 0.0 110.965 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -143.33 31.91 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.192 -0.943 . . . . 0.0 111.754 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.34 17.19 79.68 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.84 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 32.6 t80 -61.58 129.57 41.72 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.079 -1.248 . . . . 0.0 108.5 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.58 147.42 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.13 -0.981 . . . . 0.0 112.511 -177.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.419 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 33.6 t80 -108.93 107.94 18.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -79.61 83.26 5.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.9 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.1 -17.65 19.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.883 -0.51 . . . . 0.0 110.871 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.17 -30.37 71.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.097 -1.002 . . . . 0.0 108.616 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.87 -41.52 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 125.82 -106.46 0.87 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.31 93.61 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.322 -1.105 . . . . 0.0 109.167 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.4 -14.79 46.79 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.387 1.204 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.0 -33.28 39.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.28 -0.888 . . . . 0.0 109.677 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -101.96 13.8 33.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.59 -0.694 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.71 71.9 0.67 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HD13 ' CD1' ' A' ' 36' ' ' TRP . 43.1 mm -116.52 162.33 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.545 -0.974 . . . . 0.0 110.855 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.06 170.67 14.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.873 -0.517 . . . . 0.0 110.034 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.03 112.3 3.09 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.34 1.179 . . . . 0.0 109.195 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.16 -98.1 2.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 -178.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.2 m 55.52 101.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.695 -0.885 . . . . 0.0 110.674 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 19.2 mttt -63.18 130.85 46.36 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.202 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -48.41 -30.4 5.0 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.139 -0.976 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.57 -18.6 59.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.475 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.43 -16.47 22.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 111.127 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.431 HD12 ' CD1' ' A' ' 36' ' ' TRP . 12.7 mt -54.36 165.22 0.89 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.042 -1.037 . . . . 0.0 110.061 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.42 175.77 9.29 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.238 1.125 . . . . 0.0 110.885 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.86 -4.15 53.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.649 -0.657 . . . . 0.0 110.865 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.36 21.28 6.23 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.431 ' CD1' HD12 ' A' ' 32' ' ' LEU . 71.3 t90 -92.25 117.43 29.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.863 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.86 139.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.597 -0.689 . . . . 0.0 110.017 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.83 105.1 16.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.686 -0.634 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.96 -30.22 21.71 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.304 1.16 . . . . 0.0 110.15 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pp -75.19 73.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 109.898 179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m 54.72 70.78 0.58 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.429 -0.794 . . . . 0.0 110.524 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.46 -135.56 2.76 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -168.15 173.64 2.63 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.614 -0.933 . . . . 0.0 110.354 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.32 -166.02 0.36 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.505 1.266 . . . . 0.0 110.823 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -66.65 -46.64 75.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.713 -0.617 . . . . 0.0 110.233 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -71.45 64.75 0.42 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.13 -34.84 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.537 -0.727 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -78.84 165.11 23.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.253 -0.905 . . . . 0.0 111.401 -179.096 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -160.13 126.53 4.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.86 148.72 2.09 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.3 -0.875 . . . . 0.0 111.213 -179.152 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.5 tt -79.91 -10.33 59.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.683 -0.636 . . . . 0.0 111.129 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.73 140.55 18.78 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.113 -0.992 . . . . 0.0 111.013 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 t70 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.868 -179.701 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.143 0.496 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -129.57 -178.87 4.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.699 . . . . 0.0 110.283 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.513 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -137.58 108.13 6.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.755 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -86.04 148.35 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.758 0.789 . . . . 0.0 111.311 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.431 ' HG ' ' CE1' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -107.49 119.06 38.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -53.24 -21.95 6.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 111.312 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.25 -68.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -130.94 37.41 3.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.283 -0.885 . . . . 0.0 111.72 -178.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.79 36.56 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' OH ' ' CH2' ' A' ' 36' ' ' TRP . 40.7 t80 -61.24 130.39 45.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.331 -1.1 . . . . 0.0 108.962 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.4 164.69 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.003 0.906 . . . . 0.0 111.728 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.7 t80 -133.26 113.08 12.23 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -79.32 77.05 5.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.843 0.83 . . . . 0.0 108.981 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.22 -22.67 4.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.855 -0.528 . . . . 0.0 111.198 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.72 -31.05 72.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.898 . . . . 0.0 108.975 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.63 -30.81 6.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 0.0 109.784 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 106.49 -106.5 2.55 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.98 88.18 0.35 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.484 -1.009 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.07 -24.08 52.69 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.412 1.217 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -31.9 57.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.757 . . . . 0.0 109.327 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -95.62 5.81 50.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.665 -0.647 . . . . 0.0 110.57 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.98 3.18 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.04 166.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.683 -0.892 . . . . 0.0 111.438 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -60.86 143.12 91.81 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 122.014 -0.429 . . . . 0.0 110.145 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 122.24 7.44 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.321 1.169 . . . . 0.0 110.147 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.89 67.04 1.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.2 m -118.73 119.99 36.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.77 -0.841 . . . . 0.0 110.309 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.4 125.76 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 179.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.513 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.1 t80 -46.84 -29.31 1.91 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.357 -0.839 . . . . 0.0 111.452 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -20.31 58.99 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.501 -0.749 . . . . 0.0 110.552 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.41 -24.63 25.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.79 138.5 70.74 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.335 -0.853 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.67 -179.27 5.03 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.148 1.078 . . . . 0.0 110.796 -179.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -16.2 59.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 110.65 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.69 -9.19 48.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.241 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.411 ' CH2' ' OH ' ' A' ' 10' ' ' TYR . 14.5 t90 -113.01 120.75 42.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t -149.62 -73.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.474 -0.766 . . . . 0.0 109.667 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.77 170.12 4.31 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.746 . . . . 0.0 110.094 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.97 -51.43 0.17 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.369 1.194 . . . . 0.0 110.495 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.1 tp -168.52 69.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 110.129 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 p -153.3 -56.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.83 -140.94 11.4 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . . . -172.77 -50.52 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.635 -0.92 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 44.5 Cg_endo -94.93 116.6 0.21 Allowed 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 120.705 0.937 . . . . 0.0 109.835 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -18.6 37.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.462 -0.774 . . . . 0.0 110.942 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 0.97 24.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.334 -0.854 . . . . 0.0 111.196 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.9 26.85 5.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 109.817 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.431 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 6.2 m-85 -96.67 -169.29 1.86 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 110.652 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -155.97 122.44 5.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -57.5 174.91 0.19 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.399 -0.813 . . . . 0.0 110.408 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tp -79.99 -32.35 39.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.632 . . . . 0.0 109.936 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 49.57 -167.7 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.466 -0.771 . . . . 0.0 111.174 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.674 -179.732 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.111 0.481 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.76 179.8 4.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.522 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 14.9 m95 -139.08 107.67 5.88 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.632 -0.668 . . . . 0.0 109.378 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.67 143.72 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.956 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -95.55 112.75 24.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -54.66 -21.45 10.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.414 -0.804 . . . . 0.0 111.384 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.02 -63.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.324 -0.86 . . . . 0.0 110.413 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -122.02 -22.4 5.69 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.374 -0.829 . . . . 0.0 111.549 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.85 18.02 7.61 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.96 140.44 58.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.33 -1.1 . . . . 0.0 108.703 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.53 149.06 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.444 -178.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.3 t80 -119.18 112.7 19.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.5 82.84 5.57 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.692 0.758 . . . . 0.0 109.311 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.02 -18.48 24.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.66 -0.65 . . . . 0.0 110.795 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.13 -31.33 72.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 0.0 108.698 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.19 -46.23 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.81 -108.0 0.87 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.42 94.3 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.377 -1.072 . . . . 0.0 109.297 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.07 -11.93 33.24 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.457 1.241 . . . . 0.0 111.217 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.82 -36.76 62.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.171 -0.956 . . . . 0.0 110.123 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -105.13 16.96 24.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.8 68.11 1.86 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.7 mm -106.29 165.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.662 -0.905 . . . . 0.0 110.938 -178.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.92 165.93 44.02 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.913 -0.492 . . . . 0.0 110.222 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.8 111.29 2.57 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.332 1.175 . . . . 0.0 109.233 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.71 -96.94 1.88 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 -178.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.9 m 55.08 102.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.741 -0.858 . . . . 0.0 110.688 178.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.9 mttt -63.0 131.86 50.05 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.104 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.6 t80 -48.75 -42.11 34.34 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.001 -1.062 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 17.0 mt-10 -72.13 -8.59 55.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.508 -0.745 . . . . 0.0 110.625 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -105.14 -12.73 15.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 36' ' ' TRP . 6.6 mt -52.27 168.91 0.28 Allowed Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.037 -1.04 . . . . 0.0 109.316 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -89.37 -167.29 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 122.953 0.975 . . . . 0.0 110.756 -178.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.54 169.66 13.36 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.321 0.581 . . . . 0.0 110.002 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t0 65.2 8.28 4.74 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.514 -0.741 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CD2' HD13 ' A' ' 32' ' ' LEU . 91.6 t90 -71.92 -75.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 109.175 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.3 t 43.69 -94.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.952 -0.467 . . . . 0.0 111.457 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -178.07 178.56 0.37 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.91 -1.119 . . . . 0.0 109.911 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.13 -31.88 11.49 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.206 1.108 . . . . 0.0 110.21 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 pt -142.34 154.3 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 109.988 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m 55.45 174.45 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.471 -0.768 . . . . 0.0 110.504 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.89 165.93 6.38 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . . . -177.8 -49.55 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.428 -1.042 . . . . 0.0 110.878 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 46.0 Cg_endo -92.79 133.1 1.04 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.008 1.004 . . . . 0.0 110.211 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -40.99 88.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.292 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.7 61.31 1.82 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.677 -0.64 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.08 23.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 110.214 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.442 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.4 m-85 -114.75 -168.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.832 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -160.0 123.76 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.747 -0.596 . . . . 0.0 109.69 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.5 mtmt -60.22 166.13 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 0.0 110.256 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -82.4 -25.9 33.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.704 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.17 177.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.385 -0.822 . . . . 0.0 110.836 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.645 -179.754 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.29 173.91 6.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.552 -0.717 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.508 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 10.9 m95 -139.04 107.05 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.026 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -98.43 106.29 18.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.14 -19.34 19.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.762 . . . . 0.0 111.472 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.15 -9.59 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 111.653 -178.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -149.33 -47.84 0.14 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.989 -1.069 . . . . 0.0 111.625 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.54 -15.1 9.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -51.71 117.75 2.91 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.117 -1.226 . . . . 0.0 109.584 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.76 140.2 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.527 -0.733 . . . . 0.0 111.332 -178.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 36.4 t80 -104.91 110.95 23.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.21 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.4 78.73 5.9 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.74 0.781 . . . . 0.0 109.26 -179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -51.52 -22.67 3.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.782 -0.574 . . . . 0.0 111.255 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.71 -29.65 70.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.234 -0.916 . . . . 0.0 108.997 178.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.66 -41.66 3.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.74 -0.6 . . . . 0.0 109.516 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 131.69 -109.17 0.85 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.37 91.45 0.18 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.411 -1.052 . . . . 0.0 109.806 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.41 -13.88 41.77 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.337 1.178 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -80.19 -41.03 26.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -95.57 12.2 30.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.519 -0.738 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.55 73.23 0.43 Allowed Glycine 0 N--CA 1.502 3.085 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.52 166.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.697 -0.884 . . . . 0.0 111.49 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.97 141.3 98.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.46 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.48 107.78 2.37 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.154 1.081 . . . . 0.0 110.671 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.1 63.99 1.3 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -123.34 134.85 53.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.759 -0.848 . . . . 0.0 110.122 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -70.88 132.27 45.0 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 13.3 t80 -47.97 -38.52 17.01 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.184 -0.947 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -67.92 -22.43 65.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.545 -0.722 . . . . 0.0 110.136 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.66 -19.96 30.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.535 -0.728 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD11 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -52.53 158.1 2.22 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.085 -1.009 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -93.59 -170.73 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.098 1.052 . . . . 0.0 110.436 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -76.76 174.87 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.651 -0.655 . . . . 0.0 109.902 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 66.34 7.07 4.66 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.399 -0.813 . . . . 0.0 111.801 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 91.0 t90 -86.54 4.21 40.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.931 -1.106 . . . . 0.0 110.392 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.84 -156.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.06 -1.025 . . . . 0.0 109.787 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . . . -171.22 -60.46 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.372 -0.83 . . . . 0.0 110.254 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 38' ' ' ALA . 45.2 Cg_endo -71.19 -177.58 2.41 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.022 1.011 . . . . 0.0 109.606 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.5 mt -77.67 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.35 -0.844 . . . . 0.0 109.282 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.1 p 42.12 39.22 1.31 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 120.94 -1.1 . . . . 0.0 112.062 179.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.23 -147.83 50.34 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -147.39 58.74 4.31 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.386 -1.067 . . . . 0.0 110.926 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 53.3 Cg_endo -86.55 142.28 6.95 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.064 1.034 . . . . 0.0 110.164 179.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -42.36 94.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.458 -0.777 . . . . 0.0 110.065 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.8 m -75.65 59.81 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.712 -0.617 . . . . 0.0 110.483 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -118.12 -29.35 5.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 0.0 110.174 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.0 m-85 -83.53 -169.18 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.595 -0.691 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.03 118.41 2.69 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 15.4 mtmt -55.06 171.12 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.391 -0.818 . . . . 0.0 110.71 -179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tt -80.04 -26.97 39.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.703 -0.623 . . . . 0.0 110.341 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -54.23 -29.75 47.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.465 -0.772 . . . . 0.0 110.997 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.759 -179.901 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.023 0.439 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.8 175.39 7.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.506 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 11.1 m95 -141.63 98.79 3.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.545 -0.722 . . . . 0.0 109.633 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -89.32 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.656 0.741 . . . . 0.0 111.224 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -99.65 101.98 13.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.391 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -57.79 -19.65 29.86 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.502 -0.749 . . . . 0.0 110.95 -179.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG23 HD12 ' A' ' 7' ' ' ILE . 83.1 mt -71.22 -19.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.303 -0.873 . . . . 0.0 111.059 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 t -154.14 -34.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.141 -0.974 . . . . 0.0 112.394 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.55 -17.09 6.54 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.442 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -51.05 150.01 3.34 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.096 -1.237 . . . . 0.0 109.871 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.491 HG21 HD12 ' A' ' 11' ' ' ILE . 45.0 mt -136.01 167.14 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.042 0.925 . . . . 0.0 111.789 -179.218 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.438 ' HB2' ' CH2' ' A' ' 36' ' ' TRP . 46.0 t80 -135.82 106.81 6.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -79.24 86.89 4.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . 3.3 tt0 -47.55 -25.88 1.26 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 0.0 111.697 -178.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.0 -29.72 70.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.394 -0.816 . . . . 0.0 109.179 178.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.23 -25.28 9.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.663 -0.648 . . . . 0.0 110.241 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 101.83 -105.61 2.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.62 87.07 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.46 -1.023 . . . . 0.0 109.912 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.11 -28.73 40.73 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.428 1.225 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.1 -32.15 72.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.605 -0.684 . . . . 0.0 109.191 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.91 6.39 36.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.699 -0.626 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.0 66.73 2.51 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.451 HG13 ' CD1' ' A' ' 36' ' ' TRP . 44.6 mm -118.99 167.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.175 0.988 . . . . 0.0 112.683 -176.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 t -48.04 121.01 8.5 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.699 179.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 131.13 18.17 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.179 1.094 . . . . 0.0 111.217 -179.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.78 59.7 8.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 32' ' ' LEU . 1.8 m -123.42 132.74 54.04 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.827 -0.808 . . . . 0.0 110.289 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -62.16 126.99 29.27 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.836 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 7.8 t80 -48.89 -27.01 2.77 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.43 -0.794 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -91.34 7.9 38.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -0.752 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -142.62 17.95 2.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 111.4 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.472 ' CD1' ' CG ' ' A' ' 36' ' ' TRP . 1.1 pt? -80.57 -163.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.093 -1.004 . . . . 0.0 108.866 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 32' ' ' LEU . 41.6 Cg_endo -89.66 143.02 4.27 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 122.457 0.714 . . . . 0.0 110.539 -177.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -52.93 171.69 0.06 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.691 -0.631 . . . . 0.0 110.432 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t70 72.88 -6.43 1.68 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.811 -0.556 . . . . 0.0 112.257 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.472 ' CG ' ' CD1' ' A' ' 32' ' ' LEU . 86.4 t90 -77.09 114.55 16.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.626 -1.296 . . . . 0.0 109.621 179.153 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m -153.78 -112.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.682 -0.636 . . . . 0.0 109.585 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.78 146.83 6.79 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.524 -1.36 . . . . 0.0 110.135 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.92 -30.49 11.07 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.351 1.185 . . . . 0.0 110.475 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.64 -57.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.632 -0.668 . . . . 0.0 109.877 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -161.52 82.31 0.6 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.629 -0.669 . . . . 0.0 110.412 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.14 153.39 25.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . . . -176.64 -51.28 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.544 -0.974 . . . . 0.0 110.705 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 50.9 Cg_endo -89.68 155.49 5.18 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 O-C-N 123.091 1.048 . . . . 0.0 110.58 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.56 -46.53 46.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.67 -0.644 . . . . 0.0 110.358 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -76.76 59.44 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.552 -0.717 . . . . 0.0 110.644 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.67 -29.81 3.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.374 -0.829 . . . . 0.0 110.795 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 7.2 m-85 -79.91 -167.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.4 -0.813 . . . . 0.0 110.263 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.22 123.24 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.715 -0.616 . . . . 0.0 109.526 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.0 mtmt -55.35 167.5 0.47 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.586 -0.696 . . . . 0.0 110.898 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tt -83.22 -25.49 31.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.659 . . . . 0.0 110.576 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -54.61 166.68 0.43 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.46 -0.775 . . . . 0.0 110.832 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.696 -179.907 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.154 0.502 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -123.13 172.47 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 110.256 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.502 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.05 109.81 7.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 109.417 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.47 150.23 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.896 0.855 . . . . 0.0 111.384 -179.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.445 ' HG ' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -110.02 118.0 35.26 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.749 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -19.96 22.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.414 -0.804 . . . . 0.0 111.126 -179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 7' ' ' ILE . 47.4 mm -64.47 -58.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.835 . . . . 0.0 110.653 -179.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 t -137.85 26.98 2.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.299 -0.876 . . . . 0.0 111.373 -179.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.17 65.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 5' ' ' LEU . 7.9 t80 -61.0 136.27 58.04 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -1.202 . . . . 0.0 108.791 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.4 mm -119.84 127.41 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.409 -0.807 . . . . 0.0 111.551 -178.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 29.0 t80 -94.55 113.57 25.42 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.5 82.44 5.63 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.388 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.61 -21.13 9.56 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.874 -0.516 . . . . 0.0 111.06 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.37 -32.97 74.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.305 -0.872 . . . . 0.0 108.975 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.67 -43.3 4.08 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 179.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.69 -108.27 1.16 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.99 94.38 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.359 -1.083 . . . . 0.0 109.243 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.93 -13.06 38.09 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.438 1.231 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -77.52 -40.02 44.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.204 -0.935 . . . . 0.0 109.949 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -97.94 16.57 20.53 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.596 -0.69 . . . . 0.0 110.674 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 58.0 16.7 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 36' ' ' TRP . 44.8 mm -100.43 157.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.97 . . . . 0.0 110.63 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -74.2 158.22 85.77 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.873 -0.517 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.57 109.52 2.65 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.299 1.157 . . . . 0.0 110.31 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.34 79.89 0.74 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -132.49 119.49 20.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.749 -0.854 . . . . 0.0 110.116 -179.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.2 mttt -55.38 121.57 9.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.477 -0.764 . . . . 0.0 110.04 179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.0 t80 -46.79 -46.36 20.57 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.396 -0.815 . . . . 0.0 111.269 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mt-10 -63.72 -18.83 64.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.475 -0.766 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -87.79 -21.13 25.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.35 163.7 2.34 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.114 -0.991 . . . . 0.0 109.829 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.43 163.12 38.52 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.148 1.078 . . . . 0.0 110.977 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.49 -18.62 61.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.632 -0.667 . . . . 0.0 110.622 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -75.68 -2.02 27.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 110.336 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.433 ' CD1' HD13 ' A' ' 23' ' ' ILE . 37.4 t90 -75.6 134.5 40.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.099 -1.001 . . . . 0.0 109.814 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 p -174.51 136.28 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.489 -0.757 . . . . 0.0 109.693 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.93 134.99 48.89 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.487 -0.758 . . . . 0.0 110.069 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.33 -173.29 1.41 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.128 1.068 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.6 mt 55.61 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.587 -0.696 . . . . 0.0 110.715 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -126.73 64.11 1.28 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.224 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.54 -157.05 10.86 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.78 165.58 13.54 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.563 -0.963 . . . . 0.0 110.174 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.88 -166.0 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.406 1.214 . . . . 0.0 110.647 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -71.84 -55.41 7.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.698 -0.626 . . . . 0.0 110.896 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -73.37 59.53 0.59 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.47 -0.769 . . . . 0.0 111.063 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -160.2 25.69 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -0.832 . . . . 0.0 110.295 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 10.2 m-85 -119.76 -168.11 1.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.406 -0.809 . . . . 0.0 110.45 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -160.07 121.57 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.681 -0.637 . . . . 0.0 109.362 179.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -54.98 173.11 0.1 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.375 -0.828 . . . . 0.0 110.841 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tp -86.74 -32.17 20.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.031 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -50.62 113.09 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.618 -0.676 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.643 -179.759 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 1.4199999999999999 110.261 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -114.92 173.39 6.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 2.6899999999999999 110.098 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.936 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 15.2 m95 -130.83 120.09 23.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.51000000000000001 109.736 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.965 ' HA ' HD11 ' A' ' 11' ' ' ILE . 13.3 p -100.21 139.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 1.3999999999999999 110.717 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.782 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -100.26 100.26 11.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 1.4299999999999999 109.991 179.726 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -44.39 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.351 -0.843 . . . . 2.46 110.943 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' LEU . 4.7 mt -66.96 -40.76 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 2.6099999999999999 110.474 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 8' ' ' THR . 0.5 OUTLIER -149.23 15.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 2.4199999999999999 110.52 -179.867 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 11' ' ' ILE . . . 77.65 -3.41 60.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.694 -1.362 . . . . 0.90000000000000002 109.694 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.909 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 39.9 t80 -39.89 125.39 1.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -1.225 . . . . 2.8900000000000001 109.615 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.965 HD11 ' HA ' ' A' ' 4' ' ' VAL . 27.9 mm -114.93 145.29 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 1.4299999999999999 111.204 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.9 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 27.6 t80 -116.04 109.55 17.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.769 -0.826 . . . . 2.0800000000000001 108.769 178.42 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 1.065 ' OD2' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -79.65 82.01 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 2.2200000000000002 110.35 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.574 ' CD ' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -51.81 -18.62 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 1.1399999999999999 110.049 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -18.59 65.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.74 109.621 179.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 1.065 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . . . -127.88 -23.85 3.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.768 . . . . 1.05 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.756 ' O ' ' HB2' ' A' ' 18' ' ' ASP . . . 101.87 -98.24 1.72 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.46999999999999997 109.677 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.756 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 164.74 97.82 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.244 -1.15 . . . . 1.3500000000000001 110.072 -179.886 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.82 -14.93 36.57 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.129 1.594 . . . . 0.90000000000000002 110.372 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -35.09 37.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 1.6000000000000001 109.901 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -102.38 24.81 9.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.51 110.081 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.11 58.53 4.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.502 -1.439 . . . . 0.66000000000000003 109.502 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.782 HD11 HD23 ' A' ' 32' ' ' LEU . 51.6 mm -104.92 166.71 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 1.3899999999999999 110.286 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.68 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -76.36 157.71 82.41 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 1.23 110.147 179.993 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.05 110.81 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.65000000000000002 110.317 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 14' ' ' GLU . . . 78.09 67.39 1.63 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.418 -1.473 . . . . 1.1100000000000001 109.418 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.747 HG23 ' HG ' ' A' ' 32' ' ' LEU . 1.1 m -118.23 114.16 22.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -1.124 . . . . 1.03 110.458 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HA ' ' CD ' ' A' ' 14' ' ' GLU . 6.4 mptt -47.98 117.48 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.268 -0.895 . . . . 2.1600000000000001 110.303 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 1.021 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 36.4 t80 -46.14 -41.17 12.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.895 . . . . 2.1600000000000001 110.116 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -68.44 -13.11 62.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 2.1400000000000001 110.371 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' LEU . 21.8 tt0 -99.52 -26.05 14.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 1.9199999999999999 110.547 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 1.08 HD22 ' HD2' ' A' ' 33' ' ' PRO . 6.4 mt -40.82 160.92 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.95 . . . . 1.1299999999999999 110.087 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 1.08 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.4 Cg_endo -78.62 -179.14 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.979 1.515 . . . . 1.1799999999999999 110.18 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -80.26 -31.97 38.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 2.7799999999999998 109.942 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -7.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 2.7599999999999998 109.706 179.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.696 ' HH2' ' HE2' ' A' ' 10' ' ' TYR . 23.7 t90 -90.72 135.25 33.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 1.03 110.191 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 1.249 HG21 ' CB ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER 175.75 104.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.034 . . . . 2.29 110.488 179.825 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 1.092 ' O ' ' O ' ' A' ' 37' ' ' VAL . . . -9.6 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.614 -0.678 . . . . 1.6899999999999999 111.156 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.575 ' O ' ' CG1' ' A' ' 40' ' ' ILE . 45.7 Cg_endo -85.71 37.76 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.158 1.609 . . . . 4.0300000000000002 110.713 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 mt -164.6 169.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.259 -0.9 . . . . 4.9199999999999999 109.734 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 1.183 ' O ' ' O ' ' A' ' 42' ' ' GLY . 66.7 p 10.47 122.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.054 . . . . 4.6200000000000001 110.335 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 1.183 ' O ' ' O ' ' A' ' 41' ' ' THR . . . -7.93 157.72 0.0 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.796 -1.322 . . . . 3.3900000000000001 109.796 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 1.249 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -148.71 52.49 1.19 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.274 -1.133 . . . . 3.5 110.09 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -73.7 148.36 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.004 1.529 . . . . 1.8 110.97 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.203 ' O ' ' N ' ' A' ' 47' ' ' GLU . 16.8 mmtt -41.78 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 2.6600000000000001 110.046 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.72 32.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 1.78 110.247 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 1.203 ' N ' ' O ' ' A' ' 45' ' ' LYS . 9.7 tp10 -128.45 -9.96 5.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 2.04 110.188 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.909 ' CE2' ' CD2' ' A' ' 10' ' ' TYR . 7.1 m-85 -103.89 -171.89 2.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 1.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 1.082 ' O ' ' O ' ' A' ' 50' ' ' LYS . 16.0 tt0 -160.18 100.95 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.39 -0.819 . . . . 2.2400000000000002 109.758 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 1.082 ' O ' ' O ' ' A' ' 49' ' ' GLU . 13.3 mtpt -29.17 -172.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.853 . . . . 2.2400000000000002 110.366 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.665 ' O ' ' O ' ' A' ' 52' ' ' GLU . 6.1 tt -111.09 -14.35 13.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.6099999999999999 109.821 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.665 ' O ' ' O ' ' A' ' 51' ' ' LEU . 6.2 pt-20 -37.53 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.427 -0.796 . . . . 2.3799999999999999 110.531 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t0 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 117.998 -1.001 . . . . 3.4300000000000002 110.23 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.484 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -122.84 175.84 6.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.619 -0.676 . . . . 0.0 110.288 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.9 108.09 6.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.596 -0.69 . . . . 0.0 109.658 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.782 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -87.73 147.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.842 0.829 . . . . 0.0 111.209 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -102.59 101.21 11.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -47.5 -24.75 0.91 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.532 -0.73 . . . . 0.0 112.431 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.23 -49.85 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 0.0 110.566 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -127.6 -29.99 2.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.37 -0.831 . . . . 0.0 111.597 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.85 4.99 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 17.4 t80 -72.3 131.82 43.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.384 -1.068 . . . . 0.0 108.831 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.782 HD13 ' HA ' ' A' ' 4' ' ' VAL . 37.9 mm -113.62 123.19 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.464 -0.772 . . . . 0.0 111.466 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 30.9 t80 -91.71 113.25 25.47 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.38 87.11 5.04 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.284 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -53.86 -21.4 7.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.858 -0.526 . . . . 0.0 111.23 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.74 -31.49 72.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.354 -0.841 . . . . 0.0 109.026 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -35.07 5.83 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.294 0.569 . . . . 0.0 109.574 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 109.62 -107.06 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -176.28 90.54 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.431 -1.041 . . . . 0.0 109.949 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.09 -19.3 63.22 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.422 1.222 . . . . 0.0 110.533 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -30.32 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 109.307 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 6.3 48.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.69 . . . . 0.0 110.56 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.26 70.13 1.06 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 24' ' ' SER . 47.1 mm -126.45 166.72 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.935 . . . . 0.0 111.2 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.8 t -65.42 148.08 98.25 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.012 -0.43 . . . . 0.0 110.409 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 119.07 5.91 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.488 1.257 . . . . 0.0 110.015 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.35 71.26 1.24 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 32' ' ' LEU . 12.6 m -122.5 122.61 39.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.722 -0.869 . . . . 0.0 110.407 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.7 mttt -60.82 114.81 3.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.614 -0.679 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -51.13 -30.02 15.15 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.17 -0.956 . . . . 0.0 110.728 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -77.24 -2.85 36.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.684 -0.635 . . . . 0.0 110.824 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.29 -3.89 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 111.262 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 36' ' ' TRP . 6.1 mt -58.83 156.54 24.49 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.128 -0.982 . . . . 0.0 109.864 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.3 Cg_endo -84.34 172.72 9.22 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.287 1.151 . . . . 0.0 110.404 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.88 -16.46 63.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.591 -0.693 . . . . 0.0 110.504 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -16.15 48.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 110.008 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 32' ' ' LEU . 30.7 t90 -93.39 129.9 39.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.797 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 37' ' ' VAL . 10.0 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.495 0.188 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 8.8 m-85 -109.78 -169.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.11 -0.994 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.692 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.2 tm-20 -160.07 121.34 3.12 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.482 -0.761 . . . . 0.0 109.534 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 18.4 mtpt -54.22 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.0 110.878 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.504 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.4 tt -96.89 -12.5 23.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.697 -0.627 . . . . 0.0 111.188 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.083 -1.011 . . . . 0.0 110.943 -179.619 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.066 0.46 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.58 178.65 6.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 17.1 m95 -140.39 143.86 35.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.2 p -118.92 137.53 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.752 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -92.76 95.7 9.71 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -51.11 -23.29 3.05 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.455 -0.778 . . . . 0.0 111.682 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.415 ' C ' HG23 ' A' ' 8' ' ' THR . 76.4 mt -81.37 -9.8 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.347 -0.845 . . . . 0.0 111.361 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 7' ' ' ILE . 71.1 p -147.94 -41.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.976 -1.077 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 -13.19 21.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.601 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.4 t80 -51.82 156.4 1.46 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.117 -1.225 . . . . 0.0 109.681 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 10' ' ' TYR . 43.6 mm -133.53 130.78 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 54.0 t80 -92.33 110.91 22.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.47 83.69 5.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.9 tt0 -51.02 -23.89 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.792 -0.568 . . . . 0.0 111.151 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.57 -30.09 71.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.411 -0.805 . . . . 0.0 108.935 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.39 -34.04 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.323 0.582 . . . . 0.0 109.62 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.62 -104.5 2.5 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -173.72 88.81 0.36 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.398 -1.06 . . . . 0.0 110.102 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 -21.1 62.04 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.427 1.225 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.46 -34.95 47.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.236 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -92.13 3.81 54.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.758 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.87 63.79 4.88 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.4 mm -119.89 165.99 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.95 . . . . 0.0 110.728 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -60.13 143.31 88.69 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.442 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.85 115.93 4.49 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.333 1.175 . . . . 0.0 109.679 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.46 66.48 1.6 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -120.21 125.13 47.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.857 . . . . 0.0 110.146 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 30.6 mmtt -59.7 122.64 14.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.66 -0.65 . . . . 0.0 109.396 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 36.6 t80 -48.43 -33.15 8.78 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.21 -0.931 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.15 -22.92 62.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -82.44 -26.23 32.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.67 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.633 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.9 mt -57.64 141.17 79.74 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.251 -0.905 . . . . 0.0 109.806 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.11 175.59 6.44 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.151 1.079 . . . . 0.0 110.536 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.65 -18.14 58.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 110.405 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.81 -15.51 42.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.382 -0.824 . . . . 0.0 110.131 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -86.23 136.14 33.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 0.0 109.805 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 37' ' ' VAL . 8.9 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.581 -0.699 . . . . 0.0 109.776 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.913 0.387 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 5.7 m-85 -105.33 -172.55 2.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.48 -0.762 . . . . 0.0 110.673 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.27 140.48 11.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CG ' ' CZ2' ' A' ' 3' ' ' TRP . 29.3 mtpt -57.99 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.194 -0.941 . . . . 0.0 110.452 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 41.2 tp -111.1 63.61 0.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.61 0.719 . . . . 0.0 110.036 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.718 -0.614 . . . . 0.0 110.612 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.117 0.484 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -118.11 174.69 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -140.01 110.82 6.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.0 109.733 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.6 p -81.93 150.68 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 111.112 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.33 118.18 35.15 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -55.46 -21.47 16.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.557 -0.714 . . . . 0.0 111.215 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 47' ' ' GLU . 88.4 mt -64.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -135.74 29.74 3.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 111.07 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.38 58.01 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CD1' HD12 ' A' ' 5' ' ' LEU . 5.8 t80 -60.99 134.95 57.62 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.229 -1.159 . . . . 0.0 108.722 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.775 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.6 mm -117.14 118.48 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.557 -0.714 . . . . 0.0 111.205 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 27.4 t80 -85.41 112.55 20.96 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -79.56 82.34 5.7 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.086 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tm-20 -57.04 -19.5 19.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.686 -0.634 . . . . 0.0 110.776 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -62.28 -31.04 71.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.2 -0.937 . . . . 0.0 108.751 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.73 -44.07 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 127.65 -108.55 0.96 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.24 94.42 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.339 -1.094 . . . . 0.0 109.174 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -13.62 40.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.386 1.203 . . . . 0.0 110.971 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.95 -33.41 57.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.246 -0.908 . . . . 0.0 109.745 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -106.04 11.46 31.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.736 . . . . 0.0 110.852 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.95 66.99 2.44 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.633 HD11 ' CD1' ' A' ' 36' ' ' TRP . 46.7 mm -103.6 164.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.924 . . . . 0.0 110.686 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.05 172.83 8.85 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.931 -0.481 . . . . 0.0 110.051 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.85 107.11 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.335 1.176 . . . . 0.0 109.41 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.14 -95.71 1.67 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD21 ' A' ' 32' ' ' LEU . 52.4 m 55.64 101.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.716 -0.873 . . . . 0.0 110.708 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -63.12 125.86 25.46 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.399 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.7 t80 -50.69 -25.93 4.87 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.49 -6.58 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.552 -0.718 . . . . 0.0 110.752 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.89 -16.52 14.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 27' ' ' THR . 11.5 mt -54.87 156.42 6.79 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.12 169.41 21.55 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.258 1.136 . . . . 0.0 110.985 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -71.74 -14.21 61.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.747 -0.596 . . . . 0.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -75.2 -3.12 31.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.411 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.633 ' CD1' HD11 ' A' ' 23' ' ' ILE . 74.8 t90 -80.32 120.78 24.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.141 -0.974 . . . . 0.0 110.024 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 36' ' ' TRP . 25.0 t . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 7' ' ' ILE . 6.9 tt0 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.648 0.261 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 13.7 m-85 -121.54 -172.45 2.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.865 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.826 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.4 tt0 -160.2 122.75 3.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 2.8 mtpt -58.48 173.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.34 -28.31 21.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.673 -0.642 . . . . 0.0 110.268 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.58 -0.7 . . . . 0.0 110.565 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.87 -166.76 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 110.314 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 9.3 m95 -138.07 122.5 18.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 9.9 p -118.47 146.48 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.269 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.5 tt -108.03 118.38 36.61 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.76 -39.81 68.71 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.326 -0.859 . . . . 0.0 111.414 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.56 -49.15 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.532 -0.73 . . . . 0.0 111.345 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -102.1 -57.77 2.0 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.13 -0.981 . . . . 0.0 110.79 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.5 23.64 4.02 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.717 ' O ' HD13 ' A' ' 11' ' ' ILE . 29.3 m-85 -55.76 164.34 1.15 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.049 -1.265 . . . . 0.0 109.588 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.717 HD13 ' O ' ' A' ' 10' ' ' TYR . 28.6 mm -146.5 83.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 63.8 t80 -79.8 109.94 14.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.984 -1.073 . . . . 0.0 108.659 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.45 85.81 5.2 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.1 tt0 -52.8 -22.6 5.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.778 -0.576 . . . . 0.0 111.089 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -29.39 70.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.376 -0.827 . . . . 0.0 109.086 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.69 -37.53 4.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.751 -0.593 . . . . 0.0 109.531 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 108.43 -105.26 2.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.59 90.13 0.22 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.377 -1.072 . . . . 0.0 109.795 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.6 -18.8 48.61 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.353 1.186 . . . . 0.0 110.638 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.14 -32.94 38.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.0 110.021 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -95.58 13.98 24.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.716 . . . . 0.0 110.735 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.5 66.37 2.89 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 32' ' ' LEU . 49.0 mm -122.51 166.89 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.692 -0.887 . . . . 0.0 111.157 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.465 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -73.06 148.97 89.44 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.826 -0.546 . . . . 0.0 110.537 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 120.4 6.51 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.386 1.203 . . . . 0.0 109.985 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.82 70.12 1.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.0 m -124.25 121.35 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.713 -0.875 . . . . 0.0 110.247 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.68 120.22 7.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.804 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB3' ' CE2' ' A' ' 3' ' ' TRP . 33.5 t80 -48.7 -38.27 20.95 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.221 -0.924 . . . . 0.0 110.936 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.93 -20.06 63.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -91.01 -16.42 27.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 110.955 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -56.03 159.34 5.83 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.073 -1.017 . . . . 0.0 110.144 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -85.91 -178.29 2.84 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.359 1.189 . . . . 0.0 110.5 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -67.55 -16.25 64.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.663 -0.648 . . . . 0.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.03 -16.72 46.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.824 . . . . 0.0 110.105 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CG ' HD13 ' A' ' 32' ' ' LEU . 1.1 t90 -106.93 114.1 27.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.424 -0.798 . . . . 0.0 109.256 179.759 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 120.983 0.42 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.5 m-85 -79.81 -173.03 3.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 110.325 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -149.34 110.01 4.26 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.671 -0.643 . . . . 0.0 109.38 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -57.76 168.3 0.93 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.584 -0.697 . . . . 0.0 110.509 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.9 48.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.209 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.596 -0.69 . . . . 0.0 110.153 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.23 149.02 23.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 110.774 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.43 ' CZ2' ' HD3' ' A' ' 50' ' ' LYS . 19.9 m95 -114.84 173.04 6.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.557 -0.714 . . . . 0.0 110.061 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 51' ' ' LEU . 7.6 p -130.35 142.05 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 110.29 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.89 117.56 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -52.66 -23.58 6.87 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.597 -0.689 . . . . 0.0 111.46 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CG1' HD22 ' A' ' 5' ' ' LEU . 42.3 mm -60.39 -57.39 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.377 -0.827 . . . . 0.0 110.586 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -146.81 36.59 0.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.225 -0.922 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.45 20.06 49.83 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD1' HD12 ' A' ' 5' ' ' LEU . 3.2 t80 -58.41 164.88 2.31 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.138 -1.213 . . . . 0.0 108.643 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.5 mt -141.52 165.79 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.282 1.039 . . . . 0.0 112.241 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 60.6 t80 -126.16 109.91 12.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.29 81.21 5.58 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.6 tt0 -48.94 -25.03 1.72 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.559 -0.713 . . . . 0.0 111.337 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.19 -30.02 71.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 0.0 108.905 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -111.5 -32.55 6.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.826 -0.546 . . . . 0.0 109.581 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.14 -103.26 2.7 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -174.48 88.7 0.33 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.41 -1.053 . . . . 0.0 110.059 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.64 -19.03 60.02 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.455 1.24 . . . . 0.0 110.533 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -34.7 39.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.77 11.2 23.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.677 -0.64 . . . . 0.0 110.765 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.02 55.5 27.77 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 24' ' ' SER . 49.5 mm -112.35 165.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.751 -0.852 . . . . 0.0 111.246 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.6 t -65.1 143.05 98.78 Favored Pre-proline 0 N--CA 1.494 1.775 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.097 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.95 123.09 8.16 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.275 1.145 . . . . 0.0 110.007 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.24 67.65 1.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 m -122.76 123.76 41.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.789 -0.83 . . . . 0.0 110.315 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.82 120.65 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.662 -0.648 . . . . 0.0 109.387 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 69.6 t80 -46.66 -49.39 19.29 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.322 -0.862 . . . . 0.0 111.258 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -59.59 -20.06 53.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.0 110.492 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.27 -29.34 34.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.31 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.449 HD21 HG23 ' A' ' 23' ' ' ILE . 11.5 mt -58.15 150.46 51.81 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.497 -0.752 . . . . 0.0 109.846 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.31 176.22 8.93 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.273 1.144 . . . . 0.0 110.724 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.11 -14.86 62.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.55 -0.719 . . . . 0.0 110.658 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.95 -9.13 50.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.476 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.44 ' O ' HG13 ' A' ' 37' ' ' VAL . 30.3 t90 -91.81 140.43 29.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 36' ' ' TRP . 16.5 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 8.3 m-85 -84.41 178.74 7.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 110.877 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.25 147.82 16.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -72.25 157.19 38.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.18 35.35 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.585 -0.697 . . . . 0.0 109.921 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.228 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.191 0.519 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -121.94 175.2 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m95 -139.41 104.88 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.676 -0.64 . . . . 0.0 109.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.8 p -83.84 150.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.718 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.8 116.13 31.74 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -54.27 -21.03 8.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.521 -0.737 . . . . 0.0 111.373 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 5' ' ' LEU . 93.9 mt -58.54 -68.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -123.29 -15.82 7.08 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.473 -0.767 . . . . 0.0 111.647 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 14.77 8.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.58 130.92 48.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.154 -1.204 . . . . 0.0 108.987 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.795 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.4 mm -111.34 114.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.706 . . . . 0.0 111.292 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 23.1 t80 -82.58 113.34 20.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.41 87.44 5.05 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.813 0.816 . . . . 0.0 109.398 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -55.49 -21.21 15.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.632 -0.668 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.55 -32.12 73.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 108.694 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.91 -46.65 3.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 116.31 -106.47 1.51 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 176.17 94.14 0.1 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.391 -1.064 . . . . 0.0 109.282 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.57 -12.79 36.67 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.416 1.219 . . . . 0.0 111.085 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.7 -40.41 55.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.178 -0.951 . . . . 0.0 109.834 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.88 17.38 10.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.02 41.81 92.65 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.3 mm -84.83 165.59 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.787 -0.831 . . . . 0.0 110.848 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.3 154.22 74.38 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.84 107.35 2.19 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.307 1.161 . . . . 0.0 109.8 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.46 65.05 1.47 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 32' ' ' LEU . 1.4 m -116.17 126.78 54.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.861 -0.787 . . . . 0.0 109.643 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 14.4 mtpt -63.56 118.44 8.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.731 -0.606 . . . . 0.0 110.048 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 30.4 t80 -51.34 -35.29 37.63 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.188 -0.945 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.06 -8.81 57.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.643 -0.661 . . . . 0.0 110.492 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -113.17 -4.42 13.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.201 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -52.99 171.4 0.23 Allowed Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 120.906 -1.121 . . . . 0.0 109.444 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.8 Cg_endo -89.26 -175.04 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 122.967 0.983 . . . . 0.0 110.824 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.29 171.43 15.07 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.649 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.9 -0.12 2.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.591 -0.693 . . . . 0.0 112.113 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.679 ' CD1' HD11 ' A' ' 23' ' ' ILE . 64.9 t90 -73.88 119.2 17.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.796 -1.19 . . . . 0.0 109.119 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' C ' ' A' ' 36' ' ' TRP . 57.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 109.827 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.5 m-85 -79.52 -172.49 3.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.541 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.741 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.7 tm-20 -160.23 125.59 3.97 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.753 -0.592 . . . . 0.0 109.651 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.418 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 21.2 mtmt -63.12 168.23 4.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.103 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.88 29.52 6.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 110.429 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.02 0.438 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.65 159.29 20.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.568 -0.707 . . . . 0.0 110.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.538 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.6 m95 -132.54 112.11 11.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -81.03 150.98 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.467 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -114.57 120.93 41.89 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -52.21 -22.14 4.06 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.483 -0.761 . . . . 0.0 111.715 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 5' ' ' LEU . 95.7 mt -56.15 -74.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.725 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -133.06 20.0 4.09 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.36 23.1 55.34 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.68 ' O ' HD13 ' A' ' 11' ' ' ILE . 3.9 t80 -59.3 152.12 21.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.292 -1.122 . . . . 0.0 108.783 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.2 mm -135.4 137.9 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.326 -0.859 . . . . 0.0 111.654 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 49.8 t80 -105.11 112.71 25.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.26 81.96 5.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -50.19 -24.78 3.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.615 -0.678 . . . . 0.0 110.869 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.41 -31.92 73.21 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -107.2 -52.33 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.13 -107.42 1.04 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -175.61 88.72 0.29 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -14.39 44.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.475 1.25 . . . . 0.0 110.688 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.06 -37.15 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.309 -0.869 . . . . 0.0 109.793 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.33 12.98 27.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 110.701 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.68 66.6 2.7 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 32' ' ' LEU . 50.9 mm -119.39 166.06 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.964 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -65.06 147.52 98.47 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.992 -0.442 . . . . 0.0 110.673 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 48.8 Cg_endo -74.97 111.4 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.391 1.206 . . . . 0.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 66.31 1.47 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -117.81 127.85 54.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.826 -0.808 . . . . 0.0 110.006 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 18.8 mmtm -63.33 118.53 8.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.538 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 57.9 t80 -49.18 -34.85 15.46 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.287 -0.883 . . . . 0.0 111.092 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.79 -18.08 62.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -93.17 -17.76 23.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.161 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 23' ' ' ILE . 8.0 mt -58.64 155.53 29.08 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.15 -0.969 . . . . 0.0 110.137 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.06 165.31 26.27 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.31 1.163 . . . . 0.0 110.245 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.16 -12.35 60.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.682 . . . . 0.0 110.845 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.21 -1.88 28.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.748 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.46 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.8 t90 -86.12 127.4 34.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 0.0 109.883 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 36' ' ' TRP . 15.8 m . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 0.0 109.724 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.641 0.257 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 14.2 m-85 -125.11 -173.93 2.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.307 -0.871 . . . . 0.0 110.994 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.83 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.4 mt-10 -160.41 131.4 5.62 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 23.5 mtmt -76.11 151.92 36.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -97.71 47.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.631 -0.668 . . . . 0.0 110.157 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.743 . . . . 0.0 110.709 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HD3' HD13 ' A' ' 51' ' ' LEU . 9.7 mtpt -111.21 173.7 6.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 0.0 110.063 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -139.72 111.34 7.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.494 -0.754 . . . . 0.0 109.623 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.3 p -87.61 145.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.873 0.844 . . . . 0.0 110.96 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.627 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -96.42 98.98 10.68 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -52.27 -24.33 7.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.384 -0.823 . . . . 0.0 111.153 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 5' ' ' LEU . 50.4 mm -75.93 -13.87 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 7' ' ' ILE . 78.7 p -149.72 -54.14 0.16 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.094 -1.004 . . . . 0.0 111.061 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 132.59 -9.18 5.27 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 11' ' ' ILE . 4.7 t80 -50.62 150.57 2.7 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.267 . . . . 0.0 110.075 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.1 mm -130.08 123.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.502 -0.749 . . . . 0.0 110.939 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 32.2 t80 -88.81 111.54 22.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -79.81 84.99 5.52 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.292 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -55.25 -20.18 10.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.582 -0.699 . . . . 0.0 110.839 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -61.78 -30.41 70.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.146 -0.971 . . . . 0.0 108.819 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.36 -41.78 3.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.0 109.067 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.17 -108.05 1.17 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.25 95.12 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.325 -1.103 . . . . 0.0 109.045 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.46 -12.57 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.301 1.158 . . . . 0.0 111.247 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.94 -33.82 72.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.221 -0.924 . . . . 0.0 109.899 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -111.53 16.09 20.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.56 -0.713 . . . . 0.0 110.802 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.29 62.97 5.75 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 36' ' ' TRP . 42.4 mm -94.13 163.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.968 . . . . 0.0 110.598 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.01 172.9 8.66 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.863 -0.523 . . . . 0.0 110.007 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.84 108.42 2.28 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.272 1.143 . . . . 0.0 109.457 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.89 -94.87 1.74 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 32' ' ' LEU . 51.9 m 55.11 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.947 . . . . 0.0 110.636 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 16.1 mttm -60.05 123.8 18.25 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.101 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -49.75 -26.29 3.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.152 -0.967 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 -12.67 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.622 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -101.88 -16.86 16.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 111.038 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 27' ' ' THR . 10.4 mt -53.86 151.96 11.0 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.108 -0.995 . . . . 0.0 109.988 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.21 156.06 42.04 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.237 1.125 . . . . 0.0 110.858 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.25 -18.14 56.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.622 -0.673 . . . . 0.0 110.589 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.25 1.02 22.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.73 ' CD1' HD11 ' A' ' 23' ' ' ILE . 68.6 t90 -61.79 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.087 -1.008 . . . . 0.0 109.72 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.539 -0.725 . . . . 0.0 110.912 179.624 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.518 0.199 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 11.3 m-85 -116.66 -170.29 1.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.0 110.456 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.678 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.8 mm-40 -160.12 123.53 3.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 109.447 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mtmt -58.42 167.19 1.47 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.277 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.547 HD13 ' HD3' ' A' ' 2' ' ' LYS . 9.2 tt -81.15 -27.53 35.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.49 -0.756 . . . . 0.0 110.756 -179.75 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.18 0.514 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -82.33 156.33 24.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 28.5 m95 -130.41 167.93 17.79 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.7 139.71 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.82 -1.175 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -102.04 121.0 41.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -56.11 -20.37 17.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.458 -0.776 . . . . 0.0 111.11 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 5' ' ' LEU . 86.6 mt -59.22 -63.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.86 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -144.88 44.24 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.212 -0.93 . . . . 0.0 111.976 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.39 20.25 43.91 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.947 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.724 ' HD2' HD12 ' A' ' 5' ' ' LEU . 31.6 t80 -64.16 132.21 49.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -1.137 . . . . 0.0 108.195 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.2 mt -119.52 166.66 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.355 1.074 . . . . 0.0 112.233 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.609 ' OH ' HD11 ' A' ' 32' ' ' LEU . 16.2 t80 -127.19 109.2 11.59 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.6 p-10 -78.86 73.94 5.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.2 tt0 -50.4 -25.73 4.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.741 -0.6 . . . . 0.0 110.812 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.24 -25.37 64.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -105.7 -54.31 2.5 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 110.247 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.6 68.12 0.54 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t0 21.61 82.09 0.13 Allowed Pre-proline 0 N--CA 1.51 2.53 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.43 -21.32 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.664 1.35 . . . . 0.0 109.955 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -80.29 -45.16 18.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.447 -0.783 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.91 -35.14 17.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.47 -0.769 . . . . 0.0 110.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.06 52.04 0.85 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.724 HD11 ' CD1' ' A' ' 36' ' ' TRP . 18.8 mm -89.68 155.69 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.491 -1.005 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -47.62 145.36 4.34 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.602 . . . . 0.0 111.444 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.17 105.46 1.2 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.5 1.263 . . . . 0.0 110.329 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.52 83.59 0.31 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.619 HG22 HD12 ' A' ' 32' ' ' LEU . 1.7 m -140.09 117.14 11.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.677 -0.896 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.0 tptt -51.76 126.68 18.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 110.098 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HA ' HD13 ' A' ' 32' ' ' LEU . 23.3 t80 -42.26 -29.27 0.24 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.449 -0.782 . . . . 0.0 112.165 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.304 -0.873 . . . . 0.0 110.93 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -87.0 -31.69 20.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.683 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -47.2 149.78 1.67 Allowed Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.464 -0.772 . . . . 0.0 111.702 -179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -85.28 -178.29 3.04 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.57 1.3 . . . . 0.0 110.482 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.42 -14.67 59.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.637 -0.664 . . . . 0.0 110.7 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.63 -12.73 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.256 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.724 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.8 t90 -96.25 95.79 8.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.09 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.476 HG13 ' C ' ' A' ' 36' ' ' TRP . 27.4 m . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 109.905 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.722 ' HG2' HD21 ' A' ' 5' ' ' LEU . 34.5 tt0 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -79.39 -179.49 6.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.858 0.837 . . . . 0.0 111.326 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.11 144.72 14.68 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CD ' ' CZ2' ' A' ' 3' ' ' TRP . 1.1 mtmt -61.89 170.66 1.98 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 51' ' ' LEU . 39.7 tp -106.5 61.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.692 0.758 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.849 -0.532 . . . . 0.0 110.716 -179.552 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.005 0.431 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 51' ' ' LEU . 32.4 mttt -118.97 166.7 12.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.715 . . . . 0.0 110.37 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.8 m95 -130.0 106.44 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.737 -0.602 . . . . 0.0 109.4 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 11' ' ' ILE . 8.5 p -91.7 147.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.649 0.738 . . . . 0.0 111.146 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -100.89 101.17 11.93 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -54.73 -21.57 11.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 111.455 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.2 mp -82.46 -9.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.339 -0.851 . . . . 0.0 111.232 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.439 HG23 ' C ' ' A' ' 7' ' ' ILE . 70.1 p -148.2 -47.23 0.16 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.955 -1.09 . . . . 0.0 111.225 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.27 -13.89 9.5 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' HD13 ' A' ' 11' ' ' ILE . 7.4 t80 -52.5 140.56 22.34 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.17 -1.194 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.676 ' CD1' HG23 ' A' ' 4' ' ' VAL . 26.7 mm -123.08 121.4 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.48 -0.763 . . . . 0.0 111.343 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 38.3 t80 -85.92 111.23 20.04 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.51 81.63 5.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.71 0.767 . . . . 0.0 109.427 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -54.08 -21.32 8.2 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.755 -0.591 . . . . 0.0 110.933 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -29.14 70.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.933 . . . . 0.0 108.754 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.34 -43.5 2.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.97 -108.21 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.44 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.33 -14.35 42.5 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.353 1.186 . . . . 0.0 110.694 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.91 -39.11 31.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -92.24 17.76 9.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.563 -0.711 . . . . 0.0 110.448 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.08 65.07 3.81 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 24' ' ' SER . 41.5 mm -114.27 165.4 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.733 -0.863 . . . . 0.0 111.958 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -79.1 148.93 72.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.675 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 45.3 Cg_endo -71.76 105.25 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.237 1.125 . . . . 0.0 110.709 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.67 61.73 1.35 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.508 HG21 HD23 ' A' ' 32' ' ' LEU . 16.9 m -115.99 134.05 55.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.934 -0.745 . . . . 0.0 109.833 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -76.87 124.84 28.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.661 -0.65 . . . . 0.0 110.307 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' HA ' HD12 ' A' ' 32' ' ' LEU . 6.3 t80 -45.55 -43.61 12.1 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.166 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.42 -25.49 10.1 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -103.56 -87.42 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 29' ' ' PHE . 6.7 mt 52.15 179.52 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.295 0 O-C-N 120.99 -1.069 . . . . 0.0 110.042 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.2 Cg_endo -83.63 -164.05 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 109.804 -0.883 . . . . 0.0 109.804 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -93.44 160.41 14.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 110.475 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 58.33 17.24 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.486 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 76.4 t90 -65.21 112.9 3.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.181 -0.949 . . . . 0.0 109.35 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 36' ' ' TRP . 32.8 m . . . . . 0 N--CA 1.499 1.979 0 O-C-N 121.399 -0.813 . . . . 0.0 110.062 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.235 0.54 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 6.2 m-85 -120.28 -167.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.729 -0.607 . . . . 0.0 110.567 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.605 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.2 tp10 -160.13 112.26 2.02 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.675 -0.641 . . . . 0.0 109.758 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 12.2 mtpt -55.88 177.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.442 -0.787 . . . . 0.0 110.67 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.748 ' O ' HD12 ' A' ' 51' ' ' LEU . 3.9 pp -89.65 18.1 5.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.584 -0.698 . . . . 0.0 111.181 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.175 -0.953 . . . . 0.0 110.768 -179.678 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.064 0.459 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -114.98 179.12 4.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 110.158 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.54 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -139.87 104.23 4.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 109.749 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.65 158.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.96 0.886 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -119.44 113.48 20.84 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.501 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -53.26 -22.62 7.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.432 -0.793 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 5' ' ' LEU . 96.5 mt -58.81 -52.7 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.674 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -149.47 33.42 0.71 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.251 -0.905 . . . . 0.0 111.403 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 15.94 58.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 5' ' ' LEU . 4.2 t80 -60.54 146.18 45.95 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.079 -1.248 . . . . 0.0 108.875 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 12' ' ' TYR . 42.7 mt -131.3 166.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 122.221 1.01 . . . . 0.0 111.624 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 11' ' ' ILE . 42.7 t80 -134.17 110.71 9.75 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.18 87.19 4.92 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.95 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.2 tt0 -53.55 -21.4 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.857 -0.527 . . . . 0.0 111.104 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.09 -31.18 71.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.229 -0.919 . . . . 0.0 108.844 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.26 -49.61 3.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.285 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.21 -107.84 1.08 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 95.35 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.497 -1.002 . . . . 0.0 109.076 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.19 -11.66 32.2 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.376 1.198 . . . . 0.0 111.416 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.79 -39.2 70.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.76 23.62 9.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 110.264 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.69 48.24 66.95 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.759 HD12 ' CD2' ' A' ' 32' ' ' LEU . 47.0 mm -87.83 160.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.86 -0.788 . . . . 0.0 111.337 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 154.9 74.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.965 -0.459 . . . . 0.0 109.906 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.51 106.44 1.95 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.359 1.189 . . . . 0.0 110.0 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 69.33 1.38 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.639 HG21 HD23 ' A' ' 32' ' ' LEU . 6.3 m -119.17 124.61 47.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.7 -0.883 . . . . 0.0 110.289 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.3 mptt -62.14 113.52 2.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.818 -0.551 . . . . 0.0 109.856 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 26.2 t80 -49.22 -32.75 11.1 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.379 -0.826 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.18 -21.24 46.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.376 -0.827 . . . . 0.0 109.62 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -109.55 -81.82 0.57 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.759 ' CD2' HD12 ' A' ' 23' ' ' ILE . 6.1 mt 52.47 -179.63 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.085 -1.01 . . . . 0.0 109.605 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 49.3 Cg_endo -82.47 157.2 16.68 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.92 158.71 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.327 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t0 59.02 15.99 4.38 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.586 -0.696 . . . . 0.0 111.707 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.4 t90 -60.58 126.08 26.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.972 -1.08 . . . . 0.0 109.421 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 36' ' ' TRP . 25.0 t . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.739 0.304 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.497 ' CD2' ' CZ ' ' A' ' 29' ' ' PHE . 10.1 m-85 -116.85 164.78 14.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.122 -0.986 . . . . 0.0 110.532 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -128.12 117.93 22.49 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 33.1 mtpt -57.07 -173.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.548 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.11 32.74 5.84 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.425 0.631 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.748 -0.595 . . . . 0.0 110.637 -179.747 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.188 0.518 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 158.48 21.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.72 . . . . 0.0 110.687 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 17.1 m95 -131.83 112.84 12.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.712 ' HA ' HD13 ' A' ' 11' ' ' ILE . 88.4 t -79.62 158.65 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.179 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -116.8 101.11 8.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -24.87 2.02 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.409 -0.807 . . . . 0.0 111.809 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.588 ' HB ' HD22 ' A' ' 5' ' ' LEU . 51.1 mm -71.45 -23.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.488 -0.758 . . . . 0.0 110.851 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 7' ' ' ILE . 67.3 p -150.71 -41.84 0.12 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.136 -0.977 . . . . 0.0 111.702 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.67 -0.93 11.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.641 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -51.02 160.52 0.47 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.049 -1.265 . . . . 0.0 109.913 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 4' ' ' VAL . 43.5 mm -134.88 125.65 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.386 -0.821 . . . . 0.0 111.248 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 48.0 t80 -93.85 111.22 22.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.37 87.1 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -52.55 -22.63 5.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.819 -0.55 . . . . 0.0 111.197 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.07 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.416 -0.803 . . . . 0.0 108.966 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.65 -30.45 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.68 -0.638 . . . . 0.0 109.857 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.56 -104.74 2.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.67 89.31 0.29 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.429 -1.042 . . . . 0.0 109.843 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.27 -22.84 52.74 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.41 1.216 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.28 -30.55 60.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.563 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.07 8.8 43.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.695 . . . . 0.0 110.625 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.19 63.84 4.95 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.06 166.71 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 110.91 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -64.68 145.71 98.62 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.814 -0.554 . . . . 0.0 110.333 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.53 119.55 5.8 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.351 1.185 . . . . 0.0 109.804 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.72 64.99 1.82 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -118.39 126.04 51.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.696 -0.885 . . . . 0.0 109.939 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -61.17 122.24 14.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.626 -0.671 . . . . 0.0 109.761 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 69.3 t80 -49.25 -26.95 3.31 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.265 -0.897 . . . . 0.0 110.993 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -19.67 53.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.44 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -87.77 -24.24 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.647 HD21 ' CG2' ' A' ' 23' ' ' ILE . 12.3 mt -56.79 142.76 71.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.254 -0.904 . . . . 0.0 109.798 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.67 -175.68 2.57 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.308 1.162 . . . . 0.0 110.992 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.37 -18.9 62.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.71 -0.619 . . . . 0.0 110.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.02 -14.28 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.453 -0.779 . . . . 0.0 110.07 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -89.74 127.52 35.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 37' ' ' VAL . 8.0 p . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 109.315 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.956 0.408 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 9.9 m-85 -119.03 171.32 8.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 110.014 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 92.92 2.99 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.579 -0.701 . . . . 0.0 109.676 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -60.62 164.59 4.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.59 -0.694 . . . . 0.0 110.28 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.16 59.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.692 -0.63 . . . . 0.0 110.34 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 N--CA 1.501 2.089 0 O-C-N 121.697 -0.627 . . . . 0.0 111.323 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -100.58 -170.28 1.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.689 . . . . 0.0 110.112 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 8.0 m95 -140.27 119.36 12.76 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 14.0 p -117.95 146.28 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.33 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.658 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.6 tt -107.56 115.86 30.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.013 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -53.11 -40.3 64.06 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.241 -0.912 . . . . 0.0 111.397 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.658 ' HB ' HD22 ' A' ' 5' ' ' LEU . 87.2 mt -61.61 -58.7 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -0.75 . . . . 0.0 110.598 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 p -93.18 -59.44 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.33 -0.856 . . . . 0.0 110.828 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.01 23.07 3.37 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.695 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 m-85 -54.91 165.91 0.58 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.989 -1.3 . . . . 0.0 109.692 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 10' ' ' TYR . 36.3 mm -148.89 82.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.548 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 66.4 t80 -79.81 108.33 13.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 46.4 p-10 -79.39 84.84 5.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 4.3 tt0 -49.0 -24.79 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.578 -0.701 . . . . 0.0 111.337 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -64.55 -29.9 70.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.411 -0.806 . . . . 0.0 109.036 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.58 -32.43 6.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.812 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.23 -104.46 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -175.45 88.77 0.3 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.396 -1.061 . . . . 0.0 110.088 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.85 -19.8 46.3 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.356 1.187 . . . . 0.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.15 -31.02 38.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.1 13.4 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.532 -0.73 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.25 67.08 2.39 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 24' ' ' SER . 45.8 mm -122.4 167.36 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.693 -0.886 . . . . 0.0 111.113 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -69.36 145.51 95.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.913 -0.492 . . . . 0.0 110.309 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.24 120.21 6.17 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.324 1.171 . . . . 0.0 110.184 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 67.3 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 10.7 m -122.89 126.33 47.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.68 -0.894 . . . . 0.0 110.088 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.4 mttt -59.08 120.89 9.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.404 -0.81 . . . . 0.0 109.852 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 53.6 t80 -49.05 -44.01 41.28 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.328 -0.858 . . . . 0.0 110.799 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.9 -18.07 64.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.601 -0.687 . . . . 0.0 110.421 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.53 -8.29 29.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.391 -0.818 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 ' CE1' ' A' ' 12' ' ' TYR . 5.8 mt -57.47 155.54 19.36 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.052 -1.03 . . . . 0.0 109.89 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.422 ' CD ' HD23 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -84.54 -174.41 1.79 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 O-C-N 123.275 1.145 . . . . 0.0 110.852 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.11 -17.25 63.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.677 -0.64 . . . . 0.0 110.449 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.63 -16.06 45.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 109.999 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -109.16 117.46 34.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 109.862 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' VAL . 8.6 p . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 109.028 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.037 0.446 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 3.1 m-85 -79.82 -170.29 2.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -160.19 124.34 3.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 22.1 mtpt -52.28 177.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.281 -0.887 . . . . 0.0 111.294 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.46 -25.84 20.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 110.508 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.304 -0.873 . . . . 0.0 110.902 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.11 0.481 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 11' ' ' ILE . 13.1 mtmt -116.0 176.99 4.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.341 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 15.5 m95 -135.66 105.36 6.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.797 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -87.16 147.27 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.758 0.789 . . . . 0.0 110.942 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -105.32 116.27 31.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -54.61 -21.06 9.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.502 -0.749 . . . . 0.0 111.502 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.84 -61.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.324 -0.86 . . . . 0.0 110.571 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -131.07 0.23 4.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 111.753 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.94 35.61 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -63.17 129.1 38.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.311 -1.111 . . . . 0.0 108.895 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.797 HD13 ' HA ' ' A' ' 4' ' ' VAL . 35.8 mm -113.68 142.84 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.489 -0.757 . . . . 0.0 111.263 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.4 t80 -116.08 112.99 22.55 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.759 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.9 p-10 -79.59 83.97 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.413 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.4 tt0 -58.79 -17.39 22.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.662 -0.649 . . . . 0.0 110.698 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -63.01 -30.36 71.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.088 -1.007 . . . . 0.0 108.7 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -113.89 -46.68 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.26 -107.03 0.82 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.28 94.5 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.374 -1.074 . . . . 0.0 109.115 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.6 -12.44 35.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.408 1.215 . . . . 0.0 111.292 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.07 -42.34 57.01 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -96.51 14.18 25.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 110.682 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.04 67.63 2.11 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 36' ' ' TRP . 43.7 mm -103.98 166.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.908 . . . . 0.0 111.354 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.456 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -78.05 167.66 33.9 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 122.001 -0.437 . . . . 0.0 110.076 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.94 110.51 2.61 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.391 1.206 . . . . 0.0 109.364 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.07 -91.07 1.18 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.576 HG21 HD21 ' A' ' 32' ' ' LEU . 99.6 m 54.75 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.918 . . . . 0.0 110.618 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.77 125.95 25.63 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.115 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 25.6 t80 -50.57 -28.28 8.35 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -79.57 -0.91 35.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.625 -0.672 . . . . 0.0 110.64 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -122.59 -6.08 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 111.211 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 ' HD3' ' A' ' 33' ' ' PRO . 6.4 mt -52.45 162.87 0.83 Allowed Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 120.979 -1.076 . . . . 0.0 109.412 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.8 Cg_endo -93.7 -165.54 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 120.874 1.05 . . . . 0.0 110.986 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.75 176.47 6.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.694 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t70 68.33 2.41 3.28 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.44 -0.788 . . . . 0.0 111.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.585 ' CD2' HD13 ' A' ' 32' ' ' LEU . 6.6 t90 -106.23 119.63 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.818 -1.176 . . . . 0.0 109.764 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 36' ' ' TRP . 91.8 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 0.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -97.44 -170.82 2.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.981 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.712 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.2 tt0 -160.21 118.08 2.59 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.769 -0.582 . . . . 0.0 109.733 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.464 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 28.2 mtmt -62.97 166.32 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 110.428 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.65 48.66 1.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 110.698 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.088 0.471 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -96.74 169.15 10.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.213 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.1 m95 -133.09 110.41 10.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.55 -0.719 . . . . 0.0 109.516 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.727 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -89.03 147.59 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.045 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.32 97.73 7.76 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -50.84 -24.28 3.41 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.44 -0.788 . . . . 0.0 111.66 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 5' ' ' LEU . 85.0 mt -75.8 -13.08 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.409 -0.807 . . . . 0.0 111.041 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.432 HG23 ' C ' ' A' ' 7' ' ' ILE . 76.1 p -148.97 -47.72 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.172 -0.955 . . . . 0.0 111.265 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.92 -10.37 7.91 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.512 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.3 t80 -50.58 146.65 5.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.118 -1.224 . . . . 0.0 110.114 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.727 HD13 ' HA ' ' A' ' 4' ' ' VAL . 36.2 mm -128.99 111.65 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.549 -0.719 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 51.8 t80 -79.96 110.46 15.36 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.56 87.39 5.14 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.8 tt0 -53.72 -21.32 6.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.798 -0.563 . . . . 0.0 111.174 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -29.75 70.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.255 -0.903 . . . . 0.0 108.898 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.92 -41.71 3.32 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 119.28 -106.39 1.25 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.6 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.43 -1.041 . . . . 0.0 109.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.15 -13.65 40.91 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.349 1.184 . . . . 0.0 110.979 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.28 -33.3 59.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 109.809 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.99 18.59 21.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.514 -0.741 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 55.9 27.38 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.688 HD12 ' CD2' ' A' ' 32' ' ' LEU . 46.0 mm -98.62 163.92 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.612 -0.934 . . . . 0.0 110.846 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.09 156.5 74.31 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 122.011 -0.431 . . . . 0.0 109.971 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.88 99.46 0.87 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.302 1.159 . . . . 0.0 110.145 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 69.95 1.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 HD23 ' A' ' 32' ' ' LEU . 4.6 m -120.24 125.99 49.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.751 -0.852 . . . . 0.0 109.954 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mptt -61.23 119.46 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.591 -0.693 . . . . 0.0 109.883 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.516 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 44.5 t80 -50.96 -39.71 55.77 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.38 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.64 -13.41 62.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.661 -0.65 . . . . 0.0 110.31 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -112.56 2.78 16.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 111.252 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.688 ' CD2' HD12 ' A' ' 23' ' ' ILE . 7.0 mt -54.26 173.96 0.2 Allowed Pre-proline 0 N--CA 1.506 2.334 0 O-C-N 120.888 -1.133 . . . . 0.0 109.351 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -88.46 -174.57 1.11 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 122.944 0.97 . . . . 0.0 110.899 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.33 170.18 16.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 109.853 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 69.0 0.94 2.97 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.541 -0.725 . . . . 0.0 112.146 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.65 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.1 t90 -71.41 129.54 39.07 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.791 -1.193 . . . . 0.0 109.453 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 37' ' ' VAL . 9.5 p . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.901 0.381 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.8 m-85 -119.69 -170.74 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.392 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.722 ' O ' HG12 ' A' ' 4' ' ' VAL . 16.5 tt0 -160.27 118.91 2.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.671 -0.643 . . . . 0.0 109.878 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 17.5 mtmm -62.18 163.45 8.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 0.0 109.926 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.98 -30.9 39.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.583 -0.698 . . . . 0.0 110.106 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.845 -179.788 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.09 0.471 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -114.99 175.34 5.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.3 m95 -136.58 106.66 6.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.504 -0.748 . . . . 0.0 109.207 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.793 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -86.23 151.07 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.683 0.754 . . . . 0.0 111.431 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -110.8 117.96 34.85 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -54.18 -21.62 9.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.364 -0.835 . . . . 0.0 111.475 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.21 -59.39 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.851 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -137.62 34.22 2.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.195 -0.94 . . . . 0.0 111.51 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.67 20.57 39.78 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 5' ' ' LEU . 26.9 t80 -60.95 129.25 40.47 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.107 . . . . 0.0 109.035 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.793 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.7 mm -113.76 164.51 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.838 0.828 . . . . 0.0 111.33 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.479 ' N ' HG22 ' A' ' 11' ' ' ILE . 33.3 t80 -135.7 112.52 10.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 10.1 p-10 -79.5 79.2 5.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.893 0.854 . . . . 0.0 109.166 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.28 -21.45 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.708 -0.62 . . . . 0.0 111.005 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.58 -30.69 71.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.323 -0.86 . . . . 0.0 108.87 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.87 -45.66 3.18 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.83 -107.79 1.04 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.25 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.422 -1.046 . . . . 0.0 109.456 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.383 1.202 . . . . 0.0 111.106 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -75.06 -45.7 39.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.936 . . . . 0.0 110.054 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.35 17.48 9.77 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.688 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.1 60.18 9.37 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 32' ' ' LEU . 41.4 mm -101.44 166.57 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.771 -0.841 . . . . 0.0 111.098 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.91 153.35 75.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.878 -0.514 . . . . 0.0 109.777 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.46 112.5 3.36 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.251 1.132 . . . . 0.0 110.236 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.52 66.24 1.81 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.8 m -114.44 118.36 33.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.777 -0.837 . . . . 0.0 110.042 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.5 mptt -59.22 123.68 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -48.2 -28.62 3.1 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.301 -0.874 . . . . 0.0 111.142 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.19 -20.11 52.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.547 -0.721 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.51 -15.18 27.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.355 -0.841 . . . . 0.0 111.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.631 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -53.72 162.48 1.33 Allowed Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.031 -1.043 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HD3' HD23 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -93.69 -165.72 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 120.91 1.073 . . . . 0.0 110.932 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -80.11 176.39 9.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.354 0.597 . . . . 0.0 109.981 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 67.78 3.36 3.44 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.898 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.753 ' O ' HG13 ' A' ' 37' ' ' VAL . 23.2 t90 -96.92 125.62 41.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.84 -1.162 . . . . 0.0 109.384 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.119 0.485 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.6 m-85 -117.92 -169.03 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.563 -0.711 . . . . 0.0 110.515 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.0 tp10 -159.33 123.11 3.79 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.706 -0.621 . . . . 0.0 109.427 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 20.9 mtpt -57.69 178.11 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.469 -0.769 . . . . 0.0 110.552 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -95.28 -26.06 16.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.697 -0.627 . . . . 0.0 110.321 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.467 -0.77 . . . . 0.0 111.033 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -120.54 176.23 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.372 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.518 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.3 m95 -141.4 110.0 6.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.698 . . . . 0.0 109.435 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -84.3 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.844 0.831 . . . . 0.0 111.511 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.42 117.41 33.0 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -58.04 -19.84 34.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.542 -0.724 . . . . 0.0 111.155 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.41 -48.71 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.854 . . . . 0.0 110.754 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -150.61 30.63 0.66 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.27 -0.893 . . . . 0.0 111.468 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.34 15.15 60.8 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.677 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' HD12 ' A' ' 5' ' ' LEU . 8.8 t80 -59.87 138.48 57.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.088 -1.242 . . . . 0.0 108.824 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.729 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -121.41 114.18 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 42.8 t80 -81.09 111.37 17.48 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -79.43 85.83 5.19 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.155 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.9 tt0 -51.43 -23.36 3.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.786 -0.571 . . . . 0.0 111.283 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.37 -29.95 71.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.317 -0.864 . . . . 0.0 108.947 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -28.62 7.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.709 -0.619 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.06 -102.52 2.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -173.92 88.32 0.36 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.448 -1.031 . . . . 0.0 109.974 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.86 -19.01 58.79 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.421 1.222 . . . . 0.0 110.444 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -76.75 -29.96 56.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.782 . . . . 0.0 109.579 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.55 12.19 37.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.62 -0.675 . . . . 0.0 110.603 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.28 68.29 1.74 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 24' ' ' SER . 49.8 mm -123.31 167.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.89 . . . . 0.0 111.138 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -61.0 143.08 92.39 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.925 -0.484 . . . . 0.0 110.504 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 114.53 3.97 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.263 1.138 . . . . 0.0 109.938 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.01 66.55 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 6.2 m -119.09 125.41 49.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.825 -0.809 . . . . 0.0 110.002 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 26.3 mtpt -60.8 119.21 7.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.605 -0.684 . . . . 0.0 109.746 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.518 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.8 t80 -51.11 -28.12 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.244 -0.91 . . . . 0.0 110.577 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.72 -2.98 41.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.653 -0.654 . . . . 0.0 110.895 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -112.93 -15.87 12.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.889 . . . . 0.0 111.053 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.529 HD13 ' CG ' ' A' ' 36' ' ' TRP . 5.6 mt -54.54 150.64 16.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.09 -1.006 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' HD23 ' A' ' 32' ' ' LEU . 49.4 Cg_endo -83.4 -175.75 2.48 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.285 1.15 . . . . 0.0 110.784 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.4 -16.51 61.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.722 -0.611 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.26 -13.39 49.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.529 ' CG ' HD13 ' A' ' 32' ' ' LEU . 24.6 t90 -101.9 121.86 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 37' ' ' VAL . 10.5 p . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.465 -0.772 . . . . 0.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 120.941 0.4 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -87.8 -170.32 2.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 0.0 110.425 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.86 ' O ' HG12 ' A' ' 4' ' ' VAL . 18.8 tt0 -160.3 121.9 3.14 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.686 -0.634 . . . . 0.0 109.642 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 34.0 mtmt -59.9 165.63 3.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.99 51.3 1.23 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.658 -0.651 . . . . 0.0 110.22 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 110.705 -179.849 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.051 0.453 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 -164.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.625 -0.672 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 8.0 m95 -138.53 117.1 12.12 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -121.78 152.29 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.015 -1.074 . . . . 0.0 113.281 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.571 HD11 ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -106.01 117.96 35.39 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.18 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -54.48 -21.4 9.85 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.566 -0.709 . . . . 0.0 111.812 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.424 ' HB ' HD22 ' A' ' 5' ' ' LEU . 76.8 mt -90.0 -61.09 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.247 -0.908 . . . . 0.0 110.984 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.4 p -80.18 -58.72 3.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.28 -0.887 . . . . 0.0 110.415 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.03 21.43 3.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.685 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.0 m-85 -55.98 164.18 1.28 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.991 -1.299 . . . . 0.0 109.515 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 10' ' ' TYR . 35.3 mm -150.47 79.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.803 -0.561 . . . . 0.0 109.618 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 57.0 t80 -79.9 107.89 13.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.821 -1.175 . . . . 0.0 108.914 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -79.61 90.09 5.14 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.4 tt0 -52.75 -23.23 6.36 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.98 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.99 -29.04 70.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.431 -0.793 . . . . 0.0 108.942 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.32 -43.8 3.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.687 -0.633 . . . . 0.0 109.417 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 113.37 -105.81 1.7 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -179.84 90.42 0.2 Allowed Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.405 -1.056 . . . . 0.0 109.706 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.89 -20.67 45.03 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.319 1.168 . . . . 0.0 110.67 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -80.05 -33.77 38.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.392 -0.817 . . . . 0.0 110.276 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.06 17.3 11.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.15 65.13 3.68 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -122.01 167.38 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.646 -0.914 . . . . 0.0 110.83 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.3 t -78.25 151.3 78.16 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.77 -0.581 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 119.3 6.01 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.399 1.21 . . . . 0.0 110.133 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.77 71.46 1.16 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 HD23 ' A' ' 32' ' ' LEU . 8.6 m -125.0 122.12 36.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.706 -0.879 . . . . 0.0 110.274 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 2.5 mptp? -58.19 113.92 2.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.151 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 64.4 t80 -49.42 -31.72 10.28 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.37 -0.831 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.45 -12.18 60.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.548 -0.72 . . . . 0.0 110.611 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -127.85 19.41 6.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.66 HD23 HG21 ' A' ' 27' ' ' THR . 7.4 mt -62.65 171.03 1.97 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.324 -0.86 . . . . 0.0 109.39 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.8 Cg_endo -78.36 -174.89 2.44 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.216 1.114 . . . . 0.0 110.47 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.81 -15.54 56.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.565 -0.709 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -67.42 -11.28 57.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' C ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -103.99 96.48 6.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.045 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 36' ' ' TRP . 57.8 t . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.429 -0.794 . . . . 0.0 109.593 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' OE1' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 120.661 0.267 . . . . 0.0 110.915 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.7 m-85 -83.97 -170.74 3.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.261 -0.899 . . . . 0.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.12 119.42 2.79 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.485 -0.76 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 11.4 mtmt -55.29 165.63 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 51' ' ' LEU . 5.5 tt -83.86 -23.41 31.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.692 -0.63 . . . . 0.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.332 -0.855 . . . . 0.0 111.22 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HG2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.06 159.63 23.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 110.7 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.4 m95 -130.78 110.09 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.746 -0.596 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 11' ' ' ILE . 10.8 p -88.58 142.33 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 110.98 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -97.81 103.27 15.2 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.522 -0.736 . . . . 0.0 111.26 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 47' ' ' GLU . 63.1 mt -71.77 -20.45 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.83 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 7' ' ' ILE . 73.1 p -148.56 -48.46 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.146 -0.972 . . . . 0.0 111.136 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.76 -3.95 7.0 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.61 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.6 t80 -51.75 155.29 1.73 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.324 . . . . 0.0 109.753 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.0 mm -132.83 124.18 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.77 . . . . 0.0 111.233 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 35.5 t80 -93.45 111.34 22.98 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.4 87.59 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.055 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -52.82 -22.35 5.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.782 -0.574 . . . . 0.0 111.156 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -31.65 72.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.313 -0.867 . . . . 0.0 108.883 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.71 -29.82 7.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.74 -0.6 . . . . 0.0 109.754 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 98.47 -104.62 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.65 88.99 0.32 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.429 -1.042 . . . . 0.0 109.947 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 -19.15 59.47 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.433 1.228 . . . . 0.0 110.382 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -80.04 -31.99 39.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.644 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -93.79 8.73 39.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.64 -0.662 . . . . 0.0 110.743 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.8 62.65 6.07 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CG2' HD21 ' A' ' 32' ' ' LEU . 49.2 mm -121.41 166.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.936 . . . . 0.0 110.729 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.0 t -67.7 146.31 98.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.827 -0.546 . . . . 0.0 110.302 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.19 122.44 8.03 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.351 1.185 . . . . 0.0 110.091 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.58 67.04 1.74 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 1.9 m -122.09 126.99 49.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.772 -0.84 . . . . 0.0 109.949 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 6.9 mptt -61.08 119.64 8.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -49.69 -39.58 37.18 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.183 -0.948 . . . . 0.0 110.784 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.07 -17.37 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.587 -0.695 . . . . 0.0 110.291 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -91.16 -21.92 20.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.876 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.1 mt -54.94 151.43 16.01 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.21 -0.931 . . . . 0.0 109.911 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.71 178.88 6.14 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.272 1.143 . . . . 0.0 110.735 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.74 -18.02 63.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.659 -0.651 . . . . 0.0 110.528 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.7 -15.22 51.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.367 -0.833 . . . . 0.0 109.969 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.89 139.05 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 110.092 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG2' HD11 ' A' ' 7' ' ' ILE . 1.2 tp10 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.3 m-85 -86.57 -169.83 2.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 110.854 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.04 119.0 6.21 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 7.7 mtmm -54.29 171.47 0.11 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 110.541 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 ' HG2' ' A' ' 2' ' ' LYS . 2.6 pp -79.78 -22.84 42.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.66 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 N--CA 1.498 1.925 0 O-C-N 121.439 -0.788 . . . . 0.0 110.953 -179.758 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.029 0.442 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HE2' HG21 ' A' ' 11' ' ' ILE . 19.9 mtpt -128.45 177.03 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 11.1 m95 -141.26 108.18 5.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.579 -0.701 . . . . 0.0 109.452 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.789 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.0 p -84.17 148.31 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.741 0.781 . . . . 0.0 111.22 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -106.33 116.41 31.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -55.43 -21.12 14.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.506 -0.746 . . . . 0.0 111.347 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 5' ' ' LEU . 92.8 mt -65.72 -56.34 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 110.732 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 t -136.19 27.76 3.16 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.343 -0.848 . . . . 0.0 111.219 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.35 50.54 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -62.18 131.49 49.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.789 HD13 ' HA ' ' A' ' 4' ' ' VAL . 40.2 mm -112.81 118.19 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 111.446 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 31.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -79.31 83.09 5.38 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.766 0.793 . . . . 0.0 109.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tt0 -53.36 -22.7 7.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.737 -0.602 . . . . 0.0 110.968 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 0.0 109.044 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.04 -37.07 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.489 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 111.41 -105.94 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.94 90.19 0.28 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.403 -1.057 . . . . 0.0 109.82 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.14 -16.08 53.33 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.403 1.212 . . . . 0.0 110.531 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -101.65 10.7 39.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.59 -0.694 . . . . 0.0 110.704 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.56 1.2 Allowed Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.67 163.38 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.939 . . . . 0.0 111.454 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.41 145.61 81.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.86 118.29 5.23 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.367 1.193 . . . . 0.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.65 64.97 1.97 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.8 m -117.07 126.85 53.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.842 -0.799 . . . . 0.0 109.673 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 11.7 mptt -61.28 123.73 18.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.551 -0.718 . . . . 0.0 109.624 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.5 t80 -48.99 -43.85 40.61 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.242 -0.912 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.8 -20.21 65.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.589 -0.694 . . . . 0.0 110.117 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -90.71 -15.54 30.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.438 -0.789 . . . . 0.0 111.333 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.726 HD23 ' HD3' ' A' ' 33' ' ' PRO . 5.6 mt -52.69 156.44 3.23 Favored Pre-proline 0 N--CA 1.506 2.341 0 O-C-N 121.028 -1.045 . . . . 0.0 109.686 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.726 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.4 Cg_endo -97.62 -165.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.154 1.236 . . . . 0.0 110.937 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.98 -179.2 2.64 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.17 1.85 2.99 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.379 -0.825 . . . . 0.0 111.916 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CD2' HD13 ' A' ' 32' ' ' LEU . 52.0 t90 -101.35 103.14 14.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.849 -1.157 . . . . 0.0 108.644 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.475 -0.766 . . . . 0.0 110.352 -179.357 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.816 0.341 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 8.4 m-85 -95.05 -168.58 1.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.775 . . . . 0.0 110.673 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.6 tt0 -158.84 123.23 4.04 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.733 -0.604 . . . . 0.0 109.371 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -56.3 165.58 1.03 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.577 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -82.84 -27.76 30.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 110.182 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.518 -0.739 . . . . 0.0 110.895 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.021 0.438 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.98 175.43 10.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 110.48 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.0 m95 -141.14 124.68 16.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -119.8 147.29 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.075 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.619 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.3 tt -103.5 119.72 39.45 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.107 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -57.26 -38.89 74.56 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.369 -0.832 . . . . 0.0 111.119 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.619 ' HB ' HD22 ' A' ' 5' ' ' LEU . 80.5 mt -64.57 -50.26 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.549 -0.719 . . . . 0.0 111.15 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.508 HG21 ' OH ' ' A' ' 10' ' ' TYR . 22.0 p -101.51 -57.25 2.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.219 -0.925 . . . . 0.0 110.606 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.94 25.78 3.5 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.736 ' O ' HD13 ' A' ' 11' ' ' ILE . 24.0 m-85 -60.31 170.2 1.4 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.13 -1.217 . . . . 0.0 109.586 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 10' ' ' TYR . 26.9 mm -147.74 89.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 55.0 t80 -79.76 111.71 16.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.877 -1.139 . . . . 0.0 108.8 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -79.47 85.07 5.28 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.686 0.755 . . . . 0.0 109.287 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 6.5 tt0 -53.49 -22.32 7.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.66 -31.7 72.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 108.898 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.07 -53.74 2.61 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.445 0.64 . . . . 0.0 109.311 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 130.05 -108.54 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.33 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.411 -1.052 . . . . 0.0 109.283 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.6 -12.7 36.28 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.414 1.218 . . . . 0.0 111.135 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -77.63 -44.78 27.08 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.19 16.04 10.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.436 -0.79 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.74 40.16 88.35 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CD1' ' A' ' 36' ' ' TRP . 38.3 mm -81.75 161.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.663 -0.904 . . . . 0.0 110.365 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 156.78 79.41 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.757 -0.589 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 112.32 3.28 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.272 1.143 . . . . 0.0 110.026 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.93 67.77 1.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -120.32 121.13 37.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.733 -0.863 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -57.2 119.36 6.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.744 . . . . 0.0 109.815 179.045 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 34.9 t80 -49.64 -29.16 6.8 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.224 -0.923 . . . . 0.0 110.961 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.87 -18.03 59.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.527 -0.733 . . . . 0.0 110.508 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -92.66 -19.69 21.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 111.001 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD21 HG23 ' A' ' 23' ' ' ILE . 7.8 mt -55.32 166.79 0.82 Allowed Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.192 -0.942 . . . . 0.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' HD22 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -78.72 154.63 26.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -65.04 -16.65 63.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.637 -0.665 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.06 -7.68 48.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 110.235 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.822 ' CD1' HD11 ' A' ' 23' ' ' ILE . 40.6 t90 -71.06 132.55 45.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG23 ' C ' ' A' ' 36' ' ' TRP . 81.4 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.463 -0.773 . . . . 0.0 108.928 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.844 0.354 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 2.7 m-85 -79.44 -174.24 4.12 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.566 -0.709 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.11 114.81 2.28 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.638 -0.664 . . . . 0.0 109.651 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' CD ' ' HG2' ' A' ' 52' ' ' GLU . 8.7 ptpt -58.37 163.6 2.97 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.534 -0.729 . . . . 0.0 110.19 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -86.34 -29.9 22.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.643 -0.661 . . . . 0.0 110.208 -179.467 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.419 ' HG2' ' CD ' ' A' ' 50' ' ' LYS . 4.3 mm-40 . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 0.0 111.413 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -104.8 -166.87 1.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 11.6 m95 -141.47 121.03 13.3 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 10.3 p -120.88 152.42 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.058 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.4 tt -110.3 118.32 36.01 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.324 178.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -53.43 -39.6 64.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.428 -0.795 . . . . 0.0 111.43 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.53 -59.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.782 . . . . 0.0 110.908 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 9' ' ' GLY . 23.5 p -89.51 -58.2 2.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.322 -0.861 . . . . 0.0 110.678 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' A' ' 8' ' ' THR . . . 116.01 25.05 3.7 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.7 m-85 -56.97 168.76 0.6 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.133 -1.216 . . . . 0.0 109.44 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 10' ' ' TYR . 33.7 mm -149.34 79.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 32' ' ' LEU . 70.6 t80 -79.89 108.29 13.35 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.771 -1.205 . . . . 0.0 108.716 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.45 84.64 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.5 tt0 -49.92 -24.67 2.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.26 -30.0 71.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.803 . . . . 0.0 109.028 178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.54 -29.4 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 97.62 -102.94 2.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.99 89.25 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.429 -1.042 . . . . 0.0 109.761 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.14 -23.14 46.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.34 1.179 . . . . 0.0 110.488 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.95 -31.11 39.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.798 . . . . 0.0 110.0 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.11 16.82 15.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.485 -0.76 . . . . 0.0 110.523 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.59 63.2 5.43 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -121.53 167.07 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.69 -0.888 . . . . 0.0 111.183 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -73.68 148.61 87.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.964 -0.46 . . . . 0.0 110.512 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 110.98 3.21 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.475 1.25 . . . . 0.0 109.997 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.71 1.37 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.428 HG22 ' HG ' ' A' ' 32' ' ' LEU . 17.9 m -121.39 126.06 48.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.787 -0.831 . . . . 0.0 110.084 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 5.3 mptt -60.77 121.09 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 58.7 t80 -47.39 -50.43 22.5 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.349 -0.844 . . . . 0.0 111.016 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.85 -17.29 55.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.632 -0.668 . . . . 0.0 110.55 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.66 -12.55 23.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.24 -0.912 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -55.43 160.39 3.74 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.056 -1.028 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 49.8 Cg_endo -82.32 -176.52 3.0 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.213 1.112 . . . . 0.0 110.512 -179.196 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.43 -16.24 62.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 0.0 110.582 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.73 -14.52 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.109 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -107.24 116.81 32.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 109.817 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.882 179.845 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.099 0.476 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.4 m-85 -79.86 -168.73 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.691 . . . . 0.0 110.537 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.31 115.93 2.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.639 -0.663 . . . . 0.0 109.402 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -62.06 163.67 7.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.431 -0.793 . . . . 0.0 110.07 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -45.28 19.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 110.04 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.516 2.831 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.491 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 14' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -89.54 155.05 19.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.535 -0.728 . . . . 0.0 110.787 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.779 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 m95 -129.6 158.6 38.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD13 ' A' ' 11' ' ' ILE . 11.1 p -132.32 144.52 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.209 -0.932 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.692 HD22 HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -104.49 120.77 42.01 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -56.28 -20.43 18.65 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.429 -0.795 . . . . 0.0 110.969 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.692 HG12 HD22 ' A' ' 5' ' ' LEU . 45.3 mm -55.09 -66.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.309 -0.87 . . . . 0.0 110.965 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -143.33 31.91 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.192 -0.943 . . . . 0.0 111.754 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.34 17.19 79.68 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.84 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.674 ' HD2' HD12 ' A' ' 5' ' ' LEU . 32.6 t80 -61.58 129.57 41.72 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.079 -1.248 . . . . 0.0 108.5 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 3' ' ' TRP . 30.9 mm -118.58 147.42 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.13 -0.981 . . . . 0.0 112.511 -177.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 33.6 t80 -108.93 107.94 18.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -79.61 83.26 5.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.9 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 1.6 tt0 -58.1 -17.65 19.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.883 -0.51 . . . . 0.0 110.871 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.17 -30.37 71.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.097 -1.002 . . . . 0.0 108.616 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.87 -41.52 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 125.82 -106.46 0.87 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.31 93.61 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.322 -1.105 . . . . 0.0 109.167 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.4 -14.79 46.79 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.387 1.204 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.0 -33.28 39.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.28 -0.888 . . . . 0.0 109.677 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -101.96 13.8 33.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.59 -0.694 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.71 71.9 0.67 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' CD2' ' A' ' 32' ' ' LEU . 43.1 mm -116.52 162.33 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.545 -0.974 . . . . 0.0 110.855 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.06 170.67 14.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.873 -0.517 . . . . 0.0 110.034 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.03 112.3 3.09 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.34 1.179 . . . . 0.0 109.195 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.16 -98.1 2.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 -178.286 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.604 HG21 HD21 ' A' ' 32' ' ' LEU . 54.2 m 55.52 101.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.695 -0.885 . . . . 0.0 110.674 178.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 19.2 mttt -63.18 130.85 46.36 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.202 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -48.41 -30.4 5.0 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.139 -0.976 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.57 -18.6 59.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.475 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.43 -16.47 22.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 111.127 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 23' ' ' ILE . 12.7 mt -54.36 165.22 0.89 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.042 -1.037 . . . . 0.0 110.061 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.42 175.77 9.29 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.238 1.125 . . . . 0.0 110.885 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.86 -4.15 53.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.649 -0.657 . . . . 0.0 110.865 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.36 21.28 6.23 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' HD11 ' A' ' 23' ' ' ILE . 71.3 t90 -92.25 117.43 29.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.863 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.597 -0.689 . . . . 0.0 110.017 -179.772 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.718 0.294 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -78.84 165.11 23.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.253 -0.905 . . . . 0.0 111.401 -179.096 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' CZ3' ' A' ' 3' ' ' TRP . 2.2 tt0 -160.13 126.53 4.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HG3' ' CZ2' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.86 148.72 2.09 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.3 -0.875 . . . . 0.0 111.213 -179.152 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 51' ' ' LEU . 7.5 tt -79.91 -10.33 59.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.683 -0.636 . . . . 0.0 111.129 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.995 0 O-C-N 121.113 -0.992 . . . . 0.0 111.013 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.143 0.496 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -129.57 -178.87 4.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.699 . . . . 0.0 110.283 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.513 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -137.58 108.13 6.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.755 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -86.04 148.35 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.758 0.789 . . . . 0.0 111.311 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -107.49 119.06 38.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -53.24 -21.95 6.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 111.312 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.25 -68.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -130.94 37.41 3.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.283 -0.885 . . . . 0.0 111.72 -178.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.79 36.56 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 5' ' ' LEU . 40.7 t80 -61.24 130.39 45.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.331 -1.1 . . . . 0.0 108.962 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.786 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.9 mm -115.4 164.69 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.003 0.906 . . . . 0.0 111.728 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 27.7 t80 -133.26 113.08 12.23 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.882 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.32 77.05 5.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.843 0.83 . . . . 0.0 108.981 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -52.22 -22.67 4.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.855 -0.528 . . . . 0.0 111.198 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.72 -31.05 72.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.898 . . . . 0.0 108.975 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.882 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.63 -30.81 6.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 0.0 109.784 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 106.49 -106.5 2.55 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.98 88.18 0.35 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.484 -1.009 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.07 -24.08 52.69 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.412 1.217 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -31.9 57.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.757 . . . . 0.0 109.327 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -95.62 5.81 50.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.665 -0.647 . . . . 0.0 110.57 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.98 3.18 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 32' ' ' LEU . 48.9 mm -123.04 166.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.683 -0.892 . . . . 0.0 111.438 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.2 t -60.86 143.12 91.81 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 122.014 -0.429 . . . . 0.0 110.145 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 122.24 7.44 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.321 1.169 . . . . 0.0 110.147 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.89 67.04 1.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.2 m -118.73 119.99 36.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.77 -0.841 . . . . 0.0 110.309 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -58.4 125.76 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 179.055 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.513 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.1 t80 -46.84 -29.31 1.91 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.357 -0.839 . . . . 0.0 111.452 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -20.31 58.99 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.501 -0.749 . . . . 0.0 110.552 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.41 -24.63 25.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD13 ' CD2' ' A' ' 36' ' ' TRP . 10.8 mt -55.79 138.5 70.74 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.335 -0.853 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.67 -179.27 5.03 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.148 1.078 . . . . 0.0 110.796 -179.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -16.2 59.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 110.65 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.69 -9.19 48.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.241 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.701 ' CD2' HD13 ' A' ' 32' ' ' LEU . 14.5 t90 -113.01 120.75 42.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG23 ' C ' ' A' ' 36' ' ' TRP . 65.2 t . . . . . 0 N--CA 1.496 1.85 0 O-C-N 121.474 -0.766 . . . . 0.0 109.667 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.241 0.543 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 6.2 m-85 -96.67 -169.29 1.86 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 110.652 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.4 tm-20 -155.97 122.44 5.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -57.5 174.91 0.19 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.399 -0.813 . . . . 0.0 110.408 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tp -79.99 -32.35 39.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.632 . . . . 0.0 109.936 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.466 -0.771 . . . . 0.0 111.174 179.46 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.111 0.481 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.76 179.8 4.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.522 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 14.9 m95 -139.08 107.67 5.88 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.632 -0.668 . . . . 0.0 109.378 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.769 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.2 p -88.67 143.72 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.956 -179.386 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -95.55 112.75 24.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -54.66 -21.45 10.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.414 -0.804 . . . . 0.0 111.384 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' A' ' 5' ' ' LEU . 97.6 mt -60.02 -63.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.324 -0.86 . . . . 0.0 110.413 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -122.02 -22.4 5.69 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.374 -0.829 . . . . 0.0 111.549 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.85 18.02 7.61 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.96 140.44 58.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.33 -1.1 . . . . 0.0 108.703 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.769 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.3 mm -118.53 149.06 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.444 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.3 t80 -119.18 112.7 19.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.6 p-10 -79.5 82.84 5.57 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.692 0.758 . . . . 0.0 109.311 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.02 -18.48 24.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.66 -0.65 . . . . 0.0 110.795 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.13 -31.33 72.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 0.0 108.698 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.19 -46.23 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.81 -108.0 0.87 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.42 94.3 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.377 -1.072 . . . . 0.0 109.297 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.07 -11.93 33.24 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.457 1.241 . . . . 0.0 111.217 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.82 -36.76 62.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.171 -0.956 . . . . 0.0 110.123 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -105.13 16.96 24.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.8 68.11 1.86 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 42.7 mm -106.29 165.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.662 -0.905 . . . . 0.0 110.938 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.92 165.93 44.02 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.913 -0.492 . . . . 0.0 110.222 -179.873 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.8 111.29 2.57 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.332 1.175 . . . . 0.0 109.233 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.71 -96.94 1.88 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 -178.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 51.9 m 55.08 102.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.741 -0.858 . . . . 0.0 110.688 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.9 mttt -63.0 131.86 50.05 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.104 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.6 t80 -48.75 -42.11 34.34 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.001 -1.062 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 17.0 mt-10 -72.13 -8.59 55.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.508 -0.745 . . . . 0.0 110.625 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -105.14 -12.73 15.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' A' ' 23' ' ' ILE . 6.6 mt -52.27 168.91 0.28 Allowed Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.037 -1.04 . . . . 0.0 109.316 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.6 Cg_endo -89.37 -167.29 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 122.953 0.975 . . . . 0.0 110.756 -178.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.54 169.66 13.36 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.321 0.581 . . . . 0.0 110.002 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t0 65.2 8.28 4.74 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.514 -0.741 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CD1' HD11 ' A' ' 23' ' ' ILE . 91.6 t90 -71.92 -75.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 109.175 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.952 -0.467 . . . . 0.0 111.457 179.573 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.139 0.495 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.4 m-85 -114.75 -168.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.832 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.1 tp10 -160.0 123.76 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.747 -0.596 . . . . 0.0 109.69 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.5 mtmt -60.22 166.13 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 0.0 110.256 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -82.4 -25.9 33.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.704 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.385 -0.822 . . . . 0.0 110.836 -179.66 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.29 173.91 6.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.552 -0.717 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 10.9 m95 -139.04 107.05 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.659 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.026 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -98.43 106.29 18.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.14 -19.34 19.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.762 . . . . 0.0 111.472 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.3 mp -89.15 -9.59 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 111.653 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -149.33 -47.84 0.14 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.989 -1.069 . . . . 0.0 111.625 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.54 -15.1 9.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -51.71 117.75 2.91 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.117 -1.226 . . . . 0.0 109.584 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 4' ' ' VAL . 32.8 mm -100.76 140.2 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.527 -0.733 . . . . 0.0 111.332 -178.44 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 36.4 t80 -104.91 110.95 23.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.21 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.919 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 6.0 p-10 -79.4 78.73 5.9 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.74 0.781 . . . . 0.0 109.26 -179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -51.52 -22.67 3.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.782 -0.574 . . . . 0.0 111.255 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.71 -29.65 70.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.234 -0.916 . . . . 0.0 108.997 178.761 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.919 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.66 -41.66 3.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.74 -0.6 . . . . 0.0 109.516 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 131.69 -109.17 0.85 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.37 91.45 0.18 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.411 -1.052 . . . . 0.0 109.806 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.41 -13.88 41.77 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.337 1.178 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -80.19 -41.03 26.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -95.57 12.2 30.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.519 -0.738 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.55 73.23 0.43 Allowed Glycine 0 N--CA 1.502 3.085 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.606 ' CG2' HD21 ' A' ' 32' ' ' LEU . 44.2 mm -120.52 166.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.697 -0.884 . . . . 0.0 111.49 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -63.97 141.3 98.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.46 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 47.0 Cg_endo -72.48 107.78 2.37 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.154 1.081 . . . . 0.0 110.671 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.1 63.99 1.3 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -123.34 134.85 53.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.759 -0.848 . . . . 0.0 110.122 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -70.88 132.27 45.0 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 13.3 t80 -47.97 -38.52 17.01 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.184 -0.947 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -67.92 -22.43 65.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.545 -0.722 . . . . 0.0 110.136 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.66 -19.96 30.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.535 -0.728 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -52.53 158.1 2.22 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.085 -1.009 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD3' HD23 ' A' ' 32' ' ' LEU . 45.3 Cg_endo -93.59 -170.73 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.098 1.052 . . . . 0.0 110.436 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -76.76 174.87 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.651 -0.655 . . . . 0.0 109.902 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 66.34 7.07 4.66 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.399 -0.813 . . . . 0.0 111.801 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.622 ' CD2' HD13 ' A' ' 32' ' ' LEU . 91.0 t90 -86.54 4.21 40.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.931 -1.106 . . . . 0.0 110.392 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.06 -1.025 . . . . 0.0 109.787 -179.82 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.064 0.459 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.0 m-85 -83.53 -169.18 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.595 -0.691 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -160.03 118.41 2.69 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.391 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 15.4 mtmt -55.06 171.12 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.391 -0.818 . . . . 0.0 110.71 -179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 51' ' ' LEU . 7.8 tt -80.04 -26.97 39.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.703 -0.623 . . . . 0.0 110.341 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.465 -0.772 . . . . 0.0 110.997 -179.83 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.023 0.439 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.8 175.39 7.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.506 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 11.1 m95 -141.63 98.79 3.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.545 -0.722 . . . . 0.0 109.633 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -89.32 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.656 0.741 . . . . 0.0 111.224 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -99.65 101.98 13.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.391 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -57.79 -19.65 29.86 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.502 -0.749 . . . . 0.0 110.95 -179.586 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.44 ' HB ' HD22 ' A' ' 5' ' ' LEU . 83.1 mt -71.22 -19.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.303 -0.873 . . . . 0.0 111.059 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 10' ' ' TYR . 5.7 t -154.14 -34.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.141 -0.974 . . . . 0.0 112.394 -179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.55 -17.09 6.54 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.442 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.595 ' H ' HG23 ' A' ' 8' ' ' THR . 33.5 t80 -51.05 150.01 3.34 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.096 -1.237 . . . . 0.0 109.871 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 12' ' ' TYR . 45.0 mt -136.01 167.14 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.042 0.925 . . . . 0.0 111.789 -179.218 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.55 ' N ' HG22 ' A' ' 11' ' ' ILE . 46.0 t80 -135.82 106.81 6.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -79.24 86.89 4.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.3 tt0 -47.55 -25.88 1.26 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 0.0 111.697 -178.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.0 -29.72 70.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.394 -0.816 . . . . 0.0 109.179 178.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.23 -25.28 9.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.663 -0.648 . . . . 0.0 110.241 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 101.83 -105.61 2.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.454 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.62 87.07 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.46 -1.023 . . . . 0.0 109.912 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.11 -28.73 40.73 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.428 1.225 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.1 -32.15 72.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.605 -0.684 . . . . 0.0 109.191 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.91 6.39 36.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.699 -0.626 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.0 66.73 2.51 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' SER . 44.6 mm -118.99 167.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.175 0.988 . . . . 0.0 112.683 -176.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.0 t -48.04 121.01 8.5 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.699 179.053 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 131.13 18.17 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.179 1.094 . . . . 0.0 111.217 -179.125 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.78 59.7 8.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 32' ' ' LEU . 1.8 m -123.42 132.74 54.04 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.827 -0.808 . . . . 0.0 110.289 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.9 mttt -62.16 126.99 29.27 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.836 179.138 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 7.8 t80 -48.89 -27.01 2.77 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.43 -0.794 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -91.34 7.9 38.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -0.752 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -142.62 17.95 2.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 111.4 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 36' ' ' TRP . 1.1 pt? -80.57 -163.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.093 -1.004 . . . . 0.0 108.866 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 41.6 Cg_endo -89.66 143.02 4.27 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 122.457 0.714 . . . . 0.0 110.539 -177.716 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -52.93 171.69 0.06 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.691 -0.631 . . . . 0.0 110.432 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t70 72.88 -6.43 1.68 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.811 -0.556 . . . . 0.0 112.257 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.801 ' CG ' HD11 ' A' ' 32' ' ' LEU . 86.4 t90 -77.09 114.55 16.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.626 -1.296 . . . . 0.0 109.621 179.153 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 36' ' ' TRP . 4.1 m . . . . . 0 N--CA 1.499 2.016 0 O-C-N 121.682 -0.636 . . . . 0.0 109.585 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 120.961 0.41 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 7.2 m-85 -79.91 -167.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.4 -0.813 . . . . 0.0 110.263 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.22 123.24 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.715 -0.616 . . . . 0.0 109.526 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.0 mtmt -55.35 167.5 0.47 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.586 -0.696 . . . . 0.0 110.898 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 51' ' ' LEU . 3.1 tt -83.22 -25.49 31.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.659 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.46 -0.775 . . . . 0.0 110.832 -179.769 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.154 0.502 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 11' ' ' ILE . 9.7 mttp -123.13 172.47 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 110.256 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.502 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.05 109.81 7.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 109.417 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.777 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.8 p -83.47 150.23 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.896 0.855 . . . . 0.0 111.384 -179.041 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -110.02 118.0 35.26 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.749 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -19.96 22.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.414 -0.804 . . . . 0.0 111.126 -179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.47 -58.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.835 . . . . 0.0 110.653 -179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 t -137.85 26.98 2.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.299 -0.876 . . . . 0.0 111.373 -179.316 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.17 65.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' HD12 ' A' ' 5' ' ' LEU . 7.9 t80 -61.0 136.27 58.04 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -1.202 . . . . 0.0 108.791 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.777 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -119.84 127.41 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.409 -0.807 . . . . 0.0 111.551 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 29.0 t80 -94.55 113.57 25.42 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.12 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.5 82.44 5.63 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.388 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.61 -21.13 9.56 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.874 -0.516 . . . . 0.0 111.06 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.37 -32.97 74.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.305 -0.872 . . . . 0.0 108.975 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.67 -43.3 4.08 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 179.161 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.69 -108.27 1.16 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.99 94.38 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.359 -1.083 . . . . 0.0 109.243 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.93 -13.06 38.09 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.438 1.231 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -77.52 -40.02 44.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.204 -0.935 . . . . 0.0 109.949 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -97.94 16.57 20.53 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.596 -0.69 . . . . 0.0 110.674 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 58.0 16.7 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.678 HD12 HD21 ' A' ' 32' ' ' LEU . 44.8 mm -100.43 157.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.97 . . . . 0.0 110.63 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -74.2 158.22 85.77 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.873 -0.517 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.57 109.52 2.65 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.299 1.157 . . . . 0.0 110.31 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.34 79.89 0.74 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.6 m -132.49 119.49 20.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.749 -0.854 . . . . 0.0 110.116 -179.156 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.2 mttt -55.38 121.57 9.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.477 -0.764 . . . . 0.0 110.04 179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.0 t80 -46.79 -46.36 20.57 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.396 -0.815 . . . . 0.0 111.269 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mt-10 -63.72 -18.83 64.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.475 -0.766 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -87.79 -21.13 25.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.678 HD21 HD12 ' A' ' 23' ' ' ILE . 9.3 mt -56.35 163.7 2.34 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.114 -0.991 . . . . 0.0 109.829 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 46.7 Cg_endo -73.43 163.12 38.52 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.148 1.078 . . . . 0.0 110.977 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.49 -18.62 61.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.632 -0.667 . . . . 0.0 110.622 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -75.68 -2.02 27.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 110.336 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.659 ' CD1' HD11 ' A' ' 23' ' ' ILE . 37.4 t90 -75.6 134.5 40.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.099 -1.001 . . . . 0.0 109.814 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.489 -0.757 . . . . 0.0 109.693 179.972 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 120.929 0.395 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 10.2 m-85 -119.76 -168.11 1.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.406 -0.809 . . . . 0.0 110.45 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.772 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.3 mt-10 -160.07 121.57 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.681 -0.637 . . . . 0.0 109.362 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -54.98 173.11 0.1 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.375 -0.828 . . . . 0.0 110.841 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tp -86.74 -32.17 20.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.031 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.618 -0.676 . . . . 0.0 111.145 -179.831 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 0.87 110.261 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -114.92 173.39 6.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 2.2599999999999998 110.098 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.978 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 15.2 m95 -130.83 120.09 23.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.51000000000000001 109.736 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.035 ' HA ' HD13 ' A' ' 11' ' ' ILE . 13.3 p -100.21 139.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 0.77000000000000002 110.717 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.799 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -100.26 100.26 11.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.92000000000000004 109.991 179.726 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -44.39 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.351 -0.843 . . . . 2.0699999999999998 110.943 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 8' ' ' THR . 4.7 mt -66.96 -40.76 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 2.0600000000000001 110.474 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.539 HG22 HG22 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -149.23 15.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 2.1099999999999999 110.52 -179.867 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.696 ' O ' HG12 ' A' ' 11' ' ' ILE . . . 77.65 -3.41 60.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.694 -1.362 . . . . 0.69999999999999996 109.694 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.909 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 39.9 t80 -39.89 125.39 1.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -1.225 . . . . 2.46 109.615 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.035 HD13 ' HA ' ' A' ' 4' ' ' VAL . 27.9 mm -114.93 145.29 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.78000000000000003 111.204 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.923 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 27.6 t80 -116.04 109.55 17.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 178.42 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.926 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -79.65 82.01 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 2.2200000000000002 110.35 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' CD ' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -51.81 -18.62 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 1.1399999999999999 110.049 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -18.59 65.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.74 109.621 179.641 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.926 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -127.88 -23.85 3.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.768 . . . . 0.52000000000000002 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 18' ' ' ASP . . . 101.87 -98.24 1.72 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.42999999999999999 109.677 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 164.74 97.82 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.244 -1.15 . . . . 1.3500000000000001 110.072 -179.886 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ASP . 41.9 Cg_endo -69.82 -14.93 36.57 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.129 1.594 . . . . 0.83999999999999997 110.372 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -35.09 37.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 1.6000000000000001 109.901 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -102.38 24.81 9.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.1799999999999999 110.081 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.11 58.53 4.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.502 -1.439 . . . . 0.62 109.502 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.848 HG23 HD21 ' A' ' 32' ' ' LEU . 51.6 mm -104.92 166.71 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.81999999999999995 110.286 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -76.36 157.71 82.41 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.80000000000000004 110.147 179.993 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.05 110.81 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.56000000000000005 110.317 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 14' ' ' GLU . . . 78.09 67.39 1.63 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.418 -1.473 . . . . 1.1100000000000001 109.418 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.561 ' CG2' ' HG ' ' A' ' 32' ' ' LEU . 1.1 m -118.23 114.16 22.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -1.124 . . . . 0.42999999999999999 110.458 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HA ' ' CD ' ' A' ' 14' ' ' GLU . 6.4 mptt -47.98 117.48 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.268 -0.895 . . . . 1.6100000000000001 110.303 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.748 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 36.4 t80 -46.14 -41.17 12.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.895 . . . . 1.26 110.116 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -68.44 -13.11 62.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 2.1400000000000001 110.371 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' LEU . 21.8 tt0 -99.52 -26.05 14.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 1.9199999999999999 110.547 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.848 HD21 HG23 ' A' ' 23' ' ' ILE . 6.4 mt -40.82 160.92 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.95 . . . . 0.79000000000000004 110.087 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.4 Cg_endo -78.62 -179.14 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.979 1.515 . . . . 1.03 110.18 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -80.26 -31.97 38.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 2.7799999999999998 109.942 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -7.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 2.7599999999999998 109.706 179.516 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.696 ' HH2' ' HE2' ' A' ' 10' ' ' TYR . 23.7 t90 -90.72 135.25 33.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 1.03 110.191 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.796 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.034 . . . . 1.76 110.488 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.224 0.535 . . . . 2.04 110.188 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.909 ' CE2' ' CD2' ' A' ' 10' ' ' TYR . 7.1 m-85 -103.89 -171.89 2.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.83999999999999997 110.519 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 1.082 ' O ' ' O ' ' A' ' 50' ' ' LYS . 16.0 tt0 -160.18 100.95 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.39 -0.819 . . . . 2.2400000000000002 109.758 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 1.082 ' O ' ' O ' ' A' ' 49' ' ' GLU . 13.3 mtpt -29.17 -172.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.853 . . . . 1.78 110.366 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.978 HD23 ' O ' ' A' ' 51' ' ' LEU . 6.1 tt -111.09 -14.35 13.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 109.821 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.665 ' O ' ' O ' ' A' ' 51' ' ' LEU . 6.2 pt-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.427 -0.796 . . . . 2.3799999999999999 110.531 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.484 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -122.84 175.84 6.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.619 -0.676 . . . . 0.0 110.288 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.9 108.09 6.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.596 -0.69 . . . . 0.0 109.658 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.782 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -87.73 147.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.842 0.829 . . . . 0.0 111.209 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -102.59 101.21 11.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -47.5 -24.75 0.91 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.532 -0.73 . . . . 0.0 112.431 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD12 ' CA ' ' A' ' 42' ' ' GLY . 94.5 mt -63.23 -49.85 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 0.0 110.566 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -127.6 -29.99 2.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.37 -0.831 . . . . 0.0 111.597 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.85 4.99 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 17.4 t80 -72.3 131.82 43.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.384 -1.068 . . . . 0.0 108.831 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.782 HD13 ' HA ' ' A' ' 4' ' ' VAL . 37.9 mm -113.62 123.19 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.464 -0.772 . . . . 0.0 111.466 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 30.9 t80 -91.71 113.25 25.47 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.38 87.11 5.04 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.284 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -53.86 -21.4 7.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.858 -0.526 . . . . 0.0 111.23 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.74 -31.49 72.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.354 -0.841 . . . . 0.0 109.026 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -35.07 5.83 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.294 0.569 . . . . 0.0 109.574 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 109.62 -107.06 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -176.28 90.54 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.431 -1.041 . . . . 0.0 109.949 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.09 -19.3 63.22 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.422 1.222 . . . . 0.0 110.533 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -30.32 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 109.307 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 6.3 48.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.69 . . . . 0.0 110.56 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.26 70.13 1.06 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 24' ' ' SER . 47.1 mm -126.45 166.72 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.935 . . . . 0.0 111.2 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.8 t -65.42 148.08 98.25 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.012 -0.43 . . . . 0.0 110.409 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 119.07 5.91 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.488 1.257 . . . . 0.0 110.015 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.35 71.26 1.24 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 32' ' ' LEU . 12.6 m -122.5 122.61 39.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.722 -0.869 . . . . 0.0 110.407 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.7 mttt -60.82 114.81 3.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.614 -0.679 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -51.13 -30.02 15.15 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.17 -0.956 . . . . 0.0 110.728 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -77.24 -2.85 36.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.684 -0.635 . . . . 0.0 110.824 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.29 -3.89 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 111.262 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 36' ' ' TRP . 6.1 mt -58.83 156.54 24.49 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.128 -0.982 . . . . 0.0 109.864 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.3 Cg_endo -84.34 172.72 9.22 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.287 1.151 . . . . 0.0 110.404 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.88 -16.46 63.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.591 -0.693 . . . . 0.0 110.504 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -16.15 48.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 110.008 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 32' ' ' LEU . 30.7 t90 -93.39 129.9 39.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.797 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.86 HG23 ' HB1' ' A' ' 43' ' ' ALA . 10.0 p -167.43 117.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 110.006 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -58.71 177.17 0.24 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.656 -0.653 . . . . 0.0 110.459 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 42.2 Cg_endo -69.3 -160.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.353 1.186 . . . . 0.0 110.328 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 41' ' ' THR . 6.2 tp -48.94 -36.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.208 -0.932 . . . . 0.0 111.349 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 39' ' ' PRO . 7.1 t -77.59 87.48 3.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -0.788 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' CA ' HD12 ' A' ' 7' ' ' ILE . . . 84.4 164.67 38.11 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.86 ' HB1' HG23 ' A' ' 37' ' ' VAL . . . -169.17 -62.65 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.429 -1.042 . . . . 0.0 110.982 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 43.4 Cg_endo -70.33 -170.76 0.45 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 O-C-N 122.944 0.971 . . . . 0.0 110.827 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 74.1 mmtt -89.27 -45.67 9.35 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.651 0.739 . . . . 0.0 110.343 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.0 m -54.82 -21.62 11.82 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.84 -0.537 . . . . 0.0 111.238 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.62 7.15 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.351 -0.843 . . . . 0.0 111.427 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 8.8 m-85 -109.78 -169.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.11 -0.994 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.692 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.2 tm-20 -160.07 121.34 3.12 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.482 -0.761 . . . . 0.0 109.534 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 18.4 mtpt -54.22 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.0 110.878 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 51' ' ' LEU . 8.4 tt -96.89 -12.5 23.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.697 -0.627 . . . . 0.0 111.188 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -52.36 148.73 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.083 -1.011 . . . . 0.0 110.943 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.451 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.066 0.46 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.58 178.65 6.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 17.1 m95 -140.39 143.86 35.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.2 p -118.92 137.53 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.752 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -92.76 95.7 9.71 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -51.11 -23.29 3.05 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.455 -0.778 . . . . 0.0 111.682 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.415 ' C ' HG23 ' A' ' 8' ' ' THR . 76.4 mt -81.37 -9.8 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.347 -0.845 . . . . 0.0 111.361 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 7' ' ' ILE . 71.1 p -147.94 -41.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.976 -1.077 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 -13.19 21.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.4 t80 -51.82 156.4 1.46 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.117 -1.225 . . . . 0.0 109.681 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 10' ' ' TYR . 43.6 mm -133.53 130.78 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 54.0 t80 -92.33 110.91 22.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.47 83.69 5.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.9 tt0 -51.02 -23.89 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.792 -0.568 . . . . 0.0 111.151 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.57 -30.09 71.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.411 -0.805 . . . . 0.0 108.935 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.39 -34.04 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.323 0.582 . . . . 0.0 109.62 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.62 -104.5 2.5 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -173.72 88.81 0.36 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.398 -1.06 . . . . 0.0 110.102 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 -21.1 62.04 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.427 1.225 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.46 -34.95 47.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.236 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -92.13 3.81 54.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.758 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.87 63.79 4.88 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.4 mm -119.89 165.99 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.95 . . . . 0.0 110.728 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -60.13 143.31 88.69 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.442 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.85 115.93 4.49 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.333 1.175 . . . . 0.0 109.679 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.46 66.48 1.6 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -120.21 125.13 47.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.857 . . . . 0.0 110.146 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 30.6 mmtt -59.7 122.64 14.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.66 -0.65 . . . . 0.0 109.396 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 36.6 t80 -48.43 -33.15 8.78 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.21 -0.931 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.15 -22.92 62.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -82.44 -26.23 32.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.67 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.633 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.9 mt -57.64 141.17 79.74 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.251 -0.905 . . . . 0.0 109.806 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.11 175.59 6.44 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.151 1.079 . . . . 0.0 110.536 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.65 -18.14 58.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 110.405 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.81 -15.51 42.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.382 -0.824 . . . . 0.0 110.131 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -86.23 136.14 33.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 0.0 109.805 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 43' ' ' ALA . 8.9 p -168.17 126.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.581 -0.699 . . . . 0.0 109.776 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . . . -70.76 141.5 87.39 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.582 -0.698 . . . . 0.0 110.253 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.11 -8.65 22.44 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.358 1.189 . . . . 0.0 111.301 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.53 94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 41' ' ' THR . 32.6 m 53.04 29.6 8.25 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.556 -0.715 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 117.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.671 ' O ' HG23 ' A' ' 37' ' ' VAL . . . -150.67 112.2 3.17 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.949 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.08 -175.08 1.11 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.143 1.075 . . . . 0.0 110.174 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.65 -24.84 19.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -73.17 -12.2 60.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.399 -0.813 . . . . 0.0 110.845 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -95.67 21.8 7.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 5.7 m-85 -105.33 -172.55 2.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.48 -0.762 . . . . 0.0 110.673 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.27 140.48 11.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CG ' ' CZ2' ' A' ' 3' ' ' TRP . 29.3 mtpt -57.99 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.194 -0.941 . . . . 0.0 110.452 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 41.2 tp -111.1 63.61 0.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.61 0.719 . . . . 0.0 110.036 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -55.9 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.718 -0.614 . . . . 0.0 110.612 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 N--CA 1.5 2.05 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.821 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.117 0.484 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -118.11 174.69 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -140.01 110.82 6.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.0 109.733 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.6 p -81.93 150.68 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 111.112 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.33 118.18 35.15 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -55.46 -21.47 16.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.557 -0.714 . . . . 0.0 111.215 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 47' ' ' GLU . 88.4 mt -64.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -135.74 29.74 3.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 111.07 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.38 58.01 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CD1' HD12 ' A' ' 5' ' ' LEU . 5.8 t80 -60.99 134.95 57.62 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.229 -1.159 . . . . 0.0 108.722 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.775 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.6 mm -117.14 118.48 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.557 -0.714 . . . . 0.0 111.205 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 27.4 t80 -85.41 112.55 20.96 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -79.56 82.34 5.7 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.086 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tm-20 -57.04 -19.5 19.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.686 -0.634 . . . . 0.0 110.776 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -62.28 -31.04 71.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.2 -0.937 . . . . 0.0 108.751 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.73 -44.07 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 127.65 -108.55 0.96 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.24 94.42 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.339 -1.094 . . . . 0.0 109.174 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -13.62 40.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.386 1.203 . . . . 0.0 110.971 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.95 -33.41 57.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.246 -0.908 . . . . 0.0 109.745 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -106.04 11.46 31.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.736 . . . . 0.0 110.852 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.95 66.99 2.44 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.633 HD11 ' CD1' ' A' ' 36' ' ' TRP . 46.7 mm -103.6 164.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.924 . . . . 0.0 110.686 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.05 172.83 8.85 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.931 -0.481 . . . . 0.0 110.051 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.85 107.11 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.335 1.176 . . . . 0.0 109.41 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.14 -95.71 1.67 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD21 ' A' ' 32' ' ' LEU . 52.4 m 55.64 101.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.716 -0.873 . . . . 0.0 110.708 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -63.12 125.86 25.46 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.399 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.7 t80 -50.69 -25.93 4.87 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.49 -6.58 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.552 -0.718 . . . . 0.0 110.752 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.89 -16.52 14.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 27' ' ' THR . 11.5 mt -54.87 156.42 6.79 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.12 169.41 21.55 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.258 1.136 . . . . 0.0 110.985 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -71.74 -14.21 61.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.747 -0.596 . . . . 0.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -75.2 -3.12 31.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.411 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.633 ' CD1' HD11 ' A' ' 23' ' ' ILE . 74.8 t90 -80.32 120.78 24.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.141 -0.974 . . . . 0.0 110.024 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 36' ' ' TRP . 25.0 t -154.13 118.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -88.3 -62.35 0.22 Allowed Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 111.228 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -71.88 -162.46 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.909 0.952 . . . . 0.0 110.061 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 tt -50.45 167.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.406 -0.809 . . . . 0.0 110.711 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 p -53.48 98.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.406 -0.809 . . . . 0.0 110.985 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.45 61.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . . . -138.83 51.06 3.18 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.496 -1.002 . . . . 0.0 110.802 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 43.2 Cg_endo -69.61 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.263 1.138 . . . . 0.0 110.381 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 67.7 mmtt -83.86 -20.1 33.72 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 0.0 110.947 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.0 p -78.13 0.58 24.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 111.553 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 7' ' ' ILE . 6.9 tt0 -114.3 20.25 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.042 -1.036 . . . . 0.0 111.001 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 13.7 m-85 -121.54 -172.45 2.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.865 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.826 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.4 tt0 -160.2 122.75 3.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 2.8 mtpt -58.48 173.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.34 -28.31 21.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.673 -0.642 . . . . 0.0 110.268 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -56.69 141.35 44.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.58 -0.7 . . . . 0.0 110.565 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.7 -179.814 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.87 -166.76 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 110.314 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 9.3 m95 -138.07 122.5 18.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 9.9 p -118.47 146.48 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.269 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.5 tt -108.03 118.38 36.61 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.76 -39.81 68.71 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.326 -0.859 . . . . 0.0 111.414 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.56 -49.15 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.532 -0.73 . . . . 0.0 111.345 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -102.1 -57.77 2.0 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.13 -0.981 . . . . 0.0 110.79 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.5 23.64 4.02 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.717 ' O ' HD13 ' A' ' 11' ' ' ILE . 29.3 m-85 -55.76 164.34 1.15 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.049 -1.265 . . . . 0.0 109.588 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.717 HD13 ' O ' ' A' ' 10' ' ' TYR . 28.6 mm -146.5 83.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 63.8 t80 -79.8 109.94 14.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.984 -1.073 . . . . 0.0 108.659 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.45 85.81 5.2 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.1 tt0 -52.8 -22.6 5.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.778 -0.576 . . . . 0.0 111.089 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -29.39 70.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.376 -0.827 . . . . 0.0 109.086 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.69 -37.53 4.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.751 -0.593 . . . . 0.0 109.531 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 108.43 -105.26 2.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.59 90.13 0.22 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.377 -1.072 . . . . 0.0 109.795 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.6 -18.8 48.61 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.353 1.186 . . . . 0.0 110.638 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.14 -32.94 38.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.0 110.021 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -95.58 13.98 24.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.716 . . . . 0.0 110.735 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.5 66.37 2.89 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 32' ' ' LEU . 49.0 mm -122.51 166.89 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.692 -0.887 . . . . 0.0 111.157 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.465 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -73.06 148.97 89.44 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.826 -0.546 . . . . 0.0 110.537 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 120.4 6.51 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.386 1.203 . . . . 0.0 109.985 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.82 70.12 1.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.0 m -124.25 121.35 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.713 -0.875 . . . . 0.0 110.247 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.68 120.22 7.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.804 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB3' ' CE2' ' A' ' 3' ' ' TRP . 33.5 t80 -48.7 -38.27 20.95 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.221 -0.924 . . . . 0.0 110.936 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.93 -20.06 63.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -91.01 -16.42 27.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 110.955 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -56.03 159.34 5.83 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.073 -1.017 . . . . 0.0 110.144 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -85.91 -178.29 2.84 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.359 1.189 . . . . 0.0 110.5 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -67.55 -16.25 64.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.663 -0.648 . . . . 0.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.03 -16.72 46.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.824 . . . . 0.0 110.105 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CG ' HD13 ' A' ' 32' ' ' LEU . 1.1 t90 -106.93 114.1 27.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 43' ' ' ALA . 9.3 p -174.08 150.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.424 -0.798 . . . . 0.0 109.256 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.98 109.28 31.7 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.591 -0.693 . . . . 0.0 110.562 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -22.2 15.68 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.255 1.134 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 41' ' ' THR . 96.9 mt -60.76 -40.25 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 109.982 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 40' ' ' ILE . 3.1 p -154.36 46.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.183 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.7 -169.45 28.31 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.856 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -177.0 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.995 . . . . 0.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 51.8 Cg_endo -93.6 174.82 1.56 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.086 1.045 . . . . 0.0 110.274 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -70.44 -40.97 73.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.535 -0.728 . . . . 0.0 110.327 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -70.14 63.29 0.23 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.761 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -33.1 1.3 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.745 . . . . 0.0 110.501 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.5 m-85 -79.81 -173.03 3.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 110.325 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -149.34 110.01 4.26 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.671 -0.643 . . . . 0.0 109.38 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -57.76 168.3 0.93 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.584 -0.697 . . . . 0.0 110.509 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.9 48.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.209 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.23 168.58 3.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.596 -0.69 . . . . 0.0 110.153 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.172 179.804 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.23 149.02 23.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 110.774 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.43 ' CZ2' ' HD3' ' A' ' 50' ' ' LYS . 19.9 m95 -114.84 173.04 6.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.557 -0.714 . . . . 0.0 110.061 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 51' ' ' LEU . 7.6 p -130.35 142.05 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 110.29 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.89 117.56 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -52.66 -23.58 6.87 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.597 -0.689 . . . . 0.0 111.46 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CG1' HD22 ' A' ' 5' ' ' LEU . 42.3 mm -60.39 -57.39 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.377 -0.827 . . . . 0.0 110.586 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -146.81 36.59 0.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.225 -0.922 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.45 20.06 49.83 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD1' HD12 ' A' ' 5' ' ' LEU . 3.2 t80 -58.41 164.88 2.31 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.138 -1.213 . . . . 0.0 108.643 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.5 mt -141.52 165.79 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.282 1.039 . . . . 0.0 112.241 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 60.6 t80 -126.16 109.91 12.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.29 81.21 5.58 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.6 tt0 -48.94 -25.03 1.72 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.559 -0.713 . . . . 0.0 111.337 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.19 -30.02 71.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 0.0 108.905 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -111.5 -32.55 6.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.826 -0.546 . . . . 0.0 109.581 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.14 -103.26 2.7 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -174.48 88.7 0.33 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.41 -1.053 . . . . 0.0 110.059 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.64 -19.03 60.02 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.455 1.24 . . . . 0.0 110.533 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -34.7 39.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.77 11.2 23.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.677 -0.64 . . . . 0.0 110.765 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.02 55.5 27.77 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 24' ' ' SER . 49.5 mm -112.35 165.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.751 -0.852 . . . . 0.0 111.246 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.6 t -65.1 143.05 98.78 Favored Pre-proline 0 N--CA 1.494 1.775 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.097 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.95 123.09 8.16 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.275 1.145 . . . . 0.0 110.007 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.24 67.65 1.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 m -122.76 123.76 41.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.789 -0.83 . . . . 0.0 110.315 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.82 120.65 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.662 -0.648 . . . . 0.0 109.387 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 69.6 t80 -46.66 -49.39 19.29 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.322 -0.862 . . . . 0.0 111.258 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -59.59 -20.06 53.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.0 110.492 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.27 -29.34 34.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.31 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.449 HD21 HG23 ' A' ' 23' ' ' ILE . 11.5 mt -58.15 150.46 51.81 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.497 -0.752 . . . . 0.0 109.846 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.31 176.22 8.93 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.273 1.144 . . . . 0.0 110.724 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.11 -14.86 62.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.55 -0.719 . . . . 0.0 110.658 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.95 -9.13 50.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.476 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.44 ' O ' HG13 ' A' ' 37' ' ' VAL . 30.3 t90 -91.81 140.43 29.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 36' ' ' TRP . 16.5 m -154.86 -160.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.74 155.34 63.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.615 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.88 83.88 1.1 Allowed 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.471 1.248 . . . . 0.0 110.844 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 41' ' ' THR . 4.7 tt -169.19 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.938 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.472 ' N ' HG23 ' A' ' 40' ' ' ILE . 80.5 m -161.73 -44.04 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.659 -0.651 . . . . 0.0 110.015 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.47 78.51 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.46 116.01 62.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.436 -1.038 . . . . 0.0 110.691 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.34 -163.48 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.22 1.116 . . . . 0.0 110.292 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 29' ' ' PHE . 72.8 mmtt -76.6 -36.39 57.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -0.781 . . . . 0.0 110.187 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -19.63 40.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.884 -0.51 . . . . 0.0 111.03 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -91.92 -21.94 20.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 111.032 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 8.3 m-85 -84.41 178.74 7.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 110.877 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.25 147.82 16.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -72.25 157.19 38.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.18 35.35 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.585 -0.697 . . . . 0.0 109.921 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.04 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.228 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 N--CA 1.502 2.162 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.622 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.191 0.519 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -121.94 175.2 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m95 -139.41 104.88 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.676 -0.64 . . . . 0.0 109.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.8 p -83.84 150.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.718 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.8 116.13 31.74 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -54.27 -21.03 8.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.521 -0.737 . . . . 0.0 111.373 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 5' ' ' LEU . 93.9 mt -58.54 -68.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -123.29 -15.82 7.08 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.473 -0.767 . . . . 0.0 111.647 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 14.77 8.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.58 130.92 48.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.154 -1.204 . . . . 0.0 108.987 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.795 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.4 mm -111.34 114.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.706 . . . . 0.0 111.292 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 23.1 t80 -82.58 113.34 20.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.41 87.44 5.05 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.813 0.816 . . . . 0.0 109.398 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -55.49 -21.21 15.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.632 -0.668 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.55 -32.12 73.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 108.694 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.91 -46.65 3.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 116.31 -106.47 1.51 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 176.17 94.14 0.1 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.391 -1.064 . . . . 0.0 109.282 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.57 -12.79 36.67 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.416 1.219 . . . . 0.0 111.085 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.7 -40.41 55.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.178 -0.951 . . . . 0.0 109.834 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.88 17.38 10.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.02 41.81 92.65 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.3 mm -84.83 165.59 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.787 -0.831 . . . . 0.0 110.848 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.3 154.22 74.38 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.84 107.35 2.19 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.307 1.161 . . . . 0.0 109.8 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.46 65.05 1.47 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 32' ' ' LEU . 1.4 m -116.17 126.78 54.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.861 -0.787 . . . . 0.0 109.643 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 14.4 mtpt -63.56 118.44 8.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.731 -0.606 . . . . 0.0 110.048 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 30.4 t80 -51.34 -35.29 37.63 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.188 -0.945 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.06 -8.81 57.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.643 -0.661 . . . . 0.0 110.492 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -113.17 -4.42 13.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.201 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -52.99 171.4 0.23 Allowed Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 120.906 -1.121 . . . . 0.0 109.444 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.8 Cg_endo -89.26 -175.04 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 122.967 0.983 . . . . 0.0 110.824 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.29 171.43 15.07 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.649 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.9 -0.12 2.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.591 -0.693 . . . . 0.0 112.113 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.679 ' CD1' HD11 ' A' ' 23' ' ' ILE . 64.9 t90 -73.88 119.2 17.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.796 -1.19 . . . . 0.0 109.119 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' C ' ' A' ' 36' ' ' TRP . 57.5 t -150.17 106.62 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 109.827 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.586 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -60.47 154.76 52.85 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.532 -0.73 . . . . 0.0 109.968 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' N ' HD12 ' A' ' 40' ' ' ILE . 50.7 Cg_endo -75.52 61.37 6.05 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.384 1.202 . . . . 0.0 110.75 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.586 ' CD1' ' HB1' ' A' ' 38' ' ' ALA . 4.9 mp -140.98 71.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.505 -0.747 . . . . 0.0 109.934 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.5 p 44.28 70.31 0.34 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.825 -0.547 . . . . 0.0 111.734 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.23 141.01 0.24 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' H ' HG13 ' A' ' 37' ' ' VAL . . . -163.25 57.14 0.62 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.934 . . . . 0.0 110.134 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.18 -164.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.41 1.216 . . . . 0.0 110.39 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mmtm -78.43 -57.87 3.55 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.338 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.34 68.17 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.389 0.614 . . . . 0.0 109.807 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -160.17 -33.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.701 -0.624 . . . . 0.0 111.073 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.5 m-85 -79.52 -172.49 3.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.541 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.741 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.7 tm-20 -160.23 125.59 3.97 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.753 -0.592 . . . . 0.0 109.651 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 21.2 mtmt -63.12 168.23 4.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.103 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.88 29.52 6.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -60.26 157.08 14.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 110.429 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.502 2.135 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.886 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.02 0.438 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.65 159.29 20.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.568 -0.707 . . . . 0.0 110.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.538 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.6 m95 -132.54 112.11 11.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -81.03 150.98 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.467 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -114.57 120.93 41.89 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -52.21 -22.14 4.06 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.483 -0.761 . . . . 0.0 111.715 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 5' ' ' LEU . 95.7 mt -56.15 -74.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.725 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -133.06 20.0 4.09 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.36 23.1 55.34 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.68 ' O ' HD13 ' A' ' 11' ' ' ILE . 3.9 t80 -59.3 152.12 21.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.292 -1.122 . . . . 0.0 108.783 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.2 mm -135.4 137.9 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.326 -0.859 . . . . 0.0 111.654 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 49.8 t80 -105.11 112.71 25.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.26 81.96 5.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -50.19 -24.78 3.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.615 -0.678 . . . . 0.0 110.869 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.41 -31.92 73.21 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -107.2 -52.33 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.13 -107.42 1.04 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -175.61 88.72 0.29 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -14.39 44.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.475 1.25 . . . . 0.0 110.688 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.06 -37.15 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.309 -0.869 . . . . 0.0 109.793 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.33 12.98 27.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 110.701 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.68 66.6 2.7 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 32' ' ' LEU . 50.9 mm -119.39 166.06 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.964 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -65.06 147.52 98.47 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.992 -0.442 . . . . 0.0 110.673 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 48.8 Cg_endo -74.97 111.4 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.391 1.206 . . . . 0.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 66.31 1.47 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -117.81 127.85 54.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.826 -0.808 . . . . 0.0 110.006 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 18.8 mmtm -63.33 118.53 8.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.538 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 57.9 t80 -49.18 -34.85 15.46 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.287 -0.883 . . . . 0.0 111.092 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.79 -18.08 62.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -93.17 -17.76 23.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.161 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 23' ' ' ILE . 8.0 mt -58.64 155.53 29.08 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.15 -0.969 . . . . 0.0 110.137 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.06 165.31 26.27 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.31 1.163 . . . . 0.0 110.245 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.16 -12.35 60.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.682 . . . . 0.0 110.845 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.21 -1.88 28.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.748 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.46 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.8 t90 -86.12 127.4 34.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 0.0 109.883 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.777 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 15.8 m -154.41 117.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 0.0 109.724 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.796 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -77.02 -58.65 1.0 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.446 -0.784 . . . . 0.0 110.613 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.2 Cg_endo -71.81 -163.03 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.075 1.039 . . . . 0.0 110.057 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 tt -51.86 168.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.8 p -50.97 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.353 -0.842 . . . . 0.0 110.973 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.12 73.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.777 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . . . -151.62 56.6 1.99 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.969 . . . . 0.0 110.29 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.21 -164.82 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.441 1.232 . . . . 0.0 110.466 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.14 -20.18 30.66 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.464 -0.772 . . . . 0.0 110.842 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.6 m -79.98 5.2 14.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.495 -0.753 . . . . 0.0 111.82 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -118.84 22.09 12.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.002 -1.061 . . . . 0.0 110.917 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 14.2 m-85 -125.11 -173.93 2.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.307 -0.871 . . . . 0.0 110.994 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.83 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.4 mt-10 -160.41 131.4 5.62 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 23.5 mtmt -76.11 151.92 36.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -97.71 47.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.631 -0.668 . . . . 0.0 110.157 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.67 143.72 29.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.743 . . . . 0.0 110.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.212 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HD3' HD13 ' A' ' 51' ' ' LEU . 9.7 mtpt -111.21 173.7 6.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 0.0 110.063 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -139.72 111.34 7.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.494 -0.754 . . . . 0.0 109.623 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.3 p -87.61 145.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.873 0.844 . . . . 0.0 110.96 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.627 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -96.42 98.98 10.68 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -52.27 -24.33 7.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.384 -0.823 . . . . 0.0 111.153 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 5' ' ' LEU . 50.4 mm -75.93 -13.87 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 7' ' ' ILE . 78.7 p -149.72 -54.14 0.16 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.094 -1.004 . . . . 0.0 111.061 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 132.59 -9.18 5.27 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 11' ' ' ILE . 4.7 t80 -50.62 150.57 2.7 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.267 . . . . 0.0 110.075 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.1 mm -130.08 123.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.502 -0.749 . . . . 0.0 110.939 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 32.2 t80 -88.81 111.54 22.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -79.81 84.99 5.52 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.292 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -55.25 -20.18 10.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.582 -0.699 . . . . 0.0 110.839 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -61.78 -30.41 70.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.146 -0.971 . . . . 0.0 108.819 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.36 -41.78 3.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.0 109.067 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.17 -108.05 1.17 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.25 95.12 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.325 -1.103 . . . . 0.0 109.045 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.46 -12.57 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.301 1.158 . . . . 0.0 111.247 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.94 -33.82 72.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.221 -0.924 . . . . 0.0 109.899 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -111.53 16.09 20.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.56 -0.713 . . . . 0.0 110.802 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.29 62.97 5.75 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 36' ' ' TRP . 42.4 mm -94.13 163.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.968 . . . . 0.0 110.598 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.01 172.9 8.66 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.863 -0.523 . . . . 0.0 110.007 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.84 108.42 2.28 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.272 1.143 . . . . 0.0 109.457 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.89 -94.87 1.74 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 32' ' ' LEU . 51.9 m 55.11 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.947 . . . . 0.0 110.636 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 16.1 mttm -60.05 123.8 18.25 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.101 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -49.75 -26.29 3.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.152 -0.967 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 -12.67 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.622 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -101.88 -16.86 16.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 111.038 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 27' ' ' THR . 10.4 mt -53.86 151.96 11.0 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.108 -0.995 . . . . 0.0 109.988 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.21 156.06 42.04 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.237 1.125 . . . . 0.0 110.858 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.25 -18.14 56.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.622 -0.673 . . . . 0.0 110.589 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.25 1.02 22.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.73 ' CD1' HD11 ' A' ' 23' ' ' ILE . 68.6 t90 -61.79 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.087 -1.008 . . . . 0.0 109.72 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t 52.84 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.539 -0.725 . . . . 0.0 110.912 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -53.09 172.73 0.2 Allowed Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.507 -0.746 . . . . 0.0 110.91 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -76.71 -57.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.408 1.215 . . . . 0.0 111.177 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.8 mm -75.65 98.29 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -0.769 . . . . 0.0 110.192 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m 51.96 45.04 28.95 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.507 -0.746 . . . . 0.0 110.664 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -61.53 169.65 10.84 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -168.29 174.9 2.03 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.967 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 43.6 Cg_endo -69.05 -164.78 0.12 Allowed 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.465 1.245 . . . . 0.0 110.66 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 39.8 mmtm -81.68 -21.55 38.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 p -75.72 -1.3 24.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 111.558 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -114.29 11.29 17.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.01 -1.056 . . . . 0.0 111.343 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 11.3 m-85 -116.66 -170.29 1.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.0 110.456 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.678 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.8 mm-40 -160.12 123.53 3.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 109.447 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mtmt -58.42 167.19 1.47 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.277 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.547 HD13 ' HD3' ' A' ' 2' ' ' LYS . 9.2 tt -81.15 -27.53 35.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.92 158.08 4.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.49 -0.756 . . . . 0.0 110.756 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.695 -179.819 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.18 0.514 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -82.33 156.33 24.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 28.5 m95 -130.41 167.93 17.79 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.7 139.71 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.82 -1.175 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -102.04 121.0 41.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -56.11 -20.37 17.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.458 -0.776 . . . . 0.0 111.11 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 5' ' ' LEU . 86.6 mt -59.22 -63.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.86 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -144.88 44.24 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.212 -0.93 . . . . 0.0 111.976 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.39 20.25 43.91 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.947 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.724 ' HD2' HD12 ' A' ' 5' ' ' LEU . 31.6 t80 -64.16 132.21 49.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -1.137 . . . . 0.0 108.195 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.2 mt -119.52 166.66 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.355 1.074 . . . . 0.0 112.233 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.609 ' OH ' HD11 ' A' ' 32' ' ' LEU . 16.2 t80 -127.19 109.2 11.59 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.6 p-10 -78.86 73.94 5.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.2 tt0 -50.4 -25.73 4.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.741 -0.6 . . . . 0.0 110.812 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.24 -25.37 64.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -105.7 -54.31 2.5 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 110.247 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.6 68.12 0.54 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t0 21.61 82.09 0.13 Allowed Pre-proline 0 N--CA 1.51 2.53 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.43 -21.32 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.664 1.35 . . . . 0.0 109.955 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -80.29 -45.16 18.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.447 -0.783 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.91 -35.14 17.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.47 -0.769 . . . . 0.0 110.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.06 52.04 0.85 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.724 HD11 ' CD1' ' A' ' 36' ' ' TRP . 18.8 mm -89.68 155.69 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.491 -1.005 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -47.62 145.36 4.34 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.602 . . . . 0.0 111.444 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.17 105.46 1.2 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.5 1.263 . . . . 0.0 110.329 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.52 83.59 0.31 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.619 HG22 HD12 ' A' ' 32' ' ' LEU . 1.7 m -140.09 117.14 11.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.677 -0.896 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.0 tptt -51.76 126.68 18.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 110.098 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HA ' HD13 ' A' ' 32' ' ' LEU . 23.3 t80 -42.26 -29.27 0.24 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.449 -0.782 . . . . 0.0 112.165 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.304 -0.873 . . . . 0.0 110.93 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -87.0 -31.69 20.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.683 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -47.2 149.78 1.67 Allowed Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.464 -0.772 . . . . 0.0 111.702 -179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -85.28 -178.29 3.04 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.57 1.3 . . . . 0.0 110.482 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.42 -14.67 59.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.637 -0.664 . . . . 0.0 110.7 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.63 -12.73 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.256 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.724 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.8 t90 -96.25 95.79 8.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.09 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG11 ' HB1' ' A' ' 43' ' ' ALA . 27.4 m -152.73 -166.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.3 146.54 62.01 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.714 -0.617 . . . . 0.0 110.005 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.21 -171.19 0.75 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.316 1.166 . . . . 0.0 110.783 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.629 ' O ' HG22 ' A' ' 40' ' ' ILE . 11.4 mt 54.56 23.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 110.553 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -160.77 -43.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.16 -140.06 11.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -155.34 61.56 2.98 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.55 -0.971 . . . . 0.0 110.921 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 51.4 Cg_endo -93.07 125.74 0.62 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.068 1.036 . . . . 0.0 109.93 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -58.11 -39.49 78.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.277 -0.889 . . . . 0.0 110.034 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -80.11 57.15 2.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 110.208 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.722 ' HG2' HD21 ' A' ' 5' ' ' LEU . 34.5 tt0 -114.5 -42.71 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.258 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -79.39 -179.49 6.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.858 0.837 . . . . 0.0 111.326 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.11 144.72 14.68 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CD ' ' CZ2' ' A' ' 3' ' ' TRP . 1.1 mtmt -61.89 170.66 1.98 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 51' ' ' LEU . 39.7 tp -106.5 61.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.692 0.758 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -57.06 -50.61 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.849 -0.532 . . . . 0.0 110.716 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.779 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.005 0.431 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 51' ' ' LEU . 32.4 mttt -118.97 166.7 12.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.715 . . . . 0.0 110.37 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.8 m95 -130.0 106.44 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.737 -0.602 . . . . 0.0 109.4 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 11' ' ' ILE . 8.5 p -91.7 147.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.649 0.738 . . . . 0.0 111.146 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -100.89 101.17 11.93 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -54.73 -21.57 11.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 111.455 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.2 mp -82.46 -9.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.339 -0.851 . . . . 0.0 111.232 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.439 HG23 ' C ' ' A' ' 7' ' ' ILE . 70.1 p -148.2 -47.23 0.16 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.955 -1.09 . . . . 0.0 111.225 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.27 -13.89 9.5 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' HD13 ' A' ' 11' ' ' ILE . 7.4 t80 -52.5 140.56 22.34 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.17 -1.194 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.676 ' CD1' HG23 ' A' ' 4' ' ' VAL . 26.7 mm -123.08 121.4 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.48 -0.763 . . . . 0.0 111.343 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 38.3 t80 -85.92 111.23 20.04 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.51 81.63 5.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.71 0.767 . . . . 0.0 109.427 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -54.08 -21.32 8.2 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.755 -0.591 . . . . 0.0 110.933 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -29.14 70.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.933 . . . . 0.0 108.754 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.34 -43.5 2.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.97 -108.21 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.44 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.33 -14.35 42.5 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.353 1.186 . . . . 0.0 110.694 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.91 -39.11 31.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -92.24 17.76 9.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.563 -0.711 . . . . 0.0 110.448 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.08 65.07 3.81 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 24' ' ' SER . 41.5 mm -114.27 165.4 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.733 -0.863 . . . . 0.0 111.958 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -79.1 148.93 72.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.675 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 45.3 Cg_endo -71.76 105.25 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.237 1.125 . . . . 0.0 110.709 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.67 61.73 1.35 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.508 HG21 HD23 ' A' ' 32' ' ' LEU . 16.9 m -115.99 134.05 55.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.934 -0.745 . . . . 0.0 109.833 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -76.87 124.84 28.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.661 -0.65 . . . . 0.0 110.307 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' HA ' HD12 ' A' ' 32' ' ' LEU . 6.3 t80 -45.55 -43.61 12.1 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.166 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.42 -25.49 10.1 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -103.56 -87.42 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 29' ' ' PHE . 6.7 mt 52.15 179.52 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.295 0 O-C-N 120.99 -1.069 . . . . 0.0 110.042 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.2 Cg_endo -83.63 -164.05 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 109.804 -0.883 . . . . 0.0 109.804 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -93.44 160.41 14.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 110.475 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 58.33 17.24 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.486 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 76.4 t90 -65.21 112.9 3.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.181 -0.949 . . . . 0.0 109.35 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 43' ' ' ALA . 32.8 m -146.54 -149.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.399 -0.813 . . . . 0.0 110.062 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -169.27 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.985 . . . . 0.0 110.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.9 Cg_endo -70.74 -164.23 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 122.98 0.989 . . . . 0.0 110.486 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.6 tt -113.0 -26.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.726 . . . . 0.0 110.505 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 p -60.17 93.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 0.0 109.967 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.18 -177.53 6.89 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -147.5 61.83 6.58 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.47 -1.018 . . . . 0.0 111.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 50.5 Cg_endo -96.11 119.67 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.25 -1.096 . . . . 0.0 109.25 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.41 65.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.148 -0.97 . . . . 0.0 109.818 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 p -80.71 54.11 2.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.01 31.1 4.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 109.695 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 6.2 m-85 -120.28 -167.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.729 -0.607 . . . . 0.0 110.567 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.605 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.2 tp10 -160.13 112.26 2.02 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.675 -0.641 . . . . 0.0 109.758 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 12.2 mtpt -55.88 177.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.442 -0.787 . . . . 0.0 110.67 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.748 ' O ' HD12 ' A' ' 51' ' ' LEU . 3.9 pp -89.65 18.1 5.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.584 -0.698 . . . . 0.0 111.181 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.19 170.08 0.22 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.175 -0.953 . . . . 0.0 110.768 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.72 -179.798 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.064 0.459 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -114.98 179.12 4.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 110.158 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.54 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -139.87 104.23 4.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 109.749 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.65 158.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.96 0.886 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -119.44 113.48 20.84 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.501 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -53.26 -22.62 7.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.432 -0.793 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 5' ' ' LEU . 96.5 mt -58.81 -52.7 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.674 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -149.47 33.42 0.71 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.251 -0.905 . . . . 0.0 111.403 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 15.94 58.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 5' ' ' LEU . 4.2 t80 -60.54 146.18 45.95 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.079 -1.248 . . . . 0.0 108.875 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 12' ' ' TYR . 42.7 mt -131.3 166.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 122.221 1.01 . . . . 0.0 111.624 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 11' ' ' ILE . 42.7 t80 -134.17 110.71 9.75 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.18 87.19 4.92 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.95 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.2 tt0 -53.55 -21.4 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.857 -0.527 . . . . 0.0 111.104 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.09 -31.18 71.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.229 -0.919 . . . . 0.0 108.844 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.26 -49.61 3.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.285 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.21 -107.84 1.08 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 95.35 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.497 -1.002 . . . . 0.0 109.076 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.19 -11.66 32.2 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.376 1.198 . . . . 0.0 111.416 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.79 -39.2 70.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.76 23.62 9.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 110.264 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.69 48.24 66.95 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.759 HD12 ' CD2' ' A' ' 32' ' ' LEU . 47.0 mm -87.83 160.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.86 -0.788 . . . . 0.0 111.337 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 154.9 74.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.965 -0.459 . . . . 0.0 109.906 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.51 106.44 1.95 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.359 1.189 . . . . 0.0 110.0 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 69.33 1.38 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.639 HG21 HD23 ' A' ' 32' ' ' LEU . 6.3 m -119.17 124.61 47.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.7 -0.883 . . . . 0.0 110.289 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.3 mptt -62.14 113.52 2.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.818 -0.551 . . . . 0.0 109.856 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 26.2 t80 -49.22 -32.75 11.1 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.379 -0.826 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.18 -21.24 46.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.376 -0.827 . . . . 0.0 109.62 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -109.55 -81.82 0.57 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.759 ' CD2' HD12 ' A' ' 23' ' ' ILE . 6.1 mt 52.47 -179.63 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.085 -1.01 . . . . 0.0 109.605 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 49.3 Cg_endo -82.47 157.2 16.68 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.92 158.71 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.327 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t0 59.02 15.99 4.38 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.586 -0.696 . . . . 0.0 111.707 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.4 t90 -60.58 126.08 26.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.972 -1.08 . . . . 0.0 109.421 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.714 HG11 ' HA ' ' A' ' 41' ' ' THR . 25.0 t -155.73 112.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.831 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -55.58 -56.89 24.6 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.587 -0.696 . . . . 0.0 110.794 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 48.0 Cg_endo -73.62 -165.09 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.162 1.085 . . . . 0.0 110.188 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.9 mt -67.6 -40.56 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.562 -0.711 . . . . 0.0 109.793 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.714 ' HA ' HG11 ' A' ' 37' ' ' VAL . 7.0 t -170.28 131.1 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.97 44.35 0.41 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . . . -142.5 51.3 1.86 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.527 -0.984 . . . . 0.0 110.716 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 43.0 Cg_endo -68.66 -164.05 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.182 1.096 . . . . 0.0 110.48 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -93.54 -24.92 17.79 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.497 -0.752 . . . . 0.0 110.586 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -80.19 4.71 16.63 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.541 -0.724 . . . . 0.0 111.734 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -117.77 18.51 14.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.057 -1.027 . . . . 0.0 111.09 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.497 ' CD2' ' CZ ' ' A' ' 29' ' ' PHE . 10.1 m-85 -116.85 164.78 14.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.122 -0.986 . . . . 0.0 110.532 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -128.12 117.93 22.49 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 33.1 mtpt -57.07 -173.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.548 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.11 32.74 5.84 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.425 0.631 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.08 -175.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.748 -0.595 . . . . 0.0 110.637 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.797 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.188 0.518 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 158.48 21.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.72 . . . . 0.0 110.687 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 17.1 m95 -131.83 112.84 12.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.712 ' HA ' HD13 ' A' ' 11' ' ' ILE . 88.4 t -79.62 158.65 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.179 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -116.8 101.11 8.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -24.87 2.02 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.409 -0.807 . . . . 0.0 111.809 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.588 ' HB ' HD22 ' A' ' 5' ' ' LEU . 51.1 mm -71.45 -23.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.488 -0.758 . . . . 0.0 110.851 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 7' ' ' ILE . 67.3 p -150.71 -41.84 0.12 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.136 -0.977 . . . . 0.0 111.702 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.67 -0.93 11.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.641 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -51.02 160.52 0.47 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.049 -1.265 . . . . 0.0 109.913 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 4' ' ' VAL . 43.5 mm -134.88 125.65 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.386 -0.821 . . . . 0.0 111.248 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 48.0 t80 -93.85 111.22 22.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.37 87.1 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -52.55 -22.63 5.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.819 -0.55 . . . . 0.0 111.197 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.07 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.416 -0.803 . . . . 0.0 108.966 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.65 -30.45 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.68 -0.638 . . . . 0.0 109.857 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.56 -104.74 2.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.67 89.31 0.29 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.429 -1.042 . . . . 0.0 109.843 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.27 -22.84 52.74 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.41 1.216 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.28 -30.55 60.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.563 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.07 8.8 43.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.695 . . . . 0.0 110.625 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.19 63.84 4.95 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.06 166.71 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 110.91 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -64.68 145.71 98.62 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.814 -0.554 . . . . 0.0 110.333 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.53 119.55 5.8 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.351 1.185 . . . . 0.0 109.804 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.72 64.99 1.82 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -118.39 126.04 51.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.696 -0.885 . . . . 0.0 109.939 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -61.17 122.24 14.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.626 -0.671 . . . . 0.0 109.761 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 69.3 t80 -49.25 -26.95 3.31 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.265 -0.897 . . . . 0.0 110.993 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -19.67 53.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.44 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -87.77 -24.24 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.647 HD21 ' CG2' ' A' ' 23' ' ' ILE . 12.3 mt -56.79 142.76 71.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.254 -0.904 . . . . 0.0 109.798 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.67 -175.68 2.57 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.308 1.162 . . . . 0.0 110.992 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.37 -18.9 62.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.71 -0.619 . . . . 0.0 110.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.02 -14.28 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.453 -0.779 . . . . 0.0 110.07 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -89.74 127.52 35.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 37' ' ' VAL . 8.0 p -174.29 122.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 109.315 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.46 141.43 78.39 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 0.0 110.53 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.31 -21.74 17.22 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.23 1.121 . . . . 0.0 111.3 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 41' ' ' THR . 16.9 tt -54.52 -40.39 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.251 -0.906 . . . . 0.0 110.686 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.471 ' N ' HG23 ' A' ' 40' ' ' ILE . 32.0 m -160.82 169.4 22.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.578 -0.701 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 41' ' ' THR . . . -61.55 90.22 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 5' ' ' LEU . . . -106.97 76.47 0.45 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.693 -0.886 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 -164.14 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.387 1.203 . . . . 0.0 109.979 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -83.05 -56.41 3.81 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.473 -0.767 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.6 m -73.5 59.12 0.6 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.54 -0.725 . . . . 0.0 110.829 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -160.14 25.7 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.163 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 9.9 m-85 -119.03 171.32 8.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 110.014 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 92.92 2.99 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.579 -0.701 . . . . 0.0 109.676 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -60.62 164.59 4.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.59 -0.694 . . . . 0.0 110.28 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.16 59.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.692 -0.63 . . . . 0.0 110.34 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -47.56 -67.38 0.28 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.697 -0.627 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.097 179.621 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -100.58 -170.28 1.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.689 . . . . 0.0 110.112 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 8.0 m95 -140.27 119.36 12.76 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 14.0 p -117.95 146.28 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.33 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.658 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.6 tt -107.56 115.86 30.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.013 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -53.11 -40.3 64.06 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.241 -0.912 . . . . 0.0 111.397 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.658 ' HB ' HD22 ' A' ' 5' ' ' LEU . 87.2 mt -61.61 -58.7 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -0.75 . . . . 0.0 110.598 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 p -93.18 -59.44 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.33 -0.856 . . . . 0.0 110.828 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.01 23.07 3.37 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.695 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 m-85 -54.91 165.91 0.58 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.989 -1.3 . . . . 0.0 109.692 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 10' ' ' TYR . 36.3 mm -148.89 82.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.548 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 66.4 t80 -79.81 108.33 13.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 46.4 p-10 -79.39 84.84 5.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 4.3 tt0 -49.0 -24.79 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.578 -0.701 . . . . 0.0 111.337 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -64.55 -29.9 70.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.411 -0.806 . . . . 0.0 109.036 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.58 -32.43 6.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.812 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.23 -104.46 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -175.45 88.77 0.3 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.396 -1.061 . . . . 0.0 110.088 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.85 -19.8 46.3 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.356 1.187 . . . . 0.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.15 -31.02 38.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.1 13.4 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.532 -0.73 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.25 67.08 2.39 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 24' ' ' SER . 45.8 mm -122.4 167.36 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.693 -0.886 . . . . 0.0 111.113 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -69.36 145.51 95.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.913 -0.492 . . . . 0.0 110.309 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.24 120.21 6.17 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.324 1.171 . . . . 0.0 110.184 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 67.3 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 10.7 m -122.89 126.33 47.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.68 -0.894 . . . . 0.0 110.088 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.4 mttt -59.08 120.89 9.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.404 -0.81 . . . . 0.0 109.852 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 53.6 t80 -49.05 -44.01 41.28 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.328 -0.858 . . . . 0.0 110.799 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.9 -18.07 64.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.601 -0.687 . . . . 0.0 110.421 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.53 -8.29 29.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.391 -0.818 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 ' CE1' ' A' ' 12' ' ' TYR . 5.8 mt -57.47 155.54 19.36 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.052 -1.03 . . . . 0.0 109.89 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.422 ' CD ' HD23 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -84.54 -174.41 1.79 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 O-C-N 123.275 1.145 . . . . 0.0 110.852 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.11 -17.25 63.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.677 -0.64 . . . . 0.0 110.449 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.63 -16.06 45.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 109.999 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -109.16 117.46 34.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 109.862 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 43' ' ' ALA . 8.6 p -174.84 123.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 109.028 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.825 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -52.4 150.53 8.68 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.504 -0.747 . . . . 0.0 110.798 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.78 -14.6 32.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.408 1.215 . . . . 0.0 111.575 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 7.6 tp -54.27 159.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.131 -0.981 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -53.88 100.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.417 -0.802 . . . . 0.0 110.727 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.5 97.7 0.03 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 38' ' ' ALA . . . -130.19 52.56 9.63 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.586 -0.949 . . . . 0.0 110.405 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 46.3 Cg_endo -71.0 -164.11 0.14 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.333 1.175 . . . . 0.0 110.559 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.15 -26.37 65.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 0.0 110.515 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -80.03 2.7 22.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.764 -0.585 . . . . 0.0 111.516 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.82 -31.72 12.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.06 -1.025 . . . . 0.0 110.447 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 3.1 m-85 -79.82 -170.29 2.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -160.19 124.34 3.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 22.1 mtpt -52.28 177.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.281 -0.887 . . . . 0.0 111.294 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.46 -25.84 20.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 110.508 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.7 -29.88 19.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.304 -0.873 . . . . 0.0 110.902 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 t0 . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.705 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.11 0.481 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 11' ' ' ILE . 13.1 mtmt -116.0 176.99 4.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.341 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 15.5 m95 -135.66 105.36 6.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.797 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -87.16 147.27 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.758 0.789 . . . . 0.0 110.942 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -105.32 116.27 31.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -54.61 -21.06 9.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.502 -0.749 . . . . 0.0 111.502 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.84 -61.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.324 -0.86 . . . . 0.0 110.571 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -131.07 0.23 4.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 111.753 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.94 35.61 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -63.17 129.1 38.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.311 -1.111 . . . . 0.0 108.895 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.797 HD13 ' HA ' ' A' ' 4' ' ' VAL . 35.8 mm -113.68 142.84 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.489 -0.757 . . . . 0.0 111.263 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.4 t80 -116.08 112.99 22.55 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.759 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.9 p-10 -79.59 83.97 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.413 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.4 tt0 -58.79 -17.39 22.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.662 -0.649 . . . . 0.0 110.698 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -63.01 -30.36 71.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.088 -1.007 . . . . 0.0 108.7 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -113.89 -46.68 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.26 -107.03 0.82 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.28 94.5 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.374 -1.074 . . . . 0.0 109.115 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.6 -12.44 35.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.408 1.215 . . . . 0.0 111.292 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.07 -42.34 57.01 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -96.51 14.18 25.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 110.682 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.04 67.63 2.11 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 36' ' ' TRP . 43.7 mm -103.98 166.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.908 . . . . 0.0 111.354 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.456 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -78.05 167.66 33.9 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 122.001 -0.437 . . . . 0.0 110.076 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.94 110.51 2.61 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.391 1.206 . . . . 0.0 109.364 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.07 -91.07 1.18 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.576 HG21 HD21 ' A' ' 32' ' ' LEU . 99.6 m 54.75 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.918 . . . . 0.0 110.618 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.77 125.95 25.63 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.115 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 25.6 t80 -50.57 -28.28 8.35 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -79.57 -0.91 35.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.625 -0.672 . . . . 0.0 110.64 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -122.59 -6.08 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 111.211 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 ' HD3' ' A' ' 33' ' ' PRO . 6.4 mt -52.45 162.87 0.83 Allowed Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 120.979 -1.076 . . . . 0.0 109.412 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.8 Cg_endo -93.7 -165.54 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 120.874 1.05 . . . . 0.0 110.986 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.75 176.47 6.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.694 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t70 68.33 2.41 3.28 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.44 -0.788 . . . . 0.0 111.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.585 ' CD2' HD13 ' A' ' 32' ' ' LEU . 6.6 t90 -106.23 119.63 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.818 -1.176 . . . . 0.0 109.764 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 43' ' ' ALA . 91.8 t -144.13 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 0.0 110.218 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.92 161.49 3.72 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.32 10.85 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.284 1.15 . . . . 0.0 110.269 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.901 HG22 HG23 ' A' ' 41' ' ' THR . 15.2 mt 60.08 148.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 121.46 0.648 . . . . 0.0 110.745 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.901 HG23 HG22 ' A' ' 40' ' ' ILE . 69.2 p 44.57 -166.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.706 -0.621 . . . . 0.0 111.78 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.53 170.21 1.1 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -171.28 -51.33 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.616 -0.932 . . . . 0.0 110.86 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 45.5 Cg_endo -94.03 118.18 0.29 Allowed 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 122.885 0.939 . . . . 0.0 109.95 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 -19.32 40.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 110.707 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 t -76.37 0.68 18.66 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.338 -0.851 . . . . 0.0 111.348 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -95.66 24.5 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.15 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -97.44 -170.82 2.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.981 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.712 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.2 tt0 -160.21 118.08 2.59 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.769 -0.582 . . . . 0.0 109.733 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 28.2 mtmt -62.97 166.32 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 110.428 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.65 48.66 1.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.29 131.2 44.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.817 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.088 0.471 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -96.74 169.15 10.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.213 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.1 m95 -133.09 110.41 10.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.55 -0.719 . . . . 0.0 109.516 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.727 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -89.03 147.59 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.045 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.32 97.73 7.76 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -50.84 -24.28 3.41 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.44 -0.788 . . . . 0.0 111.66 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 5' ' ' LEU . 85.0 mt -75.8 -13.08 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.409 -0.807 . . . . 0.0 111.041 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.432 HG23 ' C ' ' A' ' 7' ' ' ILE . 76.1 p -148.97 -47.72 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.172 -0.955 . . . . 0.0 111.265 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.92 -10.37 7.91 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.3 t80 -50.58 146.65 5.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.118 -1.224 . . . . 0.0 110.114 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.727 HD13 ' HA ' ' A' ' 4' ' ' VAL . 36.2 mm -128.99 111.65 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.549 -0.719 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 51.8 t80 -79.96 110.46 15.36 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.56 87.39 5.14 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.8 tt0 -53.72 -21.32 6.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.798 -0.563 . . . . 0.0 111.174 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -29.75 70.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.255 -0.903 . . . . 0.0 108.898 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.92 -41.71 3.32 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 119.28 -106.39 1.25 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.6 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.43 -1.041 . . . . 0.0 109.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.15 -13.65 40.91 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.349 1.184 . . . . 0.0 110.979 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.28 -33.3 59.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 109.809 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.99 18.59 21.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.514 -0.741 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 55.9 27.38 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.688 HD12 ' CD2' ' A' ' 32' ' ' LEU . 46.0 mm -98.62 163.92 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.612 -0.934 . . . . 0.0 110.846 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.09 156.5 74.31 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 122.011 -0.431 . . . . 0.0 109.971 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.88 99.46 0.87 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.302 1.159 . . . . 0.0 110.145 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 69.95 1.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 HD23 ' A' ' 32' ' ' LEU . 4.6 m -120.24 125.99 49.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.751 -0.852 . . . . 0.0 109.954 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mptt -61.23 119.46 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.591 -0.693 . . . . 0.0 109.883 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.516 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 44.5 t80 -50.96 -39.71 55.77 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.38 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.64 -13.41 62.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.661 -0.65 . . . . 0.0 110.31 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -112.56 2.78 16.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 111.252 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.688 ' CD2' HD12 ' A' ' 23' ' ' ILE . 7.0 mt -54.26 173.96 0.2 Allowed Pre-proline 0 N--CA 1.506 2.334 0 O-C-N 120.888 -1.133 . . . . 0.0 109.351 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -88.46 -174.57 1.11 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 122.944 0.97 . . . . 0.0 110.899 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.33 170.18 16.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 109.853 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 69.0 0.94 2.97 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.541 -0.725 . . . . 0.0 112.146 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.65 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.1 t90 -71.41 129.54 39.07 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.791 -1.193 . . . . 0.0 109.453 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 43' ' ' ALA . 9.5 p -173.69 121.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 109.557 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -57.85 176.36 0.25 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.526 -0.733 . . . . 0.0 110.565 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -72.8 -12.66 26.55 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 O-C-N 123.503 1.265 . . . . 0.0 111.565 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -60.03 -169.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.196 -0.94 . . . . 0.0 110.287 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.5 m -104.9 93.75 4.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.557 -0.714 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.38 84.3 1.76 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.71 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -135.67 52.33 6.68 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.952 . . . . 0.0 110.527 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 44.5 Cg_endo -71.74 -168.73 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.246 1.129 . . . . 0.0 110.454 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -58.79 3.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.608 -0.683 . . . . 0.0 110.756 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 p -72.42 59.83 0.44 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.478 -0.764 . . . . 0.0 111.155 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.14 23.99 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 0.0 110.479 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.8 m-85 -119.69 -170.74 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.392 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.722 ' O ' HG12 ' A' ' 4' ' ' VAL . 16.5 tt0 -160.27 118.91 2.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.671 -0.643 . . . . 0.0 109.878 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 17.5 mtmm -62.18 163.45 8.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 0.0 109.926 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.98 -30.9 39.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.583 -0.698 . . . . 0.0 110.106 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.45 116.95 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.845 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.61 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.09 0.471 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -114.99 175.34 5.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.3 m95 -136.58 106.66 6.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.504 -0.748 . . . . 0.0 109.207 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.793 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -86.23 151.07 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.683 0.754 . . . . 0.0 111.431 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -110.8 117.96 34.85 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -54.18 -21.62 9.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.364 -0.835 . . . . 0.0 111.475 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.21 -59.39 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.851 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -137.62 34.22 2.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.195 -0.94 . . . . 0.0 111.51 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.67 20.57 39.78 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 5' ' ' LEU . 26.9 t80 -60.95 129.25 40.47 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.107 . . . . 0.0 109.035 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.793 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.7 mm -113.76 164.51 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.838 0.828 . . . . 0.0 111.33 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.479 ' N ' HG22 ' A' ' 11' ' ' ILE . 33.3 t80 -135.7 112.52 10.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 10.1 p-10 -79.5 79.2 5.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.893 0.854 . . . . 0.0 109.166 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.28 -21.45 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.708 -0.62 . . . . 0.0 111.005 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.58 -30.69 71.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.323 -0.86 . . . . 0.0 108.87 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.87 -45.66 3.18 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.83 -107.79 1.04 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.25 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.422 -1.046 . . . . 0.0 109.456 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.383 1.202 . . . . 0.0 111.106 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -75.06 -45.7 39.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.936 . . . . 0.0 110.054 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.35 17.48 9.77 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.688 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.1 60.18 9.37 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 32' ' ' LEU . 41.4 mm -101.44 166.57 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.771 -0.841 . . . . 0.0 111.098 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.91 153.35 75.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.878 -0.514 . . . . 0.0 109.777 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.46 112.5 3.36 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.251 1.132 . . . . 0.0 110.236 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.52 66.24 1.81 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.8 m -114.44 118.36 33.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.777 -0.837 . . . . 0.0 110.042 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.5 mptt -59.22 123.68 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -48.2 -28.62 3.1 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.301 -0.874 . . . . 0.0 111.142 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.19 -20.11 52.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.547 -0.721 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.51 -15.18 27.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.355 -0.841 . . . . 0.0 111.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.631 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -53.72 162.48 1.33 Allowed Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.031 -1.043 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HD3' HD23 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -93.69 -165.72 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 120.91 1.073 . . . . 0.0 110.932 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -80.11 176.39 9.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.354 0.597 . . . . 0.0 109.981 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 67.78 3.36 3.44 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.898 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.753 ' O ' HG13 ' A' ' 37' ' ' VAL . 23.2 t90 -96.92 125.62 41.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.84 -1.162 . . . . 0.0 109.384 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -172.24 -80.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.796 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -169.72 178.94 0.84 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.796 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -72.42 -22.49 21.48 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.309 1.163 . . . . 0.0 110.822 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 41' ' ' THR . 6.7 tp -159.4 -40.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.84 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 15.0 p -78.18 146.55 34.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.329 -0.857 . . . . 0.0 110.421 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.94 172.92 30.89 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.815 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -171.68 -52.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.996 . . . . 0.0 110.944 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -89.95 138.9 3.03 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 O-C-N 122.866 0.93 . . . . 0.0 110.291 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -58.88 -44.5 91.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.411 -0.806 . . . . 0.0 110.083 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 m -72.39 64.24 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.606 -0.684 . . . . 0.0 109.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -157.14 28.11 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.6 m-85 -117.92 -169.03 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.563 -0.711 . . . . 0.0 110.515 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.0 tp10 -159.33 123.11 3.79 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.706 -0.621 . . . . 0.0 109.427 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 20.9 mtpt -57.69 178.11 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.469 -0.769 . . . . 0.0 110.552 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -95.28 -26.06 16.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.697 -0.627 . . . . 0.0 110.321 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.49 178.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.467 -0.77 . . . . 0.0 111.033 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.095 179.864 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -120.54 176.23 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.372 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.518 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.3 m95 -141.4 110.0 6.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.698 . . . . 0.0 109.435 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -84.3 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.844 0.831 . . . . 0.0 111.511 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.42 117.41 33.0 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -58.04 -19.84 34.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.542 -0.724 . . . . 0.0 111.155 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.41 -48.71 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.854 . . . . 0.0 110.754 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -150.61 30.63 0.66 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.27 -0.893 . . . . 0.0 111.468 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.34 15.15 60.8 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.677 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' HD12 ' A' ' 5' ' ' LEU . 8.8 t80 -59.87 138.48 57.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.088 -1.242 . . . . 0.0 108.824 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.729 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -121.41 114.18 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 42.8 t80 -81.09 111.37 17.48 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -79.43 85.83 5.19 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.155 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.9 tt0 -51.43 -23.36 3.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.786 -0.571 . . . . 0.0 111.283 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.37 -29.95 71.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.317 -0.864 . . . . 0.0 108.947 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -28.62 7.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.709 -0.619 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.06 -102.52 2.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -173.92 88.32 0.36 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.448 -1.031 . . . . 0.0 109.974 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.86 -19.01 58.79 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.421 1.222 . . . . 0.0 110.444 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -76.75 -29.96 56.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.782 . . . . 0.0 109.579 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.55 12.19 37.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.62 -0.675 . . . . 0.0 110.603 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.28 68.29 1.74 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 24' ' ' SER . 49.8 mm -123.31 167.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.89 . . . . 0.0 111.138 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -61.0 143.08 92.39 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.925 -0.484 . . . . 0.0 110.504 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 114.53 3.97 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.263 1.138 . . . . 0.0 109.938 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.01 66.55 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 6.2 m -119.09 125.41 49.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.825 -0.809 . . . . 0.0 110.002 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 26.3 mtpt -60.8 119.21 7.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.605 -0.684 . . . . 0.0 109.746 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.518 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.8 t80 -51.11 -28.12 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.244 -0.91 . . . . 0.0 110.577 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.72 -2.98 41.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.653 -0.654 . . . . 0.0 110.895 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -112.93 -15.87 12.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.889 . . . . 0.0 111.053 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.529 HD13 ' CG ' ' A' ' 36' ' ' TRP . 5.6 mt -54.54 150.64 16.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.09 -1.006 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' CD ' HD23 ' A' ' 32' ' ' LEU . 49.4 Cg_endo -83.4 -175.75 2.48 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.285 1.15 . . . . 0.0 110.784 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.4 -16.51 61.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.722 -0.611 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.26 -13.39 49.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.529 ' CG ' HD13 ' A' ' 32' ' ' LEU . 24.6 t90 -101.9 121.86 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.705 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 10.5 p -162.39 121.64 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.465 -0.772 . . . . 0.0 110.455 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.822 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -74.81 -56.24 2.23 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.614 -0.679 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.822 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 46.4 Cg_endo -73.47 -164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.315 1.166 . . . . 0.0 110.422 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.4 pt -59.29 -165.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -56.78 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.482 -0.761 . . . . 0.0 110.786 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 -65.83 0.88 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.705 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . . . 51.54 62.95 10.22 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.494 -1.004 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 42.6 Cg_endo -92.22 121.01 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.171 1.09 . . . . 0.0 110.072 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -61.03 -19.07 60.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.551 -0.718 . . . . 0.0 110.774 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -78.76 0.24 27.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.491 -0.756 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -87.4 -24.84 24.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -87.8 -170.32 2.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 0.0 110.425 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.86 ' O ' HG12 ' A' ' 4' ' ' VAL . 18.8 tt0 -160.3 121.9 3.14 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.686 -0.634 . . . . 0.0 109.642 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 34.0 mtmt -59.9 165.63 3.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.99 51.3 1.23 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.658 -0.651 . . . . 0.0 110.22 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -55.16 132.4 47.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 110.705 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 t0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.159 179.833 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.051 0.453 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 -164.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.625 -0.672 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 8.0 m95 -138.53 117.1 12.12 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -121.78 152.29 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.015 -1.074 . . . . 0.0 113.281 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.571 HD11 ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -106.01 117.96 35.39 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.18 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -54.48 -21.4 9.85 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.566 -0.709 . . . . 0.0 111.812 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.424 ' HB ' HD22 ' A' ' 5' ' ' LEU . 76.8 mt -90.0 -61.09 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.247 -0.908 . . . . 0.0 110.984 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.4 p -80.18 -58.72 3.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.28 -0.887 . . . . 0.0 110.415 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.03 21.43 3.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.685 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.0 m-85 -55.98 164.18 1.28 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.991 -1.299 . . . . 0.0 109.515 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 10' ' ' TYR . 35.3 mm -150.47 79.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.803 -0.561 . . . . 0.0 109.618 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 57.0 t80 -79.9 107.89 13.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.821 -1.175 . . . . 0.0 108.914 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -79.61 90.09 5.14 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.4 tt0 -52.75 -23.23 6.36 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.98 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.99 -29.04 70.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.431 -0.793 . . . . 0.0 108.942 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.32 -43.8 3.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.687 -0.633 . . . . 0.0 109.417 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 113.37 -105.81 1.7 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -179.84 90.42 0.2 Allowed Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.405 -1.056 . . . . 0.0 109.706 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.89 -20.67 45.03 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.319 1.168 . . . . 0.0 110.67 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -80.05 -33.77 38.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.392 -0.817 . . . . 0.0 110.276 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.06 17.3 11.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.15 65.13 3.68 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -122.01 167.38 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.646 -0.914 . . . . 0.0 110.83 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.3 t -78.25 151.3 78.16 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.77 -0.581 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 119.3 6.01 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.399 1.21 . . . . 0.0 110.133 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.77 71.46 1.16 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 HD23 ' A' ' 32' ' ' LEU . 8.6 m -125.0 122.12 36.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.706 -0.879 . . . . 0.0 110.274 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 2.5 mptp? -58.19 113.92 2.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.151 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 64.4 t80 -49.42 -31.72 10.28 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.37 -0.831 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.45 -12.18 60.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.548 -0.72 . . . . 0.0 110.611 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -127.85 19.41 6.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.66 HD23 HG21 ' A' ' 27' ' ' THR . 7.4 mt -62.65 171.03 1.97 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.324 -0.86 . . . . 0.0 109.39 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.8 Cg_endo -78.36 -174.89 2.44 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.216 1.114 . . . . 0.0 110.47 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.81 -15.54 56.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.565 -0.709 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -67.42 -11.28 57.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' C ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -103.99 96.48 6.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.045 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.637 HG13 ' C ' ' A' ' 43' ' ' ALA . 57.8 t -150.27 111.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.429 -0.794 . . . . 0.0 109.593 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . . . -59.08 113.13 6.16 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.147 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 -14.2 38.11 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.148 1.078 . . . . 0.0 111.251 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.76 151.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 96.1 m 56.22 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.712 -0.618 . . . . 0.0 111.226 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 47' ' ' GLU . . . -103.78 -141.22 11.09 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -178.24 -57.86 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.528 -0.983 . . . . 0.0 111.271 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 42.6 Cg_endo -69.42 -158.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 O-C-N 122.949 0.973 . . . . 0.0 111.071 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -89.58 -24.23 21.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.165 -0.96 . . . . 0.0 110.465 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -6.68 43.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.583 -0.698 . . . . 0.0 111.8 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.713 ' OE2' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -89.0 -21.73 23.36 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.049 -1.032 . . . . 0.0 110.915 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.7 m-85 -83.97 -170.74 3.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.261 -0.899 . . . . 0.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.12 119.42 2.79 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.485 -0.76 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 11.4 mtmt -55.29 165.63 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 51' ' ' LEU . 5.5 tt -83.86 -23.41 31.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.692 -0.63 . . . . 0.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -22.79 7.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.332 -0.855 . . . . 0.0 111.22 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HG2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.06 159.63 23.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 110.7 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.4 m95 -130.78 110.09 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.746 -0.596 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 11' ' ' ILE . 10.8 p -88.58 142.33 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 110.98 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -97.81 103.27 15.2 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.522 -0.736 . . . . 0.0 111.26 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 47' ' ' GLU . 63.1 mt -71.77 -20.45 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.83 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 7' ' ' ILE . 73.1 p -148.56 -48.46 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.146 -0.972 . . . . 0.0 111.136 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.76 -3.95 7.0 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.61 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.6 t80 -51.75 155.29 1.73 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.324 . . . . 0.0 109.753 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.0 mm -132.83 124.18 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.77 . . . . 0.0 111.233 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 35.5 t80 -93.45 111.34 22.98 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.4 87.59 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.055 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -52.82 -22.35 5.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.782 -0.574 . . . . 0.0 111.156 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -31.65 72.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.313 -0.867 . . . . 0.0 108.883 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.71 -29.82 7.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.74 -0.6 . . . . 0.0 109.754 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 98.47 -104.62 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.65 88.99 0.32 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.429 -1.042 . . . . 0.0 109.947 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 -19.15 59.47 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.433 1.228 . . . . 0.0 110.382 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -80.04 -31.99 39.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.644 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -93.79 8.73 39.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.64 -0.662 . . . . 0.0 110.743 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.8 62.65 6.07 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CG2' HD21 ' A' ' 32' ' ' LEU . 49.2 mm -121.41 166.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.936 . . . . 0.0 110.729 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.0 t -67.7 146.31 98.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.827 -0.546 . . . . 0.0 110.302 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.19 122.44 8.03 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.351 1.185 . . . . 0.0 110.091 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.58 67.04 1.74 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 1.9 m -122.09 126.99 49.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.772 -0.84 . . . . 0.0 109.949 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 6.9 mptt -61.08 119.64 8.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -49.69 -39.58 37.18 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.183 -0.948 . . . . 0.0 110.784 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.07 -17.37 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.587 -0.695 . . . . 0.0 110.291 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -91.16 -21.92 20.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.876 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.1 mt -54.94 151.43 16.01 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.21 -0.931 . . . . 0.0 109.911 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.71 178.88 6.14 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.272 1.143 . . . . 0.0 110.735 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.74 -18.02 63.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.659 -0.651 . . . . 0.0 110.528 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.7 -15.22 51.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.367 -0.833 . . . . 0.0 109.969 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.89 139.05 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 ' N ' ' A' ' 38' ' ' ALA . 8.8 p -168.34 166.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -110.67 178.21 1.05 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 43.8 Cg_endo -71.17 81.8 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.253 1.133 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 41' ' ' THR . 82.6 mt -135.47 169.04 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.646 -0.659 . . . . 0.0 109.577 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 40' ' ' ILE . 22.6 p -54.95 -77.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.0 -143.56 0.42 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -161.65 57.93 0.85 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.458 -1.025 . . . . 0.0 111.396 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 43.4 Cg_endo -97.34 102.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 N-CA-C 109.328 -1.066 . . . . 0.0 109.328 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -22.91 12.47 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.259 -0.901 . . . . 0.0 110.7 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.3 t -80.07 6.16 12.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.475 -0.765 . . . . 0.0 111.392 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG2' HD11 ' A' ' 7' ' ' ILE . 1.2 tp10 -80.9 4.85 17.96 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.018 -1.051 . . . . 0.0 111.268 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.3 m-85 -86.57 -169.83 2.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 110.854 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.04 119.0 6.21 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 7.7 mtmm -54.29 171.47 0.11 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 110.541 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 ' HG2' ' A' ' 2' ' ' LYS . 2.6 pp -79.78 -22.84 42.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.66 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -53.76 135.85 40.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.439 -0.788 . . . . 0.0 110.953 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.74 -179.73 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.029 0.442 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HE2' HG21 ' A' ' 11' ' ' ILE . 19.9 mtpt -128.45 177.03 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 11.1 m95 -141.26 108.18 5.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.579 -0.701 . . . . 0.0 109.452 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.789 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.0 p -84.17 148.31 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.741 0.781 . . . . 0.0 111.22 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -106.33 116.41 31.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -55.43 -21.12 14.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.506 -0.746 . . . . 0.0 111.347 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 5' ' ' LEU . 92.8 mt -65.72 -56.34 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 110.732 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 t -136.19 27.76 3.16 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.343 -0.848 . . . . 0.0 111.219 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.35 50.54 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -62.18 131.49 49.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.789 HD13 ' HA ' ' A' ' 4' ' ' VAL . 40.2 mm -112.81 118.19 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 111.446 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 31.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -79.31 83.09 5.38 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.766 0.793 . . . . 0.0 109.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tt0 -53.36 -22.7 7.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.737 -0.602 . . . . 0.0 110.968 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 0.0 109.044 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.04 -37.07 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.489 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 111.41 -105.94 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.94 90.19 0.28 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.403 -1.057 . . . . 0.0 109.82 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.14 -16.08 53.33 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.403 1.212 . . . . 0.0 110.531 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -101.65 10.7 39.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.59 -0.694 . . . . 0.0 110.704 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.56 1.2 Allowed Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.67 163.38 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.939 . . . . 0.0 111.454 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.41 145.61 81.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.86 118.29 5.23 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.367 1.193 . . . . 0.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.65 64.97 1.97 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.8 m -117.07 126.85 53.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.842 -0.799 . . . . 0.0 109.673 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 11.7 mptt -61.28 123.73 18.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.551 -0.718 . . . . 0.0 109.624 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.5 t80 -48.99 -43.85 40.61 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.242 -0.912 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.8 -20.21 65.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.589 -0.694 . . . . 0.0 110.117 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -90.71 -15.54 30.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.438 -0.789 . . . . 0.0 111.333 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.726 HD23 ' HD3' ' A' ' 33' ' ' PRO . 5.6 mt -52.69 156.44 3.23 Favored Pre-proline 0 N--CA 1.506 2.341 0 O-C-N 121.028 -1.045 . . . . 0.0 109.686 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.726 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.4 Cg_endo -97.62 -165.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.154 1.236 . . . . 0.0 110.937 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.98 -179.2 2.64 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.17 1.85 2.99 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.379 -0.825 . . . . 0.0 111.916 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CD2' HD13 ' A' ' 32' ' ' LEU . 52.0 t90 -101.35 103.14 14.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.849 -1.157 . . . . 0.0 108.644 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.606 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 91.9 t -142.73 116.35 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.475 -0.766 . . . . 0.0 110.352 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -85.08 -50.14 0.56 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.152 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 51.0 Cg_endo -82.63 -163.67 0.23 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 O-C-N 123.239 1.126 . . . . 0.0 109.993 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 40' ' ' ILE . 3.2 tt -114.06 67.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 110.308 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 41' ' ' THR . 7.7 t -161.25 58.85 0.29 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 37' ' ' VAL . . . 61.48 -155.8 36.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . . . -130.37 71.4 82.29 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.452 -1.028 . . . . 0.0 110.236 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -93.58 114.62 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.154 1.081 . . . . 0.0 110.222 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -59.48 -24.85 63.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.565 -0.709 . . . . 0.0 110.355 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -8.52 54.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.743 -0.598 . . . . 0.0 110.781 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.91 -20.86 44.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 8.4 m-85 -95.05 -168.58 1.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.775 . . . . 0.0 110.673 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.6 tt0 -158.84 123.23 4.04 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.733 -0.604 . . . . 0.0 109.371 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -56.3 165.58 1.03 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.577 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -82.84 -27.76 30.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 110.182 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -26.29 36.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.518 -0.739 . . . . 0.0 110.895 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.851 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.021 0.438 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.98 175.43 10.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 110.48 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.0 m95 -141.14 124.68 16.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -119.8 147.29 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.075 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.619 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.3 tt -103.5 119.72 39.45 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.107 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -57.26 -38.89 74.56 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.369 -0.832 . . . . 0.0 111.119 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.619 ' HB ' HD22 ' A' ' 5' ' ' LEU . 80.5 mt -64.57 -50.26 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.549 -0.719 . . . . 0.0 111.15 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.508 HG21 ' OH ' ' A' ' 10' ' ' TYR . 22.0 p -101.51 -57.25 2.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.219 -0.925 . . . . 0.0 110.606 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.94 25.78 3.5 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.736 ' O ' HD13 ' A' ' 11' ' ' ILE . 24.0 m-85 -60.31 170.2 1.4 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.13 -1.217 . . . . 0.0 109.586 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 10' ' ' TYR . 26.9 mm -147.74 89.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 55.0 t80 -79.76 111.71 16.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.877 -1.139 . . . . 0.0 108.8 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -79.47 85.07 5.28 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.686 0.755 . . . . 0.0 109.287 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 6.5 tt0 -53.49 -22.32 7.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.66 -31.7 72.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 108.898 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.07 -53.74 2.61 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.445 0.64 . . . . 0.0 109.311 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 130.05 -108.54 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.33 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.411 -1.052 . . . . 0.0 109.283 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.6 -12.7 36.28 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.414 1.218 . . . . 0.0 111.135 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -77.63 -44.78 27.08 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.19 16.04 10.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.436 -0.79 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.74 40.16 88.35 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CD1' ' A' ' 36' ' ' TRP . 38.3 mm -81.75 161.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.663 -0.904 . . . . 0.0 110.365 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 156.78 79.41 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.757 -0.589 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 112.32 3.28 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.272 1.143 . . . . 0.0 110.026 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.93 67.77 1.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -120.32 121.13 37.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.733 -0.863 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -57.2 119.36 6.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.744 . . . . 0.0 109.815 179.045 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 34.9 t80 -49.64 -29.16 6.8 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.224 -0.923 . . . . 0.0 110.961 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.87 -18.03 59.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.527 -0.733 . . . . 0.0 110.508 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -92.66 -19.69 21.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 111.001 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD21 HG23 ' A' ' 23' ' ' ILE . 7.8 mt -55.32 166.79 0.82 Allowed Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.192 -0.942 . . . . 0.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' HD22 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -78.72 154.63 26.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -65.04 -16.65 63.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.637 -0.665 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.06 -7.68 48.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 110.235 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.822 ' CD1' HD11 ' A' ' 23' ' ' ILE . 40.6 t90 -71.06 132.55 45.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 43' ' ' ALA . 81.4 t -149.98 137.19 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.463 -0.773 . . . . 0.0 108.928 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -84.6 -48.49 0.65 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.675 -0.641 . . . . 0.0 111.939 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -74.66 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.055 1.029 . . . . 0.0 110.871 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -136.9 -67.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.049 -1.032 . . . . 0.0 110.075 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -151.24 36.27 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.34 57.95 0.47 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -160.85 55.4 0.65 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.638 -0.919 . . . . 0.0 110.221 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -163.05 0.1 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.381 1.2 . . . . 0.0 110.263 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -56.85 -36.51 70.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.393 -0.817 . . . . 0.0 110.276 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.85 60.35 3.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 0.0 109.758 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -159.34 -41.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 110.422 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 2.7 m-85 -79.44 -174.24 4.12 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.566 -0.709 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.11 114.81 2.28 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.638 -0.664 . . . . 0.0 109.651 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' CD ' ' HG2' ' A' ' 52' ' ' GLU . 8.7 ptpt -58.37 163.6 2.97 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.534 -0.729 . . . . 0.0 110.19 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -86.34 -29.9 22.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.643 -0.661 . . . . 0.0 110.208 -179.467 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.419 ' HG2' ' CD ' ' A' ' 50' ' ' LYS . 4.3 mm-40 48.41 -169.53 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 0.0 111.413 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.674 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -104.8 -166.87 1.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 11.6 m95 -141.47 121.03 13.3 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 10.3 p -120.88 152.42 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.058 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.4 tt -110.3 118.32 36.01 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.324 178.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -53.43 -39.6 64.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.428 -0.795 . . . . 0.0 111.43 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.53 -59.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.782 . . . . 0.0 110.908 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 9' ' ' GLY . 23.5 p -89.51 -58.2 2.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.322 -0.861 . . . . 0.0 110.678 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' A' ' 8' ' ' THR . . . 116.01 25.05 3.7 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.7 m-85 -56.97 168.76 0.6 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.133 -1.216 . . . . 0.0 109.44 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 10' ' ' TYR . 33.7 mm -149.34 79.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 32' ' ' LEU . 70.6 t80 -79.89 108.29 13.35 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.771 -1.205 . . . . 0.0 108.716 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.45 84.64 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.5 tt0 -49.92 -24.67 2.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.26 -30.0 71.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.803 . . . . 0.0 109.028 178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.54 -29.4 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 97.62 -102.94 2.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.99 89.25 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.429 -1.042 . . . . 0.0 109.761 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.14 -23.14 46.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.34 1.179 . . . . 0.0 110.488 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.95 -31.11 39.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.798 . . . . 0.0 110.0 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.11 16.82 15.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.485 -0.76 . . . . 0.0 110.523 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.59 63.2 5.43 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -121.53 167.07 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.69 -0.888 . . . . 0.0 111.183 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -73.68 148.61 87.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.964 -0.46 . . . . 0.0 110.512 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 110.98 3.21 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.475 1.25 . . . . 0.0 109.997 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.71 1.37 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.428 HG22 ' HG ' ' A' ' 32' ' ' LEU . 17.9 m -121.39 126.06 48.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.787 -0.831 . . . . 0.0 110.084 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 5.3 mptt -60.77 121.09 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 58.7 t80 -47.39 -50.43 22.5 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.349 -0.844 . . . . 0.0 111.016 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 4.6 mm-40 -61.85 -17.29 55.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.632 -0.668 . . . . 0.0 110.55 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.66 -12.55 23.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.24 -0.912 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -55.43 160.39 3.74 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.056 -1.028 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 49.8 Cg_endo -82.32 -176.52 3.0 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.213 1.112 . . . . 0.0 110.512 -179.196 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.43 -16.24 62.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 0.0 110.582 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.73 -14.52 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.109 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -107.24 116.81 32.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 109.817 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 38' ' ' ALA . 8.5 p -169.44 167.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 37' ' ' VAL . . . -114.34 137.76 22.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 110.338 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.79 93.87 1.0 Allowed 'Trans proline' 0 N--CA 1.485 1.01 0 O-C-N 123.25 1.131 . . . . 0.0 110.519 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.4 mt -126.3 -65.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -150.36 36.34 0.66 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.67 . . . . 0.0 109.805 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.33 -120.45 2.09 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -170.91 64.23 0.42 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.964 . . . . 0.0 110.38 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -93.07 123.08 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.128 1.068 . . . . 0.0 109.855 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -58.57 -33.15 69.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.346 -0.846 . . . . 0.0 110.03 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 p -80.34 50.19 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.759 -0.588 . . . . 0.0 110.738 179.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.54 -27.77 7.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.4 m-85 -79.86 -168.73 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.691 . . . . 0.0 110.537 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.31 115.93 2.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.639 -0.663 . . . . 0.0 109.402 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -62.06 163.67 7.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.431 -0.793 . . . . 0.0 110.07 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -45.28 19.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 110.04 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 32.67 56.91 0.42 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.77 -179.808 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 14' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -89.54 155.05 19.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.535 -0.728 . . . . 0.0 110.787 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.779 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 m95 -129.6 158.6 38.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD13 ' A' ' 11' ' ' ILE . 11.1 p -132.32 144.52 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.209 -0.932 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.692 HD22 HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -104.49 120.77 42.01 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -56.28 -20.43 18.65 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.429 -0.795 . . . . 0.0 110.969 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.692 HG12 HD22 ' A' ' 5' ' ' LEU . 45.3 mm -55.09 -66.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.309 -0.87 . . . . 0.0 110.965 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -143.33 31.91 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.192 -0.943 . . . . 0.0 111.754 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.34 17.19 79.68 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.84 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.674 ' HD2' HD12 ' A' ' 5' ' ' LEU . 32.6 t80 -61.58 129.57 41.72 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.079 -1.248 . . . . 0.0 108.5 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 3' ' ' TRP . 30.9 mm -118.58 147.42 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.13 -0.981 . . . . 0.0 112.511 -177.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 33.6 t80 -108.93 107.94 18.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -79.61 83.26 5.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.9 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 1.6 tt0 -58.1 -17.65 19.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.883 -0.51 . . . . 0.0 110.871 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.17 -30.37 71.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.097 -1.002 . . . . 0.0 108.616 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.87 -41.52 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 125.82 -106.46 0.87 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.31 93.61 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.322 -1.105 . . . . 0.0 109.167 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.4 -14.79 46.79 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.387 1.204 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.0 -33.28 39.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.28 -0.888 . . . . 0.0 109.677 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -101.96 13.8 33.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.59 -0.694 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.71 71.9 0.67 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' CD2' ' A' ' 32' ' ' LEU . 43.1 mm -116.52 162.33 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.545 -0.974 . . . . 0.0 110.855 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.06 170.67 14.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.873 -0.517 . . . . 0.0 110.034 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.03 112.3 3.09 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.34 1.179 . . . . 0.0 109.195 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.16 -98.1 2.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 -178.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.604 HG21 HD21 ' A' ' 32' ' ' LEU . 54.2 m 55.52 101.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.695 -0.885 . . . . 0.0 110.674 178.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 19.2 mttt -63.18 130.85 46.36 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.202 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -48.41 -30.4 5.0 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.139 -0.976 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.57 -18.6 59.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.475 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.43 -16.47 22.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 111.127 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 23' ' ' ILE . 12.7 mt -54.36 165.22 0.89 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.042 -1.037 . . . . 0.0 110.061 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.42 175.77 9.29 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.238 1.125 . . . . 0.0 110.885 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.86 -4.15 53.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.649 -0.657 . . . . 0.0 110.865 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.36 21.28 6.23 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' HD11 ' A' ' 23' ' ' ILE . 71.3 t90 -92.25 117.43 29.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.863 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.86 139.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.597 -0.689 . . . . 0.0 110.017 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.658 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . . . -94.83 105.1 16.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.686 -0.634 . . . . 0.0 110.127 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.96 -30.22 21.71 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.304 1.16 . . . . 0.0 110.15 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 40' ' ' ILE . 1.1 pp -75.19 73.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 109.898 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m 54.72 70.78 0.58 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.429 -0.794 . . . . 0.0 110.524 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.658 ' HA3' ' HB3' ' A' ' 38' ' ' ALA . . . -146.46 -135.56 2.76 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -168.15 173.64 2.63 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.614 -0.933 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 50.3 Cg_endo -77.32 -166.02 0.36 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.505 1.266 . . . . 0.0 110.823 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -66.65 -46.64 75.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.713 -0.617 . . . . 0.0 110.233 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -71.45 64.75 0.42 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HG3' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -160.13 -34.84 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.537 -0.727 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -78.84 165.11 23.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.253 -0.905 . . . . 0.0 111.401 -179.096 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' CZ3' ' A' ' 3' ' ' TRP . 2.2 tt0 -160.13 126.53 4.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HG3' ' CZ2' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.86 148.72 2.09 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.3 -0.875 . . . . 0.0 111.213 -179.152 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 51' ' ' LEU . 7.5 tt -79.91 -10.33 59.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.683 -0.636 . . . . 0.0 111.129 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.73 140.55 18.78 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.113 -0.992 . . . . 0.0 111.013 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 t70 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.868 -179.701 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.143 0.496 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -129.57 -178.87 4.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.699 . . . . 0.0 110.283 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.513 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -137.58 108.13 6.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.755 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -86.04 148.35 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.758 0.789 . . . . 0.0 111.311 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -107.49 119.06 38.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -53.24 -21.95 6.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 111.312 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.25 -68.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 41' ' ' THR . 7.4 t -130.94 37.41 3.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.283 -0.885 . . . . 0.0 111.72 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.79 36.56 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 5' ' ' LEU . 40.7 t80 -61.24 130.39 45.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.331 -1.1 . . . . 0.0 108.962 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.786 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.9 mm -115.4 164.69 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.003 0.906 . . . . 0.0 111.728 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 27.7 t80 -133.26 113.08 12.23 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.882 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.32 77.05 5.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.843 0.83 . . . . 0.0 108.981 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -52.22 -22.67 4.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.855 -0.528 . . . . 0.0 111.198 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.72 -31.05 72.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.898 . . . . 0.0 108.975 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.882 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.63 -30.81 6.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 0.0 109.784 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 106.49 -106.5 2.55 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.98 88.18 0.35 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.484 -1.009 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.07 -24.08 52.69 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.412 1.217 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -31.9 57.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.757 . . . . 0.0 109.327 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -95.62 5.81 50.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.665 -0.647 . . . . 0.0 110.57 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.98 3.18 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 32' ' ' LEU . 48.9 mm -123.04 166.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.683 -0.892 . . . . 0.0 111.438 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.2 t -60.86 143.12 91.81 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 122.014 -0.429 . . . . 0.0 110.145 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 122.24 7.44 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.321 1.169 . . . . 0.0 110.147 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.89 67.04 1.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.2 m -118.73 119.99 36.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.77 -0.841 . . . . 0.0 110.309 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -58.4 125.76 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 179.055 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.513 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.1 t80 -46.84 -29.31 1.91 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.357 -0.839 . . . . 0.0 111.452 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -20.31 58.99 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.501 -0.749 . . . . 0.0 110.552 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.41 -24.63 25.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD13 ' CD2' ' A' ' 36' ' ' TRP . 10.8 mt -55.79 138.5 70.74 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.335 -0.853 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.67 -179.27 5.03 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.148 1.078 . . . . 0.0 110.796 -179.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -16.2 59.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 110.65 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.69 -9.19 48.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.241 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.701 ' CD2' HD13 ' A' ' 32' ' ' LEU . 14.5 t90 -113.01 120.75 42.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.631 HG11 ' O ' ' A' ' 43' ' ' ALA . 65.2 t -149.62 -73.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.474 -0.766 . . . . 0.0 109.667 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -168.77 170.12 4.31 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.746 . . . . 0.0 110.094 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 46.2 Cg_endo -72.97 -51.43 0.17 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.369 1.194 . . . . 0.0 110.495 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 40' ' ' ILE . 2.1 tp -168.52 69.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 110.129 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 40' ' ' ILE . 9.3 p -153.3 -56.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.83 -140.94 11.4 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -172.77 -50.52 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.635 -0.92 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 44.5 Cg_endo -94.93 116.6 0.21 Allowed 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 120.705 0.937 . . . . 0.0 109.835 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -18.6 37.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.462 -0.774 . . . . 0.0 110.942 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 0.97 24.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.334 -0.854 . . . . 0.0 111.196 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 2.6 tt0 -98.9 26.85 5.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 6.2 m-85 -96.67 -169.29 1.86 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 110.652 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.4 tm-20 -155.97 122.44 5.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -57.5 174.91 0.19 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.399 -0.813 . . . . 0.0 110.408 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tp -79.99 -32.35 39.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.632 . . . . 0.0 109.936 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 49.57 -167.7 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.466 -0.771 . . . . 0.0 111.174 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.674 -179.732 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.111 0.481 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.76 179.8 4.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.522 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 14.9 m95 -139.08 107.67 5.88 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.632 -0.668 . . . . 0.0 109.378 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.769 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.2 p -88.67 143.72 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.956 -179.386 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -95.55 112.75 24.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -54.66 -21.45 10.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.414 -0.804 . . . . 0.0 111.384 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.613 HG21 ' CG2' ' A' ' 41' ' ' THR . 97.6 mt -60.02 -63.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.324 -0.86 . . . . 0.0 110.413 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -122.02 -22.4 5.69 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.374 -0.829 . . . . 0.0 111.549 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.85 18.02 7.61 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.96 140.44 58.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.33 -1.1 . . . . 0.0 108.703 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.769 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.3 mm -118.53 149.06 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.444 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.3 t80 -119.18 112.7 19.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.6 p-10 -79.5 82.84 5.57 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.692 0.758 . . . . 0.0 109.311 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.02 -18.48 24.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.66 -0.65 . . . . 0.0 110.795 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.13 -31.33 72.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 0.0 108.698 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.19 -46.23 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.81 -108.0 0.87 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.42 94.3 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.377 -1.072 . . . . 0.0 109.297 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.07 -11.93 33.24 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.457 1.241 . . . . 0.0 111.217 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.82 -36.76 62.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.171 -0.956 . . . . 0.0 110.123 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -105.13 16.96 24.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.8 68.11 1.86 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 42.7 mm -106.29 165.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.662 -0.905 . . . . 0.0 110.938 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.92 165.93 44.02 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.913 -0.492 . . . . 0.0 110.222 -179.873 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.8 111.29 2.57 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.332 1.175 . . . . 0.0 109.233 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.71 -96.94 1.88 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 -178.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 51.9 m 55.08 102.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.741 -0.858 . . . . 0.0 110.688 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.9 mttt -63.0 131.86 50.05 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.104 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.6 t80 -48.75 -42.11 34.34 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.001 -1.062 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 17.0 mt-10 -72.13 -8.59 55.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.508 -0.745 . . . . 0.0 110.625 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -105.14 -12.73 15.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' A' ' 23' ' ' ILE . 6.6 mt -52.27 168.91 0.28 Allowed Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.037 -1.04 . . . . 0.0 109.316 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.6 Cg_endo -89.37 -167.29 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 122.953 0.975 . . . . 0.0 110.756 -178.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.54 169.66 13.36 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.321 0.581 . . . . 0.0 110.002 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t0 65.2 8.28 4.74 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.514 -0.741 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CD1' HD11 ' A' ' 23' ' ' ILE . 91.6 t90 -71.92 -75.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 109.175 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 78.3 t 43.69 -94.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.952 -0.467 . . . . 0.0 111.457 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -178.07 178.56 0.37 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.91 -1.119 . . . . 0.0 109.911 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.772 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 44.7 Cg_endo -72.13 -31.88 11.49 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.206 1.108 . . . . 0.0 110.21 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 pt -142.34 154.3 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 109.988 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.613 ' CG2' HG21 ' A' ' 7' ' ' ILE . 3.1 m 55.45 174.45 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.471 -0.768 . . . . 0.0 110.504 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' H ' HG22 ' A' ' 41' ' ' THR . . . 70.89 165.93 6.38 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.761 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -177.8 -49.55 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.428 -1.042 . . . . 0.0 110.878 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.761 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 46.0 Cg_endo -92.79 133.1 1.04 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.008 1.004 . . . . 0.0 110.211 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -40.99 88.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.292 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.7 61.31 1.82 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.677 -0.64 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.08 23.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 110.214 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.4 m-85 -114.75 -168.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.832 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.1 tp10 -160.0 123.76 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.747 -0.596 . . . . 0.0 109.69 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.5 mtmt -60.22 166.13 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 0.0 110.256 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -82.4 -25.9 33.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.704 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.17 177.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.385 -0.822 . . . . 0.0 110.836 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.645 -179.754 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.29 173.91 6.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.552 -0.717 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 10.9 m95 -139.04 107.05 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.659 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.026 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -98.43 106.29 18.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.14 -19.34 19.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.762 . . . . 0.0 111.472 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.3 mp -89.15 -9.59 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 111.653 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.421 HG21 ' HB3' ' A' ' 39' ' ' PRO . 12.6 p -149.33 -47.84 0.14 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.989 -1.069 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.54 -15.1 9.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -51.71 117.75 2.91 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.117 -1.226 . . . . 0.0 109.584 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 4' ' ' VAL . 32.8 mm -100.76 140.2 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.527 -0.733 . . . . 0.0 111.332 -178.44 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 36.4 t80 -104.91 110.95 23.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.21 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.919 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 6.0 p-10 -79.4 78.73 5.9 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.74 0.781 . . . . 0.0 109.26 -179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -51.52 -22.67 3.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.782 -0.574 . . . . 0.0 111.255 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.71 -29.65 70.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.234 -0.916 . . . . 0.0 108.997 178.761 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.919 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.66 -41.66 3.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.74 -0.6 . . . . 0.0 109.516 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 131.69 -109.17 0.85 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.37 91.45 0.18 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.411 -1.052 . . . . 0.0 109.806 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.41 -13.88 41.77 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.337 1.178 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -80.19 -41.03 26.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -95.57 12.2 30.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.519 -0.738 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.55 73.23 0.43 Allowed Glycine 0 N--CA 1.502 3.085 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.606 ' CG2' HD21 ' A' ' 32' ' ' LEU . 44.2 mm -120.52 166.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.697 -0.884 . . . . 0.0 111.49 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -63.97 141.3 98.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.46 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 47.0 Cg_endo -72.48 107.78 2.37 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.154 1.081 . . . . 0.0 110.671 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.1 63.99 1.3 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -123.34 134.85 53.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.759 -0.848 . . . . 0.0 110.122 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -70.88 132.27 45.0 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 13.3 t80 -47.97 -38.52 17.01 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.184 -0.947 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -67.92 -22.43 65.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.545 -0.722 . . . . 0.0 110.136 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.66 -19.96 30.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.535 -0.728 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -52.53 158.1 2.22 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.085 -1.009 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD3' HD23 ' A' ' 32' ' ' LEU . 45.3 Cg_endo -93.59 -170.73 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.098 1.052 . . . . 0.0 110.436 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -76.76 174.87 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.651 -0.655 . . . . 0.0 109.902 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 66.34 7.07 4.66 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.399 -0.813 . . . . 0.0 111.801 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.622 ' CD2' HD13 ' A' ' 32' ' ' LEU . 91.0 t90 -86.54 4.21 40.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.931 -1.106 . . . . 0.0 110.392 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG11 ' HB1' ' A' ' 43' ' ' ALA . 33.8 m -62.84 -156.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.06 -1.025 . . . . 0.0 109.787 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.748 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -171.22 -60.46 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.372 -0.83 . . . . 0.0 110.254 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.2 Cg_endo -71.19 -177.58 2.41 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.022 1.011 . . . . 0.0 109.606 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 41' ' ' THR . 61.5 mt -77.67 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.35 -0.844 . . . . 0.0 109.282 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.416 ' N ' HG22 ' A' ' 40' ' ' ILE . 71.1 p 42.12 39.22 1.31 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 120.94 -1.1 . . . . 0.0 112.062 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.23 -147.83 50.34 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -147.39 58.74 4.31 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.386 -1.067 . . . . 0.0 110.926 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 53.3 Cg_endo -86.55 142.28 6.95 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.064 1.034 . . . . 0.0 110.164 179.57 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -42.36 94.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.458 -0.777 . . . . 0.0 110.065 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.8 m -75.65 59.81 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.712 -0.617 . . . . 0.0 110.483 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -118.12 -29.35 5.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 0.0 110.174 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.0 m-85 -83.53 -169.18 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.595 -0.691 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -160.03 118.41 2.69 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.391 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 15.4 mtmt -55.06 171.12 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.391 -0.818 . . . . 0.0 110.71 -179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 51' ' ' LEU . 7.8 tt -80.04 -26.97 39.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.703 -0.623 . . . . 0.0 110.341 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -54.23 -29.75 47.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.465 -0.772 . . . . 0.0 110.997 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.759 -179.901 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.023 0.439 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.8 175.39 7.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.506 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 11.1 m95 -141.63 98.79 3.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.545 -0.722 . . . . 0.0 109.633 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -89.32 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.656 0.741 . . . . 0.0 111.224 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -99.65 101.98 13.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.391 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -57.79 -19.65 29.86 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.502 -0.749 . . . . 0.0 110.95 -179.586 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.495 HG22 HG21 ' A' ' 41' ' ' THR . 83.1 mt -71.22 -19.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.303 -0.873 . . . . 0.0 111.059 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 10' ' ' TYR . 5.7 t -154.14 -34.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.141 -0.974 . . . . 0.0 112.394 -179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.55 -17.09 6.54 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.442 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.595 ' H ' HG23 ' A' ' 8' ' ' THR . 33.5 t80 -51.05 150.01 3.34 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.096 -1.237 . . . . 0.0 109.871 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 12' ' ' TYR . 45.0 mt -136.01 167.14 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.042 0.925 . . . . 0.0 111.789 -179.218 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.55 ' N ' HG22 ' A' ' 11' ' ' ILE . 46.0 t80 -135.82 106.81 6.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -79.24 86.89 4.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.3 tt0 -47.55 -25.88 1.26 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 0.0 111.697 -178.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.0 -29.72 70.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.394 -0.816 . . . . 0.0 109.179 178.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.23 -25.28 9.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.663 -0.648 . . . . 0.0 110.241 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 101.83 -105.61 2.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.454 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.62 87.07 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.46 -1.023 . . . . 0.0 109.912 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.11 -28.73 40.73 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.428 1.225 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.1 -32.15 72.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.605 -0.684 . . . . 0.0 109.191 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.91 6.39 36.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.699 -0.626 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.0 66.73 2.51 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' SER . 44.6 mm -118.99 167.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.175 0.988 . . . . 0.0 112.683 -176.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.0 t -48.04 121.01 8.5 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.699 179.053 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 131.13 18.17 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.179 1.094 . . . . 0.0 111.217 -179.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.78 59.7 8.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 32' ' ' LEU . 1.8 m -123.42 132.74 54.04 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.827 -0.808 . . . . 0.0 110.289 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.9 mttt -62.16 126.99 29.27 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.836 179.138 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 7.8 t80 -48.89 -27.01 2.77 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.43 -0.794 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -91.34 7.9 38.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -0.752 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -142.62 17.95 2.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 111.4 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 36' ' ' TRP . 1.1 pt? -80.57 -163.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.093 -1.004 . . . . 0.0 108.866 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 41.6 Cg_endo -89.66 143.02 4.27 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 122.457 0.714 . . . . 0.0 110.539 -177.716 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -52.93 171.69 0.06 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.691 -0.631 . . . . 0.0 110.432 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t70 72.88 -6.43 1.68 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.811 -0.556 . . . . 0.0 112.257 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.801 ' CG ' HD11 ' A' ' 32' ' ' LEU . 86.4 t90 -77.09 114.55 16.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.626 -1.296 . . . . 0.0 109.621 179.153 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 36' ' ' TRP . 4.1 m -153.78 -112.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.682 -0.636 . . . . 0.0 109.585 179.434 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.78 146.83 6.79 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.524 -1.36 . . . . 0.0 110.135 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.92 -30.49 11.07 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.351 1.185 . . . . 0.0 110.475 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.64 -57.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.632 -0.668 . . . . 0.0 109.877 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 41' ' ' THR . 6.7 t -161.52 82.31 0.6 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.629 -0.669 . . . . 0.0 110.412 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.14 153.39 25.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -176.64 -51.28 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.544 -0.974 . . . . 0.0 110.705 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 50.9 Cg_endo -89.68 155.49 5.18 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 O-C-N 123.091 1.048 . . . . 0.0 110.58 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.56 -46.53 46.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.67 -0.644 . . . . 0.0 110.358 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -76.76 59.44 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.552 -0.717 . . . . 0.0 110.644 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.67 -29.81 3.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.374 -0.829 . . . . 0.0 110.795 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 7.2 m-85 -79.91 -167.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.4 -0.813 . . . . 0.0 110.263 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.22 123.24 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.715 -0.616 . . . . 0.0 109.526 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.0 mtmt -55.35 167.5 0.47 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.586 -0.696 . . . . 0.0 110.898 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 51' ' ' LEU . 3.1 tt -83.22 -25.49 31.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.659 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -54.61 166.68 0.43 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.46 -0.775 . . . . 0.0 110.832 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.696 -179.907 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.154 0.502 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 11' ' ' ILE . 9.7 mttp -123.13 172.47 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 110.256 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.502 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.05 109.81 7.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 109.417 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.777 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.8 p -83.47 150.23 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.896 0.855 . . . . 0.0 111.384 -179.041 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -110.02 118.0 35.26 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.749 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -19.96 22.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.414 -0.804 . . . . 0.0 111.126 -179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.47 -58.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.835 . . . . 0.0 110.653 -179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 t -137.85 26.98 2.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.299 -0.876 . . . . 0.0 111.373 -179.316 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.17 65.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' HD12 ' A' ' 5' ' ' LEU . 7.9 t80 -61.0 136.27 58.04 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -1.202 . . . . 0.0 108.791 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.777 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -119.84 127.41 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.409 -0.807 . . . . 0.0 111.551 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 29.0 t80 -94.55 113.57 25.42 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.12 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.5 82.44 5.63 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.388 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.61 -21.13 9.56 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.874 -0.516 . . . . 0.0 111.06 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.37 -32.97 74.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.305 -0.872 . . . . 0.0 108.975 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.67 -43.3 4.08 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 179.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.69 -108.27 1.16 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.99 94.38 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.359 -1.083 . . . . 0.0 109.243 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.93 -13.06 38.09 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.438 1.231 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -77.52 -40.02 44.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.204 -0.935 . . . . 0.0 109.949 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -97.94 16.57 20.53 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.596 -0.69 . . . . 0.0 110.674 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 58.0 16.7 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.678 HD12 HD21 ' A' ' 32' ' ' LEU . 44.8 mm -100.43 157.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.97 . . . . 0.0 110.63 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -74.2 158.22 85.77 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.873 -0.517 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.57 109.52 2.65 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.299 1.157 . . . . 0.0 110.31 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.34 79.89 0.74 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.6 m -132.49 119.49 20.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.749 -0.854 . . . . 0.0 110.116 -179.156 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.2 mttt -55.38 121.57 9.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.477 -0.764 . . . . 0.0 110.04 179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.0 t80 -46.79 -46.36 20.57 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.396 -0.815 . . . . 0.0 111.269 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mt-10 -63.72 -18.83 64.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.475 -0.766 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -87.79 -21.13 25.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.678 HD21 HD12 ' A' ' 23' ' ' ILE . 9.3 mt -56.35 163.7 2.34 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.114 -0.991 . . . . 0.0 109.829 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 46.7 Cg_endo -73.43 163.12 38.52 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.148 1.078 . . . . 0.0 110.977 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.49 -18.62 61.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.632 -0.667 . . . . 0.0 110.622 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -75.68 -2.02 27.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 110.336 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.659 ' CD1' HD11 ' A' ' 23' ' ' ILE . 37.4 t90 -75.6 134.5 40.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.099 -1.001 . . . . 0.0 109.814 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 p -174.51 136.28 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.489 -0.757 . . . . 0.0 109.693 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.801 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . . . -81.93 134.99 48.89 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.487 -0.758 . . . . 0.0 110.069 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.33 -173.29 1.41 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.128 1.068 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.6 mt 55.61 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.587 -0.696 . . . . 0.0 110.715 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 41' ' ' THR . 7.2 t -126.73 64.11 1.28 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.801 ' HA3' ' HB3' ' A' ' 38' ' ' ALA . . . -116.54 -157.05 10.86 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.556 ' HB3' HD21 ' A' ' 5' ' ' LEU . . . -163.78 165.58 13.54 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.563 -0.963 . . . . 0.0 110.174 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 43.9 Cg_endo -69.88 -166.0 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.406 1.214 . . . . 0.0 110.647 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -71.84 -55.41 7.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.698 -0.626 . . . . 0.0 110.896 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -73.37 59.53 0.59 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.47 -0.769 . . . . 0.0 111.063 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -160.2 25.69 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -0.832 . . . . 0.0 110.295 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 10.2 m-85 -119.76 -168.11 1.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.406 -0.809 . . . . 0.0 110.45 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.772 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.3 mt-10 -160.07 121.57 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.681 -0.637 . . . . 0.0 109.362 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -54.98 173.11 0.1 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.375 -0.828 . . . . 0.0 110.841 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tp -86.74 -32.17 20.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.031 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -50.62 113.09 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.618 -0.676 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.643 -179.759 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 0.87 110.261 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -114.92 173.39 6.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 2.2599999999999998 110.098 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.978 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 15.2 m95 -130.83 120.09 23.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.51000000000000001 109.736 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.035 ' HA ' HD13 ' A' ' 11' ' ' ILE . 13.3 p -100.21 139.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 0.77000000000000002 110.717 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.799 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -100.26 100.26 11.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.92000000000000004 109.991 179.726 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -44.39 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.351 -0.843 . . . . 2.0699999999999998 110.943 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 8' ' ' THR . 4.7 mt -66.96 -40.76 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 2.0600000000000001 110.474 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.539 HG22 HG22 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -149.23 15.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 2.1099999999999999 110.52 -179.867 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.696 ' O ' HG12 ' A' ' 11' ' ' ILE . . . 77.65 -3.41 60.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.694 -1.362 . . . . 0.69999999999999996 109.694 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.909 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 39.9 t80 -39.89 125.39 1.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -1.225 . . . . 2.46 109.615 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.035 HD13 ' HA ' ' A' ' 4' ' ' VAL . 27.9 mm -114.93 145.29 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.78000000000000003 111.204 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.923 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 27.6 t80 -116.04 109.55 17.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 178.42 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.926 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -79.65 82.01 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 2.2200000000000002 110.35 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' CD ' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -51.81 -18.62 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 1.1399999999999999 110.049 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -18.59 65.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.74 109.621 179.641 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.926 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -127.88 -23.85 3.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.768 . . . . 0.52000000000000002 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 18' ' ' ASP . . . 101.87 -98.24 1.72 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.42999999999999999 109.677 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 164.74 97.82 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.244 -1.15 . . . . 1.3500000000000001 110.072 -179.886 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ASP . 41.9 Cg_endo -69.82 -14.93 36.57 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.129 1.594 . . . . 0.83999999999999997 110.372 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -35.09 37.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 1.6000000000000001 109.901 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -102.38 24.81 9.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.1799999999999999 110.081 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.11 58.53 4.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.502 -1.439 . . . . 0.62 109.502 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.848 HG23 HD21 ' A' ' 32' ' ' LEU . 51.6 mm -104.92 166.71 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.81999999999999995 110.286 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -76.36 157.71 82.41 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.80000000000000004 110.147 179.993 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.05 110.81 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.56000000000000005 110.317 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 14' ' ' GLU . . . 78.09 67.39 1.63 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.418 -1.473 . . . . 1.1100000000000001 109.418 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.561 ' CG2' ' HG ' ' A' ' 32' ' ' LEU . 1.1 m -118.23 114.16 22.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -1.124 . . . . 0.42999999999999999 110.458 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HA ' ' CD ' ' A' ' 14' ' ' GLU . 6.4 mptt -47.98 117.48 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.268 -0.895 . . . . 1.6100000000000001 110.303 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 1.021 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 36.4 t80 -46.14 -41.17 12.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.895 . . . . 1.26 110.116 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -68.44 -13.11 62.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 2.1400000000000001 110.371 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' LEU . 21.8 tt0 -99.52 -26.05 14.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 1.9199999999999999 110.547 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.848 HD21 HG23 ' A' ' 23' ' ' ILE . 6.4 mt -40.82 160.92 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.95 . . . . 0.79000000000000004 110.087 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.4 Cg_endo -78.62 -179.14 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.979 1.515 . . . . 1.03 110.18 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -80.26 -31.97 38.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 2.7799999999999998 109.942 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -7.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 2.7599999999999998 109.706 179.516 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.696 ' HH2' ' HE2' ' A' ' 10' ' ' TYR . 23.7 t90 -90.72 135.25 33.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 1.03 110.191 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.348 HG22 ' CB ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER 175.75 104.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.034 . . . . 1.76 110.488 179.825 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.092 ' O ' ' O ' ' A' ' 37' ' ' VAL . . . -9.6 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.614 -0.678 . . . . 1.6899999999999999 111.156 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.575 ' O ' ' CG1' ' A' ' 40' ' ' ILE . 45.7 Cg_endo -85.71 37.76 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.158 1.609 . . . . 3.2799999999999998 110.713 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 mt -164.6 169.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.259 -0.9 . . . . 4.5899999999999999 109.734 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.183 ' O ' ' O ' ' A' ' 42' ' ' GLY . 66.7 p 10.47 122.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.054 . . . . 4.2699999999999996 110.335 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 1.183 ' O ' ' O ' ' A' ' 41' ' ' THR . . . -7.93 157.72 0.0 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.796 -1.322 . . . . 2.7799999999999998 109.796 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.348 ' CB ' HG22 ' A' ' 37' ' ' VAL . . . -148.71 52.49 1.19 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.274 -1.133 . . . . 3.0 110.09 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -73.7 148.36 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.004 1.529 . . . . 1.45 110.97 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 1.203 ' O ' ' N ' ' A' ' 47' ' ' GLU . 16.8 mmtt -41.78 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 2.1499999999999999 110.046 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.72 32.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 1.53 110.247 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 1.203 ' N ' ' O ' ' A' ' 45' ' ' LYS . 9.7 tp10 -128.45 -9.96 5.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 2.04 110.188 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.909 ' CE2' ' CD2' ' A' ' 10' ' ' TYR . 7.1 m-85 -103.89 -171.89 2.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.83999999999999997 110.519 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 1.082 ' O ' ' O ' ' A' ' 50' ' ' LYS . 16.0 tt0 -160.18 100.95 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.39 -0.819 . . . . 2.2400000000000002 109.758 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 1.082 ' O ' ' O ' ' A' ' 49' ' ' GLU . 13.3 mtpt -29.17 -172.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.853 . . . . 1.78 110.366 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.978 HD23 ' O ' ' A' ' 51' ' ' LEU . 6.1 tt -111.09 -14.35 13.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 109.821 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.665 ' O ' ' O ' ' A' ' 51' ' ' LEU . 6.2 pt-20 -37.53 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.427 -0.796 . . . . 2.3799999999999999 110.531 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t0 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 117.998 -1.001 . . . . 3.4300000000000002 110.23 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.484 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -122.84 175.84 6.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.619 -0.676 . . . . 0.0 110.288 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.9 108.09 6.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.596 -0.69 . . . . 0.0 109.658 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.782 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -87.73 147.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.842 0.829 . . . . 0.0 111.209 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -102.59 101.21 11.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -47.5 -24.75 0.91 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.532 -0.73 . . . . 0.0 112.431 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.23 -49.85 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 0.0 110.566 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -127.6 -29.99 2.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.37 -0.831 . . . . 0.0 111.597 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.85 4.99 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 17.4 t80 -72.3 131.82 43.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.384 -1.068 . . . . 0.0 108.831 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.782 HD13 ' HA ' ' A' ' 4' ' ' VAL . 37.9 mm -113.62 123.19 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.464 -0.772 . . . . 0.0 111.466 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 30.9 t80 -91.71 113.25 25.47 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.38 87.11 5.04 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.284 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -53.86 -21.4 7.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.858 -0.526 . . . . 0.0 111.23 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.74 -31.49 72.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.354 -0.841 . . . . 0.0 109.026 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -35.07 5.83 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.294 0.569 . . . . 0.0 109.574 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 109.62 -107.06 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -176.28 90.54 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.431 -1.041 . . . . 0.0 109.949 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.09 -19.3 63.22 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.422 1.222 . . . . 0.0 110.533 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -30.32 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 109.307 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 6.3 48.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.69 . . . . 0.0 110.56 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.26 70.13 1.06 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 24' ' ' SER . 47.1 mm -126.45 166.72 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.935 . . . . 0.0 111.2 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.8 t -65.42 148.08 98.25 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.012 -0.43 . . . . 0.0 110.409 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 119.07 5.91 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.488 1.257 . . . . 0.0 110.015 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.35 71.26 1.24 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 32' ' ' LEU . 12.6 m -122.5 122.61 39.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.722 -0.869 . . . . 0.0 110.407 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.7 mttt -60.82 114.81 3.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.614 -0.679 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -51.13 -30.02 15.15 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.17 -0.956 . . . . 0.0 110.728 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -77.24 -2.85 36.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.684 -0.635 . . . . 0.0 110.824 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.29 -3.89 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 111.262 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 36' ' ' TRP . 6.1 mt -58.83 156.54 24.49 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.128 -0.982 . . . . 0.0 109.864 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.3 Cg_endo -84.34 172.72 9.22 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.287 1.151 . . . . 0.0 110.404 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.88 -16.46 63.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.591 -0.693 . . . . 0.0 110.504 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -16.15 48.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 110.008 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 32' ' ' LEU . 30.7 t90 -93.39 129.9 39.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.797 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 37' ' ' VAL . 10.0 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.495 0.188 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 8.8 m-85 -109.78 -169.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.11 -0.994 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.692 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.2 tm-20 -160.07 121.34 3.12 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.482 -0.761 . . . . 0.0 109.534 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 18.4 mtpt -54.22 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.0 110.878 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.504 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.4 tt -96.89 -12.5 23.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.697 -0.627 . . . . 0.0 111.188 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.083 -1.011 . . . . 0.0 110.943 -179.619 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.066 0.46 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.58 178.65 6.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 17.1 m95 -140.39 143.86 35.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.2 p -118.92 137.53 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.752 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -92.76 95.7 9.71 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -51.11 -23.29 3.05 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.455 -0.778 . . . . 0.0 111.682 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.415 ' C ' HG23 ' A' ' 8' ' ' THR . 76.4 mt -81.37 -9.8 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.347 -0.845 . . . . 0.0 111.361 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 7' ' ' ILE . 71.1 p -147.94 -41.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.976 -1.077 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 -13.19 21.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.601 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.4 t80 -51.82 156.4 1.46 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.117 -1.225 . . . . 0.0 109.681 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 10' ' ' TYR . 43.6 mm -133.53 130.78 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 54.0 t80 -92.33 110.91 22.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.47 83.69 5.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.9 tt0 -51.02 -23.89 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.792 -0.568 . . . . 0.0 111.151 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.57 -30.09 71.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.411 -0.805 . . . . 0.0 108.935 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.39 -34.04 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.323 0.582 . . . . 0.0 109.62 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.62 -104.5 2.5 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -173.72 88.81 0.36 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.398 -1.06 . . . . 0.0 110.102 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 -21.1 62.04 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.427 1.225 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.46 -34.95 47.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.236 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -92.13 3.81 54.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.758 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.87 63.79 4.88 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.4 mm -119.89 165.99 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.95 . . . . 0.0 110.728 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -60.13 143.31 88.69 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.442 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.85 115.93 4.49 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.333 1.175 . . . . 0.0 109.679 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.46 66.48 1.6 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -120.21 125.13 47.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.857 . . . . 0.0 110.146 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 30.6 mmtt -59.7 122.64 14.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.66 -0.65 . . . . 0.0 109.396 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 36.6 t80 -48.43 -33.15 8.78 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.21 -0.931 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.15 -22.92 62.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -82.44 -26.23 32.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.67 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.633 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.9 mt -57.64 141.17 79.74 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.251 -0.905 . . . . 0.0 109.806 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.11 175.59 6.44 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.151 1.079 . . . . 0.0 110.536 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.65 -18.14 58.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 110.405 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.81 -15.51 42.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.382 -0.824 . . . . 0.0 110.131 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -86.23 136.14 33.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 0.0 109.805 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 37' ' ' VAL . 8.9 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.581 -0.699 . . . . 0.0 109.776 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.913 0.387 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 5.7 m-85 -105.33 -172.55 2.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.48 -0.762 . . . . 0.0 110.673 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.27 140.48 11.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CG ' ' CZ2' ' A' ' 3' ' ' TRP . 29.3 mtpt -57.99 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.194 -0.941 . . . . 0.0 110.452 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 41.2 tp -111.1 63.61 0.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.61 0.719 . . . . 0.0 110.036 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.718 -0.614 . . . . 0.0 110.612 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.117 0.484 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -118.11 174.69 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -140.01 110.82 6.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.0 109.733 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.6 p -81.93 150.68 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 111.112 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.33 118.18 35.15 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -55.46 -21.47 16.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.557 -0.714 . . . . 0.0 111.215 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 47' ' ' GLU . 88.4 mt -64.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -135.74 29.74 3.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 111.07 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.38 58.01 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CD1' HD12 ' A' ' 5' ' ' LEU . 5.8 t80 -60.99 134.95 57.62 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.229 -1.159 . . . . 0.0 108.722 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.775 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.6 mm -117.14 118.48 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.557 -0.714 . . . . 0.0 111.205 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 27.4 t80 -85.41 112.55 20.96 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -79.56 82.34 5.7 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.086 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tm-20 -57.04 -19.5 19.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.686 -0.634 . . . . 0.0 110.776 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -62.28 -31.04 71.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.2 -0.937 . . . . 0.0 108.751 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.73 -44.07 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 127.65 -108.55 0.96 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.24 94.42 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.339 -1.094 . . . . 0.0 109.174 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -13.62 40.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.386 1.203 . . . . 0.0 110.971 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.95 -33.41 57.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.246 -0.908 . . . . 0.0 109.745 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -106.04 11.46 31.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.736 . . . . 0.0 110.852 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.95 66.99 2.44 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.633 HD11 ' CD1' ' A' ' 36' ' ' TRP . 46.7 mm -103.6 164.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.924 . . . . 0.0 110.686 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.05 172.83 8.85 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.931 -0.481 . . . . 0.0 110.051 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.85 107.11 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.335 1.176 . . . . 0.0 109.41 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.14 -95.71 1.67 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD21 ' A' ' 32' ' ' LEU . 52.4 m 55.64 101.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.716 -0.873 . . . . 0.0 110.708 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -63.12 125.86 25.46 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.399 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.7 t80 -50.69 -25.93 4.87 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.49 -6.58 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.552 -0.718 . . . . 0.0 110.752 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.89 -16.52 14.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 27' ' ' THR . 11.5 mt -54.87 156.42 6.79 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.12 169.41 21.55 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.258 1.136 . . . . 0.0 110.985 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -71.74 -14.21 61.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.747 -0.596 . . . . 0.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -75.2 -3.12 31.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.411 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.633 ' CD1' HD11 ' A' ' 23' ' ' ILE . 74.8 t90 -80.32 120.78 24.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.141 -0.974 . . . . 0.0 110.024 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 36' ' ' TRP . 25.0 t . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 7' ' ' ILE . 6.9 tt0 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.648 0.261 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 13.7 m-85 -121.54 -172.45 2.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.865 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.826 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.4 tt0 -160.2 122.75 3.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 2.8 mtpt -58.48 173.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.34 -28.31 21.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.673 -0.642 . . . . 0.0 110.268 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.58 -0.7 . . . . 0.0 110.565 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.87 -166.76 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 110.314 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 9.3 m95 -138.07 122.5 18.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 9.9 p -118.47 146.48 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.269 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.5 tt -108.03 118.38 36.61 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.76 -39.81 68.71 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.326 -0.859 . . . . 0.0 111.414 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.56 -49.15 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.532 -0.73 . . . . 0.0 111.345 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -102.1 -57.77 2.0 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.13 -0.981 . . . . 0.0 110.79 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.5 23.64 4.02 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.717 ' O ' HD13 ' A' ' 11' ' ' ILE . 29.3 m-85 -55.76 164.34 1.15 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.049 -1.265 . . . . 0.0 109.588 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.717 HD13 ' O ' ' A' ' 10' ' ' TYR . 28.6 mm -146.5 83.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 63.8 t80 -79.8 109.94 14.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.984 -1.073 . . . . 0.0 108.659 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.45 85.81 5.2 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.1 tt0 -52.8 -22.6 5.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.778 -0.576 . . . . 0.0 111.089 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -29.39 70.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.376 -0.827 . . . . 0.0 109.086 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.69 -37.53 4.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.751 -0.593 . . . . 0.0 109.531 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 108.43 -105.26 2.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.59 90.13 0.22 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.377 -1.072 . . . . 0.0 109.795 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.6 -18.8 48.61 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.353 1.186 . . . . 0.0 110.638 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.14 -32.94 38.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.0 110.021 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -95.58 13.98 24.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.716 . . . . 0.0 110.735 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.5 66.37 2.89 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 32' ' ' LEU . 49.0 mm -122.51 166.89 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.692 -0.887 . . . . 0.0 111.157 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.465 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -73.06 148.97 89.44 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.826 -0.546 . . . . 0.0 110.537 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 120.4 6.51 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.386 1.203 . . . . 0.0 109.985 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.82 70.12 1.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.0 m -124.25 121.35 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.713 -0.875 . . . . 0.0 110.247 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.68 120.22 7.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.804 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB3' ' CE2' ' A' ' 3' ' ' TRP . 33.5 t80 -48.7 -38.27 20.95 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.221 -0.924 . . . . 0.0 110.936 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.93 -20.06 63.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -91.01 -16.42 27.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 110.955 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -56.03 159.34 5.83 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.073 -1.017 . . . . 0.0 110.144 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -85.91 -178.29 2.84 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.359 1.189 . . . . 0.0 110.5 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -67.55 -16.25 64.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.663 -0.648 . . . . 0.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.03 -16.72 46.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.824 . . . . 0.0 110.105 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CG ' HD13 ' A' ' 32' ' ' LEU . 1.1 t90 -106.93 114.1 27.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.424 -0.798 . . . . 0.0 109.256 179.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 120.983 0.42 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.5 m-85 -79.81 -173.03 3.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 110.325 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -149.34 110.01 4.26 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.671 -0.643 . . . . 0.0 109.38 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -57.76 168.3 0.93 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.584 -0.697 . . . . 0.0 110.509 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.9 48.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.209 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.596 -0.69 . . . . 0.0 110.153 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.23 149.02 23.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 110.774 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.43 ' CZ2' ' HD3' ' A' ' 50' ' ' LYS . 19.9 m95 -114.84 173.04 6.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.557 -0.714 . . . . 0.0 110.061 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 51' ' ' LEU . 7.6 p -130.35 142.05 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 110.29 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.89 117.56 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -52.66 -23.58 6.87 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.597 -0.689 . . . . 0.0 111.46 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CG1' HD22 ' A' ' 5' ' ' LEU . 42.3 mm -60.39 -57.39 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.377 -0.827 . . . . 0.0 110.586 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -146.81 36.59 0.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.225 -0.922 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.45 20.06 49.83 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD1' HD12 ' A' ' 5' ' ' LEU . 3.2 t80 -58.41 164.88 2.31 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.138 -1.213 . . . . 0.0 108.643 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.5 mt -141.52 165.79 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.282 1.039 . . . . 0.0 112.241 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 60.6 t80 -126.16 109.91 12.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.29 81.21 5.58 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.6 tt0 -48.94 -25.03 1.72 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.559 -0.713 . . . . 0.0 111.337 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.19 -30.02 71.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 0.0 108.905 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -111.5 -32.55 6.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.826 -0.546 . . . . 0.0 109.581 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.14 -103.26 2.7 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -174.48 88.7 0.33 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.41 -1.053 . . . . 0.0 110.059 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.64 -19.03 60.02 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.455 1.24 . . . . 0.0 110.533 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -34.7 39.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.77 11.2 23.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.677 -0.64 . . . . 0.0 110.765 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.02 55.5 27.77 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 24' ' ' SER . 49.5 mm -112.35 165.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.751 -0.852 . . . . 0.0 111.246 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.6 t -65.1 143.05 98.78 Favored Pre-proline 0 N--CA 1.494 1.775 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.097 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.95 123.09 8.16 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.275 1.145 . . . . 0.0 110.007 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.24 67.65 1.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 m -122.76 123.76 41.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.789 -0.83 . . . . 0.0 110.315 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.82 120.65 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.662 -0.648 . . . . 0.0 109.387 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 69.6 t80 -46.66 -49.39 19.29 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.322 -0.862 . . . . 0.0 111.258 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -59.59 -20.06 53.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.0 110.492 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.27 -29.34 34.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.31 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.449 HD21 HG23 ' A' ' 23' ' ' ILE . 11.5 mt -58.15 150.46 51.81 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.497 -0.752 . . . . 0.0 109.846 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.31 176.22 8.93 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.273 1.144 . . . . 0.0 110.724 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.11 -14.86 62.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.55 -0.719 . . . . 0.0 110.658 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.95 -9.13 50.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.476 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.44 ' O ' HG13 ' A' ' 37' ' ' VAL . 30.3 t90 -91.81 140.43 29.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 36' ' ' TRP . 16.5 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 8.3 m-85 -84.41 178.74 7.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 110.877 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.25 147.82 16.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -72.25 157.19 38.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.18 35.35 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.585 -0.697 . . . . 0.0 109.921 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.228 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.191 0.519 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -121.94 175.2 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m95 -139.41 104.88 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.676 -0.64 . . . . 0.0 109.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.8 p -83.84 150.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.718 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.8 116.13 31.74 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -54.27 -21.03 8.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.521 -0.737 . . . . 0.0 111.373 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 5' ' ' LEU . 93.9 mt -58.54 -68.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -123.29 -15.82 7.08 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.473 -0.767 . . . . 0.0 111.647 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 14.77 8.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.58 130.92 48.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.154 -1.204 . . . . 0.0 108.987 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.795 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.4 mm -111.34 114.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.706 . . . . 0.0 111.292 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 23.1 t80 -82.58 113.34 20.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.41 87.44 5.05 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.813 0.816 . . . . 0.0 109.398 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -55.49 -21.21 15.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.632 -0.668 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.55 -32.12 73.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 108.694 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.91 -46.65 3.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 116.31 -106.47 1.51 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 176.17 94.14 0.1 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.391 -1.064 . . . . 0.0 109.282 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.57 -12.79 36.67 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.416 1.219 . . . . 0.0 111.085 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.7 -40.41 55.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.178 -0.951 . . . . 0.0 109.834 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.88 17.38 10.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.02 41.81 92.65 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.3 mm -84.83 165.59 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.787 -0.831 . . . . 0.0 110.848 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.3 154.22 74.38 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.84 107.35 2.19 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.307 1.161 . . . . 0.0 109.8 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.46 65.05 1.47 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 32' ' ' LEU . 1.4 m -116.17 126.78 54.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.861 -0.787 . . . . 0.0 109.643 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 14.4 mtpt -63.56 118.44 8.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.731 -0.606 . . . . 0.0 110.048 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 30.4 t80 -51.34 -35.29 37.63 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.188 -0.945 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.06 -8.81 57.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.643 -0.661 . . . . 0.0 110.492 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -113.17 -4.42 13.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.201 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -52.99 171.4 0.23 Allowed Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 120.906 -1.121 . . . . 0.0 109.444 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.8 Cg_endo -89.26 -175.04 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 122.967 0.983 . . . . 0.0 110.824 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.29 171.43 15.07 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.649 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.9 -0.12 2.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.591 -0.693 . . . . 0.0 112.113 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.679 ' CD1' HD11 ' A' ' 23' ' ' ILE . 64.9 t90 -73.88 119.2 17.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.796 -1.19 . . . . 0.0 109.119 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' C ' ' A' ' 36' ' ' TRP . 57.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 109.827 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.5 m-85 -79.52 -172.49 3.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.541 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.741 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.7 tm-20 -160.23 125.59 3.97 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.753 -0.592 . . . . 0.0 109.651 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.418 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 21.2 mtmt -63.12 168.23 4.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.103 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.88 29.52 6.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 110.429 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.02 0.438 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.65 159.29 20.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.568 -0.707 . . . . 0.0 110.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.538 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.6 m95 -132.54 112.11 11.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -81.03 150.98 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.467 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -114.57 120.93 41.89 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -52.21 -22.14 4.06 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.483 -0.761 . . . . 0.0 111.715 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 5' ' ' LEU . 95.7 mt -56.15 -74.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.725 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -133.06 20.0 4.09 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.36 23.1 55.34 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.68 ' O ' HD13 ' A' ' 11' ' ' ILE . 3.9 t80 -59.3 152.12 21.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.292 -1.122 . . . . 0.0 108.783 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.2 mm -135.4 137.9 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.326 -0.859 . . . . 0.0 111.654 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 49.8 t80 -105.11 112.71 25.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.26 81.96 5.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -50.19 -24.78 3.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.615 -0.678 . . . . 0.0 110.869 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.41 -31.92 73.21 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -107.2 -52.33 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.13 -107.42 1.04 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -175.61 88.72 0.29 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -14.39 44.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.475 1.25 . . . . 0.0 110.688 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.06 -37.15 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.309 -0.869 . . . . 0.0 109.793 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.33 12.98 27.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 110.701 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.68 66.6 2.7 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 32' ' ' LEU . 50.9 mm -119.39 166.06 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.964 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -65.06 147.52 98.47 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.992 -0.442 . . . . 0.0 110.673 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 48.8 Cg_endo -74.97 111.4 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.391 1.206 . . . . 0.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 66.31 1.47 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -117.81 127.85 54.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.826 -0.808 . . . . 0.0 110.006 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 18.8 mmtm -63.33 118.53 8.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.538 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 57.9 t80 -49.18 -34.85 15.46 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.287 -0.883 . . . . 0.0 111.092 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.79 -18.08 62.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -93.17 -17.76 23.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.161 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 23' ' ' ILE . 8.0 mt -58.64 155.53 29.08 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.15 -0.969 . . . . 0.0 110.137 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.06 165.31 26.27 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.31 1.163 . . . . 0.0 110.245 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.16 -12.35 60.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.682 . . . . 0.0 110.845 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.21 -1.88 28.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.748 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.46 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.8 t90 -86.12 127.4 34.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 0.0 109.883 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 36' ' ' TRP . 15.8 m . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 0.0 109.724 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.641 0.257 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 14.2 m-85 -125.11 -173.93 2.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.307 -0.871 . . . . 0.0 110.994 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.83 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.4 mt-10 -160.41 131.4 5.62 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 23.5 mtmt -76.11 151.92 36.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -97.71 47.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.631 -0.668 . . . . 0.0 110.157 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.743 . . . . 0.0 110.709 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HD3' HD13 ' A' ' 51' ' ' LEU . 9.7 mtpt -111.21 173.7 6.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 0.0 110.063 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -139.72 111.34 7.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.494 -0.754 . . . . 0.0 109.623 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.3 p -87.61 145.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.873 0.844 . . . . 0.0 110.96 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.627 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -96.42 98.98 10.68 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -52.27 -24.33 7.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.384 -0.823 . . . . 0.0 111.153 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 5' ' ' LEU . 50.4 mm -75.93 -13.87 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 7' ' ' ILE . 78.7 p -149.72 -54.14 0.16 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.094 -1.004 . . . . 0.0 111.061 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 132.59 -9.18 5.27 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 11' ' ' ILE . 4.7 t80 -50.62 150.57 2.7 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.267 . . . . 0.0 110.075 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.1 mm -130.08 123.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.502 -0.749 . . . . 0.0 110.939 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 32.2 t80 -88.81 111.54 22.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -79.81 84.99 5.52 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.292 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -55.25 -20.18 10.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.582 -0.699 . . . . 0.0 110.839 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -61.78 -30.41 70.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.146 -0.971 . . . . 0.0 108.819 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.36 -41.78 3.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.0 109.067 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.17 -108.05 1.17 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.25 95.12 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.325 -1.103 . . . . 0.0 109.045 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.46 -12.57 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.301 1.158 . . . . 0.0 111.247 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.94 -33.82 72.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.221 -0.924 . . . . 0.0 109.899 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.53 16.09 20.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.56 -0.713 . . . . 0.0 110.802 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.29 62.97 5.75 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 36' ' ' TRP . 42.4 mm -94.13 163.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.968 . . . . 0.0 110.598 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.01 172.9 8.66 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.863 -0.523 . . . . 0.0 110.007 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.84 108.42 2.28 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.272 1.143 . . . . 0.0 109.457 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.89 -94.87 1.74 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 32' ' ' LEU . 51.9 m 55.11 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.947 . . . . 0.0 110.636 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 16.1 mttm -60.05 123.8 18.25 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.101 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -49.75 -26.29 3.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.152 -0.967 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 -12.67 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.622 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -101.88 -16.86 16.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 111.038 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 27' ' ' THR . 10.4 mt -53.86 151.96 11.0 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.108 -0.995 . . . . 0.0 109.988 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.21 156.06 42.04 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.237 1.125 . . . . 0.0 110.858 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.25 -18.14 56.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.622 -0.673 . . . . 0.0 110.589 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.25 1.02 22.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.73 ' CD1' HD11 ' A' ' 23' ' ' ILE . 68.6 t90 -61.79 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.087 -1.008 . . . . 0.0 109.72 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.539 -0.725 . . . . 0.0 110.912 179.624 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.518 0.199 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 11.3 m-85 -116.66 -170.29 1.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.0 110.456 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.678 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.8 mm-40 -160.12 123.53 3.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 109.447 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mtmt -58.42 167.19 1.47 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.277 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.547 HD13 ' HD3' ' A' ' 2' ' ' LYS . 9.2 tt -81.15 -27.53 35.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.49 -0.756 . . . . 0.0 110.756 -179.75 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.18 0.514 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -82.33 156.33 24.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 28.5 m95 -130.41 167.93 17.79 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.7 139.71 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.82 -1.175 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -102.04 121.0 41.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -56.11 -20.37 17.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.458 -0.776 . . . . 0.0 111.11 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 5' ' ' LEU . 86.6 mt -59.22 -63.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.86 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -144.88 44.24 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.212 -0.93 . . . . 0.0 111.976 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.39 20.25 43.91 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.947 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.724 ' HD2' HD12 ' A' ' 5' ' ' LEU . 31.6 t80 -64.16 132.21 49.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -1.137 . . . . 0.0 108.195 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.2 mt -119.52 166.66 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.355 1.074 . . . . 0.0 112.233 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.609 ' OH ' HD11 ' A' ' 32' ' ' LEU . 16.2 t80 -127.19 109.2 11.59 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.6 p-10 -78.86 73.94 5.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.2 tt0 -50.4 -25.73 4.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.741 -0.6 . . . . 0.0 110.812 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.24 -25.37 64.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -105.7 -54.31 2.5 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 110.247 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.6 68.12 0.54 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t0 21.61 82.09 0.13 Allowed Pre-proline 0 N--CA 1.51 2.53 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.43 -21.32 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.664 1.35 . . . . 0.0 109.955 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -80.29 -45.16 18.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.447 -0.783 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.91 -35.14 17.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.47 -0.769 . . . . 0.0 110.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.06 52.04 0.85 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.724 HD11 ' CD1' ' A' ' 36' ' ' TRP . 18.8 mm -89.68 155.69 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.491 -1.005 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -47.62 145.36 4.34 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.602 . . . . 0.0 111.444 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.17 105.46 1.2 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.5 1.263 . . . . 0.0 110.329 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.52 83.59 0.31 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.619 HG22 HD12 ' A' ' 32' ' ' LEU . 1.7 m -140.09 117.14 11.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.677 -0.896 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.0 tptt -51.76 126.68 18.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 110.098 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HA ' HD13 ' A' ' 32' ' ' LEU . 23.3 t80 -42.26 -29.27 0.24 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.449 -0.782 . . . . 0.0 112.165 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.304 -0.873 . . . . 0.0 110.93 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -87.0 -31.69 20.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.683 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -47.2 149.78 1.67 Allowed Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.464 -0.772 . . . . 0.0 111.702 -179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -85.28 -178.29 3.04 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.57 1.3 . . . . 0.0 110.482 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.42 -14.67 59.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.637 -0.664 . . . . 0.0 110.7 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.63 -12.73 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.256 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.724 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.8 t90 -96.25 95.79 8.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.09 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.476 HG13 ' C ' ' A' ' 36' ' ' TRP . 27.4 m . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 109.905 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.722 ' HG2' HD21 ' A' ' 5' ' ' LEU . 34.5 tt0 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -79.39 -179.49 6.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.858 0.837 . . . . 0.0 111.326 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.11 144.72 14.68 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CD ' ' CZ2' ' A' ' 3' ' ' TRP . 1.1 mtmt -61.89 170.66 1.98 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 51' ' ' LEU . 39.7 tp -106.5 61.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.692 0.758 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.849 -0.532 . . . . 0.0 110.716 -179.552 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.005 0.431 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 51' ' ' LEU . 32.4 mttt -118.97 166.7 12.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.715 . . . . 0.0 110.37 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.8 m95 -130.0 106.44 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.737 -0.602 . . . . 0.0 109.4 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 11' ' ' ILE . 8.5 p -91.7 147.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.649 0.738 . . . . 0.0 111.146 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -100.89 101.17 11.93 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -54.73 -21.57 11.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 111.455 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.2 mp -82.46 -9.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.339 -0.851 . . . . 0.0 111.232 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.439 HG23 ' C ' ' A' ' 7' ' ' ILE . 70.1 p -148.2 -47.23 0.16 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.955 -1.09 . . . . 0.0 111.225 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.27 -13.89 9.5 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' HD13 ' A' ' 11' ' ' ILE . 7.4 t80 -52.5 140.56 22.34 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.17 -1.194 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.676 ' CD1' HG23 ' A' ' 4' ' ' VAL . 26.7 mm -123.08 121.4 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.48 -0.763 . . . . 0.0 111.343 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 38.3 t80 -85.92 111.23 20.04 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.51 81.63 5.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.71 0.767 . . . . 0.0 109.427 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -54.08 -21.32 8.2 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.755 -0.591 . . . . 0.0 110.933 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -29.14 70.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.933 . . . . 0.0 108.754 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.34 -43.5 2.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.97 -108.21 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.44 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.33 -14.35 42.5 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.353 1.186 . . . . 0.0 110.694 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.91 -39.11 31.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -92.24 17.76 9.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.563 -0.711 . . . . 0.0 110.448 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.08 65.07 3.81 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 24' ' ' SER . 41.5 mm -114.27 165.4 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.733 -0.863 . . . . 0.0 111.958 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -79.1 148.93 72.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.675 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 45.3 Cg_endo -71.76 105.25 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.237 1.125 . . . . 0.0 110.709 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.67 61.73 1.35 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.508 HG21 HD23 ' A' ' 32' ' ' LEU . 16.9 m -115.99 134.05 55.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.934 -0.745 . . . . 0.0 109.833 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -76.87 124.84 28.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.661 -0.65 . . . . 0.0 110.307 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' HA ' HD12 ' A' ' 32' ' ' LEU . 6.3 t80 -45.55 -43.61 12.1 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.166 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.42 -25.49 10.1 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -103.56 -87.42 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 29' ' ' PHE . 6.7 mt 52.15 179.52 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.295 0 O-C-N 120.99 -1.069 . . . . 0.0 110.042 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.2 Cg_endo -83.63 -164.05 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 109.804 -0.883 . . . . 0.0 109.804 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -93.44 160.41 14.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 110.475 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 58.33 17.24 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.486 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 76.4 t90 -65.21 112.9 3.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.181 -0.949 . . . . 0.0 109.35 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 36' ' ' TRP . 32.8 m . . . . . 0 N--CA 1.499 1.979 0 O-C-N 121.399 -0.813 . . . . 0.0 110.062 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.235 0.54 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 6.2 m-85 -120.28 -167.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.729 -0.607 . . . . 0.0 110.567 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.605 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.2 tp10 -160.13 112.26 2.02 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.675 -0.641 . . . . 0.0 109.758 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 12.2 mtpt -55.88 177.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.442 -0.787 . . . . 0.0 110.67 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 51' ' ' LEU . 3.9 pp -89.65 18.1 5.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.584 -0.698 . . . . 0.0 111.181 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.175 -0.953 . . . . 0.0 110.768 -179.678 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.064 0.459 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -114.98 179.12 4.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 110.158 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.54 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -139.87 104.23 4.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 109.749 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.65 158.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.96 0.886 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -119.44 113.48 20.84 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.501 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -53.26 -22.62 7.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.432 -0.793 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 5' ' ' LEU . 96.5 mt -58.81 -52.7 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.674 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -149.47 33.42 0.71 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.251 -0.905 . . . . 0.0 111.403 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 15.94 58.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 5' ' ' LEU . 4.2 t80 -60.54 146.18 45.95 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.079 -1.248 . . . . 0.0 108.875 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 12' ' ' TYR . 42.7 mt -131.3 166.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 122.221 1.01 . . . . 0.0 111.624 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 11' ' ' ILE . 42.7 t80 -134.17 110.71 9.75 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.18 87.19 4.92 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.95 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.2 tt0 -53.55 -21.4 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.857 -0.527 . . . . 0.0 111.104 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.09 -31.18 71.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.229 -0.919 . . . . 0.0 108.844 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.26 -49.61 3.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.285 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.21 -107.84 1.08 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 95.35 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.497 -1.002 . . . . 0.0 109.076 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.19 -11.66 32.2 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.376 1.198 . . . . 0.0 111.416 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.79 -39.2 70.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.76 23.62 9.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 110.264 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.69 48.24 66.95 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.759 HD12 ' CD2' ' A' ' 32' ' ' LEU . 47.0 mm -87.83 160.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.86 -0.788 . . . . 0.0 111.337 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 154.9 74.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.965 -0.459 . . . . 0.0 109.906 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.51 106.44 1.95 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.359 1.189 . . . . 0.0 110.0 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 69.33 1.38 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.639 HG21 HD23 ' A' ' 32' ' ' LEU . 6.3 m -119.17 124.61 47.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.7 -0.883 . . . . 0.0 110.289 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.3 mptt -62.14 113.52 2.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.818 -0.551 . . . . 0.0 109.856 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 26.2 t80 -49.22 -32.75 11.1 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.379 -0.826 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.18 -21.24 46.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.376 -0.827 . . . . 0.0 109.62 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -109.55 -81.82 0.57 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.759 ' CD2' HD12 ' A' ' 23' ' ' ILE . 6.1 mt 52.47 -179.63 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.085 -1.01 . . . . 0.0 109.605 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 49.3 Cg_endo -82.47 157.2 16.68 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.92 158.71 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.327 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t0 59.02 15.99 4.38 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.586 -0.696 . . . . 0.0 111.707 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.4 t90 -60.58 126.08 26.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.972 -1.08 . . . . 0.0 109.421 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 36' ' ' TRP . 25.0 t . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.739 0.304 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.497 ' CD2' ' CZ ' ' A' ' 29' ' ' PHE . 10.1 m-85 -116.85 164.78 14.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.122 -0.986 . . . . 0.0 110.532 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -128.12 117.93 22.49 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 33.1 mtpt -57.07 -173.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.548 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.11 32.74 5.84 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.425 0.631 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.748 -0.595 . . . . 0.0 110.637 -179.747 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.188 0.518 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 158.48 21.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.72 . . . . 0.0 110.687 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 17.1 m95 -131.83 112.84 12.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.712 ' HA ' HD13 ' A' ' 11' ' ' ILE . 88.4 t -79.62 158.65 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.179 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -116.8 101.11 8.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -24.87 2.02 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.409 -0.807 . . . . 0.0 111.809 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.588 ' HB ' HD22 ' A' ' 5' ' ' LEU . 51.1 mm -71.45 -23.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.488 -0.758 . . . . 0.0 110.851 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 7' ' ' ILE . 67.3 p -150.71 -41.84 0.12 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.136 -0.977 . . . . 0.0 111.702 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.67 -0.93 11.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.641 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -51.02 160.52 0.47 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.049 -1.265 . . . . 0.0 109.913 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 4' ' ' VAL . 43.5 mm -134.88 125.65 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.386 -0.821 . . . . 0.0 111.248 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 48.0 t80 -93.85 111.22 22.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.37 87.1 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -52.55 -22.63 5.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.819 -0.55 . . . . 0.0 111.197 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.07 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.416 -0.803 . . . . 0.0 108.966 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.65 -30.45 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.68 -0.638 . . . . 0.0 109.857 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.56 -104.74 2.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.67 89.31 0.29 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.429 -1.042 . . . . 0.0 109.843 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.27 -22.84 52.74 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.41 1.216 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.28 -30.55 60.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.563 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.07 8.8 43.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.695 . . . . 0.0 110.625 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.19 63.84 4.95 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.06 166.71 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 110.91 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -64.68 145.71 98.62 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.814 -0.554 . . . . 0.0 110.333 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.53 119.55 5.8 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.351 1.185 . . . . 0.0 109.804 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.72 64.99 1.82 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -118.39 126.04 51.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.696 -0.885 . . . . 0.0 109.939 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -61.17 122.24 14.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.626 -0.671 . . . . 0.0 109.761 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 69.3 t80 -49.25 -26.95 3.31 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.265 -0.897 . . . . 0.0 110.993 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -19.67 53.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.44 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -87.77 -24.24 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.647 HD21 ' CG2' ' A' ' 23' ' ' ILE . 12.3 mt -56.79 142.76 71.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.254 -0.904 . . . . 0.0 109.798 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.67 -175.68 2.57 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.308 1.162 . . . . 0.0 110.992 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.37 -18.9 62.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.71 -0.619 . . . . 0.0 110.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.02 -14.28 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.453 -0.779 . . . . 0.0 110.07 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -89.74 127.52 35.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 37' ' ' VAL . 8.0 p . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 109.315 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.956 0.408 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 9.9 m-85 -119.03 171.32 8.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 110.014 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 92.92 2.99 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.579 -0.701 . . . . 0.0 109.676 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -60.62 164.59 4.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.59 -0.694 . . . . 0.0 110.28 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.16 59.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.692 -0.63 . . . . 0.0 110.34 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 N--CA 1.501 2.089 0 O-C-N 121.697 -0.627 . . . . 0.0 111.323 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -100.58 -170.28 1.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.689 . . . . 0.0 110.112 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 8.0 m95 -140.27 119.36 12.76 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 14.0 p -117.95 146.28 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.33 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.658 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.6 tt -107.56 115.86 30.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.013 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -53.11 -40.3 64.06 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.241 -0.912 . . . . 0.0 111.397 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.658 ' HB ' HD22 ' A' ' 5' ' ' LEU . 87.2 mt -61.61 -58.7 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -0.75 . . . . 0.0 110.598 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 p -93.18 -59.44 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.33 -0.856 . . . . 0.0 110.828 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.01 23.07 3.37 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.695 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 m-85 -54.91 165.91 0.58 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.989 -1.3 . . . . 0.0 109.692 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 10' ' ' TYR . 36.3 mm -148.89 82.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.548 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 66.4 t80 -79.81 108.33 13.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 46.4 p-10 -79.39 84.84 5.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 4.3 tt0 -49.0 -24.79 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.578 -0.701 . . . . 0.0 111.337 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -64.55 -29.9 70.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.411 -0.806 . . . . 0.0 109.036 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.58 -32.43 6.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.812 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.23 -104.46 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -175.45 88.77 0.3 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.396 -1.061 . . . . 0.0 110.088 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.85 -19.8 46.3 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.356 1.187 . . . . 0.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.15 -31.02 38.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.1 13.4 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.532 -0.73 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.25 67.08 2.39 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 24' ' ' SER . 45.8 mm -122.4 167.36 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.693 -0.886 . . . . 0.0 111.113 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -69.36 145.51 95.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.913 -0.492 . . . . 0.0 110.309 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.24 120.21 6.17 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.324 1.171 . . . . 0.0 110.184 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 67.3 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 10.7 m -122.89 126.33 47.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.68 -0.894 . . . . 0.0 110.088 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.4 mttt -59.08 120.89 9.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.404 -0.81 . . . . 0.0 109.852 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 53.6 t80 -49.05 -44.01 41.28 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.328 -0.858 . . . . 0.0 110.799 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.9 -18.07 64.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.601 -0.687 . . . . 0.0 110.421 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.53 -8.29 29.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.391 -0.818 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 ' CE1' ' A' ' 12' ' ' TYR . 5.8 mt -57.47 155.54 19.36 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.052 -1.03 . . . . 0.0 109.89 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.422 ' CD ' HD23 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -84.54 -174.41 1.79 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 O-C-N 123.275 1.145 . . . . 0.0 110.852 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.11 -17.25 63.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.677 -0.64 . . . . 0.0 110.449 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.63 -16.06 45.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 109.999 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -109.16 117.46 34.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 109.862 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 37' ' ' VAL . 8.6 p . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 109.028 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.037 0.446 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 3.1 m-85 -79.82 -170.29 2.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -160.19 124.34 3.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 22.1 mtpt -52.28 177.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.281 -0.887 . . . . 0.0 111.294 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.46 -25.84 20.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 110.508 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.304 -0.873 . . . . 0.0 110.902 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.11 0.481 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 11' ' ' ILE . 13.1 mtmt -116.0 176.99 4.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.341 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 15.5 m95 -135.66 105.36 6.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.797 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -87.16 147.27 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.758 0.789 . . . . 0.0 110.942 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -105.32 116.27 31.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -54.61 -21.06 9.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.502 -0.749 . . . . 0.0 111.502 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.84 -61.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.324 -0.86 . . . . 0.0 110.571 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -131.07 0.23 4.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 111.753 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.94 35.61 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -63.17 129.1 38.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.311 -1.111 . . . . 0.0 108.895 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.797 HD13 ' HA ' ' A' ' 4' ' ' VAL . 35.8 mm -113.68 142.84 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.489 -0.757 . . . . 0.0 111.263 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.4 t80 -116.08 112.99 22.55 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.759 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.9 p-10 -79.59 83.97 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.413 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.4 tt0 -58.79 -17.39 22.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.662 -0.649 . . . . 0.0 110.698 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -63.01 -30.36 71.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.088 -1.007 . . . . 0.0 108.7 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -113.89 -46.68 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.26 -107.03 0.82 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.28 94.5 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.374 -1.074 . . . . 0.0 109.115 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.6 -12.44 35.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.408 1.215 . . . . 0.0 111.292 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.07 -42.34 57.01 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -96.51 14.18 25.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 110.682 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.04 67.63 2.11 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 36' ' ' TRP . 43.7 mm -103.98 166.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.908 . . . . 0.0 111.354 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.456 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -78.05 167.66 33.9 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 122.001 -0.437 . . . . 0.0 110.076 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.94 110.51 2.61 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.391 1.206 . . . . 0.0 109.364 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.07 -91.07 1.18 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.576 HG21 HD21 ' A' ' 32' ' ' LEU . 99.6 m 54.75 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.918 . . . . 0.0 110.618 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.77 125.95 25.63 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.115 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 25.6 t80 -50.57 -28.28 8.35 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -79.57 -0.91 35.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.625 -0.672 . . . . 0.0 110.64 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -122.59 -6.08 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 111.211 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 ' HD3' ' A' ' 33' ' ' PRO . 6.4 mt -52.45 162.87 0.83 Allowed Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 120.979 -1.076 . . . . 0.0 109.412 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.8 Cg_endo -93.7 -165.54 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 120.874 1.05 . . . . 0.0 110.986 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.75 176.47 6.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.694 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t70 68.33 2.41 3.28 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.44 -0.788 . . . . 0.0 111.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.585 ' CD2' HD13 ' A' ' 32' ' ' LEU . 6.6 t90 -106.23 119.63 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.818 -1.176 . . . . 0.0 109.764 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 36' ' ' TRP . 91.8 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 0.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -97.44 -170.82 2.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.981 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.712 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.2 tt0 -160.21 118.08 2.59 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.769 -0.582 . . . . 0.0 109.733 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.464 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 28.2 mtmt -62.97 166.32 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 110.428 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.65 48.66 1.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 110.698 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.088 0.471 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -96.74 169.15 10.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.213 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.1 m95 -133.09 110.41 10.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.55 -0.719 . . . . 0.0 109.516 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.727 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -89.03 147.59 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.045 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.32 97.73 7.76 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -50.84 -24.28 3.41 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.44 -0.788 . . . . 0.0 111.66 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 5' ' ' LEU . 85.0 mt -75.8 -13.08 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.409 -0.807 . . . . 0.0 111.041 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.432 HG23 ' C ' ' A' ' 7' ' ' ILE . 76.1 p -148.97 -47.72 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.172 -0.955 . . . . 0.0 111.265 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.92 -10.37 7.91 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.512 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.3 t80 -50.58 146.65 5.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.118 -1.224 . . . . 0.0 110.114 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.727 HD13 ' HA ' ' A' ' 4' ' ' VAL . 36.2 mm -128.99 111.65 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.549 -0.719 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 51.8 t80 -79.96 110.46 15.36 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.56 87.39 5.14 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.8 tt0 -53.72 -21.32 6.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.798 -0.563 . . . . 0.0 111.174 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -29.75 70.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.255 -0.903 . . . . 0.0 108.898 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.92 -41.71 3.32 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 119.28 -106.39 1.25 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.6 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.43 -1.041 . . . . 0.0 109.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.15 -13.65 40.91 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.349 1.184 . . . . 0.0 110.979 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.28 -33.3 59.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 109.809 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.99 18.59 21.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.514 -0.741 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 55.9 27.38 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.688 HD12 ' CD2' ' A' ' 32' ' ' LEU . 46.0 mm -98.62 163.92 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.612 -0.934 . . . . 0.0 110.846 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.09 156.5 74.31 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 122.011 -0.431 . . . . 0.0 109.971 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.88 99.46 0.87 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.302 1.159 . . . . 0.0 110.145 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 69.95 1.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 HD23 ' A' ' 32' ' ' LEU . 4.6 m -120.24 125.99 49.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.751 -0.852 . . . . 0.0 109.954 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mptt -61.23 119.46 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.591 -0.693 . . . . 0.0 109.883 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.516 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 44.5 t80 -50.96 -39.71 55.77 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.38 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.64 -13.41 62.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.661 -0.65 . . . . 0.0 110.31 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -112.56 2.78 16.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 111.252 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.688 ' CD2' HD12 ' A' ' 23' ' ' ILE . 7.0 mt -54.26 173.96 0.2 Allowed Pre-proline 0 N--CA 1.506 2.334 0 O-C-N 120.888 -1.133 . . . . 0.0 109.351 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -88.46 -174.57 1.11 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 122.944 0.97 . . . . 0.0 110.899 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.33 170.18 16.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 109.853 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 69.0 0.94 2.97 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.541 -0.725 . . . . 0.0 112.146 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.65 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.1 t90 -71.41 129.54 39.07 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.791 -1.193 . . . . 0.0 109.453 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 37' ' ' VAL . 9.5 p . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.901 0.381 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.8 m-85 -119.69 -170.74 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.392 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.722 ' O ' HG12 ' A' ' 4' ' ' VAL . 16.5 tt0 -160.27 118.91 2.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.671 -0.643 . . . . 0.0 109.878 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 17.5 mtmm -62.18 163.45 8.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 0.0 109.926 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.98 -30.9 39.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.583 -0.698 . . . . 0.0 110.106 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.845 -179.788 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.09 0.471 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -114.99 175.34 5.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.3 m95 -136.58 106.66 6.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.504 -0.748 . . . . 0.0 109.207 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.793 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -86.23 151.07 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.683 0.754 . . . . 0.0 111.431 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -110.8 117.96 34.85 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -54.18 -21.62 9.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.364 -0.835 . . . . 0.0 111.475 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.21 -59.39 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.851 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -137.62 34.22 2.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.195 -0.94 . . . . 0.0 111.51 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.67 20.57 39.78 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 5' ' ' LEU . 26.9 t80 -60.95 129.25 40.47 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.107 . . . . 0.0 109.035 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.793 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.7 mm -113.76 164.51 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.838 0.828 . . . . 0.0 111.33 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.479 ' N ' HG22 ' A' ' 11' ' ' ILE . 33.3 t80 -135.7 112.52 10.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 10.1 p-10 -79.5 79.2 5.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.893 0.854 . . . . 0.0 109.166 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.28 -21.45 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.708 -0.62 . . . . 0.0 111.005 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.58 -30.69 71.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.323 -0.86 . . . . 0.0 108.87 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.87 -45.66 3.18 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.83 -107.79 1.04 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.25 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.422 -1.046 . . . . 0.0 109.456 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.383 1.202 . . . . 0.0 111.106 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -75.06 -45.7 39.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.936 . . . . 0.0 110.054 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.35 17.48 9.77 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.688 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.1 60.18 9.37 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 32' ' ' LEU . 41.4 mm -101.44 166.57 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.771 -0.841 . . . . 0.0 111.098 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.91 153.35 75.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.878 -0.514 . . . . 0.0 109.777 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.46 112.5 3.36 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.251 1.132 . . . . 0.0 110.236 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.52 66.24 1.81 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.8 m -114.44 118.36 33.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.777 -0.837 . . . . 0.0 110.042 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.5 mptt -59.22 123.68 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -48.2 -28.62 3.1 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.301 -0.874 . . . . 0.0 111.142 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.19 -20.11 52.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.547 -0.721 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.51 -15.18 27.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.355 -0.841 . . . . 0.0 111.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.631 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -53.72 162.48 1.33 Allowed Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.031 -1.043 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HD3' HD23 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -93.69 -165.72 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 120.91 1.073 . . . . 0.0 110.932 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -80.11 176.39 9.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.354 0.597 . . . . 0.0 109.981 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 67.78 3.36 3.44 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.898 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.753 ' O ' HG13 ' A' ' 37' ' ' VAL . 23.2 t90 -96.92 125.62 41.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.84 -1.162 . . . . 0.0 109.384 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.119 0.485 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.6 m-85 -117.92 -169.03 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.563 -0.711 . . . . 0.0 110.515 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.0 tp10 -159.33 123.11 3.79 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.706 -0.621 . . . . 0.0 109.427 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 20.9 mtpt -57.69 178.11 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.469 -0.769 . . . . 0.0 110.552 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -95.28 -26.06 16.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.697 -0.627 . . . . 0.0 110.321 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.467 -0.77 . . . . 0.0 111.033 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -120.54 176.23 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.372 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.518 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.3 m95 -141.4 110.0 6.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.698 . . . . 0.0 109.435 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -84.3 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.844 0.831 . . . . 0.0 111.511 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.42 117.41 33.0 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -58.04 -19.84 34.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.542 -0.724 . . . . 0.0 111.155 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.41 -48.71 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.854 . . . . 0.0 110.754 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -150.61 30.63 0.66 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.27 -0.893 . . . . 0.0 111.468 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.34 15.15 60.8 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.677 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' HD12 ' A' ' 5' ' ' LEU . 8.8 t80 -59.87 138.48 57.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.088 -1.242 . . . . 0.0 108.824 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.729 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -121.41 114.18 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 42.8 t80 -81.09 111.37 17.48 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -79.43 85.83 5.19 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.155 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.9 tt0 -51.43 -23.36 3.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.786 -0.571 . . . . 0.0 111.283 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.37 -29.95 71.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.317 -0.864 . . . . 0.0 108.947 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -28.62 7.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.709 -0.619 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.06 -102.52 2.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -173.92 88.32 0.36 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.448 -1.031 . . . . 0.0 109.974 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.86 -19.01 58.79 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.421 1.222 . . . . 0.0 110.444 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -76.75 -29.96 56.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.782 . . . . 0.0 109.579 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.55 12.19 37.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.62 -0.675 . . . . 0.0 110.603 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.28 68.29 1.74 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 24' ' ' SER . 49.8 mm -123.31 167.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.89 . . . . 0.0 111.138 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -61.0 143.08 92.39 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.925 -0.484 . . . . 0.0 110.504 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 114.53 3.97 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.263 1.138 . . . . 0.0 109.938 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.01 66.55 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 6.2 m -119.09 125.41 49.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.825 -0.809 . . . . 0.0 110.002 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 26.3 mtpt -60.8 119.21 7.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.605 -0.684 . . . . 0.0 109.746 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.518 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.8 t80 -51.11 -28.12 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.244 -0.91 . . . . 0.0 110.577 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.72 -2.98 41.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.653 -0.654 . . . . 0.0 110.895 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -112.93 -15.87 12.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.889 . . . . 0.0 111.053 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.529 HD13 ' CG ' ' A' ' 36' ' ' TRP . 5.6 mt -54.54 150.64 16.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.09 -1.006 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 49.4 Cg_endo -83.4 -175.75 2.48 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.285 1.15 . . . . 0.0 110.784 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.4 -16.51 61.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.722 -0.611 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.26 -13.39 49.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.529 ' CG ' HD13 ' A' ' 32' ' ' LEU . 24.6 t90 -101.9 121.86 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 37' ' ' VAL . 10.5 p . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.465 -0.772 . . . . 0.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 120.941 0.4 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -87.8 -170.32 2.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 0.0 110.425 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.86 ' O ' HG12 ' A' ' 4' ' ' VAL . 18.8 tt0 -160.3 121.9 3.14 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.686 -0.634 . . . . 0.0 109.642 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 34.0 mtmt -59.9 165.63 3.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.99 51.3 1.23 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.658 -0.651 . . . . 0.0 110.22 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 110.705 -179.849 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.051 0.453 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 -164.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.625 -0.672 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 8.0 m95 -138.53 117.1 12.12 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -121.78 152.29 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.015 -1.074 . . . . 0.0 113.281 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.571 HD11 ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -106.01 117.96 35.39 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.18 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -54.48 -21.4 9.85 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.566 -0.709 . . . . 0.0 111.812 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.424 ' HB ' HD22 ' A' ' 5' ' ' LEU . 76.8 mt -90.0 -61.09 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.247 -0.908 . . . . 0.0 110.984 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.4 p -80.18 -58.72 3.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.28 -0.887 . . . . 0.0 110.415 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.03 21.43 3.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.685 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.0 m-85 -55.98 164.18 1.28 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.991 -1.299 . . . . 0.0 109.515 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 10' ' ' TYR . 35.3 mm -150.47 79.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.803 -0.561 . . . . 0.0 109.618 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 57.0 t80 -79.9 107.89 13.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.821 -1.175 . . . . 0.0 108.914 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -79.61 90.09 5.14 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.4 tt0 -52.75 -23.23 6.36 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.98 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.99 -29.04 70.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.431 -0.793 . . . . 0.0 108.942 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.32 -43.8 3.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.687 -0.633 . . . . 0.0 109.417 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 113.37 -105.81 1.7 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -179.84 90.42 0.2 Allowed Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.405 -1.056 . . . . 0.0 109.706 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.89 -20.67 45.03 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.319 1.168 . . . . 0.0 110.67 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -80.05 -33.77 38.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.392 -0.817 . . . . 0.0 110.276 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.06 17.3 11.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.15 65.13 3.68 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -122.01 167.38 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.646 -0.914 . . . . 0.0 110.83 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.3 t -78.25 151.3 78.16 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.77 -0.581 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 119.3 6.01 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.399 1.21 . . . . 0.0 110.133 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.77 71.46 1.16 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 HD23 ' A' ' 32' ' ' LEU . 8.6 m -125.0 122.12 36.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.706 -0.879 . . . . 0.0 110.274 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 2.5 mptp? -58.19 113.92 2.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.151 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 64.4 t80 -49.42 -31.72 10.28 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.37 -0.831 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.45 -12.18 60.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.548 -0.72 . . . . 0.0 110.611 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -127.85 19.41 6.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.66 HD23 HG21 ' A' ' 27' ' ' THR . 7.4 mt -62.65 171.03 1.97 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.324 -0.86 . . . . 0.0 109.39 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.8 Cg_endo -78.36 -174.89 2.44 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.216 1.114 . . . . 0.0 110.47 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.81 -15.54 56.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.565 -0.709 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -67.42 -11.28 57.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' C ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -103.99 96.48 6.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.045 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 36' ' ' TRP . 57.8 t . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.429 -0.794 . . . . 0.0 109.593 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' OE1' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 120.661 0.267 . . . . 0.0 110.915 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.7 m-85 -83.97 -170.74 3.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.261 -0.899 . . . . 0.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.12 119.42 2.79 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.485 -0.76 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 11.4 mtmt -55.29 165.63 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.5 tt -83.86 -23.41 31.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.692 -0.63 . . . . 0.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.332 -0.855 . . . . 0.0 111.22 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HG2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.06 159.63 23.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 110.7 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.4 m95 -130.78 110.09 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.746 -0.596 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 11' ' ' ILE . 10.8 p -88.58 142.33 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 110.98 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -97.81 103.27 15.2 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.522 -0.736 . . . . 0.0 111.26 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 47' ' ' GLU . 63.1 mt -71.77 -20.45 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.83 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 7' ' ' ILE . 73.1 p -148.56 -48.46 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.146 -0.972 . . . . 0.0 111.136 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.76 -3.95 7.0 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.61 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.6 t80 -51.75 155.29 1.73 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.324 . . . . 0.0 109.753 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.0 mm -132.83 124.18 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.77 . . . . 0.0 111.233 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 35.5 t80 -93.45 111.34 22.98 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.4 87.59 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.055 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -52.82 -22.35 5.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.782 -0.574 . . . . 0.0 111.156 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -31.65 72.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.313 -0.867 . . . . 0.0 108.883 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.71 -29.82 7.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.74 -0.6 . . . . 0.0 109.754 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 98.47 -104.62 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.65 88.99 0.32 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.429 -1.042 . . . . 0.0 109.947 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 -19.15 59.47 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.433 1.228 . . . . 0.0 110.382 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -80.04 -31.99 39.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.644 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -93.79 8.73 39.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.64 -0.662 . . . . 0.0 110.743 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.8 62.65 6.07 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CG2' HD21 ' A' ' 32' ' ' LEU . 49.2 mm -121.41 166.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.936 . . . . 0.0 110.729 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.0 t -67.7 146.31 98.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.827 -0.546 . . . . 0.0 110.302 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.19 122.44 8.03 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.351 1.185 . . . . 0.0 110.091 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.58 67.04 1.74 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 1.9 m -122.09 126.99 49.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.772 -0.84 . . . . 0.0 109.949 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 6.9 mptt -61.08 119.64 8.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -49.69 -39.58 37.18 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.183 -0.948 . . . . 0.0 110.784 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.07 -17.37 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.587 -0.695 . . . . 0.0 110.291 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -91.16 -21.92 20.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.876 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.1 mt -54.94 151.43 16.01 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.21 -0.931 . . . . 0.0 109.911 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.71 178.88 6.14 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.272 1.143 . . . . 0.0 110.735 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.74 -18.02 63.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.659 -0.651 . . . . 0.0 110.528 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.7 -15.22 51.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.367 -0.833 . . . . 0.0 109.969 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.89 139.05 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 110.092 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG2' HD11 ' A' ' 7' ' ' ILE . 1.2 tp10 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.3 m-85 -86.57 -169.83 2.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 110.854 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.04 119.0 6.21 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 7.7 mtmm -54.29 171.47 0.11 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 110.541 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 ' HG2' ' A' ' 2' ' ' LYS . 2.6 pp -79.78 -22.84 42.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.66 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 N--CA 1.498 1.925 0 O-C-N 121.439 -0.788 . . . . 0.0 110.953 -179.758 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.029 0.442 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HE2' HG21 ' A' ' 11' ' ' ILE . 19.9 mtpt -128.45 177.03 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 11.1 m95 -141.26 108.18 5.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.579 -0.701 . . . . 0.0 109.452 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.789 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.0 p -84.17 148.31 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.741 0.781 . . . . 0.0 111.22 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -106.33 116.41 31.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -55.43 -21.12 14.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.506 -0.746 . . . . 0.0 111.347 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 5' ' ' LEU . 92.8 mt -65.72 -56.34 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 110.732 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 t -136.19 27.76 3.16 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.343 -0.848 . . . . 0.0 111.219 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.35 50.54 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -62.18 131.49 49.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.789 HD13 ' HA ' ' A' ' 4' ' ' VAL . 40.2 mm -112.81 118.19 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 111.446 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 31.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -79.31 83.09 5.38 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.766 0.793 . . . . 0.0 109.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tt0 -53.36 -22.7 7.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.737 -0.602 . . . . 0.0 110.968 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 0.0 109.044 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.04 -37.07 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.489 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 111.41 -105.94 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.94 90.19 0.28 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.403 -1.057 . . . . 0.0 109.82 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.14 -16.08 53.33 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.403 1.212 . . . . 0.0 110.531 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -101.65 10.7 39.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.59 -0.694 . . . . 0.0 110.704 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.56 1.2 Allowed Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.67 163.38 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.939 . . . . 0.0 111.454 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.41 145.61 81.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.86 118.29 5.23 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.367 1.193 . . . . 0.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.65 64.97 1.97 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.8 m -117.07 126.85 53.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.842 -0.799 . . . . 0.0 109.673 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 11.7 mptt -61.28 123.73 18.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.551 -0.718 . . . . 0.0 109.624 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.5 t80 -48.99 -43.85 40.61 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.242 -0.912 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.8 -20.21 65.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.589 -0.694 . . . . 0.0 110.117 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -90.71 -15.54 30.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.438 -0.789 . . . . 0.0 111.333 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.726 HD23 ' HD3' ' A' ' 33' ' ' PRO . 5.6 mt -52.69 156.44 3.23 Favored Pre-proline 0 N--CA 1.506 2.341 0 O-C-N 121.028 -1.045 . . . . 0.0 109.686 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.726 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.4 Cg_endo -97.62 -165.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.154 1.236 . . . . 0.0 110.937 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.98 -179.2 2.64 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.17 1.85 2.99 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.379 -0.825 . . . . 0.0 111.916 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CD2' HD13 ' A' ' 32' ' ' LEU . 52.0 t90 -101.35 103.14 14.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.849 -1.157 . . . . 0.0 108.644 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.475 -0.766 . . . . 0.0 110.352 -179.357 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.816 0.341 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 8.4 m-85 -95.05 -168.58 1.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.775 . . . . 0.0 110.673 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.6 tt0 -158.84 123.23 4.04 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.733 -0.604 . . . . 0.0 109.371 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -56.3 165.58 1.03 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.577 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -82.84 -27.76 30.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 110.182 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.518 -0.739 . . . . 0.0 110.895 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.021 0.438 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.98 175.43 10.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 110.48 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.0 m95 -141.14 124.68 16.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -119.8 147.29 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.075 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.619 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.3 tt -103.5 119.72 39.45 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.107 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -57.26 -38.89 74.56 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.369 -0.832 . . . . 0.0 111.119 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.619 ' HB ' HD22 ' A' ' 5' ' ' LEU . 80.5 mt -64.57 -50.26 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.549 -0.719 . . . . 0.0 111.15 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.508 HG21 ' OH ' ' A' ' 10' ' ' TYR . 22.0 p -101.51 -57.25 2.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.219 -0.925 . . . . 0.0 110.606 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.94 25.78 3.5 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.736 ' O ' HD13 ' A' ' 11' ' ' ILE . 24.0 m-85 -60.31 170.2 1.4 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.13 -1.217 . . . . 0.0 109.586 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 10' ' ' TYR . 26.9 mm -147.74 89.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 55.0 t80 -79.76 111.71 16.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.877 -1.139 . . . . 0.0 108.8 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -79.47 85.07 5.28 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.686 0.755 . . . . 0.0 109.287 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 6.5 tt0 -53.49 -22.32 7.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.66 -31.7 72.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 108.898 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.07 -53.74 2.61 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.445 0.64 . . . . 0.0 109.311 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 130.05 -108.54 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.33 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.411 -1.052 . . . . 0.0 109.283 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.6 -12.7 36.28 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.414 1.218 . . . . 0.0 111.135 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -77.63 -44.78 27.08 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.19 16.04 10.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.436 -0.79 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.74 40.16 88.35 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CD1' ' A' ' 36' ' ' TRP . 38.3 mm -81.75 161.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.663 -0.904 . . . . 0.0 110.365 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 156.78 79.41 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.757 -0.589 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 112.32 3.28 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.272 1.143 . . . . 0.0 110.026 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.93 67.77 1.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -120.32 121.13 37.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.733 -0.863 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -57.2 119.36 6.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.744 . . . . 0.0 109.815 179.045 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 34.9 t80 -49.64 -29.16 6.8 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.224 -0.923 . . . . 0.0 110.961 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.87 -18.03 59.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.527 -0.733 . . . . 0.0 110.508 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -92.66 -19.69 21.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 111.001 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD21 HG23 ' A' ' 23' ' ' ILE . 7.8 mt -55.32 166.79 0.82 Allowed Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.192 -0.942 . . . . 0.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' HD22 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -78.72 154.63 26.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -65.04 -16.65 63.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.637 -0.665 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.06 -7.68 48.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 110.235 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.822 ' CD1' HD11 ' A' ' 23' ' ' ILE . 40.6 t90 -71.06 132.55 45.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG23 ' C ' ' A' ' 36' ' ' TRP . 81.4 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.463 -0.773 . . . . 0.0 108.928 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.844 0.354 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 2.7 m-85 -79.44 -174.24 4.12 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.566 -0.709 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.11 114.81 2.28 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.638 -0.664 . . . . 0.0 109.651 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' CD ' ' HG2' ' A' ' 52' ' ' GLU . 8.7 ptpt -58.37 163.6 2.97 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.534 -0.729 . . . . 0.0 110.19 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -86.34 -29.9 22.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.643 -0.661 . . . . 0.0 110.208 -179.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.419 ' HG2' ' CD ' ' A' ' 50' ' ' LYS . 4.3 mm-40 . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 0.0 111.413 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -104.8 -166.87 1.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 11.6 m95 -141.47 121.03 13.3 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 10.3 p -120.88 152.42 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.058 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.4 tt -110.3 118.32 36.01 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.324 178.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -53.43 -39.6 64.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.428 -0.795 . . . . 0.0 111.43 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.53 -59.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.782 . . . . 0.0 110.908 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 9' ' ' GLY . 23.5 p -89.51 -58.2 2.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.322 -0.861 . . . . 0.0 110.678 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' A' ' 8' ' ' THR . . . 116.01 25.05 3.7 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.7 m-85 -56.97 168.76 0.6 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.133 -1.216 . . . . 0.0 109.44 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 10' ' ' TYR . 33.7 mm -149.34 79.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 32' ' ' LEU . 70.6 t80 -79.89 108.29 13.35 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.771 -1.205 . . . . 0.0 108.716 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.45 84.64 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.5 tt0 -49.92 -24.67 2.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.26 -30.0 71.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.803 . . . . 0.0 109.028 178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.54 -29.4 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 97.62 -102.94 2.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.99 89.25 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.429 -1.042 . . . . 0.0 109.761 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.14 -23.14 46.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.34 1.179 . . . . 0.0 110.488 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.95 -31.11 39.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.798 . . . . 0.0 110.0 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.11 16.82 15.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.485 -0.76 . . . . 0.0 110.523 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.59 63.2 5.43 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -121.53 167.07 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.69 -0.888 . . . . 0.0 111.183 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -73.68 148.61 87.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.964 -0.46 . . . . 0.0 110.512 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 110.98 3.21 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.475 1.25 . . . . 0.0 109.997 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.71 1.37 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.428 HG22 ' HG ' ' A' ' 32' ' ' LEU . 17.9 m -121.39 126.06 48.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.787 -0.831 . . . . 0.0 110.084 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 5.3 mptt -60.77 121.09 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 58.7 t80 -47.39 -50.43 22.5 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.349 -0.844 . . . . 0.0 111.016 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.85 -17.29 55.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.632 -0.668 . . . . 0.0 110.55 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.66 -12.55 23.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.24 -0.912 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -55.43 160.39 3.74 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.056 -1.028 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 49.8 Cg_endo -82.32 -176.52 3.0 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.213 1.112 . . . . 0.0 110.512 -179.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.43 -16.24 62.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 0.0 110.582 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.73 -14.52 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.109 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -107.24 116.81 32.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 109.817 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.882 179.845 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.099 0.476 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.4 m-85 -79.86 -168.73 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.691 . . . . 0.0 110.537 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.31 115.93 2.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.639 -0.663 . . . . 0.0 109.402 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -62.06 163.67 7.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.431 -0.793 . . . . 0.0 110.07 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -45.28 19.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 110.04 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.516 2.831 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.491 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 14' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -89.54 155.05 19.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.535 -0.728 . . . . 0.0 110.787 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.779 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 m95 -129.6 158.6 38.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD13 ' A' ' 11' ' ' ILE . 11.1 p -132.32 144.52 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.209 -0.932 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.692 HD22 HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -104.49 120.77 42.01 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -56.28 -20.43 18.65 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.429 -0.795 . . . . 0.0 110.969 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.692 HG12 HD22 ' A' ' 5' ' ' LEU . 45.3 mm -55.09 -66.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.309 -0.87 . . . . 0.0 110.965 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -143.33 31.91 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.192 -0.943 . . . . 0.0 111.754 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.34 17.19 79.68 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.84 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.674 ' HD2' HD12 ' A' ' 5' ' ' LEU . 32.6 t80 -61.58 129.57 41.72 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.079 -1.248 . . . . 0.0 108.5 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 3' ' ' TRP . 30.9 mm -118.58 147.42 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.13 -0.981 . . . . 0.0 112.511 -177.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 33.6 t80 -108.93 107.94 18.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -79.61 83.26 5.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.9 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 1.6 tt0 -58.1 -17.65 19.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.883 -0.51 . . . . 0.0 110.871 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.17 -30.37 71.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.097 -1.002 . . . . 0.0 108.616 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.87 -41.52 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 125.82 -106.46 0.87 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.31 93.61 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.322 -1.105 . . . . 0.0 109.167 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.4 -14.79 46.79 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.387 1.204 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.0 -33.28 39.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.28 -0.888 . . . . 0.0 109.677 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -101.96 13.8 33.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.59 -0.694 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.71 71.9 0.67 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' CD2' ' A' ' 32' ' ' LEU . 43.1 mm -116.52 162.33 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.545 -0.974 . . . . 0.0 110.855 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.06 170.67 14.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.873 -0.517 . . . . 0.0 110.034 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.03 112.3 3.09 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.34 1.179 . . . . 0.0 109.195 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.16 -98.1 2.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 -178.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.604 HG21 HD21 ' A' ' 32' ' ' LEU . 54.2 m 55.52 101.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.695 -0.885 . . . . 0.0 110.674 178.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 19.2 mttt -63.18 130.85 46.36 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.202 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -48.41 -30.4 5.0 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.139 -0.976 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.57 -18.6 59.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.475 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.43 -16.47 22.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 111.127 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 23' ' ' ILE . 12.7 mt -54.36 165.22 0.89 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.042 -1.037 . . . . 0.0 110.061 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.42 175.77 9.29 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.238 1.125 . . . . 0.0 110.885 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.86 -4.15 53.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.649 -0.657 . . . . 0.0 110.865 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.36 21.28 6.23 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' HD11 ' A' ' 23' ' ' ILE . 71.3 t90 -92.25 117.43 29.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.863 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.597 -0.689 . . . . 0.0 110.017 -179.772 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.718 0.294 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -78.84 165.11 23.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.253 -0.905 . . . . 0.0 111.401 -179.096 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' CZ3' ' A' ' 3' ' ' TRP . 2.2 tt0 -160.13 126.53 4.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HG3' ' CZ2' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.86 148.72 2.09 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.3 -0.875 . . . . 0.0 111.213 -179.152 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 51' ' ' LEU . 7.5 tt -79.91 -10.33 59.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.683 -0.636 . . . . 0.0 111.129 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.995 0 O-C-N 121.113 -0.992 . . . . 0.0 111.013 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.143 0.496 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -129.57 -178.87 4.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.699 . . . . 0.0 110.283 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.513 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -137.58 108.13 6.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.755 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -86.04 148.35 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.758 0.789 . . . . 0.0 111.311 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -107.49 119.06 38.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -53.24 -21.95 6.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 111.312 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.25 -68.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -130.94 37.41 3.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.283 -0.885 . . . . 0.0 111.72 -178.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.79 36.56 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 5' ' ' LEU . 40.7 t80 -61.24 130.39 45.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.331 -1.1 . . . . 0.0 108.962 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.786 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.9 mm -115.4 164.69 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.003 0.906 . . . . 0.0 111.728 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 27.7 t80 -133.26 113.08 12.23 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.882 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.32 77.05 5.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.843 0.83 . . . . 0.0 108.981 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -52.22 -22.67 4.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.855 -0.528 . . . . 0.0 111.198 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.72 -31.05 72.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.898 . . . . 0.0 108.975 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.882 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.63 -30.81 6.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 0.0 109.784 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 106.49 -106.5 2.55 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.98 88.18 0.35 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.484 -1.009 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.07 -24.08 52.69 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.412 1.217 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -31.9 57.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.757 . . . . 0.0 109.327 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -95.62 5.81 50.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.665 -0.647 . . . . 0.0 110.57 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.98 3.18 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 32' ' ' LEU . 48.9 mm -123.04 166.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.683 -0.892 . . . . 0.0 111.438 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.2 t -60.86 143.12 91.81 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 122.014 -0.429 . . . . 0.0 110.145 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 122.24 7.44 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.321 1.169 . . . . 0.0 110.147 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.89 67.04 1.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.2 m -118.73 119.99 36.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.77 -0.841 . . . . 0.0 110.309 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -58.4 125.76 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 179.055 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.513 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.1 t80 -46.84 -29.31 1.91 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.357 -0.839 . . . . 0.0 111.452 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -20.31 58.99 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.501 -0.749 . . . . 0.0 110.552 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.41 -24.63 25.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD13 ' CD2' ' A' ' 36' ' ' TRP . 10.8 mt -55.79 138.5 70.74 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.335 -0.853 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.67 -179.27 5.03 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.148 1.078 . . . . 0.0 110.796 -179.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -16.2 59.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 110.65 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.69 -9.19 48.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.241 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.701 ' CD2' HD13 ' A' ' 32' ' ' LEU . 14.5 t90 -113.01 120.75 42.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG23 ' C ' ' A' ' 36' ' ' TRP . 65.2 t . . . . . 0 N--CA 1.496 1.85 0 O-C-N 121.474 -0.766 . . . . 0.0 109.667 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.241 0.543 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 6.2 m-85 -96.67 -169.29 1.86 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 110.652 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.4 tm-20 -155.97 122.44 5.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -57.5 174.91 0.19 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.399 -0.813 . . . . 0.0 110.408 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tp -79.99 -32.35 39.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.632 . . . . 0.0 109.936 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.466 -0.771 . . . . 0.0 111.174 179.46 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.111 0.481 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.76 179.8 4.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.522 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 14.9 m95 -139.08 107.67 5.88 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.632 -0.668 . . . . 0.0 109.378 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.769 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.2 p -88.67 143.72 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.956 -179.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -95.55 112.75 24.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -54.66 -21.45 10.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.414 -0.804 . . . . 0.0 111.384 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' A' ' 5' ' ' LEU . 97.6 mt -60.02 -63.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.324 -0.86 . . . . 0.0 110.413 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -122.02 -22.4 5.69 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.374 -0.829 . . . . 0.0 111.549 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.85 18.02 7.61 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.96 140.44 58.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.33 -1.1 . . . . 0.0 108.703 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.769 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.3 mm -118.53 149.06 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.444 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.3 t80 -119.18 112.7 19.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.6 p-10 -79.5 82.84 5.57 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.692 0.758 . . . . 0.0 109.311 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.02 -18.48 24.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.66 -0.65 . . . . 0.0 110.795 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.13 -31.33 72.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 0.0 108.698 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.19 -46.23 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.81 -108.0 0.87 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.42 94.3 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.377 -1.072 . . . . 0.0 109.297 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.07 -11.93 33.24 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.457 1.241 . . . . 0.0 111.217 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.82 -36.76 62.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.171 -0.956 . . . . 0.0 110.123 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -105.13 16.96 24.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.8 68.11 1.86 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 42.7 mm -106.29 165.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.662 -0.905 . . . . 0.0 110.938 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.92 165.93 44.02 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.913 -0.492 . . . . 0.0 110.222 -179.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.8 111.29 2.57 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.332 1.175 . . . . 0.0 109.233 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.71 -96.94 1.88 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 -178.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 51.9 m 55.08 102.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.741 -0.858 . . . . 0.0 110.688 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.9 mttt -63.0 131.86 50.05 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.104 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.6 t80 -48.75 -42.11 34.34 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.001 -1.062 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 17.0 mt-10 -72.13 -8.59 55.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.508 -0.745 . . . . 0.0 110.625 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -105.14 -12.73 15.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' A' ' 23' ' ' ILE . 6.6 mt -52.27 168.91 0.28 Allowed Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.037 -1.04 . . . . 0.0 109.316 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.6 Cg_endo -89.37 -167.29 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 122.953 0.975 . . . . 0.0 110.756 -178.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.54 169.66 13.36 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.321 0.581 . . . . 0.0 110.002 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t0 65.2 8.28 4.74 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.514 -0.741 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CD1' HD11 ' A' ' 23' ' ' ILE . 91.6 t90 -71.92 -75.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 109.175 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.952 -0.467 . . . . 0.0 111.457 179.573 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.139 0.495 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.4 m-85 -114.75 -168.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.832 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.1 tp10 -160.0 123.76 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.747 -0.596 . . . . 0.0 109.69 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.5 mtmt -60.22 166.13 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 0.0 110.256 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -82.4 -25.9 33.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.704 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.385 -0.822 . . . . 0.0 110.836 -179.66 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.29 173.91 6.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.552 -0.717 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 10.9 m95 -139.04 107.05 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.659 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.026 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -98.43 106.29 18.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.14 -19.34 19.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.762 . . . . 0.0 111.472 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.3 mp -89.15 -9.59 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 111.653 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -149.33 -47.84 0.14 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.989 -1.069 . . . . 0.0 111.625 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.54 -15.1 9.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -51.71 117.75 2.91 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.117 -1.226 . . . . 0.0 109.584 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 4' ' ' VAL . 32.8 mm -100.76 140.2 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.527 -0.733 . . . . 0.0 111.332 -178.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 36.4 t80 -104.91 110.95 23.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.21 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.919 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 6.0 p-10 -79.4 78.73 5.9 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.74 0.781 . . . . 0.0 109.26 -179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -51.52 -22.67 3.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.782 -0.574 . . . . 0.0 111.255 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.71 -29.65 70.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.234 -0.916 . . . . 0.0 108.997 178.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.919 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.66 -41.66 3.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.74 -0.6 . . . . 0.0 109.516 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 131.69 -109.17 0.85 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.37 91.45 0.18 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.411 -1.052 . . . . 0.0 109.806 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.41 -13.88 41.77 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.337 1.178 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -80.19 -41.03 26.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -95.57 12.2 30.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.519 -0.738 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.55 73.23 0.43 Allowed Glycine 0 N--CA 1.502 3.085 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.606 ' CG2' HD21 ' A' ' 32' ' ' LEU . 44.2 mm -120.52 166.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.697 -0.884 . . . . 0.0 111.49 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -63.97 141.3 98.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.46 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 47.0 Cg_endo -72.48 107.78 2.37 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.154 1.081 . . . . 0.0 110.671 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.1 63.99 1.3 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -123.34 134.85 53.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.759 -0.848 . . . . 0.0 110.122 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -70.88 132.27 45.0 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 13.3 t80 -47.97 -38.52 17.01 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.184 -0.947 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -67.92 -22.43 65.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.545 -0.722 . . . . 0.0 110.136 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.66 -19.96 30.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.535 -0.728 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -52.53 158.1 2.22 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.085 -1.009 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD3' HD23 ' A' ' 32' ' ' LEU . 45.3 Cg_endo -93.59 -170.73 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.098 1.052 . . . . 0.0 110.436 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -76.76 174.87 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.651 -0.655 . . . . 0.0 109.902 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 66.34 7.07 4.66 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.399 -0.813 . . . . 0.0 111.801 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.622 ' CD2' HD13 ' A' ' 32' ' ' LEU . 91.0 t90 -86.54 4.21 40.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.931 -1.106 . . . . 0.0 110.392 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.06 -1.025 . . . . 0.0 109.787 -179.82 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.064 0.459 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.0 m-85 -83.53 -169.18 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.595 -0.691 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -160.03 118.41 2.69 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.391 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 15.4 mtmt -55.06 171.12 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.391 -0.818 . . . . 0.0 110.71 -179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.8 tt -80.04 -26.97 39.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.703 -0.623 . . . . 0.0 110.341 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.465 -0.772 . . . . 0.0 110.997 -179.83 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.023 0.439 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.8 175.39 7.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.506 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 11.1 m95 -141.63 98.79 3.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.545 -0.722 . . . . 0.0 109.633 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -89.32 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.656 0.741 . . . . 0.0 111.224 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -99.65 101.98 13.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.391 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -57.79 -19.65 29.86 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.502 -0.749 . . . . 0.0 110.95 -179.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.44 ' HB ' HD22 ' A' ' 5' ' ' LEU . 83.1 mt -71.22 -19.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.303 -0.873 . . . . 0.0 111.059 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 10' ' ' TYR . 5.7 t -154.14 -34.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.141 -0.974 . . . . 0.0 112.394 -179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.55 -17.09 6.54 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.442 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.595 ' H ' HG23 ' A' ' 8' ' ' THR . 33.5 t80 -51.05 150.01 3.34 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.096 -1.237 . . . . 0.0 109.871 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 12' ' ' TYR . 45.0 mt -136.01 167.14 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.042 0.925 . . . . 0.0 111.789 -179.218 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.55 ' N ' HG22 ' A' ' 11' ' ' ILE . 46.0 t80 -135.82 106.81 6.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -79.24 86.89 4.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.3 tt0 -47.55 -25.88 1.26 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 0.0 111.697 -178.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.0 -29.72 70.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.394 -0.816 . . . . 0.0 109.179 178.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.23 -25.28 9.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.663 -0.648 . . . . 0.0 110.241 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 101.83 -105.61 2.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.62 87.07 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.46 -1.023 . . . . 0.0 109.912 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.11 -28.73 40.73 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.428 1.225 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.1 -32.15 72.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.605 -0.684 . . . . 0.0 109.191 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.91 6.39 36.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.699 -0.626 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.0 66.73 2.51 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' SER . 44.6 mm -118.99 167.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.175 0.988 . . . . 0.0 112.683 -176.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.0 t -48.04 121.01 8.5 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.699 179.053 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 131.13 18.17 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.179 1.094 . . . . 0.0 111.217 -179.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.78 59.7 8.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 32' ' ' LEU . 1.8 m -123.42 132.74 54.04 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.827 -0.808 . . . . 0.0 110.289 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.9 mttt -62.16 126.99 29.27 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.836 179.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 7.8 t80 -48.89 -27.01 2.77 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.43 -0.794 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -91.34 7.9 38.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -0.752 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -142.62 17.95 2.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 111.4 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 36' ' ' TRP . 1.1 pt? -80.57 -163.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.093 -1.004 . . . . 0.0 108.866 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 41.6 Cg_endo -89.66 143.02 4.27 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 122.457 0.714 . . . . 0.0 110.539 -177.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -52.93 171.69 0.06 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.691 -0.631 . . . . 0.0 110.432 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t70 72.88 -6.43 1.68 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.811 -0.556 . . . . 0.0 112.257 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.801 ' CG ' HD11 ' A' ' 32' ' ' LEU . 86.4 t90 -77.09 114.55 16.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.626 -1.296 . . . . 0.0 109.621 179.153 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 36' ' ' TRP . 4.1 m . . . . . 0 N--CA 1.499 2.016 0 O-C-N 121.682 -0.636 . . . . 0.0 109.585 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 120.961 0.41 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 7.2 m-85 -79.91 -167.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.4 -0.813 . . . . 0.0 110.263 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.22 123.24 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.715 -0.616 . . . . 0.0 109.526 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.0 mtmt -55.35 167.5 0.47 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.586 -0.696 . . . . 0.0 110.898 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 51' ' ' LEU . 3.1 tt -83.22 -25.49 31.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.659 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.46 -0.775 . . . . 0.0 110.832 -179.769 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.154 0.502 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 11' ' ' ILE . 9.7 mttp -123.13 172.47 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 110.256 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.502 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.05 109.81 7.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 109.417 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.777 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.8 p -83.47 150.23 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.896 0.855 . . . . 0.0 111.384 -179.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -110.02 118.0 35.26 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.749 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -19.96 22.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.414 -0.804 . . . . 0.0 111.126 -179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.47 -58.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.835 . . . . 0.0 110.653 -179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 t -137.85 26.98 2.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.299 -0.876 . . . . 0.0 111.373 -179.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.17 65.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' HD12 ' A' ' 5' ' ' LEU . 7.9 t80 -61.0 136.27 58.04 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -1.202 . . . . 0.0 108.791 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.777 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -119.84 127.41 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.409 -0.807 . . . . 0.0 111.551 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 29.0 t80 -94.55 113.57 25.42 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.5 82.44 5.63 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.388 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.61 -21.13 9.56 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.874 -0.516 . . . . 0.0 111.06 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.37 -32.97 74.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.305 -0.872 . . . . 0.0 108.975 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.67 -43.3 4.08 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 179.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.69 -108.27 1.16 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.99 94.38 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.359 -1.083 . . . . 0.0 109.243 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.93 -13.06 38.09 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.438 1.231 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -77.52 -40.02 44.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.204 -0.935 . . . . 0.0 109.949 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -97.94 16.57 20.53 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.596 -0.69 . . . . 0.0 110.674 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 58.0 16.7 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.678 HD12 HD21 ' A' ' 32' ' ' LEU . 44.8 mm -100.43 157.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.97 . . . . 0.0 110.63 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -74.2 158.22 85.77 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.873 -0.517 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.57 109.52 2.65 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.299 1.157 . . . . 0.0 110.31 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.34 79.89 0.74 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.6 m -132.49 119.49 20.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.749 -0.854 . . . . 0.0 110.116 -179.156 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.2 mttt -55.38 121.57 9.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.477 -0.764 . . . . 0.0 110.04 179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.0 t80 -46.79 -46.36 20.57 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.396 -0.815 . . . . 0.0 111.269 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mt-10 -63.72 -18.83 64.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.475 -0.766 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -87.79 -21.13 25.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.678 HD21 HD12 ' A' ' 23' ' ' ILE . 9.3 mt -56.35 163.7 2.34 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.114 -0.991 . . . . 0.0 109.829 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 46.7 Cg_endo -73.43 163.12 38.52 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.148 1.078 . . . . 0.0 110.977 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.49 -18.62 61.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.632 -0.667 . . . . 0.0 110.622 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -75.68 -2.02 27.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 110.336 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.659 ' CD1' HD11 ' A' ' 23' ' ' ILE . 37.4 t90 -75.6 134.5 40.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.099 -1.001 . . . . 0.0 109.814 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.489 -0.757 . . . . 0.0 109.693 179.972 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 120.929 0.395 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 10.2 m-85 -119.76 -168.11 1.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.406 -0.809 . . . . 0.0 110.45 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.772 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.3 mt-10 -160.07 121.57 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.681 -0.637 . . . . 0.0 109.362 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -54.98 173.11 0.1 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.375 -0.828 . . . . 0.0 110.841 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tp -86.74 -32.17 20.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.031 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.618 -0.676 . . . . 0.0 111.145 -179.831 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 0.87 110.261 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -114.92 173.39 6.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 2.26 110.098 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.978 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 15.2 m95 -130.83 120.09 23.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.51 109.736 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.035 ' HA ' HD13 ' A' ' 11' ' ' ILE . 13.3 p -100.21 139.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 0.77 110.717 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.799 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -100.26 100.26 11.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.92 109.991 179.726 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -44.39 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.351 -0.843 . . . . 2.07 110.943 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 8' ' ' THR . 4.7 mt -66.96 -40.76 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 2.06 110.474 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.539 HG22 HG22 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -149.23 15.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 2.11 110.52 -179.867 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.696 ' O ' HG12 ' A' ' 11' ' ' ILE . . . 77.65 -3.41 60.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.694 -1.362 . . . . 0.7 109.694 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.909 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 39.9 t80 -39.89 125.39 1.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -1.225 . . . . 2.46 109.615 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.035 HD13 ' HA ' ' A' ' 4' ' ' VAL . 27.9 mm -114.93 145.29 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.78 111.204 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.923 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 27.6 t80 -116.04 109.55 17.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 178.42 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.926 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -79.65 82.01 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 2.22 110.35 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' CD ' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -51.81 -18.62 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 1.14 110.049 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -18.59 65.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.74 109.621 179.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.926 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -127.88 -23.85 3.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.768 . . . . 0.52 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 18' ' ' ASP . . . 101.87 -98.24 1.72 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.43 109.677 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 164.74 97.82 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.244 -1.15 . . . . 1.35 110.072 -179.886 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ASP . 41.9 Cg_endo -69.82 -14.93 36.57 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.129 1.594 . . . . 0.84 110.372 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -35.09 37.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 1.6 109.901 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -102.38 24.81 9.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.18 110.081 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.11 58.53 4.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.502 -1.439 . . . . 0.62 109.502 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.848 HG23 HD21 ' A' ' 32' ' ' LEU . 51.6 mm -104.92 166.71 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.82 110.286 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -76.36 157.71 82.41 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.8 110.147 179.993 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.05 110.81 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.56 110.317 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 14' ' ' GLU . . . 78.09 67.39 1.63 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.418 -1.473 . . . . 1.11 109.418 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.561 ' CG2' ' HG ' ' A' ' 32' ' ' LEU . 1.1 m -118.23 114.16 22.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -1.124 . . . . 0.43 110.458 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HA ' ' CD ' ' A' ' 14' ' ' GLU . 6.4 mptt -47.98 117.48 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.268 -0.895 . . . . 1.61 110.303 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.748 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 36.4 t80 -46.14 -41.17 12.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.895 . . . . 1.26 110.116 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -68.44 -13.11 62.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 2.14 110.371 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' LEU . 21.8 tt0 -99.52 -26.05 14.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 1.92 110.547 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.848 HD21 HG23 ' A' ' 23' ' ' ILE . 6.4 mt -40.82 160.92 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.95 . . . . 0.79 110.087 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.4 Cg_endo -78.62 -179.14 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.979 1.515 . . . . 1.03 110.18 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -80.26 -31.97 38.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 2.78 109.942 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -7.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 2.76 109.706 179.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.696 ' HH2' ' HE2' ' A' ' 10' ' ' TYR . 23.7 t90 -90.72 135.25 33.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 1.03 110.191 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.796 ' CG1' ' O ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.034 . . . . 1.76 110.488 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.224 0.535 . . . . 2.04 110.188 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.909 ' CE2' ' CD2' ' A' ' 10' ' ' TYR . 7.1 m-85 -103.89 -171.89 2.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.84 110.519 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 1.082 ' O ' ' O ' ' A' ' 50' ' ' LYS . 16.0 tt0 -160.18 100.95 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.39 -0.819 . . . . 2.24 109.758 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 1.082 ' O ' ' O ' ' A' ' 49' ' ' GLU . 13.3 mtpt -29.17 -172.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.853 . . . . 1.78 110.366 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.978 ' O ' HD23 ' A' ' 51' ' ' LEU . 6.1 tt -111.09 -14.35 13.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 109.821 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.665 ' O ' ' O ' ' A' ' 51' ' ' LEU . 6.2 pt-20 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.427 -0.796 . . . . 2.38 110.531 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.484 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -122.84 175.84 6.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.619 -0.676 . . . . 0.0 110.288 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.9 108.09 6.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.596 -0.69 . . . . 0.0 109.658 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.782 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -87.73 147.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.842 0.829 . . . . 0.0 111.209 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -102.59 101.21 11.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -47.5 -24.75 0.91 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.532 -0.73 . . . . 0.0 112.431 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD12 ' CA ' ' A' ' 42' ' ' GLY . 94.5 mt -63.23 -49.85 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 0.0 110.566 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -127.6 -29.99 2.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.37 -0.831 . . . . 0.0 111.597 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.85 4.99 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 17.4 t80 -72.3 131.82 43.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.384 -1.068 . . . . 0.0 108.831 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.782 HD13 ' HA ' ' A' ' 4' ' ' VAL . 37.9 mm -113.62 123.19 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.464 -0.772 . . . . 0.0 111.466 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 30.9 t80 -91.71 113.25 25.47 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.38 87.11 5.04 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.284 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -53.86 -21.4 7.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.858 -0.526 . . . . 0.0 111.23 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.74 -31.49 72.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.354 -0.841 . . . . 0.0 109.026 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -35.07 5.83 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.294 0.569 . . . . 0.0 109.574 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 109.62 -107.06 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -176.28 90.54 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.431 -1.041 . . . . 0.0 109.949 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.09 -19.3 63.22 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.422 1.222 . . . . 0.0 110.533 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -30.32 43.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 109.307 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.34 6.3 48.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.597 -0.69 . . . . 0.0 110.56 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.26 70.13 1.06 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 24' ' ' SER . 47.1 mm -126.45 166.72 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.61 -0.935 . . . . 0.0 111.2 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.8 t -65.42 148.08 98.25 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.012 -0.43 . . . . 0.0 110.409 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 119.07 5.91 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.488 1.257 . . . . 0.0 110.015 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.35 71.26 1.24 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 32' ' ' LEU . 12.6 m -122.5 122.61 39.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.722 -0.869 . . . . 0.0 110.407 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.7 mttt -60.82 114.81 3.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.614 -0.679 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -51.13 -30.02 15.15 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.17 -0.956 . . . . 0.0 110.728 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -77.24 -2.85 36.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.684 -0.635 . . . . 0.0 110.824 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.29 -3.89 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 111.262 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 36' ' ' TRP . 6.1 mt -58.83 156.54 24.49 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.128 -0.982 . . . . 0.0 109.864 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.3 Cg_endo -84.34 172.72 9.22 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.287 1.151 . . . . 0.0 110.404 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.88 -16.46 63.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.591 -0.693 . . . . 0.0 110.504 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -16.15 48.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 110.008 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 32' ' ' LEU . 30.7 t90 -93.39 129.9 39.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.797 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.86 HG23 ' HB1' ' A' ' 43' ' ' ALA . 10.0 p -167.43 117.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 110.006 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -58.71 177.17 0.24 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.656 -0.653 . . . . 0.0 110.459 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 42.2 Cg_endo -69.3 -160.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.353 1.186 . . . . 0.0 110.328 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 41' ' ' THR . 6.2 tp -48.94 -36.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.208 -0.932 . . . . 0.0 111.349 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 39' ' ' PRO . 7.1 t -77.59 87.48 3.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -0.788 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' CA ' HD12 ' A' ' 7' ' ' ILE . . . 84.4 164.67 38.11 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.86 ' HB1' HG23 ' A' ' 37' ' ' VAL . . . -169.17 -62.65 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.429 -1.042 . . . . 0.0 110.982 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 43.4 Cg_endo -70.33 -170.76 0.45 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 O-C-N 122.944 0.971 . . . . 0.0 110.827 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 74.1 mmtt -89.27 -45.67 9.35 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.651 0.739 . . . . 0.0 110.343 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.0 m -54.82 -21.62 11.82 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.84 -0.537 . . . . 0.0 111.238 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.62 7.15 18.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.351 -0.843 . . . . 0.0 111.427 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 8.8 m-85 -109.78 -169.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.11 -0.994 . . . . 0.0 110.047 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.692 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.2 tm-20 -160.07 121.34 3.12 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.482 -0.761 . . . . 0.0 109.534 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 18.4 mtpt -54.22 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.482 -0.761 . . . . 0.0 110.878 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.504 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.4 tt -96.89 -12.5 23.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.697 -0.627 . . . . 0.0 111.188 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -52.36 148.73 6.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.083 -1.011 . . . . 0.0 110.943 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.451 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.066 0.46 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.58 178.65 6.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 17.1 m95 -140.39 143.86 35.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.595 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.2 p -118.92 137.53 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.752 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -92.76 95.7 9.71 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -51.11 -23.29 3.05 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.455 -0.778 . . . . 0.0 111.682 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.415 ' C ' HG23 ' A' ' 8' ' ' THR . 76.4 mt -81.37 -9.8 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.347 -0.845 . . . . 0.0 111.361 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 7' ' ' ILE . 71.1 p -147.94 -41.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.976 -1.077 . . . . 0.0 111.507 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 -13.19 21.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.4 t80 -51.82 156.4 1.46 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.117 -1.225 . . . . 0.0 109.681 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 10' ' ' TYR . 43.6 mm -133.53 130.78 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 54.0 t80 -92.33 110.91 22.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.47 83.69 5.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.9 tt0 -51.02 -23.89 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.792 -0.568 . . . . 0.0 111.151 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.57 -30.09 71.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.411 -0.805 . . . . 0.0 108.935 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.39 -34.04 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.323 0.582 . . . . 0.0 109.62 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.62 -104.5 2.5 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -173.72 88.81 0.36 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.398 -1.06 . . . . 0.0 110.102 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 -21.1 62.04 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.427 1.225 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.46 -34.95 47.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.236 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -92.13 3.81 54.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.758 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.87 63.79 4.88 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.4 mm -119.89 165.99 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.95 . . . . 0.0 110.728 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -60.13 143.31 88.69 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.442 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.85 115.93 4.49 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.333 1.175 . . . . 0.0 109.679 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.46 66.48 1.6 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -120.21 125.13 47.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.857 . . . . 0.0 110.146 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 30.6 mmtt -59.7 122.64 14.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.66 -0.65 . . . . 0.0 109.396 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 36.6 t80 -48.43 -33.15 8.78 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.21 -0.931 . . . . 0.0 111.028 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.15 -22.92 62.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -82.44 -26.23 32.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.481 -0.762 . . . . 0.0 110.67 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.633 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.9 mt -57.64 141.17 79.74 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.251 -0.905 . . . . 0.0 109.806 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.11 175.59 6.44 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.151 1.079 . . . . 0.0 110.536 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.65 -18.14 58.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 110.405 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.81 -15.51 42.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.382 -0.824 . . . . 0.0 110.131 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -86.23 136.14 33.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 0.0 109.805 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 43' ' ' ALA . 8.9 p -168.17 126.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.581 -0.699 . . . . 0.0 109.776 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . . . -70.76 141.5 87.39 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.582 -0.698 . . . . 0.0 110.253 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.11 -8.65 22.44 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.358 1.189 . . . . 0.0 111.301 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.53 94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 41' ' ' THR . 32.6 m 53.04 29.6 8.25 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.556 -0.715 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 117.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.671 ' O ' HG23 ' A' ' 37' ' ' VAL . . . -150.67 112.2 3.17 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.587 -0.949 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.08 -175.08 1.11 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.143 1.075 . . . . 0.0 110.174 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.65 -24.84 19.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -73.17 -12.2 60.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.399 -0.813 . . . . 0.0 110.845 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -95.67 21.8 7.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 5.7 m-85 -105.33 -172.55 2.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.48 -0.762 . . . . 0.0 110.673 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.27 140.48 11.54 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CG ' ' CZ2' ' A' ' 3' ' ' TRP . 29.3 mtpt -57.99 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.194 -0.941 . . . . 0.0 110.452 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 41.2 tp -111.1 63.61 0.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.61 0.719 . . . . 0.0 110.036 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -55.9 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.718 -0.614 . . . . 0.0 110.612 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 N--CA 1.5 2.05 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.821 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.117 0.484 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -118.11 174.69 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -140.01 110.82 6.83 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.0 109.733 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.6 p -81.93 150.68 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 111.112 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.33 118.18 35.15 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -55.46 -21.47 16.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.557 -0.714 . . . . 0.0 111.215 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 47' ' ' GLU . 88.4 mt -64.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -135.74 29.74 3.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -0.833 . . . . 0.0 111.07 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.38 58.01 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CD1' HD12 ' A' ' 5' ' ' LEU . 5.8 t80 -60.99 134.95 57.62 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.229 -1.159 . . . . 0.0 108.722 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.775 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.6 mm -117.14 118.48 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.557 -0.714 . . . . 0.0 111.205 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 27.4 t80 -85.41 112.55 20.96 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -79.56 82.34 5.7 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.086 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tm-20 -57.04 -19.5 19.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.686 -0.634 . . . . 0.0 110.776 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -62.28 -31.04 71.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.2 -0.937 . . . . 0.0 108.751 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.73 -44.07 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 127.65 -108.55 0.96 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.24 94.42 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.339 -1.094 . . . . 0.0 109.174 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -13.62 40.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.386 1.203 . . . . 0.0 110.971 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.95 -33.41 57.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.246 -0.908 . . . . 0.0 109.745 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -106.04 11.46 31.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.736 . . . . 0.0 110.852 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.95 66.99 2.44 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.633 HD11 ' CD1' ' A' ' 36' ' ' TRP . 46.7 mm -103.6 164.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.924 . . . . 0.0 110.686 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.05 172.83 8.85 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.931 -0.481 . . . . 0.0 110.051 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.85 107.11 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.335 1.176 . . . . 0.0 109.41 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.14 -95.71 1.67 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD21 ' A' ' 32' ' ' LEU . 52.4 m 55.64 101.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.716 -0.873 . . . . 0.0 110.708 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -63.12 125.86 25.46 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.399 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.7 t80 -50.69 -25.93 4.87 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.49 -6.58 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.552 -0.718 . . . . 0.0 110.752 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -108.89 -16.52 14.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 27' ' ' THR . 11.5 mt -54.87 156.42 6.79 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.12 169.41 21.55 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.258 1.136 . . . . 0.0 110.985 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -71.74 -14.21 61.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.747 -0.596 . . . . 0.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -75.2 -3.12 31.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.411 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.633 ' CD1' HD11 ' A' ' 23' ' ' ILE . 74.8 t90 -80.32 120.78 24.84 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.141 -0.974 . . . . 0.0 110.024 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 36' ' ' TRP . 25.0 t -154.13 118.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -88.3 -62.35 0.22 Allowed Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 111.228 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -71.88 -162.46 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.909 0.952 . . . . 0.0 110.061 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 tt -50.45 167.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.406 -0.809 . . . . 0.0 110.711 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 p -53.48 98.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.406 -0.809 . . . . 0.0 110.985 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.45 61.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . . . -138.83 51.06 3.18 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.496 -1.002 . . . . 0.0 110.802 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 43.2 Cg_endo -69.61 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.263 1.138 . . . . 0.0 110.381 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 67.7 mmtt -83.86 -20.1 33.72 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.545 -0.722 . . . . 0.0 110.947 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.0 p -78.13 0.58 24.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 111.553 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 7' ' ' ILE . 6.9 tt0 -114.3 20.25 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.042 -1.036 . . . . 0.0 111.001 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 13.7 m-85 -121.54 -172.45 2.42 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.865 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.826 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.4 tt0 -160.2 122.75 3.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 2.8 mtpt -58.48 173.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tt -88.34 -28.31 21.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.673 -0.642 . . . . 0.0 110.268 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -56.69 141.35 44.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.58 -0.7 . . . . 0.0 110.565 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.7 -179.814 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.87 -166.76 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 110.314 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 9.3 m95 -138.07 122.5 18.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 9.9 p -118.47 146.48 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.269 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.5 tt -108.03 118.38 36.61 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.76 -39.81 68.71 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.326 -0.859 . . . . 0.0 111.414 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.56 -49.15 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.532 -0.73 . . . . 0.0 111.345 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -102.1 -57.77 2.0 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.13 -0.981 . . . . 0.0 110.79 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.5 23.64 4.02 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.717 ' O ' HD13 ' A' ' 11' ' ' ILE . 29.3 m-85 -55.76 164.34 1.15 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.049 -1.265 . . . . 0.0 109.588 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.717 HD13 ' O ' ' A' ' 10' ' ' TYR . 28.6 mm -146.5 83.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 63.8 t80 -79.8 109.94 14.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.984 -1.073 . . . . 0.0 108.659 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.45 85.81 5.2 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.1 tt0 -52.8 -22.6 5.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.778 -0.576 . . . . 0.0 111.089 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -29.39 70.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.376 -0.827 . . . . 0.0 109.086 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.69 -37.53 4.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.751 -0.593 . . . . 0.0 109.531 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 108.43 -105.26 2.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.59 90.13 0.22 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.377 -1.072 . . . . 0.0 109.795 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.6 -18.8 48.61 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.353 1.186 . . . . 0.0 110.638 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.14 -32.94 38.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.0 110.021 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -95.58 13.98 24.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.716 . . . . 0.0 110.735 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.5 66.37 2.89 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 32' ' ' LEU . 49.0 mm -122.51 166.89 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.692 -0.887 . . . . 0.0 111.157 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.465 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -73.06 148.97 89.44 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.826 -0.546 . . . . 0.0 110.537 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 120.4 6.51 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.386 1.203 . . . . 0.0 109.985 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.82 70.12 1.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.0 m -124.25 121.35 34.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.713 -0.875 . . . . 0.0 110.247 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.68 120.22 7.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.492 -0.755 . . . . 0.0 109.804 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB3' ' CE2' ' A' ' 3' ' ' TRP . 33.5 t80 -48.7 -38.27 20.95 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.221 -0.924 . . . . 0.0 110.936 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.93 -20.06 63.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -91.01 -16.42 27.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.806 . . . . 0.0 110.955 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -56.03 159.34 5.83 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.073 -1.017 . . . . 0.0 110.144 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD3' HD23 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -85.91 -178.29 2.84 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.359 1.189 . . . . 0.0 110.5 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -67.55 -16.25 64.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.663 -0.648 . . . . 0.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.03 -16.72 46.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.824 . . . . 0.0 110.105 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CG ' HD13 ' A' ' 32' ' ' LEU . 1.1 t90 -106.93 114.1 27.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 43' ' ' ALA . 9.3 p -174.08 150.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.424 -0.798 . . . . 0.0 109.256 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.98 109.28 31.7 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.591 -0.693 . . . . 0.0 110.562 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -22.2 15.68 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.255 1.134 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 41' ' ' THR . 96.9 mt -60.76 -40.25 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.827 . . . . 0.0 109.982 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 40' ' ' ILE . 3.1 p -154.36 46.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.183 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.7 -169.45 28.31 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.856 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -177.0 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.995 . . . . 0.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 51.8 Cg_endo -93.6 174.82 1.56 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.086 1.045 . . . . 0.0 110.274 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -70.44 -40.97 73.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.535 -0.728 . . . . 0.0 110.327 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -70.14 63.29 0.23 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.761 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -33.1 1.3 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.745 . . . . 0.0 110.501 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.5 m-85 -79.81 -173.03 3.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 110.325 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -149.34 110.01 4.26 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.671 -0.643 . . . . 0.0 109.38 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -57.76 168.3 0.93 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.584 -0.697 . . . . 0.0 110.509 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.9 48.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.209 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.23 168.58 3.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.596 -0.69 . . . . 0.0 110.153 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 t70 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.172 179.804 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.169 0.509 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.23 149.02 23.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 110.774 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.43 ' CZ2' ' HD3' ' A' ' 50' ' ' LYS . 19.9 m95 -114.84 173.04 6.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.557 -0.714 . . . . 0.0 110.061 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 51' ' ' LEU . 7.6 p -130.35 142.05 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 110.29 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.89 117.56 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -52.66 -23.58 6.87 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.597 -0.689 . . . . 0.0 111.46 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CG1' HD22 ' A' ' 5' ' ' LEU . 42.3 mm -60.39 -57.39 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.377 -0.827 . . . . 0.0 110.586 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -146.81 36.59 0.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.225 -0.922 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.45 20.06 49.83 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD1' HD12 ' A' ' 5' ' ' LEU . 3.2 t80 -58.41 164.88 2.31 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.138 -1.213 . . . . 0.0 108.643 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.5 mt -141.52 165.79 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.282 1.039 . . . . 0.0 112.241 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 60.6 t80 -126.16 109.91 12.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.29 81.21 5.58 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.6 tt0 -48.94 -25.03 1.72 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.559 -0.713 . . . . 0.0 111.337 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.19 -30.02 71.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 0.0 108.905 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -111.5 -32.55 6.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.826 -0.546 . . . . 0.0 109.581 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.14 -103.26 2.7 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -174.48 88.7 0.33 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.41 -1.053 . . . . 0.0 110.059 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.64 -19.03 60.02 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.455 1.24 . . . . 0.0 110.533 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.79 -34.7 39.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.77 11.2 23.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.677 -0.64 . . . . 0.0 110.765 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.02 55.5 27.77 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 24' ' ' SER . 49.5 mm -112.35 165.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.751 -0.852 . . . . 0.0 111.246 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.6 t -65.1 143.05 98.78 Favored Pre-proline 0 N--CA 1.494 1.775 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.097 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.95 123.09 8.16 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.275 1.145 . . . . 0.0 110.007 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.24 67.65 1.66 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 m -122.76 123.76 41.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.789 -0.83 . . . . 0.0 110.315 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.82 120.65 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.662 -0.648 . . . . 0.0 109.387 178.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 69.6 t80 -46.66 -49.39 19.29 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.322 -0.862 . . . . 0.0 111.258 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -59.59 -20.06 53.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.0 110.492 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.27 -29.34 34.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.31 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.449 HD21 HG23 ' A' ' 23' ' ' ILE . 11.5 mt -58.15 150.46 51.81 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.497 -0.752 . . . . 0.0 109.846 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.31 176.22 8.93 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.273 1.144 . . . . 0.0 110.724 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.11 -14.86 62.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.55 -0.719 . . . . 0.0 110.658 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.95 -9.13 50.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.476 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.44 ' O ' HG13 ' A' ' 37' ' ' VAL . 30.3 t90 -91.81 140.43 29.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 36' ' ' TRP . 16.5 m -154.86 -160.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.74 155.34 63.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.615 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.88 83.88 1.1 Allowed 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.471 1.248 . . . . 0.0 110.844 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 41' ' ' THR . 4.7 tt -169.19 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.596 -0.69 . . . . 0.0 109.938 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.472 ' N ' HG23 ' A' ' 40' ' ' ILE . 80.5 m -161.73 -44.04 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.659 -0.651 . . . . 0.0 110.015 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.47 78.51 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.46 116.01 62.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.436 -1.038 . . . . 0.0 110.691 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.34 -163.48 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.22 1.116 . . . . 0.0 110.292 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 29' ' ' PHE . 72.8 mmtt -76.6 -36.39 57.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -0.781 . . . . 0.0 110.187 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -19.63 40.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.884 -0.51 . . . . 0.0 111.03 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -91.92 -21.94 20.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 111.032 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 8.3 m-85 -84.41 178.74 7.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 110.877 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.25 147.82 16.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -72.25 157.19 38.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.18 35.35 1.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.585 -0.697 . . . . 0.0 109.921 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.04 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.722 -0.611 . . . . 0.0 110.228 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 N--CA 1.502 2.162 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.622 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.191 0.519 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -121.94 175.2 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.263 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m95 -139.41 104.88 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.676 -0.64 . . . . 0.0 109.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.8 p -83.84 150.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.718 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.8 116.13 31.74 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -54.27 -21.03 8.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.521 -0.737 . . . . 0.0 111.373 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 5' ' ' LEU . 93.9 mt -58.54 -68.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -123.29 -15.82 7.08 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.473 -0.767 . . . . 0.0 111.647 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.11 14.77 8.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.58 130.92 48.97 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.154 -1.204 . . . . 0.0 108.987 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.795 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.4 mm -111.34 114.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.706 . . . . 0.0 111.292 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 23.1 t80 -82.58 113.34 20.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -79.41 87.44 5.05 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.813 0.816 . . . . 0.0 109.398 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -55.49 -21.21 15.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.632 -0.668 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.55 -32.12 73.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 108.694 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.91 -46.65 3.73 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 116.31 -106.47 1.51 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 176.17 94.14 0.1 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.391 -1.064 . . . . 0.0 109.282 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.57 -12.79 36.67 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.416 1.219 . . . . 0.0 111.085 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.7 -40.41 55.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.178 -0.951 . . . . 0.0 109.834 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.88 17.38 10.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.02 41.81 92.65 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.679 HD11 ' CD1' ' A' ' 36' ' ' TRP . 41.3 mm -84.83 165.59 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.787 -0.831 . . . . 0.0 110.848 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.3 154.22 74.38 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.84 107.35 2.19 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.307 1.161 . . . . 0.0 109.8 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.46 65.05 1.47 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 32' ' ' LEU . 1.4 m -116.17 126.78 54.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.861 -0.787 . . . . 0.0 109.643 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 14.4 mtpt -63.56 118.44 8.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.731 -0.606 . . . . 0.0 110.048 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 30.4 t80 -51.34 -35.29 37.63 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.188 -0.945 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.06 -8.81 57.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.643 -0.661 . . . . 0.0 110.492 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -113.17 -4.42 13.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.201 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -52.99 171.4 0.23 Allowed Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 120.906 -1.121 . . . . 0.0 109.444 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.8 Cg_endo -89.26 -175.04 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 122.967 0.983 . . . . 0.0 110.824 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.29 171.43 15.07 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.649 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.9 -0.12 2.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.591 -0.693 . . . . 0.0 112.113 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.679 ' CD1' HD11 ' A' ' 23' ' ' ILE . 64.9 t90 -73.88 119.2 17.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.796 -1.19 . . . . 0.0 109.119 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' C ' ' A' ' 36' ' ' TRP . 57.5 t -150.17 106.62 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 109.827 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.586 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -60.47 154.76 52.85 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.532 -0.73 . . . . 0.0 109.968 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' N ' HD12 ' A' ' 40' ' ' ILE . 50.7 Cg_endo -75.52 61.37 6.05 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.384 1.202 . . . . 0.0 110.75 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.586 ' CD1' ' HB1' ' A' ' 38' ' ' ALA . 4.9 mp -140.98 71.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.505 -0.747 . . . . 0.0 109.934 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.5 p 44.28 70.31 0.34 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.825 -0.547 . . . . 0.0 111.734 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.23 141.01 0.24 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' H ' HG13 ' A' ' 37' ' ' VAL . . . -163.25 57.14 0.62 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.934 . . . . 0.0 110.134 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.18 -164.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.41 1.216 . . . . 0.0 110.39 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mmtm -78.43 -57.87 3.55 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.338 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.34 68.17 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.389 0.614 . . . . 0.0 109.807 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -160.17 -33.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.701 -0.624 . . . . 0.0 111.073 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.5 m-85 -79.52 -172.49 3.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 0.0 110.541 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.741 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.7 tm-20 -160.23 125.59 3.97 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.753 -0.592 . . . . 0.0 109.651 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 21.2 mtmt -63.12 168.23 4.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.103 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -104.88 29.52 6.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -60.26 157.08 14.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 110.429 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.502 2.135 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.886 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.02 0.438 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.65 159.29 20.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.568 -0.707 . . . . 0.0 110.474 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.538 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.6 m95 -132.54 112.11 11.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -81.03 150.98 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.406 -0.809 . . . . 0.0 111.467 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -114.57 120.93 41.89 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -52.21 -22.14 4.06 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.483 -0.761 . . . . 0.0 111.715 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 5' ' ' LEU . 95.7 mt -56.15 -74.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.205 -0.934 . . . . 0.0 110.725 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -133.06 20.0 4.09 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.36 23.1 55.34 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.68 ' O ' HD13 ' A' ' 11' ' ' ILE . 3.9 t80 -59.3 152.12 21.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.292 -1.122 . . . . 0.0 108.783 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.2 mm -135.4 137.9 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.326 -0.859 . . . . 0.0 111.654 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 49.8 t80 -105.11 112.71 25.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.0 p-10 -79.26 81.96 5.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -50.19 -24.78 3.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.615 -0.678 . . . . 0.0 110.869 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.41 -31.92 73.21 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -107.2 -52.33 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.13 -107.42 1.04 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -175.61 88.72 0.29 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -14.39 44.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.475 1.25 . . . . 0.0 110.688 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.06 -37.15 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.309 -0.869 . . . . 0.0 109.793 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.33 12.98 27.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.538 -0.726 . . . . 0.0 110.701 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.68 66.6 2.7 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 32' ' ' LEU . 50.9 mm -119.39 166.06 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.964 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -65.06 147.52 98.47 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.992 -0.442 . . . . 0.0 110.673 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 48.8 Cg_endo -74.97 111.4 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.391 1.206 . . . . 0.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.49 66.31 1.47 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -117.81 127.85 54.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.826 -0.808 . . . . 0.0 110.006 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 18.8 mmtm -63.33 118.53 8.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.538 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 57.9 t80 -49.18 -34.85 15.46 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.287 -0.883 . . . . 0.0 111.092 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.79 -18.08 62.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.661 -0.649 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -93.17 -17.76 23.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.161 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 23' ' ' ILE . 8.0 mt -58.64 155.53 29.08 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.15 -0.969 . . . . 0.0 110.137 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.06 165.31 26.27 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.31 1.163 . . . . 0.0 110.245 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.16 -12.35 60.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.682 . . . . 0.0 110.845 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.21 -1.88 28.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.748 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.46 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.8 t90 -86.12 127.4 34.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 0.0 109.883 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.777 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 15.8 m -154.41 117.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 0.0 109.724 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.796 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -77.02 -58.65 1.0 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.446 -0.784 . . . . 0.0 110.613 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.2 Cg_endo -71.81 -163.03 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.075 1.039 . . . . 0.0 110.057 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 tt -51.86 168.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.316 -0.865 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.8 p -50.97 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.353 -0.842 . . . . 0.0 110.973 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.12 73.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.777 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . . . -151.62 56.6 1.99 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.969 . . . . 0.0 110.29 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.21 -164.82 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.441 1.232 . . . . 0.0 110.466 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.14 -20.18 30.66 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.464 -0.772 . . . . 0.0 110.842 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.6 m -79.98 5.2 14.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.495 -0.753 . . . . 0.0 111.82 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -118.84 22.09 12.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.002 -1.061 . . . . 0.0 110.917 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 14.2 m-85 -125.11 -173.93 2.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.307 -0.871 . . . . 0.0 110.994 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.83 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.4 mt-10 -160.41 131.4 5.62 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 23.5 mtmt -76.11 151.92 36.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -97.71 47.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.631 -0.668 . . . . 0.0 110.157 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.67 143.72 29.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.743 . . . . 0.0 110.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.212 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HD3' HD13 ' A' ' 51' ' ' LEU . 9.7 mtpt -111.21 173.7 6.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 0.0 110.063 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -139.72 111.34 7.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.494 -0.754 . . . . 0.0 109.623 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.3 p -87.61 145.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.873 0.844 . . . . 0.0 110.96 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.627 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -96.42 98.98 10.68 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -52.27 -24.33 7.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.384 -0.823 . . . . 0.0 111.153 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.627 ' HB ' HD22 ' A' ' 5' ' ' LEU . 50.4 mm -75.93 -13.87 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 7' ' ' ILE . 78.7 p -149.72 -54.14 0.16 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.094 -1.004 . . . . 0.0 111.061 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 132.59 -9.18 5.27 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 11' ' ' ILE . 4.7 t80 -50.62 150.57 2.7 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.267 . . . . 0.0 110.075 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.773 HD13 ' HA ' ' A' ' 4' ' ' VAL . 41.1 mm -130.08 123.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.502 -0.749 . . . . 0.0 110.939 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 32.2 t80 -88.81 111.54 22.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -79.81 84.99 5.52 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.292 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -55.25 -20.18 10.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.582 -0.699 . . . . 0.0 110.839 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -61.78 -30.41 70.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.146 -0.971 . . . . 0.0 108.819 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.36 -41.78 3.42 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.0 109.067 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.17 -108.05 1.17 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.25 95.12 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.325 -1.103 . . . . 0.0 109.045 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.46 -12.57 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.301 1.158 . . . . 0.0 111.247 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.94 -33.82 72.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.221 -0.924 . . . . 0.0 109.899 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.53 16.09 20.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.56 -0.713 . . . . 0.0 110.802 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.29 62.97 5.75 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 36' ' ' TRP . 42.4 mm -94.13 163.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.968 . . . . 0.0 110.598 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.01 172.9 8.66 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.863 -0.523 . . . . 0.0 110.007 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.84 108.42 2.28 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.272 1.143 . . . . 0.0 109.457 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.89 -94.87 1.74 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 32' ' ' LEU . 51.9 m 55.11 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.59 -0.947 . . . . 0.0 110.636 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 16.1 mttm -60.05 123.8 18.25 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.101 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -49.75 -26.29 3.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.152 -0.967 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 -12.67 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.622 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -101.88 -16.86 16.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 111.038 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 27' ' ' THR . 10.4 mt -53.86 151.96 11.0 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 121.108 -0.995 . . . . 0.0 109.988 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.21 156.06 42.04 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.237 1.125 . . . . 0.0 110.858 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.25 -18.14 56.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.622 -0.673 . . . . 0.0 110.589 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.25 1.02 22.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.73 ' CD1' HD11 ' A' ' 23' ' ' ILE . 68.6 t90 -61.79 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.087 -1.008 . . . . 0.0 109.72 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t 52.84 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.539 -0.725 . . . . 0.0 110.912 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -53.09 172.73 0.2 Allowed Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.507 -0.746 . . . . 0.0 110.91 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -76.71 -57.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.408 1.215 . . . . 0.0 111.177 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.8 mm -75.65 98.29 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -0.769 . . . . 0.0 110.192 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m 51.96 45.04 28.95 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.507 -0.746 . . . . 0.0 110.664 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -61.53 169.65 10.84 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -168.29 174.9 2.03 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.967 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 43.6 Cg_endo -69.05 -164.78 0.12 Allowed 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.465 1.245 . . . . 0.0 110.66 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HD2' ' CE1' ' A' ' 29' ' ' PHE . 39.8 mmtm -81.68 -21.55 38.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 p -75.72 -1.3 24.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 111.558 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -114.29 11.29 17.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.01 -1.056 . . . . 0.0 111.343 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 11.3 m-85 -116.66 -170.29 1.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.0 110.456 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.678 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.8 mm-40 -160.12 123.53 3.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 109.447 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mtmt -58.42 167.19 1.47 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.277 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.547 HD13 ' HD3' ' A' ' 2' ' ' LYS . 9.2 tt -81.15 -27.53 35.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.357 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.92 158.08 4.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.49 -0.756 . . . . 0.0 110.756 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.695 -179.819 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.18 0.514 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -82.33 156.33 24.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 28.5 m95 -130.41 167.93 17.79 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.7 139.71 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.82 -1.175 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -102.04 121.0 41.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -56.11 -20.37 17.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.458 -0.776 . . . . 0.0 111.11 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 5' ' ' LEU . 86.6 mt -59.22 -63.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.86 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -144.88 44.24 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.212 -0.93 . . . . 0.0 111.976 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.39 20.25 43.91 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.947 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.724 ' HD2' HD12 ' A' ' 5' ' ' LEU . 31.6 t80 -64.16 132.21 49.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -1.137 . . . . 0.0 108.195 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' TYR . 37.2 mt -119.52 166.66 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.355 1.074 . . . . 0.0 112.233 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.609 ' OH ' HD11 ' A' ' 32' ' ' LEU . 16.2 t80 -127.19 109.2 11.59 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 48.6 p-10 -78.86 73.94 5.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.2 tt0 -50.4 -25.73 4.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.741 -0.6 . . . . 0.0 110.812 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.24 -25.37 64.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.59 -0.694 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -105.7 -54.31 2.5 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 110.247 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.6 68.12 0.54 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t0 21.61 82.09 0.13 Allowed Pre-proline 0 N--CA 1.51 2.53 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.43 -21.32 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.664 1.35 . . . . 0.0 109.955 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -80.29 -45.16 18.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.447 -0.783 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.91 -35.14 17.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.47 -0.769 . . . . 0.0 110.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.06 52.04 0.85 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.724 HD11 ' CD1' ' A' ' 36' ' ' TRP . 18.8 mm -89.68 155.69 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.491 -1.005 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -47.62 145.36 4.34 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.602 . . . . 0.0 111.444 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.17 105.46 1.2 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.5 1.263 . . . . 0.0 110.329 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.52 83.59 0.31 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.619 HG22 HD12 ' A' ' 32' ' ' LEU . 1.7 m -140.09 117.14 11.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.677 -0.896 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.0 tptt -51.76 126.68 18.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 110.098 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HA ' HD13 ' A' ' 32' ' ' LEU . 23.3 t80 -42.26 -29.27 0.24 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.449 -0.782 . . . . 0.0 112.165 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.304 -0.873 . . . . 0.0 110.93 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -87.0 -31.69 20.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.683 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -47.2 149.78 1.67 Allowed Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.464 -0.772 . . . . 0.0 111.702 -179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -85.28 -178.29 3.04 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.57 1.3 . . . . 0.0 110.482 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.42 -14.67 59.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.637 -0.664 . . . . 0.0 110.7 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.63 -12.73 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.256 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.724 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.8 t90 -96.25 95.79 8.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.09 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG11 ' HB1' ' A' ' 43' ' ' ALA . 27.4 m -152.73 -166.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.3 146.54 62.01 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.714 -0.617 . . . . 0.0 110.005 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.21 -171.19 0.75 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.316 1.166 . . . . 0.0 110.783 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 40' ' ' ILE . 11.4 mt 54.56 23.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 110.553 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.1 m -160.77 -43.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.16 -140.06 11.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -155.34 61.56 2.98 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.55 -0.971 . . . . 0.0 110.921 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 51.4 Cg_endo -93.07 125.74 0.62 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.068 1.036 . . . . 0.0 109.93 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -58.11 -39.49 78.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.277 -0.889 . . . . 0.0 110.034 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -80.11 57.15 2.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 110.208 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.722 ' HG2' HD21 ' A' ' 5' ' ' LEU . 34.5 tt0 -114.5 -42.71 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.258 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -79.39 -179.49 6.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.858 0.837 . . . . 0.0 111.326 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.11 144.72 14.68 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CD ' ' CZ2' ' A' ' 3' ' ' TRP . 1.1 mtmt -61.89 170.66 1.98 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 51' ' ' LEU . 39.7 tp -106.5 61.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.692 0.758 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -57.06 -50.61 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.849 -0.532 . . . . 0.0 110.716 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.779 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.005 0.431 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 51' ' ' LEU . 32.4 mttt -118.97 166.7 12.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.715 . . . . 0.0 110.37 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.8 m95 -130.0 106.44 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.737 -0.602 . . . . 0.0 109.4 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.676 HG23 ' CD1' ' A' ' 11' ' ' ILE . 8.5 p -91.7 147.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.649 0.738 . . . . 0.0 111.146 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -100.89 101.17 11.93 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -54.73 -21.57 11.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 111.455 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.2 mp -82.46 -9.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.339 -0.851 . . . . 0.0 111.232 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.439 HG23 ' C ' ' A' ' 7' ' ' ILE . 70.1 p -148.2 -47.23 0.16 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.955 -1.09 . . . . 0.0 111.225 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.27 -13.89 9.5 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' HD13 ' A' ' 11' ' ' ILE . 7.4 t80 -52.5 140.56 22.34 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.17 -1.194 . . . . 0.0 109.655 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.676 ' CD1' HG23 ' A' ' 4' ' ' VAL . 26.7 mm -123.08 121.4 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.48 -0.763 . . . . 0.0 111.343 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 38.3 t80 -85.92 111.23 20.04 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.51 81.63 5.74 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.71 0.767 . . . . 0.0 109.427 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.9 tt0 -54.08 -21.32 8.2 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.755 -0.591 . . . . 0.0 110.933 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -29.14 70.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.933 . . . . 0.0 108.754 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.34 -43.5 2.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.97 -108.21 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.44 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.33 -14.35 42.5 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.353 1.186 . . . . 0.0 110.694 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.91 -39.11 31.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -92.24 17.76 9.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.563 -0.711 . . . . 0.0 110.448 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.08 65.07 3.81 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 24' ' ' SER . 41.5 mm -114.27 165.4 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.733 -0.863 . . . . 0.0 111.958 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -79.1 148.93 72.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.675 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 45.3 Cg_endo -71.76 105.25 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.237 1.125 . . . . 0.0 110.709 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.67 61.73 1.35 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.508 HG21 HD23 ' A' ' 32' ' ' LEU . 16.9 m -115.99 134.05 55.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.934 -0.745 . . . . 0.0 109.833 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -76.87 124.84 28.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.661 -0.65 . . . . 0.0 110.307 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' HA ' HD12 ' A' ' 32' ' ' LEU . 6.3 t80 -45.55 -43.61 12.1 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.166 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.42 -25.49 10.1 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -103.56 -87.42 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 29' ' ' PHE . 6.7 mt 52.15 179.52 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.295 0 O-C-N 120.99 -1.069 . . . . 0.0 110.042 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.2 Cg_endo -83.63 -164.05 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 109.804 -0.883 . . . . 0.0 109.804 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -93.44 160.41 14.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 110.475 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 58.33 17.24 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.486 ' CZ3' ' CE2' ' A' ' 29' ' ' PHE . 76.4 t90 -65.21 112.9 3.64 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.181 -0.949 . . . . 0.0 109.35 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 43' ' ' ALA . 32.8 m -146.54 -149.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.399 -0.813 . . . . 0.0 110.062 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -169.27 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.985 . . . . 0.0 110.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.9 Cg_endo -70.74 -164.23 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 122.98 0.989 . . . . 0.0 110.486 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.6 tt -113.0 -26.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.726 . . . . 0.0 110.505 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 p -60.17 93.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 0.0 109.967 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.18 -177.53 6.89 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -147.5 61.83 6.58 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.47 -1.018 . . . . 0.0 111.243 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 50.5 Cg_endo -96.11 119.67 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.25 -1.096 . . . . 0.0 109.25 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.41 65.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.148 -0.97 . . . . 0.0 109.818 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 p -80.71 54.11 2.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.01 31.1 4.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 109.695 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 6.2 m-85 -120.28 -167.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.729 -0.607 . . . . 0.0 110.567 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.605 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.2 tp10 -160.13 112.26 2.02 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.675 -0.641 . . . . 0.0 109.758 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 12.2 mtpt -55.88 177.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.442 -0.787 . . . . 0.0 110.67 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 51' ' ' LEU . 3.9 pp -89.65 18.1 5.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.584 -0.698 . . . . 0.0 111.181 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.19 170.08 0.22 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.175 -0.953 . . . . 0.0 110.768 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.72 -179.798 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.064 0.459 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -114.98 179.12 4.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 110.158 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.54 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 16.2 m95 -139.87 104.23 4.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 109.749 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.65 158.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.96 0.886 . . . . 0.0 111.264 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -119.44 113.48 20.84 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.501 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -53.26 -22.62 7.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.432 -0.793 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' A' ' 5' ' ' LEU . 96.5 mt -58.81 -52.7 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.674 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -149.47 33.42 0.71 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.251 -0.905 . . . . 0.0 111.403 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.75 15.94 58.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 5' ' ' LEU . 4.2 t80 -60.54 146.18 45.95 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.079 -1.248 . . . . 0.0 108.875 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 12' ' ' TYR . 42.7 mt -131.3 166.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 122.221 1.01 . . . . 0.0 111.624 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 11' ' ' ILE . 42.7 t80 -134.17 110.71 9.75 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.18 87.19 4.92 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.95 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.2 tt0 -53.55 -21.4 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.857 -0.527 . . . . 0.0 111.104 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.09 -31.18 71.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.229 -0.919 . . . . 0.0 108.844 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.26 -49.61 3.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.487 0.66 . . . . 0.0 109.285 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.21 -107.84 1.08 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 95.35 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.497 -1.002 . . . . 0.0 109.076 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.19 -11.66 32.2 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.376 1.198 . . . . 0.0 111.416 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.79 -39.2 70.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.196 -0.94 . . . . 0.0 110.031 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.76 23.62 9.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 110.264 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.69 48.24 66.95 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.759 HD12 ' CD2' ' A' ' 32' ' ' LEU . 47.0 mm -87.83 160.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.86 -0.788 . . . . 0.0 111.337 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 154.9 74.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.965 -0.459 . . . . 0.0 109.906 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.51 106.44 1.95 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.359 1.189 . . . . 0.0 110.0 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 69.33 1.38 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.639 HG21 HD23 ' A' ' 32' ' ' LEU . 6.3 m -119.17 124.61 47.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.7 -0.883 . . . . 0.0 110.289 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.3 mptt -62.14 113.52 2.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.818 -0.551 . . . . 0.0 109.856 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 26.2 t80 -49.22 -32.75 11.1 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.379 -0.826 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.18 -21.24 46.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.376 -0.827 . . . . 0.0 109.62 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -109.55 -81.82 0.57 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.759 ' CD2' HD12 ' A' ' 23' ' ' ILE . 6.1 mt 52.47 -179.63 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.085 -1.01 . . . . 0.0 109.605 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' CD2' ' A' ' 32' ' ' LEU . 49.3 Cg_endo -82.47 157.2 16.68 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.92 158.71 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.327 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t0 59.02 15.99 4.38 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.586 -0.696 . . . . 0.0 111.707 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.4 t90 -60.58 126.08 26.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.972 -1.08 . . . . 0.0 109.421 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.714 HG11 ' HA ' ' A' ' 41' ' ' THR . 25.0 t -155.73 112.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.831 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -55.58 -56.89 24.6 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.587 -0.696 . . . . 0.0 110.794 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 48.0 Cg_endo -73.62 -165.09 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.162 1.085 . . . . 0.0 110.188 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.9 mt -67.6 -40.56 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.562 -0.711 . . . . 0.0 109.793 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.714 ' HA ' HG11 ' A' ' 37' ' ' VAL . 7.0 t -170.28 131.1 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.97 44.35 0.41 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . . . -142.5 51.3 1.86 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.527 -0.984 . . . . 0.0 110.716 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 43.0 Cg_endo -68.66 -164.05 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.182 1.096 . . . . 0.0 110.48 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -93.54 -24.92 17.79 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.497 -0.752 . . . . 0.0 110.586 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -80.19 4.71 16.63 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.541 -0.724 . . . . 0.0 111.734 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -117.77 18.51 14.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.057 -1.027 . . . . 0.0 111.09 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.497 ' CD2' ' CZ ' ' A' ' 29' ' ' PHE . 10.1 m-85 -116.85 164.78 14.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.122 -0.986 . . . . 0.0 110.532 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -128.12 117.93 22.49 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 33.1 mtpt -57.07 -173.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.548 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -115.11 32.74 5.84 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.425 0.631 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.08 -175.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.748 -0.595 . . . . 0.0 110.637 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.797 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.188 0.518 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 158.48 21.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.72 . . . . 0.0 110.687 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 17.1 m95 -131.83 112.84 12.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.388 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.712 ' HA ' HD13 ' A' ' 11' ' ' ILE . 88.4 t -79.62 158.65 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.179 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -116.8 101.11 8.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -24.87 2.02 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.409 -0.807 . . . . 0.0 111.809 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.588 ' HB ' HD22 ' A' ' 5' ' ' LEU . 51.1 mm -71.45 -23.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.488 -0.758 . . . . 0.0 110.851 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 7' ' ' ILE . 67.3 p -150.71 -41.84 0.12 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.136 -0.977 . . . . 0.0 111.702 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.67 -0.93 11.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.641 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -51.02 160.52 0.47 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.049 -1.265 . . . . 0.0 109.913 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 4' ' ' VAL . 43.5 mm -134.88 125.65 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.386 -0.821 . . . . 0.0 111.248 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 48.0 t80 -93.85 111.22 22.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.37 87.1 5.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.0 tt0 -52.55 -22.63 5.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.819 -0.55 . . . . 0.0 111.197 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.07 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.416 -0.803 . . . . 0.0 108.966 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.65 -30.45 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.68 -0.638 . . . . 0.0 109.857 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.56 -104.74 2.9 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.67 89.31 0.29 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.429 -1.042 . . . . 0.0 109.843 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.27 -22.84 52.74 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.41 1.216 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.28 -30.55 60.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.563 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.07 8.8 43.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.695 . . . . 0.0 110.625 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.19 63.84 4.95 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.06 166.71 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 110.91 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -64.68 145.71 98.62 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.814 -0.554 . . . . 0.0 110.333 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.53 119.55 5.8 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.351 1.185 . . . . 0.0 109.804 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.72 64.99 1.82 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -118.39 126.04 51.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.696 -0.885 . . . . 0.0 109.939 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -61.17 122.24 14.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.626 -0.671 . . . . 0.0 109.761 179.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 69.3 t80 -49.25 -26.95 3.31 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.265 -0.897 . . . . 0.0 110.993 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -19.67 53.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.44 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -87.77 -24.24 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.647 HD21 ' CG2' ' A' ' 23' ' ' ILE . 12.3 mt -56.79 142.76 71.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.254 -0.904 . . . . 0.0 109.798 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.67 -175.68 2.57 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 123.308 1.162 . . . . 0.0 110.992 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.37 -18.9 62.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.71 -0.619 . . . . 0.0 110.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.02 -14.28 45.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.453 -0.779 . . . . 0.0 110.07 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -89.74 127.52 35.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 37' ' ' VAL . 8.0 p -174.29 122.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 109.315 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.46 141.43 78.39 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 0.0 110.53 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.31 -21.74 17.22 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.23 1.121 . . . . 0.0 111.3 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 41' ' ' THR . 16.9 tt -54.52 -40.39 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.251 -0.906 . . . . 0.0 110.686 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.471 ' N ' HG23 ' A' ' 40' ' ' ILE . 32.0 m -160.82 169.4 22.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.578 -0.701 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 41' ' ' THR . . . -61.55 90.22 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 5' ' ' LEU . . . -106.97 76.47 0.45 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.693 -0.886 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 -164.14 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.387 1.203 . . . . 0.0 109.979 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -83.05 -56.41 3.81 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.473 -0.767 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.6 m -73.5 59.12 0.6 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.54 -0.725 . . . . 0.0 110.829 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -160.14 25.7 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.163 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 9.9 m-85 -119.03 171.32 8.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.483 -0.761 . . . . 0.0 110.014 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 92.92 2.99 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.579 -0.701 . . . . 0.0 109.676 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -60.62 164.59 4.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.59 -0.694 . . . . 0.0 110.28 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.16 59.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.692 -0.63 . . . . 0.0 110.34 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -47.56 -67.38 0.28 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.697 -0.627 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.097 179.621 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.08 0.467 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -100.58 -170.28 1.84 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.689 . . . . 0.0 110.112 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.515 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 8.0 m95 -140.27 119.36 12.76 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 14.0 p -117.95 146.28 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.33 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.658 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.6 tt -107.56 115.86 30.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.013 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -53.11 -40.3 64.06 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.241 -0.912 . . . . 0.0 111.397 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.658 ' HB ' HD22 ' A' ' 5' ' ' LEU . 87.2 mt -61.61 -58.7 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -0.75 . . . . 0.0 110.598 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 p -93.18 -59.44 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.33 -0.856 . . . . 0.0 110.828 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.01 23.07 3.37 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.695 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 m-85 -54.91 165.91 0.58 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.989 -1.3 . . . . 0.0 109.692 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 10' ' ' TYR . 36.3 mm -148.89 82.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.548 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 66.4 t80 -79.81 108.33 13.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 46.4 p-10 -79.39 84.84 5.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 4.3 tt0 -49.0 -24.79 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.578 -0.701 . . . . 0.0 111.337 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -64.55 -29.9 70.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.411 -0.806 . . . . 0.0 109.036 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.58 -32.43 6.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.673 -0.642 . . . . 0.0 109.812 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 103.23 -104.46 2.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -175.45 88.77 0.3 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.396 -1.061 . . . . 0.0 110.088 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.85 -19.8 46.3 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.356 1.187 . . . . 0.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.15 -31.02 38.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.1 13.4 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.532 -0.73 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.25 67.08 2.39 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 24' ' ' SER . 45.8 mm -122.4 167.36 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.693 -0.886 . . . . 0.0 111.113 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -69.36 145.51 95.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.913 -0.492 . . . . 0.0 110.309 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.24 120.21 6.17 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.324 1.171 . . . . 0.0 110.184 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 67.3 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 10.7 m -122.89 126.33 47.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.68 -0.894 . . . . 0.0 110.088 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.4 mttt -59.08 120.89 9.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.404 -0.81 . . . . 0.0 109.852 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 53.6 t80 -49.05 -44.01 41.28 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.328 -0.858 . . . . 0.0 110.799 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.9 -18.07 64.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.601 -0.687 . . . . 0.0 110.421 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.53 -8.29 29.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.391 -0.818 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 ' CE1' ' A' ' 12' ' ' TYR . 5.8 mt -57.47 155.54 19.36 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.052 -1.03 . . . . 0.0 109.89 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.422 ' CD ' HD23 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -84.54 -174.41 1.79 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 O-C-N 123.275 1.145 . . . . 0.0 110.852 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.11 -17.25 63.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.677 -0.64 . . . . 0.0 110.449 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.63 -16.06 45.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 109.999 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -109.16 117.46 34.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 109.862 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 43' ' ' ALA . 8.6 p -174.84 123.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 109.028 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.825 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -52.4 150.53 8.68 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.504 -0.747 . . . . 0.0 110.798 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.78 -14.6 32.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.408 1.215 . . . . 0.0 111.575 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 7.6 tp -54.27 159.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.131 -0.981 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -53.88 100.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.417 -0.802 . . . . 0.0 110.727 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.5 97.7 0.03 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 38' ' ' ALA . . . -130.19 52.56 9.63 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.586 -0.949 . . . . 0.0 110.405 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 46.3 Cg_endo -71.0 -164.11 0.14 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.333 1.175 . . . . 0.0 110.559 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.15 -26.37 65.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 0.0 110.515 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.2 t -80.03 2.7 22.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.764 -0.585 . . . . 0.0 111.516 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.82 -31.72 12.48 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.06 -1.025 . . . . 0.0 110.447 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 3.1 m-85 -79.82 -170.29 2.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.534 -0.729 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -160.19 124.34 3.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 22.1 mtpt -52.28 177.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.281 -0.887 . . . . 0.0 111.294 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.46 -25.84 20.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 110.508 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.7 -29.88 19.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.304 -0.873 . . . . 0.0 110.902 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 t0 . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.705 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.11 0.481 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 11' ' ' ILE . 13.1 mtmt -116.0 176.99 4.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.341 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 15.5 m95 -135.66 105.36 6.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.58 -0.7 . . . . 0.0 109.564 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.797 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -87.16 147.27 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.758 0.789 . . . . 0.0 110.942 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -105.32 116.27 31.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -54.61 -21.06 9.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.502 -0.749 . . . . 0.0 111.502 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.84 -61.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.324 -0.86 . . . . 0.0 110.571 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -131.07 0.23 4.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 111.753 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.94 35.61 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -63.17 129.1 38.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.311 -1.111 . . . . 0.0 108.895 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.797 HD13 ' HA ' ' A' ' 4' ' ' VAL . 35.8 mm -113.68 142.84 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.489 -0.757 . . . . 0.0 111.263 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.4 t80 -116.08 112.99 22.55 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.759 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.9 p-10 -79.59 83.97 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.413 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.4 tt0 -58.79 -17.39 22.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.662 -0.649 . . . . 0.0 110.698 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -63.01 -30.36 71.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.088 -1.007 . . . . 0.0 108.7 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -113.89 -46.68 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.26 -107.03 0.82 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.28 94.5 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.374 -1.074 . . . . 0.0 109.115 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.6 -12.44 35.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.408 1.215 . . . . 0.0 111.292 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.07 -42.34 57.01 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -96.51 14.18 25.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 110.682 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.04 67.63 2.11 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 36' ' ' TRP . 43.7 mm -103.98 166.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.908 . . . . 0.0 111.354 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.456 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -78.05 167.66 33.9 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 122.001 -0.437 . . . . 0.0 110.076 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.94 110.51 2.61 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.391 1.206 . . . . 0.0 109.364 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.07 -91.07 1.18 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.576 HG21 HD21 ' A' ' 32' ' ' LEU . 99.6 m 54.75 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.639 -0.918 . . . . 0.0 110.618 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.77 125.95 25.63 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.115 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 25.6 t80 -50.57 -28.28 8.35 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -79.57 -0.91 35.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.625 -0.672 . . . . 0.0 110.64 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -122.59 -6.08 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 111.211 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 ' HD3' ' A' ' 33' ' ' PRO . 6.4 mt -52.45 162.87 0.83 Allowed Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 120.979 -1.076 . . . . 0.0 109.412 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.8 Cg_endo -93.7 -165.54 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 120.874 1.05 . . . . 0.0 110.986 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.75 176.47 6.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.694 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 t70 68.33 2.41 3.28 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.44 -0.788 . . . . 0.0 111.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.585 ' CD2' HD13 ' A' ' 32' ' ' LEU . 6.6 t90 -106.23 119.63 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.818 -1.176 . . . . 0.0 109.764 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 43' ' ' ALA . 91.8 t -144.13 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 0.0 110.218 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.92 161.49 3.72 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.32 10.85 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.284 1.15 . . . . 0.0 110.269 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.901 HG22 HG23 ' A' ' 41' ' ' THR . 15.2 mt 60.08 148.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 121.46 0.648 . . . . 0.0 110.745 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.901 HG23 HG22 ' A' ' 40' ' ' ILE . 69.2 p 44.57 -166.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.706 -0.621 . . . . 0.0 111.78 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.53 170.21 1.1 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -171.28 -51.33 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.616 -0.932 . . . . 0.0 110.86 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 45.5 Cg_endo -94.03 118.18 0.29 Allowed 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 122.885 0.939 . . . . 0.0 109.95 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 -19.32 40.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 110.707 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 t -76.37 0.68 18.66 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.338 -0.851 . . . . 0.0 111.348 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -95.66 24.5 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.15 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -97.44 -170.82 2.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.981 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.712 ' O ' HG12 ' A' ' 4' ' ' VAL . 1.2 tt0 -160.21 118.08 2.59 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.769 -0.582 . . . . 0.0 109.733 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' CG ' ' CE2' ' A' ' 3' ' ' TRP . 28.2 mtmt -62.97 166.32 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 110.428 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -91.65 48.66 1.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.666 -0.646 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.29 131.2 44.98 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 110.698 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.817 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.088 0.471 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -96.74 169.15 10.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 110.213 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.1 m95 -133.09 110.41 10.18 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.55 -0.719 . . . . 0.0 109.516 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.727 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -89.03 147.59 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.045 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -103.32 97.73 7.76 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -50.84 -24.28 3.41 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.44 -0.788 . . . . 0.0 111.66 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 5' ' ' LEU . 85.0 mt -75.8 -13.08 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.409 -0.807 . . . . 0.0 111.041 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.432 HG23 ' C ' ' A' ' 7' ' ' ILE . 76.1 p -148.97 -47.72 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.172 -0.955 . . . . 0.0 111.265 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.92 -10.37 7.91 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.3 t80 -50.58 146.65 5.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.118 -1.224 . . . . 0.0 110.114 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.727 HD13 ' HA ' ' A' ' 4' ' ' VAL . 36.2 mm -128.99 111.65 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.549 -0.719 . . . . 0.0 110.76 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 29' ' ' PHE . 51.8 t80 -79.96 110.46 15.36 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.56 87.39 5.14 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.8 tt0 -53.72 -21.32 6.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.798 -0.563 . . . . 0.0 111.174 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -29.75 70.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.255 -0.903 . . . . 0.0 108.898 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.92 -41.71 3.32 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 119.28 -106.39 1.25 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.6 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.43 -1.041 . . . . 0.0 109.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.15 -13.65 40.91 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.349 1.184 . . . . 0.0 110.979 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.28 -33.3 59.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 109.809 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.99 18.59 21.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.514 -0.741 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 55.9 27.38 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.688 HD12 ' CD2' ' A' ' 32' ' ' LEU . 46.0 mm -98.62 163.92 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.612 -0.934 . . . . 0.0 110.846 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -80.09 156.5 74.31 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 122.011 -0.431 . . . . 0.0 109.971 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.88 99.46 0.87 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.302 1.159 . . . . 0.0 110.145 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 69.95 1.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 HD23 ' A' ' 32' ' ' LEU . 4.6 m -120.24 125.99 49.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.751 -0.852 . . . . 0.0 109.954 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mptt -61.23 119.46 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.591 -0.693 . . . . 0.0 109.883 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.516 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 44.5 t80 -50.96 -39.71 55.77 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.38 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -68.64 -13.41 62.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.661 -0.65 . . . . 0.0 110.31 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -112.56 2.78 16.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 111.252 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.688 ' CD2' HD12 ' A' ' 23' ' ' ILE . 7.0 mt -54.26 173.96 0.2 Allowed Pre-proline 0 N--CA 1.506 2.334 0 O-C-N 120.888 -1.133 . . . . 0.0 109.351 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD3' HD23 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -88.46 -174.57 1.11 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 122.944 0.97 . . . . 0.0 110.899 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.33 170.18 16.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.733 -0.604 . . . . 0.0 109.853 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 69.0 0.94 2.97 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.541 -0.725 . . . . 0.0 112.146 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.65 ' CD1' HD11 ' A' ' 23' ' ' ILE . 55.1 t90 -71.41 129.54 39.07 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.791 -1.193 . . . . 0.0 109.453 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 43' ' ' ALA . 9.5 p -173.69 121.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 109.557 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -57.85 176.36 0.25 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.526 -0.733 . . . . 0.0 110.565 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -72.8 -12.66 26.55 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 O-C-N 123.503 1.265 . . . . 0.0 111.565 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -60.03 -169.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.196 -0.94 . . . . 0.0 110.287 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.5 m -104.9 93.75 4.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.557 -0.714 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.38 84.3 1.76 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.71 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -135.67 52.33 6.68 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.952 . . . . 0.0 110.527 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 43' ' ' ALA . 44.5 Cg_endo -71.74 -168.73 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.246 1.129 . . . . 0.0 110.454 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -58.79 3.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.608 -0.683 . . . . 0.0 110.756 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 p -72.42 59.83 0.44 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.478 -0.764 . . . . 0.0 111.155 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.14 23.99 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 0.0 110.479 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.8 m-85 -119.69 -170.74 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.392 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.722 ' O ' HG12 ' A' ' 4' ' ' VAL . 16.5 tt0 -160.27 118.91 2.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.671 -0.643 . . . . 0.0 109.878 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 17.5 mtmm -62.18 163.45 8.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 0.0 109.926 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.98 -30.9 39.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.583 -0.698 . . . . 0.0 110.106 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.45 116.95 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.54 -0.725 . . . . 0.0 110.845 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.61 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.09 0.471 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -114.99 175.34 5.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.613 -0.68 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 17.3 m95 -136.58 106.66 6.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.504 -0.748 . . . . 0.0 109.207 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.793 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.9 p -86.23 151.07 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.683 0.754 . . . . 0.0 111.431 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -110.8 117.96 34.85 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -54.18 -21.62 9.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.364 -0.835 . . . . 0.0 111.475 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.21 -59.39 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.357 -0.839 . . . . 0.0 110.851 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -137.62 34.22 2.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.195 -0.94 . . . . 0.0 111.51 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.67 20.57 39.78 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 5' ' ' LEU . 26.9 t80 -60.95 129.25 40.47 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.107 . . . . 0.0 109.035 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.793 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.7 mm -113.76 164.51 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.838 0.828 . . . . 0.0 111.33 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.479 ' N ' HG22 ' A' ' 11' ' ' ILE . 33.3 t80 -135.7 112.52 10.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 10.1 p-10 -79.5 79.2 5.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.893 0.854 . . . . 0.0 109.166 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.28 -21.45 9.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.708 -0.62 . . . . 0.0 111.005 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.58 -30.69 71.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.323 -0.86 . . . . 0.0 108.87 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.87 -45.66 3.18 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.417 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 124.83 -107.79 1.04 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.25 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.422 -1.046 . . . . 0.0 109.456 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.383 1.202 . . . . 0.0 111.106 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -75.06 -45.7 39.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.936 . . . . 0.0 110.054 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.35 17.48 9.77 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.688 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.1 60.18 9.37 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 32' ' ' LEU . 41.4 mm -101.44 166.57 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.771 -0.841 . . . . 0.0 111.098 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.91 153.35 75.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.878 -0.514 . . . . 0.0 109.777 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.46 112.5 3.36 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.251 1.132 . . . . 0.0 110.236 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.52 66.24 1.81 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.8 m -114.44 118.36 33.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.777 -0.837 . . . . 0.0 110.042 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.5 mptt -59.22 123.68 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 38.7 t80 -48.2 -28.62 3.1 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.301 -0.874 . . . . 0.0 111.142 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.19 -20.11 52.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.547 -0.721 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.51 -15.18 27.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.355 -0.841 . . . . 0.0 111.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.631 HD21 HG23 ' A' ' 23' ' ' ILE . 7.0 mt -53.72 162.48 1.33 Allowed Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.031 -1.043 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HD3' HD23 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -93.69 -165.72 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 120.91 1.073 . . . . 0.0 110.932 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -80.11 176.39 9.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.354 0.597 . . . . 0.0 109.981 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 67.78 3.36 3.44 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.898 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.753 ' O ' HG13 ' A' ' 37' ' ' VAL . 23.2 t90 -96.92 125.62 41.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.84 -1.162 . . . . 0.0 109.384 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -172.24 -80.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.796 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -169.72 178.94 0.84 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.796 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -72.42 -22.49 21.48 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.309 1.163 . . . . 0.0 110.822 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 41' ' ' THR . 6.7 tp -159.4 -40.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.84 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 15.0 p -78.18 146.55 34.96 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.329 -0.857 . . . . 0.0 110.421 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.94 172.92 30.89 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.815 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -171.68 -52.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.996 . . . . 0.0 110.944 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -89.95 138.9 3.03 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 O-C-N 122.866 0.93 . . . . 0.0 110.291 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -58.88 -44.5 91.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.411 -0.806 . . . . 0.0 110.083 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 m -72.39 64.24 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.606 -0.684 . . . . 0.0 109.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -157.14 28.11 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.01 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 7.6 m-85 -117.92 -169.03 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.563 -0.711 . . . . 0.0 110.515 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.0 tp10 -159.33 123.11 3.79 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.706 -0.621 . . . . 0.0 109.427 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 20.9 mtpt -57.69 178.11 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.469 -0.769 . . . . 0.0 110.552 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.4 tt -95.28 -26.06 16.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.697 -0.627 . . . . 0.0 110.321 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.49 178.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.467 -0.77 . . . . 0.0 111.033 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.095 179.864 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -120.54 176.23 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.372 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.518 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.3 m95 -141.4 110.0 6.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.698 . . . . 0.0 109.435 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 49' ' ' GLU . 8.9 p -84.3 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.844 0.831 . . . . 0.0 111.511 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -111.42 117.41 33.0 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -58.04 -19.84 34.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.542 -0.724 . . . . 0.0 111.155 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.41 -48.71 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.854 . . . . 0.0 110.754 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -150.61 30.63 0.66 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.27 -0.893 . . . . 0.0 111.468 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.34 15.15 60.8 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.677 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' HD12 ' A' ' 5' ' ' LEU . 8.8 t80 -59.87 138.48 57.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.088 -1.242 . . . . 0.0 108.824 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.729 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -121.41 114.18 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.388 -0.82 . . . . 0.0 111.624 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 42.8 t80 -81.09 111.37 17.48 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -79.43 85.83 5.19 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.155 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.9 tt0 -51.43 -23.36 3.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.786 -0.571 . . . . 0.0 111.283 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.37 -29.95 71.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.317 -0.864 . . . . 0.0 108.947 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.89 -28.62 7.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.709 -0.619 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 99.06 -102.52 2.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -173.92 88.32 0.36 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.448 -1.031 . . . . 0.0 109.974 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.86 -19.01 58.79 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.421 1.222 . . . . 0.0 110.444 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -76.75 -29.96 56.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.782 . . . . 0.0 109.579 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.55 12.19 37.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.62 -0.675 . . . . 0.0 110.603 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.28 68.29 1.74 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 24' ' ' SER . 49.8 mm -123.31 167.09 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.687 -0.89 . . . . 0.0 111.138 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -61.0 143.08 92.39 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.925 -0.484 . . . . 0.0 110.504 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 114.53 3.97 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.263 1.138 . . . . 0.0 109.938 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.01 66.55 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.414 -1.875 . . . . 0.0 108.414 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 6.2 m -119.09 125.41 49.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.825 -0.809 . . . . 0.0 110.002 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 26.3 mtpt -60.8 119.21 7.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.605 -0.684 . . . . 0.0 109.746 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.518 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.8 t80 -51.11 -28.12 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.244 -0.91 . . . . 0.0 110.577 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.72 -2.98 41.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.653 -0.654 . . . . 0.0 110.895 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -112.93 -15.87 12.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.889 . . . . 0.0 111.053 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.529 HD13 ' CG ' ' A' ' 36' ' ' TRP . 5.6 mt -54.54 150.64 16.72 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.09 -1.006 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 49.4 Cg_endo -83.4 -175.75 2.48 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.285 1.15 . . . . 0.0 110.784 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.4 -16.51 61.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.722 -0.611 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.26 -13.39 49.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.529 ' CG ' HD13 ' A' ' 32' ' ' LEU . 24.6 t90 -101.9 121.86 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.705 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 10.5 p -162.39 121.64 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.465 -0.772 . . . . 0.0 110.455 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.822 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -74.81 -56.24 2.23 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.614 -0.679 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.822 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 46.4 Cg_endo -73.47 -164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.315 1.166 . . . . 0.0 110.422 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.4 pt -59.29 -165.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -56.78 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.482 -0.761 . . . . 0.0 110.786 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 -65.83 0.88 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.705 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . . . 51.54 62.95 10.22 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.494 -1.004 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 42.6 Cg_endo -92.22 121.01 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.171 1.09 . . . . 0.0 110.072 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -61.03 -19.07 60.92 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.551 -0.718 . . . . 0.0 110.774 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -78.76 0.24 27.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.491 -0.756 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -87.4 -24.84 24.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 7.3 m-85 -87.8 -170.32 2.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 0.0 110.425 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.86 ' O ' HG12 ' A' ' 4' ' ' VAL . 18.8 tt0 -160.3 121.9 3.14 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.686 -0.634 . . . . 0.0 109.642 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 34.0 mtmt -59.9 165.63 3.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -95.99 51.3 1.23 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.658 -0.651 . . . . 0.0 110.22 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -55.16 132.4 47.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 110.705 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 t0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.159 179.833 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.051 0.453 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.55 -164.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.625 -0.672 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CE3' ' CD2' ' A' ' 29' ' ' PHE . 8.0 m95 -138.53 117.1 12.12 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -121.78 152.29 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.015 -1.074 . . . . 0.0 113.281 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.571 HD11 ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -106.01 117.96 35.39 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.18 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -54.48 -21.4 9.85 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.566 -0.709 . . . . 0.0 111.812 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.424 ' HB ' HD22 ' A' ' 5' ' ' LEU . 76.8 mt -90.0 -61.09 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.247 -0.908 . . . . 0.0 110.984 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.4 p -80.18 -58.72 3.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.28 -0.887 . . . . 0.0 110.415 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.03 21.43 3.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.685 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.0 m-85 -55.98 164.18 1.28 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.991 -1.299 . . . . 0.0 109.515 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 10' ' ' TYR . 35.3 mm -150.47 79.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.803 -0.561 . . . . 0.0 109.618 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 57.0 t80 -79.9 107.89 13.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.821 -1.175 . . . . 0.0 108.914 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -79.61 90.09 5.14 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.4 tt0 -52.75 -23.23 6.36 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.98 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.99 -29.04 70.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.431 -0.793 . . . . 0.0 108.942 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.32 -43.8 3.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.687 -0.633 . . . . 0.0 109.417 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 113.37 -105.81 1.7 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -179.84 90.42 0.2 Allowed Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.405 -1.056 . . . . 0.0 109.706 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.89 -20.67 45.03 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.319 1.168 . . . . 0.0 110.67 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -80.05 -33.77 38.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.392 -0.817 . . . . 0.0 110.276 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.06 17.3 11.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.15 65.13 3.68 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -122.01 167.38 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.646 -0.914 . . . . 0.0 110.83 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.3 t -78.25 151.3 78.16 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.77 -0.581 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 119.3 6.01 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.399 1.21 . . . . 0.0 110.133 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.77 71.46 1.16 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 HD23 ' A' ' 32' ' ' LEU . 8.6 m -125.0 122.12 36.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.706 -0.879 . . . . 0.0 110.274 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 2.5 mptp? -58.19 113.92 2.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.59 -0.694 . . . . 0.0 110.151 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CD2' ' CE3' ' A' ' 3' ' ' TRP . 64.4 t80 -49.42 -31.72 10.28 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.37 -0.831 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.45 -12.18 60.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.548 -0.72 . . . . 0.0 110.611 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -127.85 19.41 6.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.66 HD23 HG21 ' A' ' 27' ' ' THR . 7.4 mt -62.65 171.03 1.97 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.324 -0.86 . . . . 0.0 109.39 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.8 Cg_endo -78.36 -174.89 2.44 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.216 1.114 . . . . 0.0 110.47 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.81 -15.54 56.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.565 -0.709 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -67.42 -11.28 57.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' C ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -103.99 96.48 6.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.045 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.637 HG13 ' C ' ' A' ' 43' ' ' ALA . 57.8 t -150.27 111.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.429 -0.794 . . . . 0.0 109.593 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . . . -59.08 113.13 6.16 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.147 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 -14.2 38.11 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.148 1.078 . . . . 0.0 111.251 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.76 151.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 96.1 m 56.22 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.712 -0.618 . . . . 0.0 111.226 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 47' ' ' GLU . . . -103.78 -141.22 11.09 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -178.24 -57.86 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.528 -0.983 . . . . 0.0 111.271 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 42.6 Cg_endo -69.42 -158.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 O-C-N 122.949 0.973 . . . . 0.0 111.071 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -89.58 -24.23 21.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.165 -0.96 . . . . 0.0 110.465 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -6.68 43.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.583 -0.698 . . . . 0.0 111.8 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.713 ' OE2' ' HB3' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -89.0 -21.73 23.36 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.049 -1.032 . . . . 0.0 110.915 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.7 m-85 -83.97 -170.74 3.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.261 -0.899 . . . . 0.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.12 119.42 2.79 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.485 -0.76 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 11.4 mtmt -55.29 165.63 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.5 tt -83.86 -23.41 31.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.692 -0.63 . . . . 0.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -22.79 7.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.332 -0.855 . . . . 0.0 111.22 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.7 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HG2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -82.06 159.63 23.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.735 -0.603 . . . . 0.0 110.7 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 12.4 m95 -130.78 110.09 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.746 -0.596 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 11' ' ' ILE . 10.8 p -88.58 142.33 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 110.98 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -97.81 103.27 15.2 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -53.46 -23.06 9.05 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.522 -0.736 . . . . 0.0 111.26 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 47' ' ' GLU . 63.1 mt -71.77 -20.45 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.83 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 7' ' ' ILE . 73.1 p -148.56 -48.46 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.146 -0.972 . . . . 0.0 111.136 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.76 -3.95 7.0 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.61 ' O ' HD13 ' A' ' 11' ' ' ILE . 9.6 t80 -51.75 155.29 1.73 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.324 . . . . 0.0 109.753 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' HA ' ' A' ' 4' ' ' VAL . 42.0 mm -132.83 124.18 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.77 . . . . 0.0 111.233 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 35.5 t80 -93.45 111.34 22.98 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.4 87.59 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.055 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -52.82 -22.35 5.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.782 -0.574 . . . . 0.0 111.156 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -31.65 72.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.313 -0.867 . . . . 0.0 108.883 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.71 -29.82 7.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.74 -0.6 . . . . 0.0 109.754 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 98.47 -104.62 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.65 88.99 0.32 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.429 -1.042 . . . . 0.0 109.947 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 -19.15 59.47 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.433 1.228 . . . . 0.0 110.382 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -80.04 -31.99 39.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.644 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -93.79 8.73 39.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.64 -0.662 . . . . 0.0 110.743 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.8 62.65 6.07 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CG2' HD21 ' A' ' 32' ' ' LEU . 49.2 mm -121.41 166.65 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.936 . . . . 0.0 110.729 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 23' ' ' ILE . 4.0 t -67.7 146.31 98.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.827 -0.546 . . . . 0.0 110.302 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.19 122.44 8.03 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.351 1.185 . . . . 0.0 110.091 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.58 67.04 1.74 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 1.9 m -122.09 126.99 49.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.772 -0.84 . . . . 0.0 109.949 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 6.9 mptt -61.08 119.64 8.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 43.3 t80 -49.69 -39.58 37.18 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.183 -0.948 . . . . 0.0 110.784 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.07 -17.37 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.587 -0.695 . . . . 0.0 110.291 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -91.16 -21.92 20.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.876 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 ' CG2' ' A' ' 23' ' ' ILE . 11.1 mt -54.94 151.43 16.01 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.21 -0.931 . . . . 0.0 109.911 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.71 178.88 6.14 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.272 1.143 . . . . 0.0 110.735 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -69.74 -18.02 63.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.659 -0.651 . . . . 0.0 110.528 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.7 -15.22 51.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.367 -0.833 . . . . 0.0 109.969 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.89 139.05 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 ' N ' ' A' ' 38' ' ' ALA . 8.8 p -168.34 166.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.749 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -110.67 178.21 1.05 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.665 -0.647 . . . . 0.0 110.072 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 43.8 Cg_endo -71.17 81.8 1.13 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.253 1.133 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 41' ' ' THR . 82.6 mt -135.47 169.04 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.646 -0.659 . . . . 0.0 109.577 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 40' ' ' ILE . 22.6 p -54.95 -77.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.0 -143.56 0.42 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -161.65 57.93 0.85 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.458 -1.025 . . . . 0.0 111.396 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 43.4 Cg_endo -97.34 102.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 N-CA-C 109.328 -1.066 . . . . 0.0 109.328 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -22.91 12.47 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.259 -0.901 . . . . 0.0 110.7 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.3 t -80.07 6.16 12.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.475 -0.765 . . . . 0.0 111.392 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG2' HD11 ' A' ' 7' ' ' ILE . 1.2 tp10 -80.9 4.85 17.96 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.018 -1.051 . . . . 0.0 111.268 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.3 m-85 -86.57 -169.83 2.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 110.854 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.04 119.0 6.21 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 7.7 mtmm -54.29 171.47 0.11 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 110.541 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 ' HG2' ' A' ' 2' ' ' LYS . 2.6 pp -79.78 -22.84 42.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.66 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -53.76 135.85 40.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.439 -0.788 . . . . 0.0 110.953 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.74 -179.73 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.029 0.442 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HE2' HG21 ' A' ' 11' ' ' ILE . 19.9 mtpt -128.45 177.03 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 11.1 m95 -141.26 108.18 5.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.579 -0.701 . . . . 0.0 109.452 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.789 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.0 p -84.17 148.31 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.741 0.781 . . . . 0.0 111.22 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -106.33 116.41 31.88 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -55.43 -21.12 14.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.506 -0.746 . . . . 0.0 111.347 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 5' ' ' LEU . 92.8 mt -65.72 -56.34 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 110.732 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 t -136.19 27.76 3.16 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.343 -0.848 . . . . 0.0 111.219 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.35 50.54 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -62.18 131.49 49.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.293 -1.121 . . . . 0.0 108.758 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.789 HD13 ' HA ' ' A' ' 4' ' ' VAL . 40.2 mm -112.81 118.19 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 111.446 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 31.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -79.31 83.09 5.38 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.766 0.793 . . . . 0.0 109.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.5 tt0 -53.36 -22.7 7.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.737 -0.602 . . . . 0.0 110.968 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 0.0 109.044 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.04 -37.07 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.489 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 111.41 -105.94 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.94 90.19 0.28 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.403 -1.057 . . . . 0.0 109.82 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.14 -16.08 53.33 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.403 1.212 . . . . 0.0 110.531 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.82 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -101.65 10.7 39.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.59 -0.694 . . . . 0.0 110.704 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.56 1.2 Allowed Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CG2' HD21 ' A' ' 32' ' ' LEU . 50.2 mm -122.67 163.38 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.939 . . . . 0.0 111.454 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.41 145.61 81.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.86 118.29 5.23 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.367 1.193 . . . . 0.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.65 64.97 1.97 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.8 m -117.07 126.85 53.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.842 -0.799 . . . . 0.0 109.673 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 11.7 mptt -61.28 123.73 18.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.551 -0.718 . . . . 0.0 109.624 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.5 t80 -48.99 -43.85 40.61 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.242 -0.912 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.8 -20.21 65.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.589 -0.694 . . . . 0.0 110.117 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -90.71 -15.54 30.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.438 -0.789 . . . . 0.0 111.333 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.726 HD23 ' HD3' ' A' ' 33' ' ' PRO . 5.6 mt -52.69 156.44 3.23 Favored Pre-proline 0 N--CA 1.506 2.341 0 O-C-N 121.028 -1.045 . . . . 0.0 109.686 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.726 ' HD3' HD23 ' A' ' 32' ' ' LEU . 49.4 Cg_endo -97.62 -165.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.154 1.236 . . . . 0.0 110.937 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.98 -179.2 2.64 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.17 1.85 2.99 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.379 -0.825 . . . . 0.0 111.916 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CD2' HD13 ' A' ' 32' ' ' LEU . 52.0 t90 -101.35 103.14 14.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.849 -1.157 . . . . 0.0 108.644 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.606 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 91.9 t -142.73 116.35 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.475 -0.766 . . . . 0.0 110.352 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -85.08 -50.14 0.56 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.152 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 51.0 Cg_endo -82.63 -163.67 0.23 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 O-C-N 123.239 1.126 . . . . 0.0 109.993 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.533 ' O ' HG23 ' A' ' 40' ' ' ILE . 3.2 tt -114.06 67.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 110.308 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 41' ' ' THR . 7.7 t -161.25 58.85 0.29 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 37' ' ' VAL . . . 61.48 -155.8 36.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . . . -130.37 71.4 82.29 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.452 -1.028 . . . . 0.0 110.236 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -93.58 114.62 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.154 1.081 . . . . 0.0 110.222 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -59.48 -24.85 63.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.565 -0.709 . . . . 0.0 110.355 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -8.52 54.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.743 -0.598 . . . . 0.0 110.781 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.91 -20.86 44.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CG ' ' CZ ' ' A' ' 29' ' ' PHE . 8.4 m-85 -95.05 -168.58 1.83 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.775 . . . . 0.0 110.673 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.6 tt0 -158.84 123.23 4.04 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.733 -0.604 . . . . 0.0 109.371 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 1.2 mtmm -56.3 165.58 1.03 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.577 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -82.84 -27.76 30.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 110.182 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -26.29 36.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.518 -0.739 . . . . 0.0 110.895 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.851 -179.982 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.021 0.438 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.98 175.43 10.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 110.48 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 12.0 m95 -141.14 124.68 16.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 11.5 p -119.8 147.29 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.075 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.619 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.3 tt -103.5 119.72 39.45 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.107 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -57.26 -38.89 74.56 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.369 -0.832 . . . . 0.0 111.119 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.619 ' HB ' HD22 ' A' ' 5' ' ' LEU . 80.5 mt -64.57 -50.26 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.549 -0.719 . . . . 0.0 111.15 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.508 HG21 ' OH ' ' A' ' 10' ' ' TYR . 22.0 p -101.51 -57.25 2.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.219 -0.925 . . . . 0.0 110.606 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.94 25.78 3.5 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.736 ' O ' HD13 ' A' ' 11' ' ' ILE . 24.0 m-85 -60.31 170.2 1.4 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.13 -1.217 . . . . 0.0 109.586 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 10' ' ' TYR . 26.9 mm -147.74 89.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 55.0 t80 -79.76 111.71 16.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.877 -1.139 . . . . 0.0 108.8 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -79.47 85.07 5.28 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.686 0.755 . . . . 0.0 109.287 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 6.5 tt0 -53.49 -22.32 7.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.66 -31.7 72.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 108.898 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.07 -53.74 2.61 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.445 0.64 . . . . 0.0 109.311 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 130.05 -108.54 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.33 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.411 -1.052 . . . . 0.0 109.283 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.6 -12.7 36.28 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.414 1.218 . . . . 0.0 111.135 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -77.63 -44.78 27.08 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.19 16.04 10.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.436 -0.79 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.74 40.16 88.35 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CD1' ' A' ' 36' ' ' TRP . 38.3 mm -81.75 161.27 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.663 -0.904 . . . . 0.0 110.365 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 156.78 79.41 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.757 -0.589 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 112.32 3.28 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.272 1.143 . . . . 0.0 110.026 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.93 67.77 1.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -120.32 121.13 37.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.733 -0.863 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -57.2 119.36 6.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.744 . . . . 0.0 109.815 179.045 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 34.9 t80 -49.64 -29.16 6.8 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.224 -0.923 . . . . 0.0 110.961 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.87 -18.03 59.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.527 -0.733 . . . . 0.0 110.508 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -92.66 -19.69 21.61 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 111.001 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD21 HG23 ' A' ' 23' ' ' ILE . 7.8 mt -55.32 166.79 0.82 Allowed Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.192 -0.942 . . . . 0.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' HD22 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -78.72 154.63 26.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.284 1.149 . . . . 0.0 110.653 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -65.04 -16.65 63.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.637 -0.665 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.06 -7.68 48.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 110.235 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.822 ' CD1' HD11 ' A' ' 23' ' ' ILE . 40.6 t90 -71.06 132.55 45.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 43' ' ' ALA . 81.4 t -149.98 137.19 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.463 -0.773 . . . . 0.0 108.928 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -84.6 -48.49 0.65 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.675 -0.641 . . . . 0.0 111.939 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -74.66 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.055 1.029 . . . . 0.0 110.871 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -136.9 -67.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.049 -1.032 . . . . 0.0 110.075 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -151.24 36.27 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.34 57.95 0.47 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -160.85 55.4 0.65 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.638 -0.919 . . . . 0.0 110.221 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -163.05 0.1 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.381 1.2 . . . . 0.0 110.263 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -56.85 -36.51 70.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.393 -0.817 . . . . 0.0 110.276 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.85 60.35 3.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.253 0.549 . . . . 0.0 109.758 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -159.34 -41.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 110.422 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 2.7 m-85 -79.44 -174.24 4.12 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.566 -0.709 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.11 114.81 2.28 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.638 -0.664 . . . . 0.0 109.651 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' CD ' ' HG2' ' A' ' 52' ' ' GLU . 8.7 ptpt -58.37 163.6 2.97 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.534 -0.729 . . . . 0.0 110.19 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -86.34 -29.9 22.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.643 -0.661 . . . . 0.0 110.208 -179.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.419 ' HG2' ' CD ' ' A' ' 50' ' ' LYS . 4.3 mm-40 48.41 -169.53 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 0.0 111.413 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.674 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -104.8 -166.87 1.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 11.6 m95 -141.47 121.03 13.3 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 10.3 p -120.88 152.42 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.058 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD22 ' HB ' ' A' ' 7' ' ' ILE . 1.4 tt -110.3 118.32 36.01 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.324 178.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -53.43 -39.6 64.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.428 -0.795 . . . . 0.0 111.43 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 5' ' ' LEU . 49.7 mm -65.53 -59.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.782 . . . . 0.0 110.908 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 9' ' ' GLY . 23.5 p -89.51 -58.2 2.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.322 -0.861 . . . . 0.0 110.678 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' A' ' 8' ' ' THR . . . 116.01 25.05 3.7 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.7 m-85 -56.97 168.76 0.6 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.133 -1.216 . . . . 0.0 109.44 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 10' ' ' TYR . 33.7 mm -149.34 79.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 32' ' ' LEU . 70.6 t80 -79.89 108.29 13.35 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.771 -1.205 . . . . 0.0 108.716 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.45 84.64 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 5.5 tt0 -49.92 -24.67 2.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.26 -30.0 71.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.803 . . . . 0.0 109.028 178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.54 -29.4 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 97.62 -102.94 2.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.99 89.25 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.429 -1.042 . . . . 0.0 109.761 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.14 -23.14 46.13 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.34 1.179 . . . . 0.0 110.488 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.95 -31.11 39.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.424 -0.798 . . . . 0.0 110.0 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.11 16.82 15.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.485 -0.76 . . . . 0.0 110.523 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.59 63.2 5.43 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 24' ' ' SER . 47.0 mm -121.53 167.07 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.69 -0.888 . . . . 0.0 111.183 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -73.68 148.61 87.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.964 -0.46 . . . . 0.0 110.512 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 110.98 3.21 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.475 1.25 . . . . 0.0 109.997 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.71 1.37 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.428 HG22 ' HG ' ' A' ' 32' ' ' LEU . 17.9 m -121.39 126.06 48.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.787 -0.831 . . . . 0.0 110.084 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 5.3 mptt -60.77 121.09 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 48' ' ' PHE . 58.7 t80 -47.39 -50.43 22.5 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.349 -0.844 . . . . 0.0 111.016 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 4.6 mm-40 -61.85 -17.29 55.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.632 -0.668 . . . . 0.0 110.55 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.66 -12.55 23.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.24 -0.912 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -55.43 160.39 3.74 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.056 -1.028 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 49.8 Cg_endo -82.32 -176.52 3.0 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.213 1.112 . . . . 0.0 110.512 -179.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.43 -16.24 62.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 0.0 110.582 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.73 -14.52 53.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.109 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.465 ' CG ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -107.24 116.81 32.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 109.817 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 38' ' ' ALA . 8.5 p -169.44 167.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 37' ' ' VAL . . . -114.34 137.76 22.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 110.338 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.79 93.87 1.0 Allowed 'Trans proline' 0 N--CA 1.485 1.01 0 O-C-N 123.25 1.131 . . . . 0.0 110.519 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.4 mt -126.3 -65.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.3 p -150.36 36.34 0.66 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.67 . . . . 0.0 109.805 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.33 -120.45 2.09 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -170.91 64.23 0.42 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.562 -0.964 . . . . 0.0 110.38 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -93.07 123.08 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.128 1.068 . . . . 0.0 109.855 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -58.57 -33.15 69.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.346 -0.846 . . . . 0.0 110.03 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 p -80.34 50.19 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.759 -0.588 . . . . 0.0 110.738 179.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.54 -27.77 7.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' CD2' ' A' ' 10' ' ' TYR . 2.4 m-85 -79.86 -168.73 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.691 . . . . 0.0 110.537 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.31 115.93 2.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.639 -0.663 . . . . 0.0 109.402 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -62.06 163.67 7.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.431 -0.793 . . . . 0.0 110.07 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -45.28 19.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 110.04 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 32.67 56.91 0.42 Allowed 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.77 -179.808 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 14' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -89.54 155.05 19.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.535 -0.728 . . . . 0.0 110.787 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.779 ' O ' HG23 ' A' ' 11' ' ' ILE . 31.4 m95 -129.6 158.6 38.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD13 ' A' ' 11' ' ' ILE . 11.1 p -132.32 144.52 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.209 -0.932 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.692 HD22 HG12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -104.49 120.77 42.01 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -56.28 -20.43 18.65 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.429 -0.795 . . . . 0.0 110.969 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.692 HG12 HD22 ' A' ' 5' ' ' LEU . 45.3 mm -55.09 -66.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.309 -0.87 . . . . 0.0 110.965 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -143.33 31.91 1.35 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.192 -0.943 . . . . 0.0 111.754 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.34 17.19 79.68 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.84 179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.674 ' HD2' HD12 ' A' ' 5' ' ' LEU . 32.6 t80 -61.58 129.57 41.72 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.079 -1.248 . . . . 0.0 108.5 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 3' ' ' TRP . 30.9 mm -118.58 147.42 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.13 -0.981 . . . . 0.0 112.511 -177.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 33.6 t80 -108.93 107.94 18.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -79.61 83.26 5.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.9 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 1.6 tt0 -58.1 -17.65 19.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.883 -0.51 . . . . 0.0 110.871 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.17 -30.37 71.01 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.097 -1.002 . . . . 0.0 108.616 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.87 -41.52 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 125.82 -106.46 0.87 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.31 93.61 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.322 -1.105 . . . . 0.0 109.167 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.4 -14.79 46.79 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.387 1.204 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.0 -33.28 39.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.28 -0.888 . . . . 0.0 109.677 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -101.96 13.8 33.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.59 -0.694 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.71 71.9 0.67 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' CD2' ' A' ' 32' ' ' LEU . 43.1 mm -116.52 162.33 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.545 -0.974 . . . . 0.0 110.855 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.06 170.67 14.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.873 -0.517 . . . . 0.0 110.034 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.03 112.3 3.09 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.34 1.179 . . . . 0.0 109.195 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.16 -98.1 2.22 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 -178.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.604 HG21 HD21 ' A' ' 32' ' ' LEU . 54.2 m 55.52 101.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.695 -0.885 . . . . 0.0 110.674 178.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 19.2 mttt -63.18 130.85 46.36 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.202 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 23.3 t80 -48.41 -30.4 5.0 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.139 -0.976 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -75.57 -18.6 59.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.475 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.43 -16.47 22.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 111.127 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 23' ' ' ILE . 12.7 mt -54.36 165.22 0.89 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.042 -1.037 . . . . 0.0 110.061 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.42 175.77 9.29 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.238 1.125 . . . . 0.0 110.885 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.86 -4.15 53.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.649 -0.657 . . . . 0.0 110.865 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.36 21.28 6.23 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' HD11 ' A' ' 23' ' ' ILE . 71.3 t90 -92.25 117.43 29.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.863 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.86 139.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.597 -0.689 . . . . 0.0 110.017 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.658 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . . . -94.83 105.1 16.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.686 -0.634 . . . . 0.0 110.127 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.96 -30.22 21.71 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.304 1.16 . . . . 0.0 110.15 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 40' ' ' ILE . 1.1 pp -75.19 73.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 109.898 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m 54.72 70.78 0.58 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.429 -0.794 . . . . 0.0 110.524 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.658 ' HA3' ' HB3' ' A' ' 38' ' ' ALA . . . -146.46 -135.56 2.76 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -168.15 173.64 2.63 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.614 -0.933 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 50.3 Cg_endo -77.32 -166.02 0.36 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.505 1.266 . . . . 0.0 110.823 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -66.65 -46.64 75.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.713 -0.617 . . . . 0.0 110.233 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -71.45 64.75 0.42 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HG3' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -160.13 -34.84 0.06 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.537 -0.727 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -78.84 165.11 23.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.253 -0.905 . . . . 0.0 111.401 -179.096 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' CZ3' ' A' ' 3' ' ' TRP . 2.2 tt0 -160.13 126.53 4.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HG3' ' CZ2' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.86 148.72 2.09 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.3 -0.875 . . . . 0.0 111.213 -179.152 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 51' ' ' LEU . 7.5 tt -79.91 -10.33 59.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.683 -0.636 . . . . 0.0 111.129 -179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.73 140.55 18.78 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.113 -0.992 . . . . 0.0 111.013 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 t70 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.868 -179.701 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.143 0.496 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -129.57 -178.87 4.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.699 . . . . 0.0 110.283 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.513 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.6 m95 -137.58 108.13 6.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.755 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.5 p -86.04 148.35 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.758 0.789 . . . . 0.0 111.311 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -107.49 119.06 38.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.474 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -53.24 -21.95 6.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 111.312 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.25 -68.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 41' ' ' THR . 7.4 t -130.94 37.41 3.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.283 -0.885 . . . . 0.0 111.72 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.79 36.56 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 5' ' ' LEU . 40.7 t80 -61.24 130.39 45.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.331 -1.1 . . . . 0.0 108.962 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.786 HD13 ' HA ' ' A' ' 4' ' ' VAL . 44.9 mm -115.4 164.69 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.003 0.906 . . . . 0.0 111.728 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 11' ' ' ILE . 27.7 t80 -133.26 113.08 12.23 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.882 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 12.4 p-10 -79.32 77.05 5.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.843 0.83 . . . . 0.0 108.981 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -52.22 -22.67 4.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.855 -0.528 . . . . 0.0 111.198 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.72 -31.05 72.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.898 . . . . 0.0 108.975 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.882 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.63 -30.81 6.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.25 0.548 . . . . 0.0 109.784 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 106.49 -106.5 2.55 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.98 88.18 0.35 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.484 -1.009 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.07 -24.08 52.69 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.412 1.217 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -31.9 57.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.757 . . . . 0.0 109.327 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -95.62 5.81 50.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.665 -0.647 . . . . 0.0 110.57 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.98 3.18 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 32' ' ' LEU . 48.9 mm -123.04 166.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.683 -0.892 . . . . 0.0 111.438 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 23' ' ' ILE . 3.2 t -60.86 143.12 91.81 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 122.014 -0.429 . . . . 0.0 110.145 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 122.24 7.44 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.321 1.169 . . . . 0.0 110.147 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.89 67.04 1.81 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.2 m -118.73 119.99 36.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.77 -0.841 . . . . 0.0 110.309 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -58.4 125.76 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.524 -0.735 . . . . 0.0 109.629 179.055 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.513 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 55.1 t80 -46.84 -29.31 1.91 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.357 -0.839 . . . . 0.0 111.452 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -20.31 58.99 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.501 -0.749 . . . . 0.0 110.552 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.41 -24.63 25.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD13 ' CD2' ' A' ' 36' ' ' TRP . 10.8 mt -55.79 138.5 70.74 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.335 -0.853 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.67 -179.27 5.03 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.148 1.078 . . . . 0.0 110.796 -179.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -16.2 59.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 110.65 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.69 -9.19 48.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.241 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.701 ' CD2' HD13 ' A' ' 32' ' ' LEU . 14.5 t90 -113.01 120.75 42.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.631 HG11 ' O ' ' A' ' 43' ' ' ALA . 65.2 t -149.62 -73.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.474 -0.766 . . . . 0.0 109.667 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -168.77 170.12 4.31 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.746 . . . . 0.0 110.094 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 46.2 Cg_endo -72.97 -51.43 0.17 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.369 1.194 . . . . 0.0 110.495 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.581 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.1 tp -168.52 69.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.505 -0.747 . . . . 0.0 110.129 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 40' ' ' ILE . 9.3 p -153.3 -56.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.83 -140.94 11.4 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -172.77 -50.52 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.635 -0.92 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 44.5 Cg_endo -94.93 116.6 0.21 Allowed 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 120.705 0.937 . . . . 0.0 109.835 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -18.6 37.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.462 -0.774 . . . . 0.0 110.942 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 0.97 24.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.334 -0.854 . . . . 0.0 111.196 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 2.6 tt0 -98.9 26.85 5.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CE1' ' HG ' ' A' ' 5' ' ' LEU . 6.2 m-85 -96.67 -169.29 1.86 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 110.652 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 4' ' ' VAL . 2.4 tm-20 -155.97 122.44 5.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -57.5 174.91 0.19 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.399 -0.813 . . . . 0.0 110.408 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tp -79.99 -32.35 39.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.688 -0.632 . . . . 0.0 109.936 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 49.57 -167.7 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.466 -0.771 . . . . 0.0 111.174 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.674 -179.732 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.111 0.481 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.76 179.8 4.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.522 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 14.9 m95 -139.08 107.67 5.88 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.632 -0.668 . . . . 0.0 109.378 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.769 ' HA ' HD13 ' A' ' 11' ' ' ILE . 9.2 p -88.67 143.72 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.956 -179.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -95.55 112.75 24.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -54.66 -21.45 10.67 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.414 -0.804 . . . . 0.0 111.384 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.613 HG21 ' CG2' ' A' ' 41' ' ' THR . 97.6 mt -60.02 -63.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.324 -0.86 . . . . 0.0 110.413 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -122.02 -22.4 5.69 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.374 -0.829 . . . . 0.0 111.549 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.85 18.02 7.61 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.96 140.44 58.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.33 -1.1 . . . . 0.0 108.703 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.769 HD13 ' HA ' ' A' ' 4' ' ' VAL . 39.3 mm -118.53 149.06 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.444 -178.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' A' ' 17' ' ' GLY . 27.3 t80 -119.18 112.7 19.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 11.6 p-10 -79.5 82.84 5.57 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.692 0.758 . . . . 0.0 109.311 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 1.6 tt0 -58.02 -18.48 24.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.66 -0.65 . . . . 0.0 110.795 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.13 -31.33 72.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 0.0 108.698 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -112.19 -46.23 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 128.81 -108.0 0.87 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.42 94.3 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.377 -1.072 . . . . 0.0 109.297 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.07 -11.93 33.24 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.457 1.241 . . . . 0.0 111.217 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -74.82 -36.76 62.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.171 -0.956 . . . . 0.0 110.123 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -105.13 16.96 24.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.8 68.11 1.86 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 42.7 mm -106.29 165.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.662 -0.905 . . . . 0.0 110.938 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.92 165.93 44.02 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.913 -0.492 . . . . 0.0 110.222 -179.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.8 111.29 2.57 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.332 1.175 . . . . 0.0 109.233 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.71 -96.94 1.88 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 -178.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 51.9 m 55.08 102.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.741 -0.858 . . . . 0.0 110.688 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 9.9 mttt -63.0 131.86 50.05 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.104 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 48.6 t80 -48.75 -42.11 34.34 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.001 -1.062 . . . . 0.0 111.02 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 17.0 mt-10 -72.13 -8.59 55.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.508 -0.745 . . . . 0.0 110.625 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -105.14 -12.73 15.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' A' ' 23' ' ' ILE . 6.6 mt -52.27 168.91 0.28 Allowed Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.037 -1.04 . . . . 0.0 109.316 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD3' HD23 ' A' ' 32' ' ' LEU . 48.6 Cg_endo -89.37 -167.29 0.27 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 122.953 0.975 . . . . 0.0 110.756 -178.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.54 169.66 13.36 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.321 0.581 . . . . 0.0 110.002 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t0 65.2 8.28 4.74 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.514 -0.741 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CD1' HD11 ' A' ' 23' ' ' ILE . 91.6 t90 -71.92 -75.78 0.12 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 109.175 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 78.3 t 43.69 -94.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.952 -0.467 . . . . 0.0 111.457 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -178.07 178.56 0.37 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.91 -1.119 . . . . 0.0 109.911 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.772 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 44.7 Cg_endo -72.13 -31.88 11.49 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.206 1.108 . . . . 0.0 110.21 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 pt -142.34 154.3 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 109.988 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.613 ' CG2' HG21 ' A' ' 7' ' ' ILE . 3.1 m 55.45 174.45 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.471 -0.768 . . . . 0.0 110.504 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' H ' HG22 ' A' ' 41' ' ' THR . . . 70.89 165.93 6.38 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.761 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -177.8 -49.55 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.428 -1.042 . . . . 0.0 110.878 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.761 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 46.0 Cg_endo -92.79 133.1 1.04 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.008 1.004 . . . . 0.0 110.211 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -40.99 88.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.292 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.7 61.31 1.82 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.677 -0.64 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.08 23.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 110.214 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 9.4 m-85 -114.75 -168.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.832 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.1 tp10 -160.0 123.76 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.747 -0.596 . . . . 0.0 109.69 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.5 mtmt -60.22 166.13 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 0.0 110.256 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -82.4 -25.9 33.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.704 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.17 177.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.385 -0.822 . . . . 0.0 110.836 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.645 -179.754 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.29 173.91 6.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.552 -0.717 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' TYR . 10.9 m95 -139.04 107.05 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.659 ' HA ' HD13 ' A' ' 11' ' ' ILE . 7.9 p -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.026 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.461 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -98.43 106.29 18.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.14 -19.34 19.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.762 . . . . 0.0 111.472 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.3 mp -89.15 -9.59 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 111.653 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.421 HG21 ' HB3' ' A' ' 39' ' ' PRO . 12.6 p -149.33 -47.84 0.14 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.989 -1.069 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.54 -15.1 9.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -51.71 117.75 2.91 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.117 -1.226 . . . . 0.0 109.584 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 4' ' ' VAL . 32.8 mm -100.76 140.2 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.527 -0.733 . . . . 0.0 111.332 -178.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 36.4 t80 -104.91 110.95 23.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.21 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.919 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 6.0 p-10 -79.4 78.73 5.9 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.74 0.781 . . . . 0.0 109.26 -179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 tt0 -51.52 -22.67 3.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.782 -0.574 . . . . 0.0 111.255 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.71 -29.65 70.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.234 -0.916 . . . . 0.0 108.997 178.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.919 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -116.66 -41.66 3.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.74 -0.6 . . . . 0.0 109.516 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 131.69 -109.17 0.85 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.37 91.45 0.18 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.411 -1.052 . . . . 0.0 109.806 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.41 -13.88 41.77 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.337 1.178 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -80.19 -41.03 26.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -95.57 12.2 30.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.519 -0.738 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.55 73.23 0.43 Allowed Glycine 0 N--CA 1.502 3.085 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.606 ' CG2' HD21 ' A' ' 32' ' ' LEU . 44.2 mm -120.52 166.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.697 -0.884 . . . . 0.0 111.49 -177.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -63.97 141.3 98.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.46 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 47.0 Cg_endo -72.48 107.78 2.37 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.154 1.081 . . . . 0.0 110.671 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.1 63.99 1.3 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -123.34 134.85 53.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.759 -0.848 . . . . 0.0 110.122 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -70.88 132.27 45.0 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 13.3 t80 -47.97 -38.52 17.01 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.184 -0.947 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -67.92 -22.43 65.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.545 -0.722 . . . . 0.0 110.136 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.66 -19.96 30.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.535 -0.728 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' CD2' ' A' ' 36' ' ' TRP . 7.0 mt -52.53 158.1 2.22 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.085 -1.009 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD3' HD23 ' A' ' 32' ' ' LEU . 45.3 Cg_endo -93.59 -170.73 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.098 1.052 . . . . 0.0 110.436 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -76.76 174.87 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.651 -0.655 . . . . 0.0 109.902 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 66.34 7.07 4.66 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.399 -0.813 . . . . 0.0 111.801 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.622 ' CD2' HD13 ' A' ' 32' ' ' LEU . 91.0 t90 -86.54 4.21 40.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.931 -1.106 . . . . 0.0 110.392 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG11 ' HB1' ' A' ' 43' ' ' ALA . 33.8 m -62.84 -156.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.06 -1.025 . . . . 0.0 109.787 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.748 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -171.22 -60.46 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.372 -0.83 . . . . 0.0 110.254 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 45.2 Cg_endo -71.19 -177.58 2.41 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.022 1.011 . . . . 0.0 109.606 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 41' ' ' THR . 61.5 mt -77.67 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.35 -0.844 . . . . 0.0 109.282 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.416 ' N ' HG22 ' A' ' 40' ' ' ILE . 71.1 p 42.12 39.22 1.31 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 120.94 -1.1 . . . . 0.0 112.062 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.23 -147.83 50.34 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' N ' ' HD3' ' A' ' 44' ' ' PRO . . . -147.39 58.74 4.31 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.386 -1.067 . . . . 0.0 110.926 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 43' ' ' ALA . 53.3 Cg_endo -86.55 142.28 6.95 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.064 1.034 . . . . 0.0 110.164 179.57 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -42.36 94.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.458 -0.777 . . . . 0.0 110.065 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.8 m -75.65 59.81 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.712 -0.617 . . . . 0.0 110.483 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -118.12 -29.35 5.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 0.0 110.174 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CZ ' ' CD1' ' A' ' 5' ' ' LEU . 8.0 m-85 -83.53 -169.18 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.595 -0.691 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -160.03 118.41 2.69 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.391 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 15.4 mtmt -55.06 171.12 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.391 -0.818 . . . . 0.0 110.71 -179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.8 tt -80.04 -26.97 39.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.703 -0.623 . . . . 0.0 110.341 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -54.23 -29.75 47.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.465 -0.772 . . . . 0.0 110.997 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.759 -179.901 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.023 0.439 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -90.8 175.39 7.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.506 ' CD2' ' CG ' ' A' ' 29' ' ' PHE . 11.1 m95 -141.63 98.79 3.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.545 -0.722 . . . . 0.0 109.633 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -89.32 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.656 0.741 . . . . 0.0 111.224 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -99.65 101.98 13.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.391 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -57.79 -19.65 29.86 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.502 -0.749 . . . . 0.0 110.95 -179.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.495 HG22 HG21 ' A' ' 41' ' ' THR . 83.1 mt -71.22 -19.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.303 -0.873 . . . . 0.0 111.059 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 10' ' ' TYR . 5.7 t -154.14 -34.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.141 -0.974 . . . . 0.0 112.394 -179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.55 -17.09 6.54 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.442 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.595 ' H ' HG23 ' A' ' 8' ' ' THR . 33.5 t80 -51.05 150.01 3.34 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.096 -1.237 . . . . 0.0 109.871 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 12' ' ' TYR . 45.0 mt -136.01 167.14 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.042 0.925 . . . . 0.0 111.789 -179.218 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.55 ' N ' HG22 ' A' ' 11' ' ' ILE . 46.0 t80 -135.82 106.81 6.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -79.24 86.89 4.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 3.3 tt0 -47.55 -25.88 1.26 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 0.0 111.697 -178.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.0 -29.72 70.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.394 -0.816 . . . . 0.0 109.179 178.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.23 -25.28 9.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.663 -0.648 . . . . 0.0 110.241 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 101.83 -105.61 2.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.62 87.07 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.46 -1.023 . . . . 0.0 109.912 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.11 -28.73 40.73 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.428 1.225 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.1 -32.15 72.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.605 -0.684 . . . . 0.0 109.191 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.91 6.39 36.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.699 -0.626 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.0 66.73 2.51 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' SER . 44.6 mm -118.99 167.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.175 0.988 . . . . 0.0 112.683 -176.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.0 t -48.04 121.01 8.5 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.699 179.053 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 131.13 18.17 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.179 1.094 . . . . 0.0 111.217 -179.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.78 59.7 8.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 32' ' ' LEU . 1.8 m -123.42 132.74 54.04 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.827 -0.808 . . . . 0.0 110.289 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.9 mttt -62.16 126.99 29.27 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.836 179.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 3' ' ' TRP . 7.8 t80 -48.89 -27.01 2.77 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.43 -0.794 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -91.34 7.9 38.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -0.752 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -142.62 17.95 2.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 111.4 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 36' ' ' TRP . 1.1 pt? -80.57 -163.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.093 -1.004 . . . . 0.0 108.866 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 41.6 Cg_endo -89.66 143.02 4.27 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 122.457 0.714 . . . . 0.0 110.539 -177.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -52.93 171.69 0.06 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.691 -0.631 . . . . 0.0 110.432 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 t70 72.88 -6.43 1.68 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.811 -0.556 . . . . 0.0 112.257 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.801 ' CG ' HD11 ' A' ' 32' ' ' LEU . 86.4 t90 -77.09 114.55 16.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.626 -1.296 . . . . 0.0 109.621 179.153 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 36' ' ' TRP . 4.1 m -153.78 -112.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.682 -0.636 . . . . 0.0 109.585 179.434 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.78 146.83 6.79 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.524 -1.36 . . . . 0.0 110.135 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.92 -30.49 11.07 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.351 1.185 . . . . 0.0 110.475 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.64 -57.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.632 -0.668 . . . . 0.0 109.877 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 41' ' ' THR . 6.7 t -161.52 82.31 0.6 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.629 -0.669 . . . . 0.0 110.412 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.14 153.39 25.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -176.64 -51.28 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.544 -0.974 . . . . 0.0 110.705 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 50.9 Cg_endo -89.68 155.49 5.18 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 O-C-N 123.091 1.048 . . . . 0.0 110.58 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.56 -46.53 46.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.67 -0.644 . . . . 0.0 110.358 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -76.76 59.44 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.552 -0.717 . . . . 0.0 110.644 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.67 -29.81 3.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.374 -0.829 . . . . 0.0 110.795 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 7.2 m-85 -79.91 -167.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.4 -0.813 . . . . 0.0 110.263 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.22 123.24 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.715 -0.616 . . . . 0.0 109.526 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' CZ2' ' A' ' 3' ' ' TRP . 4.0 mtmt -55.35 167.5 0.47 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.586 -0.696 . . . . 0.0 110.898 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 51' ' ' LEU . 3.1 tt -83.22 -25.49 31.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.659 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -54.61 166.68 0.43 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.46 -0.775 . . . . 0.0 110.832 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.696 -179.907 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.154 0.502 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 11' ' ' ILE . 9.7 mttp -123.13 172.47 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 110.256 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.502 ' CE3' ' CD1' ' A' ' 29' ' ' PHE . 13.7 m95 -138.05 109.81 7.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 109.417 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.777 ' HA ' HD13 ' A' ' 11' ' ' ILE . 8.8 p -83.47 150.23 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.896 0.855 . . . . 0.0 111.384 -179.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -110.02 118.0 35.26 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.749 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -19.96 22.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.414 -0.804 . . . . 0.0 111.126 -179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.47 -58.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.835 . . . . 0.0 110.653 -179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 t -137.85 26.98 2.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.299 -0.876 . . . . 0.0 111.373 -179.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.17 65.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' HD12 ' A' ' 5' ' ' LEU . 7.9 t80 -61.0 136.27 58.04 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -1.202 . . . . 0.0 108.791 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.777 HD13 ' HA ' ' A' ' 4' ' ' VAL . 38.4 mm -119.84 127.41 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.409 -0.807 . . . . 0.0 111.551 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 29.0 t80 -94.55 113.57 25.42 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.5 82.44 5.63 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.388 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 28' ' ' LYS . 2.0 tt0 -54.61 -21.13 9.56 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.874 -0.516 . . . . 0.0 111.06 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.37 -32.97 74.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.305 -0.872 . . . . 0.0 108.975 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.67 -43.3 4.08 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.546 0.689 . . . . 0.0 109.322 179.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 12' ' ' TYR . . . 123.69 -108.27 1.16 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.99 94.38 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.359 -1.083 . . . . 0.0 109.243 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.93 -13.06 38.09 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.438 1.231 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -77.52 -40.02 44.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.204 -0.935 . . . . 0.0 109.949 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -97.94 16.57 20.53 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.596 -0.69 . . . . 0.0 110.674 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 58.0 16.7 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.678 HD12 HD21 ' A' ' 32' ' ' LEU . 44.8 mm -100.43 157.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.97 . . . . 0.0 110.63 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -74.2 158.22 85.77 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.873 -0.517 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.57 109.52 2.65 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.299 1.157 . . . . 0.0 110.31 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.34 79.89 0.74 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.6 m -132.49 119.49 20.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.749 -0.854 . . . . 0.0 110.116 -179.156 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 10.2 mttt -55.38 121.57 9.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.477 -0.764 . . . . 0.0 110.04 179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CD1' ' CE3' ' A' ' 3' ' ' TRP . 63.0 t80 -46.79 -46.36 20.57 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.396 -0.815 . . . . 0.0 111.269 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mt-10 -63.72 -18.83 64.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.475 -0.766 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -87.79 -21.13 25.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.678 HD21 HD12 ' A' ' 23' ' ' ILE . 9.3 mt -56.35 163.7 2.34 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 121.114 -0.991 . . . . 0.0 109.829 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 46.7 Cg_endo -73.43 163.12 38.52 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.148 1.078 . . . . 0.0 110.977 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.49 -18.62 61.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.632 -0.667 . . . . 0.0 110.622 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -75.68 -2.02 27.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.361 -0.837 . . . . 0.0 110.336 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.659 ' CD1' HD11 ' A' ' 23' ' ' ILE . 37.4 t90 -75.6 134.5 40.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.099 -1.001 . . . . 0.0 109.814 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 p -174.51 136.28 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.489 -0.757 . . . . 0.0 109.693 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.801 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . . . -81.93 134.99 48.89 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.487 -0.758 . . . . 0.0 110.069 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.33 -173.29 1.41 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.128 1.068 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.6 mt 55.61 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.587 -0.696 . . . . 0.0 110.715 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 41' ' ' THR . 7.2 t -126.73 64.11 1.28 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.801 ' HA3' ' HB3' ' A' ' 38' ' ' ALA . . . -116.54 -157.05 10.86 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.556 ' HB3' HD21 ' A' ' 5' ' ' LEU . . . -163.78 165.58 13.54 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.563 -0.963 . . . . 0.0 110.174 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 43.9 Cg_endo -69.88 -166.0 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.406 1.214 . . . . 0.0 110.647 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -71.84 -55.41 7.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.698 -0.626 . . . . 0.0 110.896 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -73.37 59.53 0.59 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.47 -0.769 . . . . 0.0 111.063 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -160.2 25.69 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.369 -0.832 . . . . 0.0 110.295 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 10.2 m-85 -119.76 -168.11 1.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.406 -0.809 . . . . 0.0 110.45 -179.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.772 ' O ' HG12 ' A' ' 4' ' ' VAL . 4.3 mt-10 -160.07 121.57 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.681 -0.637 . . . . 0.0 109.362 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 3' ' ' TRP . 3.2 mtpt -54.98 173.11 0.1 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.375 -0.828 . . . . 0.0 110.841 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tp -86.74 -32.17 20.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.031 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -50.62 113.09 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.618 -0.676 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.643 -179.759 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.269 0.557 . . . . 0.87 110.261 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -114.92 173.39 6.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 2.26 110.098 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.978 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 15.2 m95 -130.83 120.09 23.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.51 109.736 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.035 ' HA ' HD13 ' A' ' 11' ' ' ILE . 13.3 p -100.21 139.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -0.89 . . . . 0.77 110.717 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.799 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -100.26 100.26 11.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.92 109.991 179.726 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -44.39 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.351 -0.843 . . . . 2.07 110.943 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 8' ' ' THR . 4.7 mt -66.96 -40.76 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.025 -1.047 . . . . 2.06 110.474 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.539 HG22 HG22 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -149.23 15.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 2.11 110.52 -179.867 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.696 ' O ' HG12 ' A' ' 11' ' ' ILE . . . 77.65 -3.41 60.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.694 -1.362 . . . . 0.7 109.694 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.909 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 39.9 t80 -39.89 125.39 1.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -1.225 . . . . 2.46 109.615 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.035 HD13 ' HA ' ' A' ' 4' ' ' VAL . 27.9 mm -114.93 145.29 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.78 111.204 -179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.923 ' HB3' ' HB2' ' A' ' 3' ' ' TRP . 27.6 t80 -116.04 109.55 17.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 178.42 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.926 ' OD2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -79.65 82.01 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 2.22 110.35 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' CD ' ' HA ' ' A' ' 28' ' ' LYS . 2.1 tt0 -51.81 -18.62 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.63 -0.669 . . . . 1.14 110.049 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -18.59 65.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.74 109.621 179.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.926 ' HB3' ' OD2' ' A' ' 13' ' ' ASP . . . -127.88 -23.85 3.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.768 . . . . 0.52 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 18' ' ' ASP . . . 101.87 -98.24 1.72 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.43 109.677 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 164.74 97.82 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 121.244 -1.15 . . . . 1.35 110.072 -179.886 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ASP . 41.9 Cg_endo -69.82 -14.93 36.57 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.129 1.594 . . . . 0.84 110.372 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -35.09 37.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 1.6 109.901 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -102.38 24.81 9.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.18 110.081 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.11 58.53 4.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.502 -1.439 . . . . 0.62 109.502 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.848 HG23 HD21 ' A' ' 32' ' ' LEU . 51.6 mm -104.92 166.71 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.82 110.286 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -76.36 157.71 82.41 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.8 110.147 179.993 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.05 110.81 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.56 110.317 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 14' ' ' GLU . . . 78.09 67.39 1.63 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.418 -1.473 . . . . 1.11 109.418 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.561 ' CG2' ' HG ' ' A' ' 32' ' ' LEU . 1.1 m -118.23 114.16 22.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -1.124 . . . . 0.43 110.458 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HA ' ' CD ' ' A' ' 14' ' ' GLU . 6.4 mptt -47.98 117.48 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.268 -0.895 . . . . 1.61 110.303 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 1.021 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 36.4 t80 -46.14 -41.17 12.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.895 . . . . 1.26 110.116 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -68.44 -13.11 62.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 2.14 110.371 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' LEU . 21.8 tt0 -99.52 -26.05 14.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 1.92 110.547 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.848 HD21 HG23 ' A' ' 23' ' ' ILE . 6.4 mt -40.82 160.92 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.179 -0.95 . . . . 0.79 110.087 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' HD2' HD22 ' A' ' 32' ' ' LEU . 51.4 Cg_endo -78.62 -179.14 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.979 1.515 . . . . 1.03 110.18 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -80.26 -31.97 38.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 2.78 109.942 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -7.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 2.76 109.706 179.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.696 ' HH2' ' HE2' ' A' ' 10' ' ' TYR . 23.7 t90 -90.72 135.25 33.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 1.03 110.191 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.348 HG22 ' CB ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER 175.75 104.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.034 . . . . 1.76 110.488 179.825 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.092 ' O ' ' O ' ' A' ' 37' ' ' VAL . . . -9.6 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.614 -0.678 . . . . 1.69 111.156 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.575 ' O ' ' CG1' ' A' ' 40' ' ' ILE . 45.7 Cg_endo -85.71 37.76 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.158 1.609 . . . . 3.28 110.713 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 mt -164.6 169.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.259 -0.9 . . . . 4.59 109.734 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.183 ' O ' ' O ' ' A' ' 42' ' ' GLY . 66.7 p 10.47 122.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.054 . . . . 4.27 110.335 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 1.183 ' O ' ' O ' ' A' ' 41' ' ' THR . . . -7.93 157.72 0.0 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.796 -1.322 . . . . 2.78 109.796 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.348 ' CB ' HG22 ' A' ' 37' ' ' VAL . . . -148.71 52.49 1.19 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.274 -1.133 . . . . 3.0 110.09 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -73.7 148.36 41.55 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.004 1.529 . . . . 1.45 110.97 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 1.203 ' O ' ' N ' ' A' ' 47' ' ' GLU . 16.8 mmtt -41.78 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 2.15 110.046 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.72 32.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 1.53 110.247 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 1.203 ' N ' ' O ' ' A' ' 45' ' ' LYS . 9.7 tp10 -128.45 -9.96 5.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 2.04 110.188 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.909 ' CE2' ' CD2' ' A' ' 10' ' ' TYR . 7.1 m-85 -103.89 -171.89 2.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.84 110.519 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 1.082 ' O ' ' O ' ' A' ' 50' ' ' LYS . 16.0 tt0 -160.18 100.95 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.39 -0.819 . . . . 2.24 109.758 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 1.082 ' O ' ' O ' ' A' ' 49' ' ' GLU . 13.3 mtpt -29.17 -172.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.853 . . . . 1.78 110.366 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.978 ' O ' HD23 ' A' ' 51' ' ' LEU . 6.1 tt -111.09 -14.35 13.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 109.821 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.665 ' O ' ' O ' ' A' ' 51' ' ' LEU . 6.2 pt-20 -37.53 172.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.427 -0.796 . . . . 2.38 110.531 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t0 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 117.998 -1.001 . . . . 3.43 110.23 179.904 . . . . . . . . 0 0 . 1 stop_ save_